<SEC-DOCUMENT>0001010549-13-000329.txt : 20130514
<SEC-HEADER>0001010549-13-000329.hdr.sgml : 20130514
<ACCEPTANCE-DATETIME>20130514163538
ACCESSION NUMBER:		0001010549-13-000329
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		10
CONFORMED PERIOD OF REPORT:	20130331
FILED AS OF DATE:		20130514
DATE AS OF CHANGE:		20130514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHINA PHARMA HOLDINGS, INC.
		CENTRAL INDEX KEY:			0001106644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				731564807
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34471
		FILM NUMBER:		13842049

	BUSINESS ADDRESS:	
		STREET 1:		2ND FLOOR, NO. 17, JINPAN ROAD
		STREET 2:		HAIKOU
		CITY:			HAINAN PROVINCE
		STATE:			F4
		ZIP:			570216
		BUSINESS PHONE:		8689866811730

	MAIL ADDRESS:	
		STREET 1:		2ND FLOOR, NO. 17, JINPAN ROAD
		STREET 2:		HAIKOU
		CITY:			HAINAN PROVINCE
		STATE:			F4
		ZIP:			570216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TS ELECTRONICS INC
		DATE OF NAME CHANGE:	20030818

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SOFTSTONE INC
		DATE OF NAME CHANGE:	20030128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SOFTSTONE INC /DE/
		DATE OF NAME CHANGE:	20010808
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cphi10q033113.htm
<DESCRIPTION>CHINA PHARMA HOLDINGS
<TEXT>
<html>
<head>
    <title>cphi10q033113.htm</title>
    <!--Licensed to: Securities Transfer Corp-->
    <!--Document Created using EDGARizerAgent 5.4.4.0-->
    <!--Copyright 1995 - 2013 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">WASHINGTON, D.C. 20549</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 16pt; FONT-WEIGHT: bold">FORM 10-Q</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Mark One)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">x</font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the quarterly period ended <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">March 31, 2013</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;For the transition period from ____________ to ____________</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Commission File Number 001-34471</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 20pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 20pt; TEXT-DECORATION: underline">CHINA PHARMA HOLDINGS, INC.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Nevada</font></font></div>
</td>
<td valign="top" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">73-1564807</font></font></div>
</td>
</tr><tr>
<td valign="top" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or other jurisdiction of</font></div>
</td>
<td valign="top" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(IRS Employer</font></div>
</td>
</tr><tr>
<td valign="top" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">incorporation or organization)</font></div>
</td>
<td valign="top" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Identification No.)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Second Floor, No. 17, Jinpan Road</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Haikou, Hainan Province, China&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;570216</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Address of principal executive offices)&#160;&#160;(Zip Code)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">+86 898-6681-1730 (China)</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Issuer's telephone number, including area code)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes <font style="DISPLAY: inline;" face="Wingdings">x</font>&#160; No <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes <font style="DISPLAY: inline;" face="Wingdings">x</font>&#160; No <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act. (Check One):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="37%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Large accelerated filer<font style="DISPLAY: inline; FONT-FAMILY: wingdings">&#160;&#160;o</font></font></div>
</td>
<td align="left" valign="top" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accelerated filer<font style="DISPLAY: inline; FONT-FAMILY: wingdings">&#160;&#160;&#160;&#160;&#160;&#160;o</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="37%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-accelerated filer<font style="DISPLAY: inline; FONT-FAMILY: wingdings">&#160;&#160;&#160;o</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Do not check if a smaller reporting company)</font></div>
</td>
<td valign="top" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Smaller reporting company<font style="DISPLAY: inline; FONT-FAMILY: wingdings">&#160;&#160;x</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <font style="DISPLAY: inline;" face="Wingdings">o</font>&#160; No <font style="DISPLAY: inline;" face="Wingdings">x</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">APPLICABLE ONLY TO CORPORATE ISSUERS:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:&#160; 43,579,557 shares of Common Stock, $.001 par value, were outstanding as of May 10, 2013.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TABLE OF CONTENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PART I&#160;&#160;&#160;FINANCIAL INFORMATION</font></div>

<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;Page</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="aliceblue">
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 1.</font></div>
</div>
</td>
<td valign="top" width="79%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Financial Statements</font></div>
</div>
</td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1&#160;</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="aliceblue">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: -36pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Condensed Consolidated Balance Sheets as of March 31, 2013 and December 31, 2012 (Unaudited)</font></div>
</div>
</td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="aliceblue">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: -36pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three Months</font></div>

<div style="TEXT-INDENT: -36pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ended March 31, 2013 and 2012 (Unaudited)</font></div>
</div>
</td>
<td valign="bottom" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="aliceblue">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: -36pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2013 and 2012 (Unaudited)</font></div>
</div>
</td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="aliceblue">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: -36pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Notes to Condensed Consolidated Financial Statements (Unaudited)</font></div>
</div>
</td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="aliceblue">
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 2.</font></div>
</div>
</td>
<td valign="top" width="79%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></div>
</div>
</td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="aliceblue">
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 3.</font></div>
</div>
</td>
<td valign="top" width="79%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Quantitative and Qualitative Disclosures about Market Risk</font></div>
</div>
</td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="aliceblue">
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 4.</font></div>
</div>
</td>
<td valign="top" width="79%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Controls and Procedures</font></div>
</div>
</td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23&#160;</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="aliceblue">
<td colspan="2" valign="top" width="84%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">PART II&#160;&#160;&#160;&#160;OTHER INFORMATION</font></div>
</div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td colspan="2" valign="top" width="84%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="aliceblue">
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 6.</font></div>
</div>
</td>
<td valign="top" width="79%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exhibits</font></div>
</div>
</td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="79%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="aliceblue">
<td colspan="2" valign="top" width="84%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Signatures</font></div>
</div>
</td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24&#160;</font></div>
</div>
</td>
</tr><tr bgcolor="white">
<td colspan="2" valign="top" width="84%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="aliceblue">
<td colspan="2" valign="top" width="84%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exhibits/Certifications</font></div>
</div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PART I - FINANCIAL INFORMATION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying unaudited condensed consolidated balance sheets, statements of operations and comprehensive income, and statements of cash flows and the related notes thereto, have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and in conjunction with the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the disclosures required by U.S. GAAP for complete financial statements. The financial statements reflect all adjustments, consisting only of normal, recurring adjustments, which are, in the opinion of management, necessary for a fair presentation for the interim periods.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying financial statements should be read in conjunction with the notes to the aforementioned financial statements and Management's Discussion and Analysis of Financial Condition and Results of Operations and the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The results of operations for the three-month period ended March 31, 2013 are not necessarily indicative of the results to be expected for the entire fiscal year or any other period.</font></div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHINA PHARMA HOLDINGS, INC.</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ASSETS</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Current Assets:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,750,468</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,029,708</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Banker's acceptances</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,180,864</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101,570</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade accounts receivable, less allowance for doubtful</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">accounts of $4,333,411 and $4,429,945, respectively</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62,697,675</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">66,175,570</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other receivables, less allowance for doubtful</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">accounts of $50,592 and $49,881, respectively</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">255,292</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">80,799</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advances to suppliers</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,119,729</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,816,354</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory, less allowance for obsolescence</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">of $1,779,729 and $1,769,984, respectively</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,260,226</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36,359,516</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax assets</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">954,980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">967,671</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Current Assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">108,219,234</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112,531,188</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Advances for purchases of intangible assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39,462,268</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39,263,977</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Property and equipment</font>, net of accumulated depreciation of</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$4,511,658 and $4,273,373, respectively</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,288,259</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,031,894</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Intangible assets</font>, net of accumulated amortization of</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$3,097,224 and $2,944,726, respectively</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,289,851</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,412,854</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TOTAL ASSETS</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">159,259,612</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">163,239,913</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">LIABILITIES AND STOCKHOLDERS' EQUITY</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Current Liabilities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade accounts payable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,978,636</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,841,862</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">240,003</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">202,185</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued taxes payable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">514,245</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,426,826</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other payables</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,014,647</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,094,886</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advances from customers</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,735,917</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,945,984</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other payables - related parties</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,354,567</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,354,567</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Short-term notes payable</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,787,285</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,761,073</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Current Liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,625,300</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,627,383</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Long-term deferred tax liability</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">110,286</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">95,963</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,735,586</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,723,346</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stockholders' Equity:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Preferred stock, $0.001 par value; 5,000,000 shares authorized;</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">no shares issued or outstanding</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock, $0.001 par value; 95,000,000 shares authorized;</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,579,557 shares and 43,579,557 shares outstanding, respectively</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,580</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,580</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional paid-in capital</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,590,204</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,590,204</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Retained earnings</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">106,092,017</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">108,904,325</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated other comprehensive income</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,798,225</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,978,458</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Stockholders' Equity</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">146,524,026</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">148,516,567</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">159,259,612</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">163,239,913</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<br>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying notes are an integral part of these condensed consolidated financial statements.</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHINA PHARMA HOLDINGS, INC.</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AND COMPREHENSIVE INCOME (LOSS)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Three Months</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ended March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,249,387</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,086,731</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cost of revenue</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,125,400</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,782,384</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory obsolescence</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,692,895</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross profit</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,568,908</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,304,347</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating expenses:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Selling expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">812,054</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">894,060</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">739,427</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">676,402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bad debt expense</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(119,930</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">320,098</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total operating expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,431,551</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,890,560</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Loss) income from operations</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,000,459</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,413,787</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other income (expense):</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest income</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,586</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">690</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest expense</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(82,445</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(77,537</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net other expense</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(80,859</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(76,847</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="aliceblue">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Loss) income before income taxes</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,081,318</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,336,940</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income tax benefit (expense)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">269,011</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(530,581</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net (loss) income</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,812,307</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,806,359</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other comprehensive income - foreign currency</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">translation adjustment</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">819,767</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(407,517</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Comprehensive (loss) income</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,992,540</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,398,842</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Loss) earnings per share:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Diluted</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying notes are an integral part of these condensed consolidated financial statements.</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHINA PHARMA HOLDINGS, INC.</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Three Months</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ended March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash Flows from Operating Activities:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net (loss) income</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,812,307</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,806,359</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation and amortization</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">350,468</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">365,223</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock based compensation</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">56,489</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bad debt expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(119,930</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">320,098</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred income taxes</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,761</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(34,312</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory obsolescence reserve</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,692,895</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes in assets and liabilities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade accounts receivable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">589,186</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,141,146</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other receivables</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(173,763</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(20,247</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advances to suppliers</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(276,405</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">944,949</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,890,843</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,351,458</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade accounts payable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">122,430</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,725,945</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(32,516</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,517</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued taxes payable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,922,780</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">443,684</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other payables</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,715</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54,337</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advances from customers</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(220,418</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">219,942</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Cash Provided by Operating Activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,107,749</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">401,380</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash Flows from Investing Activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net investment in banker's acceptances</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(281,674</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advances for purchases of property and equipment</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">and intangible assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(399,992</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(790,092</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase of property and equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,373</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7,926</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Cash Used in Investing Activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(404,365</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,079,692</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Cash Provided by Financing Activity</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Effect of Exchange Rate Changes on Cash</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,376</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(52,736</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Increase in Cash and Cash Equivalents</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">720,760</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(731,048</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and Cash Equivalents at Beginning of Period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,029,708</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,050,854</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash and Cash Equivalents at End of Period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,750,468</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,319,806</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplemental Cash Flow Information:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash paid for interest</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">111,346</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,567</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash paid for income taxes</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,593,510</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">274,587</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplemental Noncash Investing and Financing Activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable for purchases of property and equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,064</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">144,057</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable collected with banker's acceptances</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,366,655</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">406,604</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory purchased with banker's acceptances</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,289,690</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">406,604</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying notes are an integral part of these condensed consolidated financial statements.</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 1 - BASIS OF PRESENTATION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Organization and Nature of Operations &#8211; </font>China Pharma Holdings, Inc., a Nevada corporation, owns 100% of Onny Investment Limited (&#8220;Onny&#8221;), a British Virgin Islands corporation, that in turn owns 100% of Hainan Helpson Medical &amp; Biotechnology Co., Ltd (&#8220;Helpson&#8221;), a corporation organized under the laws of the People's Republic of China (the &#8220;PRC&#8221;). China Pharma Holdings, Inc. and its subsidiaries are referred to herein as the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 31, 2012, China Pharma Holdings, Inc consummated a reincorporation merger for the purpose of changing the state of incorporation from Delaware to Nevada pursuant to the terms and conditions of an Agreement and Plan of Merger dated December 27, 2012.&#160;&#160;The reincorporation merger was approved by stockholders holding the majority of the outstanding common shares on December 21, 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Foreign Investment Industrial Catalogue<font style="FONT-STYLE: italic; DISPLAY: inline">&#160;</font>(the &#8220;Catalogue&#8221;) jointly issued by the China&#8217;s Ministry of Commerce and the National Development and Reform Commission (as the latest version is the year 2012 version, effective January 30, 2012) classified various industries/businesses into three different categories: (i) encouraged for foreign investment; (ii) restricted to foreign investment; and (iii) prohibited from foreign investment. For any industry/business not covered by any of these three categories, they will be deemed industries/businesses permitted for foreign investment. A typical foreign investment ownership restriction in the pharmaceutical industry is that a foreign investment enterprise (the &#8220;FIE&#8221;) shall not have the whole or majority of its equity interests owned by a foreign owner if the FIE establishes more than 30 branch stores and distributes a variety of brands in those franchise stores, which is not the case of the Company&#8217;s business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Helpson manufactures and markets generic and branded pharmaceutical products as well as biochemical products primarily to hospitals and private retailers located throughout the PRC. The Company believes Helpson&#8217;s business is not subject to any ownership restrictions prescribed under the Catalogue. Onny acquired 100% of the ownership in Helpson from Helpson&#8217;s three former shareholders on May 25, 2005 by entry into an Equity Transfer Agreement with such three parties on May 25, 2005. The transaction was approved by the Commercial Bureau of Hainan Province on June 12, 2005 and Helpson received the Certificate of Approval for Establishing of Enterprises with Foreign Investment in the PRC on the same day and its business license evidencing its WFOE (Wholly Foreign Owned Enterprise) status on June 21, 2005.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has and continues to acquire well-accepted medical formulas to a diverse portfolio of Western and Chinese medicines.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Consolidation and Basis of Presentation </font>&#8211; The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and are expressed in United States dollars. The accompanying consolidated financial statements include the accounts and operations of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Helpson&#8217;s functional currency is the Chinese Renminbi. Helpson&#8217;s revenue and expenses are translated into United States dollars at the average exchange rate for the period. Assets and liabilities are translated at the exchange rate as of the end of the reporting period. Gains or losses from translating Helpson&#8217;s financial statements are included in accumulated other comprehensive income, which is a component of stockholders&#8217; equity. Gains and losses arising from transactions denominated in a currency other than the functional currency of the entity that is a party to the transaction are included in the results of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Condensed Financial Statements </font>&#8211; The accompanying unaudited condensed consolidated financial statements were prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission (the &#8220;Commission&#8221;). Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Management of the Company (&#8220;Management&#8221;) believes the following disclosures are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2012 filed with the Commission on March 14, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">These unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) that, in the opinion of Management, are necessary to present fairly the consolidated financial position and results of operations of the Company for the periods presented. Operating results for the three months ended March 31, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Accounting Estimates </font><font style="DISPLAY: inline; FONT-WEIGHT: bold">- </font>The preparation of financial statements in conformity with&#160;U.S. GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Basic and Diluted Earnings per Common Share </font><font style="DISPLAY: inline; FONT-WEIGHT: bold">- </font>Basic earnings per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is calculated to give effect to potentially issuable dilutive common shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table is a presentation of the numerators and denominators used in the calculation of basic and diluted earnings per share:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Three Months</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ended March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net (loss) income</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,812,307</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,806,359</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic weighted-average common shares outstanding</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,579,557</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,529,557</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Effect of dilutive securities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Diluted weighted-average common shares outstanding</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,579,557</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,529,557</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic (loss) earnings per share</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Diluted (loss) earnings per share</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following potential common shares were not included in the computation of diluted earnings per share as their effect would have been anti-dilutive:&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Three Months</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ended March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants with exercise prices of $3.00 to $3.80 per share</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">150,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">150,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options with an exercise price of $2.54 to $3.47 per share</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">310,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">175,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">460,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2 &#8211; PRODUCT RECALL</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In March 2013, the China Food and Drug Administration (&#8220;CFDA&#8221;) issued a nationwide notice (the &#8220;CFDA Notice&#8221;) for the cessation of the production, sale and use of Buflomedil effective immediately. The CFDA Notice was a result of the reevaluation done by the CFDA based on the indications from the recent China and international research materials, which found the side effect risks of Buflomedil to nerve system and cardiovascular system have surpassed its clinical treatment effect.&#160;&#160;The CFDA Notice was applicable to all the manufacturers and distributers in China who are in the business of the production and sale of Buflomedil-related products.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the CFDA Notice, the Company ceased the production and sale of Buflomedil-based products and ceased all promotional and marketing activities for Buflomedil-based products.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Furthermore, the Company recognized an inventory obsolescence expense in the amount of $3,692,895 to write off Buflomedil-related raw materials and finished goods inventory. This was recorded as inventory obsolescence on the accompanying statement of operations for the three months ended March 31, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, the Company recalled Buflomedil-based products from the market. It authorized the return of its previously sold Buflomedil-related products through April 30, 2013. The loss from the refunds to customers was $21,507 and recognized that estimated loss as a reduction of revenues for the three months ended March 31, 2013. Under CFDA regulatory provisions, the CFDA notice does not impose legal liability to the manufacturers of Buflomedil as long as they act pursuant to the CFDA Notice to cease the production, sale and use of Buflomedil and destroy such finished goods immediately.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the CFDA Notice, the CFDA revoked the production licenses for Buflomedil based products. The carrying value of the Company&#8217;s Buflomedil related intangible assets is zero; therefore, no impairment of the Company&#8217;s intangible assets was necessary.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 3 - INVENTORY</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Inventory consisted of the following:&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Raw materials</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,380,903</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,198,816</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Finished goods</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,659,052</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,930,684</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35,039,955</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">38,129,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Obsolescence reserve</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,779,729</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,769,984</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Inventory</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,260,226</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36,359,516</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 4 - PROPERTY AND EQUIPMENT</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property and equipment consisted of the following:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div align="left">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Permit of land use</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">449,474</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">447,013</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Building</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,432,442</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,419,125</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Plant, machinery and equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,418,768</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,381,209</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Motor vehicle</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">147,890</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">147,080</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Office equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">223,947</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">222,273</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Construction in progress</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,127,396</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,688,567</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,799,917</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,305,267</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less: accumulated depreciation</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,511,658</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,273,373</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Property and Equipment, net</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,288,259</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,031,894</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<br>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Construction in progress consists of machinery and construction supplies that have been paid for, but are not yet completed and placed into production.&#160;&#160;Once the machinery is working or the facility is in use, it is moved into plant, machinery and equipment and depreciated.&#160;&#160;Depreciation is computed on a straight-line basis over the estimated useful lives of the assets as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div align="center">
<table cellpadding="0" cellspacing="0" width="50%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asset</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;Life - years</font></div>
</td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Permit of land use</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40 - 70</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Building</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20 - 35</font></div>
</td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Plant, machinery and equipment</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Motor vehicle</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5 - 10</font></div>
</td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Office equipment</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3-5</font></div>
</td>
</tr></table>
</div>

<br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the three months ended March 31, 2013 and 2012, depreciation expense was $214,406 and $212,424, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 5 - INTANGIBLE ASSETS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Intangible assets represent the cost of medical formulas approved for production by the CFDA in China. During the three months ended March 31, 2013 or 2012, the Company did not obtain CFDA production approval for any medical formula and therefore there were no costs reclassified from advances to medical formulas.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Approved medical formulas are amortized from the date CFDA approval is obtained over their individually identifiable estimated useful life, which are from ten to thirteen years.&#160;&#160;It is at least reasonably possible that a change in the estimated useful lives of the medical formulas could occur in the near term due to changes in the demand for the drugs and medicines produced from these medical formulas. Amortization expense relating to intangible assets was $136,062 and $152,799 for the three months ended March 31, 2013 and 2012, respectively. Medical formulas typically do not have a residual value at the end of their amortization period.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company evaluates each approved medical formula for impairment at the date of CFDA approval, when indications of impairment are present and at the date of each financial statement. The Company&#8217;s evaluation is based on an estimated undiscounted net cash flow model, considering currently available market data for the related drug and the Company&#8217;s estimated market share. If the carrying value of the medical formula exceeds the estimated future net cash flows, an impairment loss is recognized for the excess of the carrying value over the discounted estimated future net cash flows. As a result of the evaluation, the Company has determined that each medical formula continues to provide benefits to the Company and no impairment was recognized during the three months ended March 31, 2013 or 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At March 31, 2013 and December 31, 2012, intangible assets consisted solely of CFDA approved medical formulas as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div align="center">
<div align="center">
<table cellpadding="0" cellspacing="0" width="60%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">March 31,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="16%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross carrying amount</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="15%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,387,075</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="15%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,357,580</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated amortization</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,097,224</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,944,726</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net carrying amount</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="15%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,289,851</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="15%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,412,854</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<br>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 6 &#8211; ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In order to expand the number of medicines manufactured and marketed by the Company, the Company has entered into contracts with independent laboratories for the purchase of medical formulas. Although CFDA approval has not been obtained for these medical formulas as of the dates of the contracts, the object of the contracts is for the purchase of CFDA-approved medical formulas once the CFDA approval process is completed. Some of the medical formulas currently in the CFDA approval process also come with patents. The Company has received the title for two patents. The related patents have not expired.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Prior to entering into the contracts, the laboratories typically have completed all required research and development to determine the medical formula for and the method of production of the generic medicine.&#160;&#160;Since the laboratories are not eligible to apply for CFDA production approval, they usually collaborate with a production facility (such as the Company) and apply for the production approval in the name of the manufacturer. The Company buys the final products with the production approval from the CFDA and the laboratories have to complete the CFDA approval process from the point of the contract.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A typical CFDA approval process for the production of a generic medical product involves a number of steps that generally requires three to five years. If the medical formula is purchased at the point when the generic medical product receives the CFDA&#8217;s approval for clinical study, which is very typical for the Company, the clinical study that follows will usually take from one and a half to three years to complete. After the clinical study is completed, the results are submitted to the CFDA and a production approval application is filed with the CFDA. In most cases, it will take between eight to eighteen months to prepare and submit the production approval application and obtain CFDA approval. Upon approving the generic medical product, the CFDA issues a production certificate and the Company can produce and sell the generic medical product. As a result of this process, CFDA approval is expected to be received in approximately two to five years from the dates of the medical formula contracts.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the terms of the contracts, the laboratories are required to obtain production approval (on behalf of the Company) for the medical formulas from the CFDA. Management monitors the status of each medical formula on a regular basis in order to assess whether the laboratories are performing adequately under the contracts. If a medical product is not approved by the CFDA, as evidenced by their issuance of a denial letter, or if the laboratory breaches the contract, the laboratory is required under the contract to provide a refund to the Company of the full amount of the payments made to the laboratory for that formula, or the Company can require the application of those payments to another medical formula with the same laboratory. As a result of the refund right, the Company is purchasing an approved medical product. Accordingly, payments made prior to the issuance of production approval by the CFDA are recorded as advances for purchases of intangible assets.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To date, no formula has failed to receive CFDA production approval nor has the Company been informed or become aware of any formula that may fail to receive such approval. However, there is no assurance that the medical products will receive production approval and if the Company does not receive such approval, it will enforce its contractual rights to receive the refund from the laboratory or have the payments applied to another medical formula with the same laboratory.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At March 31, 2013, the Company was obligated to pay laboratories and others approximately $6,519,000 upon completion of the various phases of contracts to provide CFDA production approval of medical formulas.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 7 &#8211; RELATED PARTY TRANSACTIONS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Total advances owing to a board member were $1,354,567 and $1,354,567 as of March 31, 2013 and December 31, 2012, respectively, and are recorded as other payables &#8211; related parties on the accompanying condensed consolidated balance sheets.<font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font>The advances bear interest at a rate of 1.0% per year.&#160;&#160;Total interest expense of $3,386 and $1,970 was recognized for the three months ended March 31, 2013 and 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 8 &#8211; NOTES PAYABLE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On October 30, 2012, the Company entered into a new revolving line of credit with another bank in the amount of RMB 30,000,000.&#160;The related note payable bears interest at an annual rate of 6.90% (based upon 115% of the PRC government&#8217;s current short term rate of 6.00%). Advances on the line of credit are due one year from the date of the advance and are collateralized by certain land use rights, buildings and accounts receivable. The outstanding balance due under the revolving line of credit was RMB 30,000,000 ($4,787,285) as of March 31, 2013.&#160;&#160;The Company has no additional amounts available to it under the line of credit.&#160;&#160;This amount has been classified as short-term notes payable in the accompanying consolidated balance sheet at December 31, 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Fair Value of</font> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Notes Payable</font> &#8211; Based on the borrowing rates currently available to the Company for bank loans with similar terms and maturities, the carrying amounts of notes payable outstanding as of March 31, 2013 and December 31, 2012 approximated their fair value because of either the immediate or short-term maturity of these financial instruments or because the underlying instruments bear interest rates that approximated current market rates.&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 9 - INCOME TAXES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax laws or rates is recognized in income in the period that includes the enactment date.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Undistributed earnings of Helpson, the Company&#8217;s foreign subsidiary, since its acquisition, amounted to approximately $110.5 million at March 31, 2013. Those earnings, as well as the investment in Helpson of approximately $23.3 million, are considered to be indefinitely reinvested and, accordingly, no U.S. federal or state income taxes have been provided thereon. Upon distribution of those earnings in the form of dividends or otherwise, the Company would be subject to U.S. federal and state income taxes (net of an adjustment for foreign tax credits) and withholding taxes payable to the PRC. Determination of the amount of unrecognized deferred U.S. income tax liability is not practicable because of the complexities associated with its hypothetical calculation; however, unrecognized foreign tax credits may be available to reduce a portion of the U.S. tax liability.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under current tax law in the PRC, the Company is and will be subject to the following enterprise income tax rates:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div align="center">
<table cellpadding="0" cellspacing="0" width="50%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Enterprise Income </font></div>
</td>
</tr><tr>
<td valign="top" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="15%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Tax Rate</font></font></td>
</tr><tr bgcolor="aliceblue">
<td valign="top" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="13%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014 and after</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25%</font></div>
</td>
</tr></table>
</div>

<br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The provision for income taxes consisted of the following:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Three months ended March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">564,893</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(269,011</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(34,312</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total income tax (benefit) expense</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(269,011</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">530,581</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has available to it net operating losses for PRC tax purposes of $482,668. The Company also provided a valuation allowance in this same amount against the operating losses during the current quarter related to the net operating loss carryforward since they did not meet the more likely than not criteria for recognition of the loss carryforward in the current period.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has also incurred various other taxes, comprised primarily of business taxes, value-added taxes, urban construction taxes, education surcharges and others. Any unpaid amounts are reflected on the balance sheets as accrued taxes payable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 10 &#8211; FAIR VALUE MEASUREMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. To measure fair value, a hierarchy has been established which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs. This hierarchy uses three levels of inputs to measure the fair value of assets and liabilities as follows: Level 1 &#8211; Quoted prices in active markets for identical assets or liabilities. Level 2 &#8211; Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. Level 3 &#8211; Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company uses fair value to measure the value of the banker&#8217;s acceptance notes it holds.&#160;&#160;The banker&#8217;s acceptance notes are recorded at cost which approximates fair value.&#160;&#160;The Company held the following assets recorded at fair value as of March 31, 2013 and December 31, 2012:&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></div>
</div>

<br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="49%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair Value Measurements at</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="49%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" width="34%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Reporting Date Using</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="49%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Description</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">March 31, 2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Level 1</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Level 2</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Level 3</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="49%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Banker's acceptance notes</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,180,864</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,180,864</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="49%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,180,864</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,180,864</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="49%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="49%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="49%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair Value Measurements at</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="49%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" width="34%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Reporting Date Using</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="49%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Description</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31, 2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Level 1</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Level 2</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Level 3</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="49%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Banker's acceptance notes</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101,570</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101,570</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="49%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101,570</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101,570</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 11 - STOCKHOLDERS' EQUITY</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Preferred and Common Stock</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The total number of authorized shares is 95,000,000 shares of common stock and 5,000,000 shares of preferred stock. The preferred stock may be issued in series with such designations, preferences, stated values, rights, qualifications or limitations as determined solely by the Company&#8217;s board of directors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrants</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of March 31, 2013, the Company had warrants outstanding and exercisable to purchase an aggregate of 150,000 shares of the Company's common stock at exercise prices ranging from $3.00 to $3.80 per share, which expire May 16, 2013. At March 31, 2013, the warrants had a weighted-average exercise price of $3.40 per share, a weighted-average remaining contractual life of 0.2 years and a total intrinsic value of $0.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock and Stock Options</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2010 Incentive Plan</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 12, 2010, the Company&#8217;s Board of Directors adopted, and on December 22, 2010 its stockholders approved, the 2010 Long-Term Incentive Plan&#160;&#160;(the &#8220;2010 Incentive Plan&#8221;), which gave the Company the ability to grant stock options, restricted stock, stock appreciation rights and performance units to its employees, directors and consultants, or those who will become employees, directors and consultants of the Company and/or its subsidiaries. The 2010 Incentive Plan currently allows for equity awards of up to 4,000,000 shares of common stock. Through March 31, 2013, 75,000 shares of common stock and options to purchase an aggregate of 25,000 shares of stock options had been granted under the 2010 Incentive Plan.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There were no securities issued from the 2010 Incentive Plan during the three months ended March 31, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At March 31, 2013, there was no remaining unrecognized compensation expense related to stock options or restrictive stock grants.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 12 &#8211; CONTINGENCIES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Economic environment </font><font style="DISPLAY: inline; FONT-WEIGHT: bold">- </font>Substantially all of the Company's operations are conducted in the PRC, and therefore the Company is subject to special considerations and significant risks not typically associated with companies operating in the United States of America. These risks include, among others, the political, economic and legal environments and fluctuations in the foreign currency exchange rate. The Company's results from operations may be adversely affected by changes in the political and social conditions in the PRC, and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things. The unfavorable changes in global macroeconomic factors may also adversely affect the Company&#8217;s operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, all of the Company's revenue is denominated in the PRC's currency of Renminbi (RMB), which must be converted into other currencies before remittance out of the PRC. Both the conversion of RMB into foreign currencies and the remittance of foreign currencies abroad require approval of the PRC government.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 13 &#8211; CONCENTRATIONS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At March 31, 2013, one customer accounted for 10.5% of accounts receivable.&#160;&#160;At December 31, 2012, no customer accounted for more than 10.0% of accounts receivable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the three months ended March 31, 2013, no customer accounted for more than 10% of sales. For the three months ended March 31, 2012, one customer accounted for 10.3% of sales.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the three months ended March 31, 2013, purchases from one supplier accounted for 34.0% of raw material purchases. For the three months ended March 31, 2012, purchases from one supplier accounted for 14.1% of raw material purchases.&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 2.&#160;&#160;&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The statements contained in this report with respect to our financial condition, results of operations and business that are not historical facts are forward-looking statements. Forward-looking statements can be identified by the use of forward-looking terminology, such as "anticipate", "believe", "expect", "plan", "intend", "seek", "estimate", "project", "could", "may" or the negative thereof or other variations thereon, or by discussions of strategy that involve risks and uncertainties. Management wishes to caution the reader of the forward-looking statements that any such statements that are contained in this report reflect our current beliefs with respect to future events and involve known and unknown risks, uncertainties and other factors, including, but not limited to, economic, competitive, regulatory, technological, key employees, and general business factors affecting our operations, markets, growth, services, products, licenses and other factors, some of which are described in this report and some of which are discussed in our other filings with the Securities and Exchange Commission. These forward-looking statements are only estimates or predictions. No assurances can be given regarding the achievement of future results, as actual results may differ materially as a result of risks facing our company, and actual events may differ from the assumptions underlying the statements that have been made regarding anticipated events.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">These risk factors should be considered in connection with any subsequent written or oral forward-looking statements that we or persons acting on our behalf may issue. All written and oral forward looking statements made in connection with this report that are attributable to our company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Given these uncertainties, we caution investors not to unduly rely on our forward-looking statements. We do not undertake any obligation to review or confirm analysts&#8217; expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date of this report or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Business Overview &amp; Recent Developments</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures, and markets pharmaceutical products for human use for a wide range of high incidence and high mortality conditions in China, including cardiovascular, central nervous system (&#8220;CNS&#8221;), infectious and digestive diseases. The Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is currently organized under the laws of the State of Nevada in the United States. Hainan Helpson Medical &amp; Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly-owned subsidiary of China Pharma Holdings, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The economic and pharmaceutical challenges and uncertainties had negatively impacted our business in 2012, which led to the overall decline in sales of our products. Additionally, in March 2013, the China Food and Drug Administration (&#8220;CFDA&#8221;) issued a nationwide notice (the &#8220;CFDA Notice&#8221;) for the cessation of the production, sale and use of Buflomedil effective immediately. The CFDA Notice was a result of the reevaluation done by the CFDA based on the indications from the recent China and international research materials, which found the side effect risks of Buflomedil to nerve system and cardiovascular system have surpassed its clinical treatment effect.&#160;&#160;It was applicable to all the manufacturers and distributors in China who are in the business of the production and sale of Buflomedil-related products. Pursuant to the CFDA Notice, the Company ceased the production and sale of Buflomedil-based products and recalled its Buflomedil-based products from the market.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During our course of business, we must comply with a variety of product safety and product testing regulations. In particular, our products are subject to, among other statutes and regulations, those issued by the CFDA. If the CFDA issues any updates to cease the production, sale and use of any of our products, we should comply with.&#160;&#160;As a result, we may incur significant costs in complying with cessation requirements, and our financial results could be materially adversely affected. Furthermore, concerns about potential liability or potential future changes in product safety regulations may lead us to voluntarily recall or otherwise discontinue selling selected products, which could materially and adversely affect our results of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Recalls could also harm our reputation, increase our costs or reduce our net sales. Governments and regulatory agencies in the markets where we manufacture and sell products may enact additional regulations relating to product safety and consumer protection in the future or take other actions.&#160;&#160;The CFDA has the authority to revoke drug approvals previously granted and remove from the market previously approved products for various reasons. We may be subject from time to time to product recalls initiated by us or by the CFDA. Delays in obtaining regulatory approvals, the revocation of prior approvals, or product recalls could impose significant costs on us and adversely affect our ability to generate revenue.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The CFDA promulgated <font style="FONT-STYLE: italic; DISPLAY: inline">Good Manufacturing Practices for Pharmaceutical Products</font> (2010 revised version) (the &#8220;new GMP&#8221;) on February 12, 2011, which became effective on March 1, 2011.&#160;&#160;The new GMP standards outline the basic principles and standards for the manufacturing of pharmaceutical products and the management of quality controls in the manufacturing process in the PRC. Pursuant to those mandatory requirements, the upgrading of our two injectable product lines must be accomplished by the end of 2013. We have completed the planning, design and an environment contamination evaluation, and worked in full swing of the construction relative to certain required facilities and equipment. We continue to evaluate and implement the additional requirements of the standards.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The products in our pipe-line progressed slowly but steadily along the development process, and are getting closer to product launch. The CFDA is also revising its production approval criteria and processes, resulting in longer approval time for new production applications across all types of products. In some cases they are adding additional requirements for products already under review.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -25.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following is a list of the current status of some of our pipeline products:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Wingdings">&#376;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cadesartan. We received production approval from the CFDA for Candesartan, a front-line drug therapy we developed for the treatment of hypertension in November 2012. We plan to launch this product during 2013.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Wingdings">&#376;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Antibiotic Combination. We completed the Phase I clinical trials of our novel cephalosporin-based combination antibiotic in the third quarter of 2010. We are currently in Phase II of the clinical trial which is progressing well.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Wingdings">&#376;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Rosuvastatin. Rosuvastatin is a generic form of Crestor, a drug for indication of high blood cholesterol level. Clinical trials for this generic drug were completed in the fourth quarter of 2010 and we have submitted an application for production approval.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">14</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Wingdings">&#376;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Heart Disease Drug. We are developing a liquid oral medicine for the treatment of coronary heart disease. This product comes with a patented Traditional Chinese Medicine (TCM) formula and we are currently conducting Phase III clinical trials for this drug. Due to the improved regulatory requests for clinical works, we adjusted our anticipated completion time frame for the clinical trials work for this product to 2013.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Market Trends</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Chinese pharmaceutical industry has been a key contributor to the PRC&#8217;s economic growth. According to the research report <font style="FONT-STYLE: italic; DISPLAY: inline">China Pharma Sector</font> issued by CITI on January 13, 2013, they estimated that the Chinese prescription market reached a size of approximately RMB548billion (approximately 88 billion USD) in 2012 and forecast that the pharma market could grow approximately 17% in 2013. We believe the growth of Chinese pharmaceutical industry.&#160;&#160;According to the CFDA information center, the Chinese pharmaceutical market size has grown from RMB157.2 billion in 2000 to RMB619.4 billion in 2009. Furthermore, according to a report from IMS Health, a leading consulting firm focusing on healthcare and pharmaceutical areas, <font style="FONT-STYLE: italic; DISPLAY: inline">Asian, Australian and Chinese Pharmaceutical Market 2010-2014 Forecast</font> released on September 2010, the pharmaceutical market in China was expected to grow by a CAGR of 23.2%, and to reach US$90 billion in 2014. According to the report, this projected growth is supported by the strong growth in the Chinese economy, the aging population, increasing rate of chronic disease in the PRC, the recent health care reform, and improvements in intellectual property right protection in the PRC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.1pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Healthcare Reform program announced by the Chinese government in late 2009 is having a significant impact on all healthcare related industries in China, including the pharmaceutical industry. Over all, the government plans to provide a basic, universal healthcare system to all citizens of China. We believe volume expansion will continue as government subsidies to rural communities expand further. While pricing is generally set at the central government level, provincial government intervention has added complexity to the pricing-volume interaction. In addition to EDL products, we have also seen pricing pressure on most of the drugs we sell. While these changes have more impact on pharmaceutical distribution companies, manufacturers of pharmaceutical products are also affected. We believe the general implication is that gross margins for pharmaceutical products will continue to be under pressure for some time. That being said, a pharmaceutical manufacturer with experienced management and the ability to react quickly to changes will not only survive but thrive in this environment.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Results of Operations for the Fiscal Year Ended March 31, 2013</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -25.6pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Revenu</font>e</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>For the three months ended March 31, 2013, our sales revenue was $8.2 million, a decrease of 49%, compared to $16.1 million in the previous year period.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>Set forth below are our revenues by product category in millions USD for the three months ended March 31, 2013 and 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">15</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td rowspan="2" valign="middle" width="32%" style="BORDER-BOTTOM: black 4px double; BORDER-LEFT: black 1.5pt solid; BORDER-TOP: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product Category</font></div>
</td>
<td colspan="2" valign="bottom" width="39%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 1.5pt solid; BORDER-TOP: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three Months Ended March 31</font></div>
</td>
<td rowspan="2" valign="middle" width="17%" style="BORDER-BOTTOM: black 4px double; BORDER-LEFT: black 1.5pt solid; BORDER-TOP: black 1.5pt solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net Change</font></div>
</td>
<td rowspan="2" valign="middle" width="12%" style="BORDER-BOTTOM: black 4px double; BORDER-TOP: black 1.5pt solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">% Change</font></div>
</td>
</tr><tr>
<td valign="bottom" width="21%" style="BORDER-BOTTOM: black 4px double; BORDER-LEFT: black 1.5pt solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font></div>
</td>
<td valign="bottom" width="18%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
</tr><tr bgcolor="aliceblue">
<td valign="bottom" width="32%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CNS Cerebral &amp; Cardio Vascular</font></div>
</td>
<td valign="bottom" width="21%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 1.5pt solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$2.1</font></div>
</td>
<td valign="bottom" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$4.8</font></div>
</td>
<td valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 1.5pt solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">($2.7)</font></div>
</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-56%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="32%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Anti-Viro/ Infection &amp; Respiratory</font></div>
</td>
<td valign="bottom" width="21%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 1.5pt solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$4.6</font></div>
</td>
<td valign="bottom" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$6.8</font></div>
</td>
<td valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 1.5pt solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">($2.2)</font></div>
</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-32%</font></div>
</td>
</tr><tr bgcolor="aliceblue">
<td valign="bottom" width="32%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Digestive Diseases</font></div>
</td>
<td valign="bottom" width="21%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 1.5pt solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.8</font></div>
</td>
<td valign="bottom" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$2.5</font></div>
</td>
<td valign="bottom" width="17%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 1.5pt solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">($1.7)</font></div>
</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-67%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="32%" style="BORDER-BOTTOM: black 1.5pt solid; BORDER-LEFT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other</font></div>
</td>
<td valign="bottom" width="21%" style="BORDER-BOTTOM: black 1.5pt solid; BORDER-LEFT: black 1.5pt solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.7</font></div>
</td>
<td valign="bottom" width="18%" style="BORDER-BOTTOM: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$2.0</font></div>
</td>
<td valign="bottom" width="17%" style="BORDER-BOTTOM: black 1.5pt solid; BORDER-LEFT: black 1.5pt solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">($1.3)</font></div>
</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.5pt solid; BORDER-RIGHT: black 1.5pt solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-66%</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>Given the capital expenditure pressure from 2013 new GMP upgrade project, we have to control credit expansion in the market, this tightening marketing strategy has negatively impacted our revenue. Sales decreased throughout our major product categories. The most significant revenue decrease in terms of dollar amount was in our &#8220;CNS Cerebral &amp; Cardio Vascular&#8221; product category, which generated $2.1 million in sales revenue in the three months ended March 31, 2013 compared to $4.8 million a year ago, a decrease of $2.7 million. This decrease was mainly due to sales of Bufomedil, because the CFDA issued a nationwide notice for the cessation of the production, sale and use of Buflomedil effective immediately. The Company ceased the production and sale of this product and voluntarily recalled limited quantities of our sold products from the market as a customer service measure. No further recall is mandated by the CFDA notice. Sales of the &#8220;Anti-Viro/Infection &amp; Respiratory&#8221; category decreased by $2.2 million to $4.6 million in the three months ended March 31, 2013 compared to $6.8 million in the previous year period. Our &#8220;Digestive Diseases&#8221; category generated $0.8 million of sales in the three months ended March 31, 2013, compared to $2.5 million in the previous year period, or a decrease of $1.7 million.&#160;&#160;Our &#8220;Other&#8221; product category sales fell to $0.7 million from $2.0 million, a decrease of $1.3 million.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>In the three months ended March 31, 2013, revenue breakdown by product category showed some changes mainly due to the CFDA notice. Sales of the &#8220;CNS, Cerebral &amp; Cardio Vascular&#8221; category represented 14% and 24% of total sales in the three months ended March 31, 2013 and 2012 respectively. Sales of the &#8220;Anti-Viro &amp; Respiratory&#8221; products category represented 32% and 34% of total sales in the three months ended March 31, 2013 and 2012. The &#8220;Digestive Diseases&#8221; category represented 4% and 11% of total revenue in the three months ended March 31, 2013 and 2012 respectively.&#160;&#160;The &#8220;Other&#8221; category represented 6% and 11% of total revenue in the three months ended March 31, 2013 and 2012 respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cost of Revenue</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>For the three months ended March 31, 2013, our cost of revenue was $6.1 million, or 74.3% of total revenue, which represented a decrease of $4.7 million from $10.8 million, or 67% of total revenue, in the three months ended March 31, 2012, a decrease of 43.2%.&#160;&#160;The decrease in cost of revenue during the first quarter of 2013 was not proportional to the revenue decrease, primarily due to increases in our average unit costs for inventory and the continuously rising cost of our raw materials and other fixed cost.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inventory Obsolescence</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In March 2013, as a result of the CFDA Notice, the Company recognized an inventory obsolescence expense in the amount of $3,692,895 to write off all of our Buflomedil-related raw materials and finished goods inventory. This was recorded as inventory obsolescence on the accompanying statement of operations for the three months ended March 31, 2013, which represented 11.1% of total inventory as of March 31, 2013. There was no comparable expense for the three months ended March 31, 2012.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">16</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gross Profit and Gross Margin</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -8.9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>Gross loss for the three months ended March 31, 2013 was $1.6 million, while gross profit for the three months ended March 31, 2012 was $5.3 million. Our gross profit margin in the first quarter of 2013 was (19%), compared to 33% in the first quarter of 2012. Without the effect of inventory obsolescence in the first quarter of 2013, management estimates that our gross profit would have been approximately $2.1 million, and gross margin would have been 26%in the first quarter of 2013. The Healthcare Reform instituted by the Chinese government since 2009 has resulted in margin compression in most pharmaceutical products on the markets today, especially in the generic space that many of our products are in. The decrease of sales and continued increases of the purchase price of raw materials attributed to the decrease of gross profit. Going forward, we expect to see continued pricing pressure on most products, but new products such as Candesartan and Rosuvastatin could help to support overall gross margin once they are launched.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -8.9pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Selling Expenses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -8.9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>Our selling expenses for the three months ended March 31, 2013 were $0.81 million, a decrease of approximately $0.08 million, compared to $0.89 million in the same period last year. Selling expenses accounted for 9.8% of the total revenue in the three months ended March 31, 2013 compared to 5.6% in the three months ended March 31, 2012.&#160;&#160;Due to many adjustments in our selling processes from healthcare reform policies, despite the decrease in sales, we still needed to maintain necessary personnel and expenses to support the sales and collection of accounts receivable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">General and Administrative Expenses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>Our general and administrative expenses for the three months ended March 31, 2013 were $0.74 million, an increase of $0.06 million from $0.68 million for the same period of 2012. General and administrative expenses accounted for 7.5% and 4.2% of our total revenues for the three months ended March 31, 2013 and 2012, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Bad Debt Expense (Benefit)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>In general, our normal credit or payment terms extended to customers are 90 days. This has not changed in recent years. Due to the peculiarity of the Chinese pharmaceutical market environment, deferred payments to pharmaceutical companies by state-owned hospitals and local medicine distributors are a normal phenomenon. Our customers are primarily pharmaceutical distributors who sell to mostly government-backed hospitals. Therefore the age of our receivables from our customers tends to be long. Although these customers typically pay after the due date of the receivables, since the majority of hospitals in China are backed by the government, management believes that the deferred payments from state-owned hospitals are secure and will eventually be collected. So far, we have always been able to collect our receivables and have not written-off any receivables in our 19-year history of doing business with hospitals.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The amount of accounts receivable that were past due (or the amount of accounts receivable that were more than 90 days old) was $52.8 million and $62.1 million as of March 31, 2013 and December 31, 2012, respectively. The following table illustrates our accounts receivable aging distribution in terms of percentage of total accounts receivable as of March 31, 2013 and December 31, 2012:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">17</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block">
<table cellpadding="0" cellspacing="0" width="60%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="66%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 31,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="66%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1 - 90 Days</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15.8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12.1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90 - 180 Days</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12.8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">180 - 360 Days</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27.6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32.4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="66%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">360 - 720 Days</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45.6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42.7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="66%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">100</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">100</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr></table>

<br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Although we have not had to write off any receivables thus far in our history, we do set aside an allowance for doubtful accounts. Our bad debt allowance estimate is currently the sum of 3.5% of accounts receivable that are less than 365 days old, 10% of accounts receivable that are between 365 days and 720 days old and 100% of accounts receivable that are greater than 720 days old (although there were no accounts receivable over 720 days old at March 31, 2013 or December 31, 2012).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To the extent that our current allowance for doubtful accounts is lower than that of the previous period, we recognize a bad debt benefit for the difference during the current period, and when the current allowance is higher than that of the previous period, we recognize a bad debt expense for the difference. The allowance for doubtful accounts was $4.33 million and $4.43 million as of March 31, 2013 and December 31, 2012, respectively. The decrease in the allowance was mainly due to the decrease in our accounts receivable balance during the quarter ended March 31, 2013. The changes in the allowance for doubtful accounts during the three months ended March 31, 2013 and 2012 were as follows (there were no write-offs or recoveries):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="60%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="66%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="7" valign="bottom" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">For the Three Months Ended</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="66%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="7" valign="bottom" width="33%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 31,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="66%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="3" valign="bottom" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td valign="bottom" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, Beginning of Period</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,429,945</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,536,405</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bad debt expense (benefit)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(119,930</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">320,098</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td align="left" valign="bottom" width="66%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation adjustment</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,396</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,966</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="66%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, End of Period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,333,411</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,876,469</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Impairment of intangible assets</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The carrying values of long-lived assets are reviewed for impairment annually or whenever events or changes in circumstances indicate that the carrying values may not be recoverable. No impairment losses were recognized during the three month ended March 31, 2013 or 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income (Loss) from Operations</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>Our operating loss for the three months ended March 31, 2013 was $3.0 million, compared to operating income of $3.4 million in the three months ended March 31, 2012, a decrease of $6.4million. The main reasons for the decrease were lower revenue, and the inventory obsolescence reserve recognized as a result of the CFDA notice on Buflomedil in the first quarter of 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">18</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Interest Expense</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>Net interest expense for the three months ended March 31, 2013 and 2012 was $80,859 and $76,847 respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income Tax Benefit (Expense)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>In the three months ended March 31, 2013 and 2012, we paid income tax at the rate of 15%. Income tax benefit was $0.27 million in the three months ended March 31, 2013; and income tax expense was $0.53 million for the three months ended March 31, 2012. As a result of the CFDA notice ceasing production of Buflomedil, we have net operating loss carry forwards of $0.48 million which, under Chinese tax law can be &#8220;carried forward&#8221; for 5 years. &#160;We believe that we will have sufficient taxable income in the near future to utilize this tax benefit. We obtained the "National High-Tech Enterprise" status ("National HT Status") from the PRC government in the fourth quarter of 2010. With this designation, we are entitled to a preferential tax rate of 15% for the years ending December 31, 2011, 2012 and 2013, which is notably lower than the statutory income tax rate of 25%.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Income (Loss)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>Net loss for three months ended March 31, 2013 was $2.8 million, a decrease of $5.6 million, from the net income of $2.8 million in the three months ended March 31, 2012.The decrease in net income was mainly due to the decrease in revenue, and the inventory obsolescence reserve recognized as a result of the CFDA notice on Buflomedil.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>For the three months ended March 31, 2013, earnings per basic and diluted common share was minus $0.06 per share, compared to $0.06 per share in the previous year period.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>The number of basic and diluted weighted average outstanding shares used to calculate earnings per share were 43,579,557 for the three months ended March 31, 2013 and 43,529,557 for the three months ended March 31, 2012.</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liquidity and Capital Resources</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Our principal sources of liquidity are cash generated from operations and short-term bank loans.&#160;&#160;Our cash and cash equivalents was $4.75 million, which represents 3.0% of our total assets as of March 31, 2013, was comparable to $4.03 million, which represents 2.5% of our total assets as of December 31, 2012. At March31, 2013, a total of $5.93 million is considered to be reinvested indefinitely in Helpson and is not expected to be available for payment of dividends, for other payments to our parent company or to its shareholders. As of March 31, 2013, we had a principal balance of $4.79 million in short-term bank loans. The cash flow generated from operating activities funded our construction of new GMP upgrading project.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>During the first quarter in 2013, we continued our vigorous collection efforts from our customers and achieved good results. While we have made progress, improving our accounts receivable collection continues to be a focus of our management team and we expect to make further progress in the quarters to come.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">19</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>At March 31, 2013, the Company was obligated to pay laboratories $6.52million upon their completion of the various phases of contracts to provide CFDA production approval of more than 10 medical formulas. Those payments are expected to be made out of the Company&#8217;s cash flow from operations ratably over approximately the following 48 months, depending on the progress of the various contracts. A typical contract requires an upfront deposit and then two to three additional milestone payments plus a final payment when the CFDA approval is obtained. Since the payments are progress driven, it is difficult to calculate the timing of the payments with any precision; however, management expects that the payments will be somewhat even over the payment period given the number of contracts in progress. The funding obligation is not expected to have an undue negative impact on the liquidity of the Company given the Company&#8217;s historical cash flows and estimated future cash flows from operating activities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Based on our current operating plan, management believes that our cash provided by operations as well as the anticipated capital expenditure project financing from a bank will be sufficient to meet our working capital needs and our anticipated capital expenditures, including expenditures for new formula acquisitions and new GMP upgrading related construction and equipment, for the next twelve months. However, if events or circumstances occur and we do not meet our operating plan as expected, we may be required to seek additional capital and/or to reduce certain discretionary spending, which could have a material adverse effect on our ability to achieve our business objectives. Notwithstanding the foregoing, we may seek additional financing as necessary for expansion purposes and when we believe market conditions are most advantageous, which may include debt and/or equity financing.&#160;&#160;There can be no assurance that any additional financing will be available on acceptable terms, if at all.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -25.6pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Operating Activities</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>Net cash provided by operating activities was $1.11 million in the three months period ended March 31, 2013compared to $0.40 million for the same period in 2012. As a common business practice in China, Banker's Acceptances (BAs) are often used to settle payment instead of checks. During the three months ended March 31, 2013, the Company collected accounts receivable with BAs with a maturity of more than 90 days, and such BAs are not treated as cash and cash equivalent under U.S. GAAP. If cash equivalent treatment were to be applied to BAs with more than 90 days maturity, $2.18million would have been generated in operating activities in the three months ended March 31, 2013. This was mainly because of the improved performance in collection of accounts receivable partially offset the decrease in net income in the first quarter 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>At March31, 2013, our accounts receivable was $62.7million, a decrease of $3.5 million from $66.2million at December 31, 2012. Our receivables decreased due to decreased sales and the improved performance of our collection in account receivables. For the three months ended March 31, 2013, $1.9million was generated from decreases in Accounts Receivable, compared to $4.1million was used to fund increases in Accounts Receivable in the comparable period a year ago.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>At March31, 2013, total inventory was $33.3 million, a decrease of $3.1 million from $36.4 million at December 31, 2012. This decrease was mainly due to the inventory obsolescence recognized pursuant to the CFDA notice on Buflomedil in March 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.3pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">20</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -2.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>For the period ending March 31, 2013, the decrease in our accounts payable was responsible for a cash usage of $0.1 million, compared to a cash usage of $2.7 million in the same period in 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Investing Activities</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -2.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>In the three months ended March 31, 2013, net cash used in investing activities was $0.4 million, a decrease of $0.68 million, compared to $1.08 million in three months ended March 31, 2012.The investment spending in the first quarter of 2013 was mainly for the new GMP upgrading related construction and equipment.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financing Activities</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -2.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>There was no cash flow generated from financing activities in the three months ended March 31, 2013 or 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -2.25pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>According to relevant PRC laws, companies registered in the PRC, including our PRC subsidiary, Helpson, are required to allocate at least ten percent (10%) of their after-tax net income, as determined under accounting standards and regulations in the PRC, to statutory surplus reserve accounts until the reserve account balances reach fifty percent (50%) of the companies&#8217; registered capital prior to their remittance of funds out of the PRC.&#160;&#160;Allocations to these reserves and funds can only be used for specific purposes and are not transferrable to the parent company in the form of loans, advances or cash dividends.&#160;&#160;As of December 31, 2012 and 2011, the net assets of Helpson were $142,597,000 and $135,748,004, respectively.&#160;&#160;Due to the restriction on dividend distribution to overseas shareholders, the amount of Helpson&#8217;s net assets that were designated for general and statutory capital reserves, and thus could not be transferred to our parent company as cash dividends, were $7,935,122and $7,863,490 (50% of registered capital) for the fiscal years ended December 31, 2012 and 2011.&#160;&#160;Since the amount that Helpson must set aside for the statutory surplus fund only accounts for 5.6% and 5.8%, respectively, of its total net assets, this reserve does not have a major impact on our liquidity.&#160;&#160;There were no allocations to the statutory surplus reserve accounts during the three months ended March 31, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The PRC government also imposes controls on the conversion of RMB into foreign currencies and the remittance of currencies out of the PRC.&#160;&#160;Our businesses and assets are primarily denominated in RMB.&#160;&#160;All foreign exchange transactions take place either through the People&#8217;s Bank of China or other banks authorized to buy and sell foreign currencies at the exchange rates quoted by the People&#8217;s Bank of China.&#160;&#160;Approval of foreign currency payments by the People&#8217;s Bank of China or other regulatory institutions requires submitting a payment application form together with applicable invoices and signed contracts.&#160;&#160;These currency exchange control procedures imposed by the PRC government authorities may restrict the ability of Helpson, our PRC subsidiary, to transfer its net assets to our parent company through loans, advances or cash dividends.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -25.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Off Balance Sheet Arrangements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -25.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>As of March 31, 2013, we did not have any off-balance sheet arrangements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -25.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Commitments</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>At March31, 2013, we were obligated to pay laboratories and others approximately $6.52 million over approximately the next four years upon completion of the various phases of contracts to provide CFDA production approval of medical formulas.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">21</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We entered into purchase and construction agreements during fiscal year 2012 in connection with the construction of a new facility and required manufacturing improvements.&#160;&#160;Future minimum commitments under the agreements are as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div align="center">
<table cellpadding="0" cellspacing="0" width="60%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="83%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Years Ending December 31:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td valign="bottom" width="83%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,133,498</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="83%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">968,860</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="aliceblue">
<td valign="bottom" width="83%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,102,358</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Critical Accounting Policies</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 45.8pt"></font>Management's discussion and analysis of its financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles. Our financial statements reflect the selection and application of accounting policies which require management to make significant estimates and judgments. The discussion of our critical accounting policies contained in Note 1 to our consolidated financial statements, &#8220;Organization and Significant Accounting Policies&#8221;, is incorporated herein by reference.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">22</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</font></div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>As a &#8220;smaller reporting company&#8221; as defined by Item 10 of Regulation S-K, we are not required to provide information required by this item.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Controls and Procedures</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Evaluation of Disclosure Controls and Procedures</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Our Chief Executive Officer and interim Chief Financial Officer, evaluated the effectiveness of our &#8220;disclosure controls and procedures&#8221; (as defined in the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) Rules 13a-15(e) or 15d-15(e)) as of the end of the period covered by this quarterly report.&#160;&#160;Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act (a) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms and (b) is accumulated and communicated to management, including our Chief Executive Officer and interim Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.&#160;&#160;Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives as described above. Based on this evaluation, our Chief Executive Officer and interim Chief Financial Officer concluded that as of the end of the period covered by this report, our disclosure controls and procedures were effective.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Changes in Internal Controls over Financial Reporting</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>During the period covered by this report, in order to remediate our material weakness in internal control over financial reporting with respect to our reporting for inventory obsolescence and impairment of long-lived assets as identified in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, we have retained accounting consultants to assist us with the reporting of such transactions, and we have made this resource available to us on an on-going basis should the need their assistance in the future.&#160;&#160;There were no other changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PART II&#160;&#160;&#160;&#160;&#160;OTHER INFORMATION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 72pt"></font>The exhibits required by this item are set forth in the Exhibit Index attached hereto.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%">&#160;</td>
<td width="50%">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CHINA PHARMA HOLDINGS, INC.</font></font></div>
</td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date: May 14, 2013&#160;&#160;</font></td>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: <font style="TEXT-DECORATION: underline"><font style="DISPLAY: inline">/s/ Zhilin Li</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name: Zhilin Li</font></font></div>
</td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title: President and Chief Executive Officer</font></font></div>
</td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(principal executive officer)</font></font></div>
</td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date: May 14, 2013</font></td>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: <font style="TEXT-DECORATION: underline"><font style="DISPLAY: inline">/s/ Zhilin Li</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name: Zhilin Li&#160;</font></td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title: Interim Chief Financial Officer</font></font></div>
</td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(principal financial officer and principal&#160;</font></td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">accounting officer)</font></font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">24</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT INDEX</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">No.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Description</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31.1 &#8211; Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31.2 &#8211; Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32.1 &#8211; Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">101.INS*&#160;&#160;&#8211; XBRL Instance Document</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">101.SCH* &#8211; XBRL Taxonomy Extension Schema Document</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">101.CAL* &#8211; XBRL Taxonomy Extension Calculation Linkbase Document</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">101.DEF* &#8211; XBRL Taxonomy Extension Definition Linkbase Document</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">101.LAB* &#8211; XBRL Taxonomy Extension Label Linkbase Document</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">101.PRE* &#8211; XBRL Taxonomy Extension Presentation Linkbase Document</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font id="TAB1" style="MARGIN-LEFT: 432pt"></font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">* Furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise not subject to liability under these sections.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">25</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>cphi10qex311033113.htm
<TEXT>
<html>
<head>
    <title>cphi10qex311033113.htm</title>
    <!--Licensed to: Securities Transfer Corp-->
    <!--Document Created using EDGARizerAgent 5.4.4.0-->
    <!--Copyright 1995 - 2013 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Exhibit 31.1</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, Zhilin Li certify that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.&#160;&#160;</font></div>
</td>
<td valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.&#160;&#160;</font></div>
</td>
<td valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.&#160;&#160;</font></div>
</td>
<td valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.&#160;&#160;</font></div>
</td>
<td valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.&#160;&#160;</font></div>
</td>
<td valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><a name="page_0_3_2"><!--EFPlaceholder--></a>a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date:&#160;&#160;May 14, 2013&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Zhilin Li</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Name: Zhilin Li</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Title: Chief Executive Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(principal executive officer)</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>cphi10qex312033113.htm
<TEXT>
<html>
<head>
    <title>cphi10qex312033113.htm</title>
    <!--Licensed to: Securities Transfer Corp-->
    <!--Document Created using EDGARizerAgent 5.4.4.0-->
    <!--Copyright 1995 - 2013 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Exhibit 31.2</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, Zhilin Li, certify that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.&#160;&#160;</font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.&#160;&#160;</font></div>
</td>
<td valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.&#160;&#160;</font></div>
</td>
<td valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.&#160;&#160;</font></div>
</td>
<td valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.&#160;&#160;</font></div>
</td>
<td valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date: May 14, 2013&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Zhilin Li</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Name: Zhilin Li</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Title: Interim Chief Financial Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(principal financial officer and principal accounting officer)</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>cphi10qex321033113.htm
<TEXT>
<html>
<head>
    <title>cphi10qex321033113.htm</title>
    <!--Licensed to: Securities Transfer Corp-->
    <!--Document Created using EDGARizerAgent 5.4.4.0-->
    <!--Copyright 1995 - 2013 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 32.1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION PURSUANT TO</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">18 U.S.C. SECTION 1350,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AS ADOPTED PURSUANT TO</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The undersigned hereby certifies, in her capacity as Chief Executive Officer and interim Chief Financial Officer of China Pharma Holdings, Inc. (the &#8220;Company&#8221;), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of her knowledge:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) &#160;The Company&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2013 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) &#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated:&#160;&#160;May 14, 2013&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Zhilin Li</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Name: Zhilin Li</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">President and Chief Executive Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(principal executive officer)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Zhilin Li</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Name: Zhilin Li</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Title: Interim Chief Financial Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(principal financial officer and principal accounting officer)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This certification accompanies each Report pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of &#167;18 of the Securities Exchange Act of 1934, as amended.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>5
<FILENAME>cphi-20130331.xml
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- NeoClarus - iFile Suite version 4.2311  -->
<xbrl xmlns:dei='http://xbrl.sec.gov/dei/2011-01-31' xmlns:fil='http://www.chinapharmaholdings.com/20130331' xmlns='http://www.xbrl.org/2003/instance' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xbrli='http://www.xbrl.org/2003/instance' xmlns:us-gaap='http://fasb.org/us-gaap/2011-01-31' xmlns:iso4217='http://www.xbrl.org/2003/iso4217' xmlns:num='http://www.xbrl.org/dtr/type/numeric' xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric' xmlns:xbrldi='http://xbrl.org/2006/xbrldi'>
	<link:schemaRef xlink:type='simple' xlink:href='cphi-20130331.xsd' />
	<dei:DocumentType contextRef='Y13Q1'>10-Q</dei:DocumentType>
	<dei:DocumentPeriodEndDate contextRef='Y13Q1'>2013-03-31</dei:DocumentPeriodEndDate>
	<dei:AmendmentFlag contextRef='Y13Q1'>false</dei:AmendmentFlag>
	<dei:EntityRegistrantName contextRef='Y13Q1'>CHINA PHARMA HOLDINGS, INC.</dei:EntityRegistrantName>
	<dei:EntityCentralIndexKey contextRef='Y13Q1'>0001106644</dei:EntityCentralIndexKey>
	<dei:CurrentFiscalYearEndDate contextRef='Y13Q1'>--12-31</dei:CurrentFiscalYearEndDate>
	<dei:EntityCommonStockSharesOutstanding unitRef='Shares' contextRef='I130510' decimals='INF'>43579557</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityFilerCategory contextRef='Y13Q1'>Smaller Reporting Company</dei:EntityFilerCategory>
	<dei:EntityCurrentReportingStatus contextRef='Y13Q1'>Yes</dei:EntityCurrentReportingStatus>
	<dei:EntityVoluntaryFilers contextRef='Y13Q1'>No</dei:EntityVoluntaryFilers>
	<dei:EntityWellKnownSeasonedIssuer contextRef='Y13Q1'>No</dei:EntityWellKnownSeasonedIssuer>
	<dei:DocumentFiscalYearFocus contextRef='Y13Q1'>2013</dei:DocumentFiscalYearFocus>
	<dei:DocumentFiscalPeriodFocus contextRef='Y13Q1'>Q1</dei:DocumentFiscalPeriodFocus>
	<us-gaap:Cash unitRef='USD' contextRef='E13Q1' decimals='INF'>4750468</us-gaap:Cash>
	<us-gaap:Cash unitRef='USD' contextRef='E12' decimals='INF'>4029708</us-gaap:Cash>
	<us-gaap:CashEquivalentsAtCarryingValue unitRef='USD' contextRef='E13Q1' decimals='INF'>1180864</us-gaap:CashEquivalentsAtCarryingValue>
	<us-gaap:CashEquivalentsAtCarryingValue unitRef='USD' contextRef='E12' decimals='INF'>101570</us-gaap:CashEquivalentsAtCarryingValue>
	<us-gaap:ReceivablesNetCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>62697675</us-gaap:ReceivablesNetCurrent>
	<us-gaap:ReceivablesNetCurrent unitRef='USD' contextRef='E12' decimals='INF'>66175570</us-gaap:ReceivablesNetCurrent>
	<us-gaap:OtherReceivablesNetCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>255292</us-gaap:OtherReceivablesNetCurrent>
	<us-gaap:OtherReceivablesNetCurrent unitRef='USD' contextRef='E12' decimals='INF'>80799</us-gaap:OtherReceivablesNetCurrent>
	<fil:AdvancesToSuppliers unitRef='USD' contextRef='E13Q1' decimals='INF'>5119729</fil:AdvancesToSuppliers>
	<fil:AdvancesToSuppliers unitRef='USD' contextRef='E12' decimals='INF'>4816354</fil:AdvancesToSuppliers>
	<us-gaap:InventoryNet unitRef='USD' contextRef='E13Q1' decimals='INF'>33260226</us-gaap:InventoryNet>
	<us-gaap:InventoryNet unitRef='USD' contextRef='E12' decimals='INF'>36359516</us-gaap:InventoryNet>
	<us-gaap:DeferredTaxAssetsNetCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>954980</us-gaap:DeferredTaxAssetsNetCurrent>
	<us-gaap:DeferredTaxAssetsNetCurrent unitRef='USD' contextRef='E12' decimals='INF'>967671</us-gaap:DeferredTaxAssetsNetCurrent>
	<us-gaap:AssetsCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>108219234</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent unitRef='USD' contextRef='E12' decimals='INF'>112531188</us-gaap:AssetsCurrent>
	<fil:AdvancesForPurchasesOfIntangibleAssets unitRef='USD' contextRef='E13Q1' decimals='INF'>39462268</fil:AdvancesForPurchasesOfIntangibleAssets>
	<fil:AdvancesForPurchasesOfIntangibleAssets unitRef='USD' contextRef='E12' decimals='INF'>39263977</fil:AdvancesForPurchasesOfIntangibleAssets>
	<us-gaap:PropertyPlantAndEquipmentNet unitRef='USD' contextRef='E13Q1' decimals='INF'>9288259</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet unitRef='USD' contextRef='E12' decimals='INF'>9031894</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef='USD' contextRef='E13Q1' decimals='INF'>2289851</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef='USD' contextRef='E12' decimals='INF'>2412854</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:Assets unitRef='USD' contextRef='E13Q1' decimals='INF'>159259612</us-gaap:Assets>
	<us-gaap:Assets unitRef='USD' contextRef='E12' decimals='INF'>163239913</us-gaap:Assets>
	<us-gaap:AccountsPayableTradeCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>2978636</us-gaap:AccountsPayableTradeCurrent>
	<us-gaap:AccountsPayableTradeCurrent unitRef='USD' contextRef='E12' decimals='INF'>2841862</us-gaap:AccountsPayableTradeCurrent>
	<us-gaap:AccruedLiabilitiesCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>240003</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent unitRef='USD' contextRef='E12' decimals='INF'>202185</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:TaxesPayableCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>514245</us-gaap:TaxesPayableCurrent>
	<us-gaap:TaxesPayableCurrent unitRef='USD' contextRef='E12' decimals='INF'>2426826</us-gaap:TaxesPayableCurrent>
	<us-gaap:AccountsPayableOtherCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>1014647</us-gaap:AccountsPayableOtherCurrent>
	<us-gaap:AccountsPayableOtherCurrent unitRef='USD' contextRef='E12' decimals='INF'>1094886</us-gaap:AccountsPayableOtherCurrent>
	<us-gaap:CustomerAdvancesCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>1735917</us-gaap:CustomerAdvancesCurrent>
	<us-gaap:CustomerAdvancesCurrent unitRef='USD' contextRef='E12' decimals='INF'>1945984</us-gaap:CustomerAdvancesCurrent>
	<us-gaap:DueToRelatedPartiesCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>1354567</us-gaap:DueToRelatedPartiesCurrent>
	<us-gaap:DueToRelatedPartiesCurrent unitRef='USD' contextRef='E12' decimals='INF'>1354567</us-gaap:DueToRelatedPartiesCurrent>
	<us-gaap:NotesPayableCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>4787285</us-gaap:NotesPayableCurrent>
	<us-gaap:NotesPayableCurrent unitRef='USD' contextRef='E12' decimals='INF'>4761073</us-gaap:NotesPayableCurrent>
	<us-gaap:LiabilitiesCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>12625300</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent unitRef='USD' contextRef='E12' decimals='INF'>14627383</us-gaap:LiabilitiesCurrent>
	<us-gaap:DeferredTaxLiabilitiesNoncurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>110286</us-gaap:DeferredTaxLiabilitiesNoncurrent>
	<us-gaap:DeferredTaxLiabilitiesNoncurrent unitRef='USD' contextRef='E12' decimals='INF'>95963</us-gaap:DeferredTaxLiabilitiesNoncurrent>
	<us-gaap:Liabilities unitRef='USD' contextRef='E13Q1' decimals='INF'>12735586</us-gaap:Liabilities>
	<us-gaap:Liabilities unitRef='USD' contextRef='E12' decimals='INF'>14723346</us-gaap:Liabilities>
	<us-gaap:PreferredStockValue unitRef='USD' contextRef='E13Q1' decimals='INF'>0</us-gaap:PreferredStockValue>
	<us-gaap:PreferredStockValue unitRef='USD' contextRef='E12' decimals='INF'>0</us-gaap:PreferredStockValue>
	<us-gaap:CommonStockValue unitRef='USD' contextRef='E13Q1' decimals='INF'>43580</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue unitRef='USD' contextRef='E12' decimals='INF'>43580</us-gaap:CommonStockValue>
	<us-gaap:AdditionalPaidInCapital unitRef='USD' contextRef='E13Q1' decimals='INF'>23590204</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AdditionalPaidInCapital unitRef='USD' contextRef='E12' decimals='INF'>23590204</us-gaap:AdditionalPaidInCapital>
	<us-gaap:RetainedEarningsAccumulatedDeficit unitRef='USD' contextRef='E13Q1' decimals='INF'>106092017</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit unitRef='USD' contextRef='E12' decimals='INF'>108904325</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax unitRef='USD' contextRef='E13Q1' decimals='INF'>16798225</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax unitRef='USD' contextRef='E12' decimals='INF'>15978458</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:StockholdersEquity unitRef='USD' contextRef='E13Q1' decimals='INF'>146524026</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity unitRef='USD' contextRef='E12' decimals='INF'>148516567</us-gaap:StockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity unitRef='USD' contextRef='E13Q1' decimals='INF'>159259612</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity unitRef='USD' contextRef='E12' decimals='INF'>163239913</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 1 - BASIS OF PRESENTATION&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;i&gt;Organization and Nature of Operations &amp;#150; &lt;/i&gt;&lt;/b&gt;China Pharma Holdings, Inc., a Nevada corporation, owns 100% of Onny Investment Limited (&amp;#147;Onny&amp;#148;), a British Virgin Islands corporation, that in turn owns 100% of Hainan Helpson Medical &amp;amp; Biotechnology Co., Ltd (&amp;#147;Helpson&amp;#148;), a corporation organized under the laws of the People&apos;s Republic of China (the &amp;#147;PRC&amp;#148;). China Pharma Holdings, Inc. and its subsidiaries are referred to herein as the Company.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;On December 31, 2012, China Pharma Holdings, Inc consummated a reincorporation merger for the purpose of changing the state of incorporation from Delaware to Nevada pursuant to the terms and conditions of an Agreement and Plan of Merger dated December 27, 2012.&amp;nbsp;&amp;nbsp;The reincorporation merger was approved by stockholders holding the majority of the outstanding common shares on December 21, 2012.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The Foreign Investment Industrial Catalogue&lt;i&gt;&amp;nbsp;&lt;/i&gt;(the &amp;#147;Catalogue&amp;#148;) jointly issued by the China&amp;#146;s Ministry of Commerce and the National Development and Reform Commission (as the latest version is the year 2012 version, effective January 30, 2012) classified various industries/businesses into three different categories: (i) encouraged for foreign investment; (ii) restricted to foreign investment; and (iii) prohibited from foreign investment. For any industry/business not covered by any of these three categories, they will be deemed industries/businesses permitted for foreign investment. A typical foreign investment ownership restriction in the pharmaceutical industry is that a foreign investment enterprise (the &amp;#147;FIE&amp;#148;) shall not have the whole or majority of its equity interests owned by a foreign owner if the FIE establishes more than 30 branch stores and distributes a variety of brands in those franchise stores, which is not the case of the Company&amp;#146;s business.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Helpson manufactures and markets generic and branded pharmaceutical products as well as biochemical products primarily to hospitals and private retailers located throughout the PRC. The Company believes Helpson&amp;#146;s business is not subject to any ownership restrictions prescribed under the Catalogue. Onny acquired 100% of the ownership in Helpson from Helpson&amp;#146;s three former shareholders on May 25, 2005 by entry into an Equity Transfer Agreement with such three parties on May 25, 2005. The transaction was approved by the Commercial Bureau of Hainan Province on June 12, 2005 and Helpson received the Certificate of Approval for Establishing of Enterprises with Foreign Investment in the PRC on the same day and its business license evidencing its WFOE (Wholly Foreign Owned Enterprise) status on June 21, 2005.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The Company has and continues to acquire well-accepted medical formulas to a diverse portfolio of Western and Chinese medicines.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;i&gt;Consolidation and Basis of Presentation &lt;/i&gt;&lt;/b&gt;&amp;#150; The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&amp;#147;U.S. GAAP&amp;#148;) and are expressed in United States dollars. The accompanying consolidated financial statements include the accounts and operations of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Helpson&amp;#146;s functional currency is the Chinese Renminbi. Helpson&amp;#146;s revenue and expenses are translated into United States dollars at the average exchange rate for the period. Assets and liabilities are translated at the exchange rate as of the end of the reporting period. Gains or losses from translating Helpson&amp;#146;s financial statements are included in accumulated other comprehensive income, which is a component of stockholders&amp;#146; equity. Gains and losses arising from transactions denominated in a currency other than the functional currency of the entity that is a party to the transaction are included in the results of operations.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;i&gt;Condensed Financial Statements &lt;/i&gt;&lt;/b&gt;&amp;#150; The accompanying unaudited condensed consolidated financial statements were prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission (the &amp;#147;Commission&amp;#148;). Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Management of the Company (&amp;#147;Management&amp;#148;) believes the following disclosures are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&apos;s Annual Report on Form 10-K for the year ended December 31, 2012 filed with the Commission on March 14, 2013.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;These unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) that, in the opinion of Management, are necessary to present fairly the consolidated financial position and results of operations of the Company for the periods presented. Operating results for the three months ended March 31, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;i&gt;Accounting Estimates &lt;/i&gt;&lt;/b&gt;&lt;b&gt;- &lt;/b&gt;The preparation of financial statements in conformity with&amp;nbsp;U.S. GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;i&gt;Basic and Diluted Earnings per Common Share &lt;/i&gt;&lt;/b&gt;&lt;b&gt;- &lt;/b&gt;Basic earnings per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is calculated to give effect to potentially issuable dilutive common shares.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The following table is a presentation of the numerators and denominators used in the calculation of basic and diluted earnings per share:&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;table width=&quot;520&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:390pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;179&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;For the Three Months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;179&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Ended March 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Net (loss) income&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (2,812,307)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 2,806,359 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Basic weighted-average common shares outstanding&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;43,579,557 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;43,529,557 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Effect of dilutive securities:&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt&quot;&gt;Warrants&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt&quot;&gt;Options&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:19.5pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Diluted weighted-average common shares outstanding&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;43,579,557 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;43,529,557 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:0.25in&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Basic (loss) earnings per share&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (0.06)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 0.06 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:0.25in&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Diluted (loss) earnings per share&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (0.06)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;0.06 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot; align=&quot;center&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot; align=&quot;center&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The following potential common shares were not included in the computation of diluted earnings per share as their effect would have been anti-dilutive:&amp;nbsp;&lt;/p&gt; &lt;table width=&quot;520&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:390pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;179&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;For the Three Months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;179&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Ended March 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Warrants with exercise prices of $3.00 to $3.80 per share&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 150,000 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 150,000 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Options with an exercise price of $2.54 to $3.47 per share&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 25,000 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 310,000 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.5pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt&quot;&gt;Total&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 175,000 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 460,000 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot; align=&quot;center&quot;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
	<us-gaap:ProductWarrantyDisclosureTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 2 &amp;#150; PRODUCT RECALL&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:11.25pt; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:11.25pt; MARGIN:0in 0in 0pt&quot;&gt;In March 2013, the China Food and Drug Administration (&amp;#147;CFDA&amp;#148;) issued a nationwide notice (the &amp;#147;CFDA Notice&amp;#148;) for the cessation of the production, sale and use of Buflomedil effective immediately. The CFDA Notice was a result of the reevaluation done by the CFDA based on the indications from the recent China and international research materials, which found the side effect risks of buflomedil to nerve system and cardiovascular system have surpassed its clinical treatment effect.&amp;nbsp; The CFDA Notice was applicable to all the manufacturers and distributers in China who are in the business of the production and sale of Buflomedil-related products.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:11.25pt; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:11.25pt; MARGIN:0in 0in 0pt&quot;&gt;Pursuant to the CFDA Notice, the Company ceased the production and sale of Buflomedil-based products and ceased all promotional and marketing activities for Buflomedil-based products. &lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:11.25pt; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Furthermore, the Company recognized an inventory obsolescence expense in the amount of $3,692,895 to write off Buflomedil-related raw materials and finished goods inventory. This was recorded as inventory obsolescence on the accompanying statement of operations for the three months ended March 31, 2013. &lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;In addition, the Company recalled Buflomedil-based products from the market. It authorized the return of its previously sold Buflomedil-related products through April 30, 2013. The loss from the refunds to customers was $21,507 and recognized that estimated loss as a reduction of revenues for the three months ended March 31, 2013. Under CFDA regulatory provisions, the CFDA notice does not impose legal liability to the manufacturers of Buflomedil as long as they act pursuant to the CFDA Notice to cease the production, sale and use of Buflomedil and destroy such finished goods immediately.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt 13.5pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Pursuant to the CFDA Notice, the CFDA revoked the production licenses for Buflomedil based products. The carrying value of the Company&amp;#146;s Buflomedil related intangible assets is zero; therefore, no impairment of the Company&amp;#146;s intangible assets was necessary.&amp;nbsp; &lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
	<us-gaap:InventoryDisclosureTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 3 - INVENTORY&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Inventory consisted of the following:&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt; &lt;/p&gt;&lt;table width=&quot;483&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:362.4pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;&amp;nbsp;March 31, &lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;&amp;nbsp;December 31, &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Raw materials&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 28,380,903&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 30,198,816 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Finished goods&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 6,659,052 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 7,930,684 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 35,039,955&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 38,129,500 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Obsolescence reserve&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (1,779,729)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (1,769,984)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10.05pt; MARGIN:0in 0in 0pt&quot;&gt;&lt;b&gt;Total Inventory&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 33,260,226 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 36,359,516 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InventoryDisclosureTextBlock>
	<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 4 - PROPERTY AND EQUIPMENT&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Property and equipment consisted of the following:&lt;/p&gt; &lt;table width=&quot;477&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:357.4pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;&amp;nbsp;March 31, &lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;&amp;nbsp;December 31, &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Permit of land use&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 449,474 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 447,013 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Building&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 2,432,442 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 2,419,125 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Plant, machinery and equipment&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 6,418,768 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 6,381,209 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Motor vehicle&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 147,890 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;147,080 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Office equipment&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 223,947 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 222,273 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Construction in progress&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 4,127,396 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 3,688,567 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10.05pt; MARGIN:0in 0in 0pt&quot;&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 13,799,917 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 13,305,267 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Less: accumulated depreciation&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;(4,511,658)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (4,273,373)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&lt;b&gt;Property and Equipment, net&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 9,288,259 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 9,031,894 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot; align=&quot;center&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Construction in progress consists of machinery and construction supplies that have been paid for, but are not yet completed and placed into production.&amp;nbsp;&amp;nbsp;Once the machinery is working or the facility is in use, it is moved into plant, machinery and equipment and depreciated.&amp;nbsp;&amp;nbsp;Depreciation is computed on a straight-line basis over the estimated useful lives of the assets as follows:&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;table width=&quot;359&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:269pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;Asset&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&amp;nbsp;Life - years &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Permit of land use&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;40 - 70&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Building&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;20 - 35&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Plant, machinery and equipment&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Motor vehicle&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;5 - 10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Office equipment&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;3-5&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot; align=&quot;center&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot; align=&quot;center&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;For the three months ended March 31, 2013 and 2012, depreciation expense was $214,406 and $212,424, respectively.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
	<us-gaap:IntangibleAssetsDisclosureTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 5 - INTANGIBLE ASSETS&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Intangible assets represent the cost of medical formulas approved for production by the CFDA in China. During the three months ended March 31, 2013 or 2012, the Company did not obtain CFDA production approval for any medical formula and therefore there were no costs reclassified from advances to medical formulas.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Approved medical formulas are amortized from the date CFDA approval is obtained over their individually identifiable estimated useful life, which are from ten to thirteen years.&amp;nbsp;&amp;nbsp;It is at least reasonably possible that a change in the estimated useful lives of the medical formulas could occur in the near term due to changes in the demand for the drugs and medicines produced from these medical formulas. Amortization expense relating to intangible assets was $136,062 and $152,799 for the three months ended March 31, 2013 and 2012, respectively. Medical formulas typically do not have a residual value at the end of their amortization period.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The Company evaluates each approved medical formula for impairment at the date of CFDA approval, when indications of impairment are present and at the date of each financial statement. The Company&amp;#146;s evaluation is based on an estimated undiscounted net cash flow model, considering currently available market data for the related drug and the Company&amp;#146;s estimated market share. If the carrying value of the medical formula exceeds the estimated future net cash flows, an impairment loss is recognized for the excess of the carrying value over the discounted estimated future net cash flows. As a result of the evaluation, the Company has determined that each medical formula continues to provide benefits to the Company and no impairment was recognized during the three months ended March 31, 2013 or 2012.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;At March 31, 2013 and December 31, 2012, intangible assets consisted solely of CFDA approved medical formulas as follows:&lt;/p&gt; &lt;table width=&quot;393&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:294.9pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;187&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;187&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;187&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Gross carrying amount&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 5,387,075 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 5,357,580 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;187&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Accumulated amortization&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (3,097,224)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (2,944,726)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.5pt&quot;&gt; &lt;td width=&quot;187&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Net carrying amount&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 2,289,851 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 2,412,854 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
	<fil:AdvancesForPurchasesOfIntangibleAssetsTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 6 &amp;#150; ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;In order to expand the number of medicines manufactured and marketed by the Company, the Company has entered into contracts with independent laboratories for the purchase of medical formulas. Although CFDA approval has not been obtained for these medical formulas as of the dates of the contracts, the object of the contracts is for the purchase of CFDA-approved medical formulas once the CFDA approval process is completed. Some of the medical formulas currently in the CFDA approval process also come with patents. The Company has received the title for two patents. The related patents have not expired.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Prior to entering into the contracts, the laboratories typically have completed all required research and development to determine the medical formula for and the method of production of the generic medicine.&amp;nbsp;&amp;nbsp;Since the laboratories are not eligible to apply for CFDA production approval, they usually collaborate with a production facility (such as the Company) and apply for the production approval in the name of the manufacturer. The Company buys the final products with the production approval from the CFDA and the laboratories have to complete the CFDA approval process from the point of the contract.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;A typical CFDA approval process for the production of a generic medical product involves a number of steps that generally requires three to five years. If the medical formula is purchased at the point when the generic medical product receives the CFDA&amp;#146;s approval for clinical study, which is very typical for the Company, the clinical study that follows will usually take from one and a half to three years to complete. After the clinical study is completed, the results are submitted to the CFDA and a production approval application is filed with the CFDA. In most cases, it will take between eight to eighteen months to prepare and submit the production approval application and obtain CFDA approval. Upon approving the generic medical product, the CFDA issues a production certificate and the Company can produce and sell the generic medical product. As a result of this process, CFDA approval is expected to be received in approximately two to five years from the dates of the medical formula contracts.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Under the terms of the contracts, the laboratories are required to obtain production approval (on behalf of the Company) for the medical formulas from the CFDA. Management monitors the status of each medical formula on a regular basis in order to assess whether the laboratories are performing adequately under the contracts. If a medical product is not approved by the CFDA, as evidenced by their issuance of a denial letter, or if the laboratory breaches the contract, the laboratory is required under the contract to provide a refund to the Company of the full amount of the payments made to the laboratory for that formula, or the Company can require the application of those payments to another medical formula with the same laboratory. As a result of the refund right, the Company is purchasing an approved medical product. Accordingly, payments made prior to the issuance of production approval by the CFDA are recorded as advances for purchases of intangible assets.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;To date, no formula has failed to receive CFDA production approval nor has the Company been informed or become aware of any formula that may fail to receive such approval. However, there is no assurance that the medical products will receive production approval and if the Company does not receive such approval, it will enforce its contractual rights to receive the refund from the laboratory or have the payments applied to another medical formula with the same laboratory.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;At March 31, 2013, the Company was obligated to pay laboratories and others approximately $6,519,000 upon completion of the various phases of contracts to provide CFDA production approval of medical formulas.&lt;/p&gt;</fil:AdvancesForPurchasesOfIntangibleAssetsTextBlock>
	<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 7 &amp;#150; RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Total advances owing to a board member were $1,354,567 and $1,354,567 as of March 31, 2013 and December 31, 2012, respectively, and are recorded as other payables &amp;#150; related parties on the accompanying condensed consolidated balance sheets.&lt;font style=&quot;BACKGROUND:white&quot;&gt; &lt;/font&gt;The advances bear interest at a rate of 1.0% per year.&amp;nbsp;&amp;nbsp;Total interest expense of $3,386 and $1,970 was recognized for the three months ended March 31, 2013 and 2012.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
	<fil:NotesPayableTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 8 &amp;#150; NOTES PAYABLE&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;On October 30, 2012, the Company entered into a new revolving line of credit with another bank in the amount of RMB 30,000,000.&amp;nbsp;The related note payable bears interest at an annual rate of 6.90% (based upon 115% of the PRC government&amp;#146;s current short term rate of 6.00%). Advances on the line of credit are due one year from the date of the advance and are collateralized by certain land use rights, buildings and accounts receivable. The outstanding balance due under the revolving line of credit was RMB 30,000,000 ($4,787,285) as of March 31, 2013.&amp;nbsp;&amp;nbsp;The Company has no additional amounts available to it under the line of credit.&amp;nbsp;&amp;nbsp;This amount has been classified as short-term notes payable in the accompanying consolidated balance sheet at December 31, 2012.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;i&gt;Fair Value of&lt;/i&gt;&lt;/b&gt; &lt;b&gt;&lt;i&gt;Notes Payable&lt;/i&gt;&lt;/b&gt; &amp;#150; Based on the borrowing rates currently available to the Company for bank loans with similar terms and maturities, the carrying amounts of notes payable outstanding as of March 31, 2013 and December 31, 2012 approximated their fair value because of either the immediate or short-term maturity of these financial instruments or because the underlying instruments bear interest rates that approximated current market rates.&amp;nbsp;&lt;/p&gt;</fil:NotesPayableTextBlock>
	<us-gaap:IncomeTaxDisclosureTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 9 - INCOME TAXES&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax laws or rates is recognized in income in the period that includes the enactment date.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Undistributed earnings of Helpson, the Company&amp;#146;s foreign subsidiary, since its acquisition, amounted to approximately $110.5 million at March 31, 2013. Those earnings, as well as the investment in Helpson of approximately $23.3 million, are considered to be indefinitely reinvested and, accordingly, no U.S. federal or state income taxes have been provided thereon. Upon distribution of those earnings in the form of dividends or otherwise, the Company would be subject to U.S. federal and state income taxes (net of an adjustment for foreign tax credits) and withholding taxes payable to the PRC. Determination of the amount of unrecognized deferred U.S. income tax liability is not practicable because of the complexities associated with its hypothetical calculation; however, unrecognized foreign tax credits may be available to reduce a portion of the U.S. tax liability.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Under current tax law in the PRC, the Company is and will be subject to the following enterprise income tax rates:&lt;/p&gt; &lt;table width=&quot;240&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:2.5in; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;25&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;119&quot; style=&quot;BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:89pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Enterprise Income Tax Rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;25&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;2013&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;25&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;119&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:89pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;15%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;2014 and after&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;25&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;119&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:89pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;25%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot; align=&quot;center&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The provision for income taxes consisted of the following:&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;table width=&quot;515&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:386pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;304&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;199&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:149pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Three months ended March 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;304&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;304&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Current&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 564,893 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;304&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Deferred&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (269,011)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (34,312)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;304&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&lt;b&gt;Total income tax (benefit) expense&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (269,011)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 530,581 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot; align=&quot;center&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot; align=&quot;center&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The Company has available to it net operating losses for PRC tax purposes of $482,668. The Company also provided a valuation allowance in this same amount against the operating losses during the current quarter related to the net operating loss carryforward since they did not meet the more likely than not criteria for recognition of the loss carryforward in the current period. &lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The Company has also incurred various other taxes, comprised primarily of business taxes, value-added taxes, urban construction taxes, education surcharges and others. Any unpaid amounts are reflected on the balance sheets as accrued taxes payable.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
	<us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 10 &amp;#150; FAIR VALUE MEASUREMENTS&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. To measure fair value, a hierarchy has been established which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs. This hierarchy uses three levels of inputs to measure the fair value of assets and liabilities as follows: Level 1 &amp;#150; Quoted prices in active markets for identical assets or liabilities. Level 2 &amp;#150; Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. Level 3 &amp;#150; Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The Company uses fair value to measure the value of the banker&amp;#146;s acceptance notes it holds.&amp;nbsp;&amp;nbsp;The banker&amp;#146;s acceptance notes are recorded at cost which approximates fair value.&amp;nbsp;&amp;nbsp;The Company held the following assets recorded at fair value as of March 31, 2013 and December 31, 2012:&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table width=&quot;549&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:411.55pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;243&quot; colspan=&quot;5&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Fair Value Measurements at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;243&quot; colspan=&quot;5&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Reporting Date Using&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&lt;b&gt;March 31, 2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Banker&apos;s acceptance notes&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 1,180,864&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 1,180,864&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.5pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Total&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 1,180,864&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 1,180,864&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;243&quot; colspan=&quot;5&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Fair Value Measurements at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;243&quot; colspan=&quot;5&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Reporting Date Using&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&lt;b&gt;December 31, 2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Banker&apos;s acceptance notes&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 101,570 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 101,570 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.5pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Total&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 101,570 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 101,570 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
	<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 11 - STOCKHOLDERS&apos; EQUITY&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;u style=&quot;text-underline:black&quot;&gt;Preferred and Common Stock&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The total number of authorized shares is 95,000,000 shares of common stock and 5,000,000 shares of preferred stock. The preferred stock may be issued in series with such designations, preferences, stated values, rights, qualifications or limitations as determined solely by the Company&amp;#146;s board of directors.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;u style=&quot;text-underline:black&quot;&gt;Warrants&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;As of March 31, 2013, the Company had warrants outstanding and exercisable to purchase an aggregate of 150,000 shares of the Company&apos;s common stock at exercise prices ranging from $3.00 to $3.80 per share, which expire May 16, 2013. At March 31, 2013, the warrants had a weighted-average exercise price of $3.40 per share, a weighted-average remaining contractual life of 0.2 years and a total intrinsic value of $0.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;u style=&quot;text-underline:black&quot;&gt;Stock and Stock Options&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;i&gt;2010 Incentive Plan&lt;/i&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;On November 12, 2010, the Company&amp;#146;s Board of Directors adopted, and on December 22, 2010 its stockholders approved, the 2010 Long-Term Incentive Plan&amp;nbsp;&amp;nbsp;(the &amp;#147;2010 Incentive Plan&amp;#148;), which gave the Company the ability to grant stock options, restricted stock, stock appreciation rights and performance units to its employees, directors and consultants, or those who will become employees, directors and consultants of the Company and/or its subsidiaries. The 2010 Incentive Plan currently allows for equity awards of up to 4,000,000 shares of common stock. Through March 31, 2013, 75,000 shares of common stock and options to purchase an aggregate of 25,000 shares of stock options had been granted under the 2010 Incentive Plan.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;There were no securities issued from the 2010 Incentive Plan during the three months ended March 31, 2013.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;At March 31, 2013, there was no remaining unrecognized compensation expense related to stock options or restrictive stock grants.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
	<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 12 &amp;#150; CONTINGENCIES&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;i&gt;Economic environment &lt;/i&gt;&lt;/b&gt;&lt;b&gt;- &lt;/b&gt;Substantially all of the Company&apos;s operations are conducted in the PRC, and therefore the Company is subject to special considerations and significant risks not typically associated with companies operating in the United States of America. These risks include, among others, the political, economic and legal environments and fluctuations in the foreign currency exchange rate. The Company&apos;s results from operations may be adversely affected by changes in the political and social conditions in the PRC, and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things. The unfavorable changes in global macroeconomic factors may also adversely affect the Company&amp;#146;s operations.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;In addition, all of the Company&apos;s revenue is denominated in the PRC&apos;s currency of Renminbi (RMB), which must be converted into other currencies before remittance out of the PRC. Both the conversion of RMB into foreign currencies and the remittance of foreign currencies abroad require approval of the PRC government.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
	<us-gaap:ConcentrationRiskDisclosureTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;NOTE 13 &amp;#150; CONCENTRATIONS&lt;/b&gt;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;At March 31, 2013, one customer accounted for 10.5% of accounts receivable.&amp;nbsp;&amp;nbsp;At December 31, 2012, no customer accounted for more than 10.0% of accounts receivable.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;For the three months ended March 31, 2013, no customer accounted for more than 10% of sales. For the three months ended March 31, 2012, one customer accounted for 10.3% of sales.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;For the three months ended March 31, 2013, purchases from one supplier accounted for 34.0% of raw material purchases. For the three months ended March 31, 2012, purchases from one supplier accounted for 14.1% of raw material purchases.&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
	<us-gaap:NatureOfOperations contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;i&gt;Organization and Nature of Operations &amp;#150; &lt;/i&gt;&lt;/b&gt;China Pharma Holdings, Inc., a Nevada corporation, owns 100% of Onny Investment Limited (&amp;#147;Onny&amp;#148;), a British Virgin Islands corporation, that in turn owns 100% of Hainan Helpson Medical &amp;amp; Biotechnology Co., Ltd (&amp;#147;Helpson&amp;#148;), a corporation organized under the laws of the People&apos;s Republic of China (the &amp;#147;PRC&amp;#148;). China Pharma Holdings, Inc. and its subsidiaries are referred to herein as the Company.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;On December 31, 2012, China Pharma Holdings, Inc consummated a reincorporation merger for the purpose of changing the state of incorporation from Delaware to Nevada pursuant to the terms and conditions of an Agreement and Plan of Merger dated December 27, 2012.&amp;nbsp;&amp;nbsp;The reincorporation merger was approved by stockholders holding the majority of the outstanding common shares on December 21, 2012.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The Foreign Investment Industrial Catalogue&lt;i&gt;&amp;nbsp;&lt;/i&gt;(the &amp;#147;Catalogue&amp;#148;) jointly issued by the China&amp;#146;s Ministry of Commerce and the National Development and Reform Commission (as the latest version is the year 2012 version, effective January 30, 2012) classified various industries/businesses into three different categories: (i) encouraged for foreign investment; (ii) restricted to foreign investment; and (iii) prohibited from foreign investment. For any industry/business not covered by any of these three categories, they will be deemed industries/businesses permitted for foreign investment. A typical foreign investment ownership restriction in the pharmaceutical industry is that a foreign investment enterprise (the &amp;#147;FIE&amp;#148;) shall not have the whole or majority of its equity interests owned by a foreign owner if the FIE establishes more than 30 branch stores and distributes a variety of brands in those franchise stores, which is not the case of the Company&amp;#146;s business.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Helpson manufactures and markets generic and branded pharmaceutical products as well as biochemical products primarily to hospitals and private retailers located throughout the PRC. The Company believes Helpson&amp;#146;s business is not subject to any ownership restrictions prescribed under the Catalogue. Onny acquired 100% of the ownership in Helpson from Helpson&amp;#146;s three former shareholders on May 25, 2005 by entry into an Equity Transfer Agreement with such three parties on May 25, 2005. The transaction was approved by the Commercial Bureau of Hainan Province on June 12, 2005 and Helpson received the Certificate of Approval for Establishing of Enterprises with Foreign Investment in the PRC on the same day and its business license evidencing its WFOE (Wholly Foreign Owned Enterprise) status on June 21, 2005.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The Company has and continues to acquire well-accepted medical formulas to a diverse portfolio of Western and Chinese medicines.&lt;/p&gt;</us-gaap:NatureOfOperations>
	<us-gaap:ConsolidationPolicyTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;i&gt;Consolidation and Basis of Presentation &lt;/i&gt;&lt;/b&gt;&amp;#150; The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&amp;#147;U.S. GAAP&amp;#148;) and are expressed in United States dollars. The accompanying consolidated financial statements include the accounts and operations of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Helpson&amp;#146;s functional currency is the Chinese Renminbi. Helpson&amp;#146;s revenue and expenses are translated into United States dollars at the average exchange rate for the period. Assets and liabilities are translated at the exchange rate as of the end of the reporting period. Gains or losses from translating Helpson&amp;#146;s financial statements are included in accumulated other comprehensive income, which is a component of stockholders&amp;#146; equity. Gains and losses arising from transactions denominated in a currency other than the functional currency of the entity that is a party to the transaction are included in the results of operations.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
	<us-gaap:UseOfEstimates contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;i&gt;Accounting Estimates &lt;/i&gt;&lt;/b&gt;&lt;b&gt;- &lt;/b&gt;The preparation of financial statements in conformity with&amp;nbsp;U.S. GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
	<us-gaap:EarningsPerSharePolicyTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;i&gt;Basic and Diluted Earnings per Common Share &lt;/i&gt;&lt;/b&gt;&lt;b&gt;- &lt;/b&gt;Basic earnings per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is calculated to give effect to potentially issuable dilutive common shares.&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The following table is a presentation of the numerators and denominators used in the calculation of basic and diluted earnings per share:&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;table width=&quot;520&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:390pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;179&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;For the Three Months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;179&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Ended March 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Net (loss) income&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (2,812,307)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 2,806,359 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Basic weighted-average common shares outstanding&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;43,579,557 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;43,529,557 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Effect of dilutive securities:&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt&quot;&gt;Warrants&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt&quot;&gt;Options&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:19.5pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Diluted weighted-average common shares outstanding&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;43,579,557 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;43,529,557 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:0.25in&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Basic (loss) earnings per share&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (0.06)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 0.06 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:0.25in&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Diluted (loss) earnings per share&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (0.06)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;0.06 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot; align=&quot;center&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot; align=&quot;center&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The following potential common shares were not included in the computation of diluted earnings per share as their effect would have been anti-dilutive:&amp;nbsp;&lt;/p&gt; &lt;table width=&quot;520&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:390pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;179&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;For the Three Months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;179&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Ended March 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Warrants with exercise prices of $3.00 to $3.80 per share&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 150,000 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 150,000 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Options with an exercise price of $2.54 to $3.47 per share&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 25,000 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 310,000 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.5pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt&quot;&gt;Total&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 175,000 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 460,000 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
	<us-gaap:BasisOfAccounting contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;i&gt;Condensed Financial Statements &lt;/i&gt;&lt;/b&gt;&amp;#150; The accompanying unaudited condensed consolidated financial statements were prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission (the &amp;#147;Commission&amp;#148;). Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Management of the Company (&amp;#147;Management&amp;#148;) believes the following disclosures are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&apos;s Annual Report on Form 10-K for the year ended December 31, 2012 filed with the Commission on March 14, 2013.&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;These unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) that, in the opinion of Management, are necessary to present fairly the consolidated financial position and results of operations of the Company for the periods presented. Operating results for the three months ended March 31, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013.&lt;/p&gt;</us-gaap:BasisOfAccounting>
	<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The following table is a presentation of the numerators and denominators used in the calculation of basic and diluted earnings per share:&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;table width=&quot;520&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:390pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;179&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;For the Three Months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;179&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Ended March 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Net (loss) income&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (2,812,307)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 2,806,359 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Basic weighted-average common shares outstanding&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;43,579,557 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;43,529,557 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Effect of dilutive securities:&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt&quot;&gt;Warrants&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt&quot;&gt;Options&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;top&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:19.5pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Diluted weighted-average common shares outstanding&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;43,579,557 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;43,529,557 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:0.25in&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Basic (loss) earnings per share&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (0.06)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 0.06 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:0.25in&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Diluted (loss) earnings per share&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (0.06)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;85&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;0.06 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
	<fil:PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The following potential common shares were not included in the computation of diluted earnings per share as their effect would have been anti-dilutive:&amp;nbsp;&lt;/p&gt; &lt;table width=&quot;520&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:390pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;179&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;For the Three Months&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;179&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Ended March 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Warrants with exercise prices of $3.00 to $3.80 per share&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 150,000 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 150,000 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Options with an exercise price of $2.54 to $3.47 per share&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 25,000 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 310,000 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.5pt&quot;&gt; &lt;td width=&quot;341&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt&quot;&gt;Total&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 175,000 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 460,000 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</fil:PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock>
	<us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Inventory consisted of the following:&amp;nbsp;&lt;/p&gt; &lt;p&gt; &lt;/p&gt;&lt;table width=&quot;483&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:362.4pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;&amp;nbsp;March 31, &lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;&amp;nbsp;December 31, &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Raw materials&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 28,380,903&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 30,198,816 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Finished goods&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 6,659,052 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 7,930,684 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 35,039,955&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 38,129,500 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Obsolescence reserve&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (1,779,729)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (1,769,984)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10.05pt; MARGIN:0in 0in 0pt&quot;&gt;&lt;b&gt;Total Inventory&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 33,260,226 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 36,359,516 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
	<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Property and equipment consisted of the following:&lt;/p&gt; &lt;table width=&quot;477&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:357.4pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;&amp;nbsp;March 31, &lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;&amp;nbsp;December 31, &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Permit of land use&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 449,474 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 447,013 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Building&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 2,432,442 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 2,419,125 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Plant, machinery and equipment&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 6,418,768 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 6,381,209 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Motor vehicle&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 147,890 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;147,080 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Office equipment&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 223,947 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 222,273 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Construction in progress&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 4,127,396 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 3,688,567 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; TEXT-INDENT:10.05pt; MARGIN:0in 0in 0pt&quot;&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 13,799,917 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 13,305,267 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Less: accumulated depreciation&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;(4,511,658)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (4,273,373)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&lt;b&gt;Property and Equipment, net&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 9,288,259 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;101&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 9,031,894 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
	<fil:UsefulLivesOfTheAssetsTableTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Depreciation is computed on a straight-line basis over the estimated useful lives of the assets as follows:&lt;/p&gt; &lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;table width=&quot;359&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:269pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;Asset&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&amp;nbsp;Life - years &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Permit of land use&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;40 - 70&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Building&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;20 - 35&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Plant, machinery and equipment&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Motor vehicle&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;5 - 10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;251&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Office equipment&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;3-5&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</fil:UsefulLivesOfTheAssetsTableTextBlock>
	<fil:IntangibleAssetsMedicalFormulasTablesTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;At March 31, 2013 and December 31, 2012, intangible assets consisted solely of CFDA approved medical formulas as follows:&lt;/p&gt; &lt;table width=&quot;393&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:294.9pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;187&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;187&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;187&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Gross carrying amount&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 5,387,075 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 5,357,580 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;187&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Accumulated amortization&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (3,097,224)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (2,944,726)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.5pt&quot;&gt; &lt;td width=&quot;187&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Net carrying amount&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;91&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 2,289,851 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;88&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 2,412,854 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</fil:IntangibleAssetsMedicalFormulasTablesTextBlock>
	<fil:IncomeTaxesTableTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Under current tax law in the PRC, the Company is and will be subject to the following enterprise income tax rates:&lt;/p&gt; &lt;table width=&quot;240&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:2.5in; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;25&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;119&quot; style=&quot;BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:89pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Enterprise Income Tax Rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;25&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;2013&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;25&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;119&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:89pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;15%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;96&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;2014 and after&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;25&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;119&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:89pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;25%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</fil:IncomeTaxesTableTextBlock>
	<fil:ProvisionForIncomeTaxesTableTextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The provision for income taxes consisted of the following:&lt;/p&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;table width=&quot;515&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:386pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;304&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;199&quot; colspan=&quot;3&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:149pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Three months ended March 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;304&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;304&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Current&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 564,893 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;304&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Deferred&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (269,011)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (34,312)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.9pt&quot;&gt; &lt;td width=&quot;304&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&lt;b&gt;Total income tax (benefit) expense&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (269,011)&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;2&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;98&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 530,581 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</fil:ProvisionForIncomeTaxesTableTextBlock>
	<fil:AssetsFairValuesTablETextBlock contextRef='Y13Q1'>&lt;!--egx--&gt;&lt;p style=&quot;TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;The Company uses fair value to measure the value of the banker&amp;#146;s acceptance notes it holds.&amp;nbsp;&amp;nbsp;The banker&amp;#146;s acceptance notes are recorded at cost which approximates fair value.&amp;nbsp;&amp;nbsp;The Company held the following assets recorded at fair value as of March 31, 2013 and December 31, 2012:&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table width=&quot;549&quot; style=&quot;MARGIN:auto auto auto -0.75pt; WIDTH:411.55pt; BORDER-COLLAPSE:collapse&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;243&quot; colspan=&quot;5&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Fair Value Measurements at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;243&quot; colspan=&quot;5&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Reporting Date Using&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&lt;b&gt;March 31, 2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Banker&apos;s acceptance notes&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 1,180,864&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 1,180,864&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.5pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Total&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 1,180,864&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 1,180,864&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;243&quot; colspan=&quot;5&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Fair Value Measurements at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;243&quot; colspan=&quot;5&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Reporting Date Using&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;right&quot;&gt;&lt;b&gt;December 31, 2012&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot; align=&quot;center&quot;&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:12.75pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Banker&apos;s acceptance notes&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 101,570 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 101,570 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:13.5pt&quot;&gt; &lt;td width=&quot;160&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;Total&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;122&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 101,570 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 101,570 &lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;3&quot; style=&quot;BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td width=&quot;65&quot; style=&quot;BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt&quot;&gt;&amp;nbsp;$&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; -&amp;nbsp;&amp;nbsp; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&quot;LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;/p&gt;</fil:AssetsFairValuesTablETextBlock>
	<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent unitRef='USD' contextRef='E13Q1' decimals='INF'>4333411</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
	<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent unitRef='USD' contextRef='E12' decimals='INF'>4429945</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
	<fil:AllowanceForDoubtfulAccountsOnOtherReceivables unitRef='USD' contextRef='E13Q1' decimals='INF'>50592</fil:AllowanceForDoubtfulAccountsOnOtherReceivables>
	<fil:AllowanceForDoubtfulAccountsOnOtherReceivables unitRef='USD' contextRef='E12' decimals='INF'>49881</fil:AllowanceForDoubtfulAccountsOnOtherReceivables>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef='USD' contextRef='E13Q1' decimals='INF'>4511658</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef='USD' contextRef='E12' decimals='INF'>4273373</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef='USD' contextRef='E13Q1' decimals='INF'>3097224</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef='USD' contextRef='E12' decimals='INF'>2944726</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:PreferredStockParOrStatedValuePerShare unitRef='UsdPerShare' contextRef='E13Q1' decimals='INF'>0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockParOrStatedValuePerShare unitRef='UsdPerShare' contextRef='E12' decimals='INF'>0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockSharesAuthorized unitRef='Shares' contextRef='E13Q1' decimals='INF'>5000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesAuthorized unitRef='Shares' contextRef='E12' decimals='INF'>5000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesIssued unitRef='Shares' contextRef='E13Q1' decimals='INF'>0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesIssued unitRef='Shares' contextRef='E12' decimals='INF'>0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesOutstanding unitRef='Shares' contextRef='E13Q1' decimals='INF'>0</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:PreferredStockSharesOutstanding unitRef='Shares' contextRef='E12' decimals='INF'>0</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:CommonStockParOrStatedValuePerShare unitRef='UsdPerShare' contextRef='E13Q1' decimals='INF'>0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare unitRef='UsdPerShare' contextRef='E12' decimals='INF'>0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized unitRef='Shares' contextRef='E13Q1' decimals='INF'>95000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized unitRef='Shares' contextRef='E12' decimals='INF'>95000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued unitRef='Shares' contextRef='E13Q1' decimals='INF'>43579557</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesIssued unitRef='Shares' contextRef='E12' decimals='INF'>43579557</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding unitRef='Shares' contextRef='E13Q1' decimals='INF'>43579557</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesOutstanding unitRef='Shares' contextRef='E12' decimals='INF'>43579557</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:Revenues unitRef='USD' contextRef='Y13Q1' decimals='INF'>8249387</us-gaap:Revenues>
	<us-gaap:Revenues unitRef='USD' contextRef='Y12Q1' decimals='INF'>16086731</us-gaap:Revenues>
	<us-gaap:CostOfRevenue unitRef='USD' contextRef='Y13Q1' decimals='INF'>6125400</us-gaap:CostOfRevenue>
	<us-gaap:CostOfRevenue unitRef='USD' contextRef='Y12Q1' decimals='INF'>10782384</us-gaap:CostOfRevenue>
	<us-gaap:InventoryWriteDown unitRef='USD' contextRef='Y13Q1' decimals='INF'>3692895</us-gaap:InventoryWriteDown>
	<us-gaap:InventoryWriteDown unitRef='USD' contextRef='Y12Q1' decimals='INF'>0</us-gaap:InventoryWriteDown>
	<us-gaap:GrossProfit unitRef='USD' contextRef='Y13Q1' decimals='INF'>-1568908</us-gaap:GrossProfit>
	<us-gaap:GrossProfit unitRef='USD' contextRef='Y12Q1' decimals='INF'>5304347</us-gaap:GrossProfit>
	<us-gaap:SellingExpense unitRef='USD' contextRef='Y13Q1' decimals='INF'>812054</us-gaap:SellingExpense>
	<us-gaap:SellingExpense unitRef='USD' contextRef='Y12Q1' decimals='INF'>894060</us-gaap:SellingExpense>
	<us-gaap:GeneralAndAdministrativeExpense unitRef='USD' contextRef='Y13Q1' decimals='INF'>739427</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense unitRef='USD' contextRef='Y12Q1' decimals='INF'>676402</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:ProvisionForDoubtfulAccounts unitRef='USD' contextRef='Y13Q1' decimals='INF'>-119930</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:ProvisionForDoubtfulAccounts unitRef='USD' contextRef='Y12Q1' decimals='INF'>320098</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:OperatingExpenses unitRef='USD' contextRef='Y13Q1' decimals='INF'>1431551</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses unitRef='USD' contextRef='Y12Q1' decimals='INF'>1890560</us-gaap:OperatingExpenses>
	<us-gaap:OperatingIncomeLoss unitRef='USD' contextRef='Y13Q1' decimals='INF'>-3000459</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss unitRef='USD' contextRef='Y12Q1' decimals='INF'>3413787</us-gaap:OperatingIncomeLoss>
	<us-gaap:InvestmentIncomeInterest unitRef='USD' contextRef='Y13Q1' decimals='INF'>1586</us-gaap:InvestmentIncomeInterest>
	<us-gaap:InvestmentIncomeInterest unitRef='USD' contextRef='Y12Q1' decimals='INF'>690</us-gaap:InvestmentIncomeInterest>
	<us-gaap:InterestExpense unitRef='USD' contextRef='Y13Q1' decimals='INF'>-82445</us-gaap:InterestExpense>
	<us-gaap:InterestExpense unitRef='USD' contextRef='Y12Q1' decimals='INF'>-77537</us-gaap:InterestExpense>
	<us-gaap:OtherExpenses unitRef='USD' contextRef='Y13Q1' decimals='INF'>-80859</us-gaap:OtherExpenses>
	<us-gaap:OtherExpenses unitRef='USD' contextRef='Y12Q1' decimals='INF'>-76847</us-gaap:OtherExpenses>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest unitRef='USD' contextRef='Y13Q1' decimals='INF'>-3081318</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest unitRef='USD' contextRef='Y12Q1' decimals='INF'>3336940</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
	<us-gaap:IncomeTaxExpenseBenefit unitRef='USD' contextRef='Y13Q1' decimals='INF'>269011</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit unitRef='USD' contextRef='Y12Q1' decimals='INF'>-530581</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:ProfitLoss unitRef='USD' contextRef='Y13Q1' decimals='INF'>2812307</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss unitRef='USD' contextRef='Y12Q1' decimals='INF'>2806359</us-gaap:ProfitLoss>
	<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease unitRef='USD' contextRef='Y13Q1' decimals='INF'>819767</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
	<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease unitRef='USD' contextRef='Y12Q1' decimals='INF'>-407517</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
	<us-gaap:ComprehensiveIncomeNetOfTax unitRef='USD' contextRef='Y13Q1' decimals='INF'>-1992540</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTax unitRef='USD' contextRef='Y12Q1' decimals='INF'>2398842</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:EarningsPerShareBasic unitRef='UsdPerShare' contextRef='Y13Q1' decimals='INF'>-0.06</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic unitRef='UsdPerShare' contextRef='Y12Q1' decimals='INF'>0.06</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareDiluted unitRef='UsdPerShare' contextRef='Y13Q1' decimals='INF'>-0.06</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted unitRef='UsdPerShare' contextRef='Y12Q1' decimals='INF'>0.06</us-gaap:EarningsPerShareDiluted>
	<us-gaap:NetIncomeLoss unitRef='USD' contextRef='Y13Q1' decimals='INF'>-2812307</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss unitRef='USD' contextRef='Y12Q1' decimals='INF'>2806359</us-gaap:NetIncomeLoss>
	<us-gaap:DepreciationAndAmortization unitRef='USD' contextRef='Y13Q1' decimals='INF'>350468</us-gaap:DepreciationAndAmortization>
	<us-gaap:DepreciationAndAmortization unitRef='USD' contextRef='Y12Q1' decimals='INF'>365223</us-gaap:DepreciationAndAmortization>
	<fil:StockBasedCompensation unitRef='USD' contextRef='Y13Q1' decimals='INF'>0</fil:StockBasedCompensation>
	<fil:StockBasedCompensation unitRef='USD' contextRef='Y12Q1' decimals='INF'>56489</fil:StockBasedCompensation>
	<us-gaap:DeferredIncomeTaxExpenseBenefit unitRef='USD' contextRef='Y13Q1' decimals='INF'>31761</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxExpenseBenefit unitRef='USD' contextRef='Y12Q1' decimals='INF'>-34312</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<fil:InventoryObsolescenceReserve unitRef='USD' contextRef='Y13Q1' decimals='INF'>3692895</fil:InventoryObsolescenceReserve>
	<fil:InventoryObsolescenceReserve unitRef='USD' contextRef='Y12Q1' decimals='INF'>0</fil:InventoryObsolescenceReserve>
	<us-gaap:IncreaseDecreaseInAccountsReceivable unitRef='USD' contextRef='Y13Q1' decimals='INF'>589186</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable unitRef='USD' contextRef='Y12Q1' decimals='INF'>-4141146</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInOtherReceivables unitRef='USD' contextRef='Y13Q1' decimals='INF'>-173763</us-gaap:IncreaseDecreaseInOtherReceivables>
	<us-gaap:IncreaseDecreaseInOtherReceivables unitRef='USD' contextRef='Y12Q1' decimals='INF'>-20247</us-gaap:IncreaseDecreaseInOtherReceivables>
	<fil:ChangesInAdvancesToSuppliers unitRef='USD' contextRef='Y13Q1' decimals='INF'>-276405</fil:ChangesInAdvancesToSuppliers>
	<fil:ChangesInAdvancesToSuppliers unitRef='USD' contextRef='Y12Q1' decimals='INF'>944949</fil:ChangesInAdvancesToSuppliers>
	<us-gaap:IncreaseDecreaseInInventories unitRef='USD' contextRef='Y13Q1' decimals='INF'>1890843</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInInventories unitRef='USD' contextRef='Y12Q1' decimals='INF'>-3351458</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInAccountsPayableTrade unitRef='USD' contextRef='Y13Q1' decimals='INF'>122430</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
	<us-gaap:IncreaseDecreaseInAccountsPayableTrade unitRef='USD' contextRef='Y12Q1' decimals='INF'>2725945</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef='USD' contextRef='Y13Q1' decimals='INF'>-32516</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef='USD' contextRef='Y12Q1' decimals='INF'>11517</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccruedTaxesPayable unitRef='USD' contextRef='Y13Q1' decimals='INF'>-1922780</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
	<us-gaap:IncreaseDecreaseInAccruedTaxesPayable unitRef='USD' contextRef='Y12Q1' decimals='INF'>443684</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
	<us-gaap:IncreaseDecreaseInOtherAccountsPayable unitRef='USD' contextRef='Y13Q1' decimals='INF'>-11715</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
	<us-gaap:IncreaseDecreaseInOtherAccountsPayable unitRef='USD' contextRef='Y12Q1' decimals='INF'>54337</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
	<us-gaap:IncreaseDecreaseInCustomerAdvances unitRef='USD' contextRef='Y13Q1' decimals='INF'>-220418</us-gaap:IncreaseDecreaseInCustomerAdvances>
	<us-gaap:IncreaseDecreaseInCustomerAdvances unitRef='USD' contextRef='Y12Q1' decimals='INF'>219942</us-gaap:IncreaseDecreaseInCustomerAdvances>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef='USD' contextRef='Y13Q1' decimals='INF'>1107749</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef='USD' contextRef='Y12Q1' decimals='INF'>401380</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<fil:NetInvestmentInBankerSAcceptances unitRef='USD' contextRef='Y13Q1' decimals='INF'>0</fil:NetInvestmentInBankerSAcceptances>
	<fil:NetInvestmentInBankerSAcceptances unitRef='USD' contextRef='Y12Q1' decimals='INF'>-281674</fil:NetInvestmentInBankerSAcceptances>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef='USD' contextRef='Y13Q1' decimals='INF'>-4373</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef='USD' contextRef='Y12Q1' decimals='INF'>-7926</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef='USD' contextRef='Y13Q1' decimals='INF'>-404365</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef='USD' contextRef='Y12Q1' decimals='INF'>-1079692</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef='USD' contextRef='Y13Q1' decimals='INF'>0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef='USD' contextRef='Y12Q1' decimals='INF'>0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents unitRef='USD' contextRef='Y13Q1' decimals='INF'>17376</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents unitRef='USD' contextRef='Y12Q1' decimals='INF'>-52736</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef='USD' contextRef='Y13Q1' decimals='INF'>720760</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef='USD' contextRef='Y12Q1' decimals='INF'>-731048</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef='USD' contextRef='E12' decimals='INF'>4029708</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef='USD' contextRef='E11' decimals='INF'>4050854</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef='USD' contextRef='E13Q1' decimals='INF'>4750468</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef='USD' contextRef='E12Q1' decimals='INF'>3319806</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:InterestPaid unitRef='USD' contextRef='Y13Q1' decimals='INF'>111346</us-gaap:InterestPaid>
	<us-gaap:InterestPaid unitRef='USD' contextRef='Y12Q1' decimals='INF'>75567</us-gaap:InterestPaid>
	<us-gaap:IncomeTaxesPaidNet unitRef='USD' contextRef='Y13Q1' decimals='INF'>1593510</us-gaap:IncomeTaxesPaidNet>
	<us-gaap:IncomeTaxesPaidNet unitRef='USD' contextRef='Y12Q1' decimals='INF'>274587</us-gaap:IncomeTaxesPaidNet>
	<fil:AccountsPayableForPurchasesOfPropertyAndEquipment unitRef='USD' contextRef='Y13Q1' decimals='INF'>151064</fil:AccountsPayableForPurchasesOfPropertyAndEquipment>
	<fil:AccountsPayableForPurchasesOfPropertyAndEquipment unitRef='USD' contextRef='Y12Q1' decimals='INF'>144057</fil:AccountsPayableForPurchasesOfPropertyAndEquipment>
	<fil:AccountsReceivableCollectedWithBankerSAcceptances unitRef='USD' contextRef='Y13Q1' decimals='INF'>3366655</fil:AccountsReceivableCollectedWithBankerSAcceptances>
	<fil:AccountsReceivableCollectedWithBankerSAcceptances unitRef='USD' contextRef='Y12Q1' decimals='INF'>406604</fil:AccountsReceivableCollectedWithBankerSAcceptances>
	<fil:InventoryPurchasedWithBankerSAcceptances unitRef='USD' contextRef='Y13Q1' decimals='INF'>2289690</fil:InventoryPurchasedWithBankerSAcceptances>
	<fil:InventoryPurchasedWithBankerSAcceptances unitRef='USD' contextRef='Y12Q1' decimals='INF'>406604</fil:InventoryPurchasedWithBankerSAcceptances>
	<fil:PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited unitRef='Pure' contextRef='E13Q1' decimals='INF'>1.0000</fil:PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited>
	<fil:PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd unitRef='Pure' contextRef='E13Q1' decimals='INF'>1.0000</fil:PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd>
	<fil:PercetageOfAcquiredByOnnyInHelpson unitRef='Pure' contextRef='E13Q1' decimals='INF'>1.0000</fil:PercetageOfAcquiredByOnnyInHelpson>
	<fil:NetIncome unitRef='USD' contextRef='Y13Q1' decimals='INF'>-2812307</fil:NetIncome>
	<fil:NetIncome unitRef='USD' contextRef='Y12Q1' decimals='INF'>2806359</fil:NetIncome>
	<us-gaap:WeightedAverageNumberOfSharesIssuedBasic unitRef='Shares' contextRef='Y13Q1' decimals='INF'>43579557</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
	<us-gaap:WeightedAverageNumberOfSharesIssuedBasic unitRef='Shares' contextRef='Y12Q1' decimals='INF'>43529557</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
	<fil:Warrants unitRef='USD' contextRef='Y13Q1' decimals='INF'>0</fil:Warrants>
	<fil:Warrants unitRef='USD' contextRef='Y12Q1' decimals='INF'>0</fil:Warrants>
	<fil:Options unitRef='USD' contextRef='Y13Q1' decimals='INF'>0</fil:Options>
	<fil:Options unitRef='USD' contextRef='Y12Q1' decimals='INF'>0</fil:Options>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding unitRef='Shares' contextRef='Y13Q1' decimals='INF'>43579557</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding unitRef='Shares' contextRef='Y12Q1' decimals='INF'>43529557</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<fil:BasicEarningsPerShare unitRef='UsdPerShare' contextRef='Y13Q1' decimals='INF'>-0.06</fil:BasicEarningsPerShare>
	<fil:BasicEarningsPerShare unitRef='UsdPerShare' contextRef='Y12Q1' decimals='INF'>0.06</fil:BasicEarningsPerShare>
	<fil:DilutedEarningsPerShare unitRef='UsdPerShare' contextRef='Y13Q1' decimals='INF'>-0.06</fil:DilutedEarningsPerShare>
	<fil:DilutedEarningsPerShare unitRef='UsdPerShare' contextRef='Y12Q1' decimals='INF'>0.06</fil:DilutedEarningsPerShare>
	<fil:WarrantsWithExercisePrice unitRef='Shares' contextRef='Y13Q1' decimals='INF'>150000</fil:WarrantsWithExercisePrice>
	<fil:WarrantsWithExercisePrice unitRef='Shares' contextRef='Y12Q1' decimals='INF'>150000</fil:WarrantsWithExercisePrice>
	<fil:OptionsWithAnExercisePrice unitRef='Shares' contextRef='Y13Q1' decimals='INF'>25000</fil:OptionsWithAnExercisePrice>
	<fil:OptionsWithAnExercisePrice unitRef='Shares' contextRef='Y12Q1' decimals='INF'>310000</fil:OptionsWithAnExercisePrice>
	<fil:TotalWarrantsAndOptions unitRef='Shares' contextRef='Y13Q1' decimals='INF'>175000</fil:TotalWarrantsAndOptions>
	<fil:TotalWarrantsAndOptions unitRef='Shares' contextRef='Y12Q1' decimals='INF'>460000</fil:TotalWarrantsAndOptions>
	<us-gaap:InventoryRawMaterials unitRef='USD' contextRef='E13Q1' decimals='INF'>28380903</us-gaap:InventoryRawMaterials>
	<us-gaap:InventoryRawMaterials unitRef='USD' contextRef='E12' decimals='INF'>30198816</us-gaap:InventoryRawMaterials>
	<us-gaap:InventoryFinishedGoods unitRef='USD' contextRef='E13Q1' decimals='INF'>6659052</us-gaap:InventoryFinishedGoods>
	<us-gaap:InventoryFinishedGoods unitRef='USD' contextRef='E12' decimals='INF'>7930684</us-gaap:InventoryFinishedGoods>
	<us-gaap:InventoryGross unitRef='USD' contextRef='E13Q1' decimals='INF'>35039955</us-gaap:InventoryGross>
	<us-gaap:InventoryGross unitRef='USD' contextRef='E12' decimals='INF'>38129500</us-gaap:InventoryGross>
	<fil:AllowanceForObsolescenceRawMaterials unitRef='USD' contextRef='E13Q1' decimals='INF'>-1779729</fil:AllowanceForObsolescenceRawMaterials>
	<fil:AllowanceForObsolescenceRawMaterials unitRef='USD' contextRef='E12' decimals='INF'>-1769984</fil:AllowanceForObsolescenceRawMaterials>
	<fil:TotalInventoryNet unitRef='USD' contextRef='E13Q1' decimals='INF'>33260226</fil:TotalInventoryNet>
	<fil:TotalInventoryNet unitRef='USD' contextRef='E12' decimals='INF'>36359516</fil:TotalInventoryNet>
	<fil:PermitOfLandUse unitRef='USD' contextRef='E13Q1' decimals='INF'>449474</fil:PermitOfLandUse>
	<fil:PermitOfLandUse unitRef='USD' contextRef='E12' decimals='INF'>447013</fil:PermitOfLandUse>
	<us-gaap:BuildingsAndImprovementsGross unitRef='USD' contextRef='E13Q1' decimals='INF'>2432442</us-gaap:BuildingsAndImprovementsGross>
	<us-gaap:BuildingsAndImprovementsGross unitRef='USD' contextRef='E12' decimals='INF'>2419125</us-gaap:BuildingsAndImprovementsGross>
	<fil:PlantMachineryAndEquipmentGross unitRef='USD' contextRef='E13Q1' decimals='INF'>6418768</fil:PlantMachineryAndEquipmentGross>
	<fil:PlantMachineryAndEquipmentGross unitRef='USD' contextRef='E12' decimals='INF'>6381209</fil:PlantMachineryAndEquipmentGross>
	<fil:MotorVehicleGross unitRef='USD' contextRef='E13Q1' decimals='INF'>147890</fil:MotorVehicleGross>
	<fil:MotorVehicleGross unitRef='USD' contextRef='E12' decimals='INF'>147080</fil:MotorVehicleGross>
	<us-gaap:FurnitureAndFixturesGross unitRef='USD' contextRef='E13Q1' decimals='INF'>223947</us-gaap:FurnitureAndFixturesGross>
	<us-gaap:FurnitureAndFixturesGross unitRef='USD' contextRef='E12' decimals='INF'>222273</us-gaap:FurnitureAndFixturesGross>
	<us-gaap:ConstructionInProgressGross unitRef='USD' contextRef='E13Q1' decimals='INF'>4127396</us-gaap:ConstructionInProgressGross>
	<us-gaap:ConstructionInProgressGross unitRef='USD' contextRef='E12' decimals='INF'>3688567</us-gaap:ConstructionInProgressGross>
	<fil:LessAccumulatedDepreciationDetails unitRef='USD' contextRef='E13Q1' decimals='INF'>-4511658</fil:LessAccumulatedDepreciationDetails>
	<fil:LessAccumulatedDepreciationDetails unitRef='USD' contextRef='E12' decimals='INF'>-4273373</fil:LessAccumulatedDepreciationDetails>
	<fil:PropertyAndEquipmentNet unitRef='USD' contextRef='E13Q1' decimals='INF'>9288259</fil:PropertyAndEquipmentNet>
	<fil:PropertyAndEquipmentNet unitRef='USD' contextRef='E12' decimals='INF'>9031894</fil:PropertyAndEquipmentNet>
	<fil:TotalPropertyAndEquipment unitRef='USD' contextRef='E13Q1' decimals='INF'>13799917</fil:TotalPropertyAndEquipment>
	<fil:TotalPropertyAndEquipment unitRef='USD' contextRef='E12' decimals='INF'>13305267</fil:TotalPropertyAndEquipment>
	<fil:PermitOfLandUseMinimumLife unitRef='Pure' contextRef='E13Q1' decimals='INF'>40</fil:PermitOfLandUseMinimumLife>
	<fil:PermitOfLandUseMaximumLife unitRef='Pure' contextRef='E13Q1' decimals='INF'>70</fil:PermitOfLandUseMaximumLife>
	<fil:BuildingMinimumLife unitRef='Pure' contextRef='E13Q1' decimals='INF'>20</fil:BuildingMinimumLife>
	<fil:BuildingMaximumLife unitRef='Pure' contextRef='E13Q1' decimals='INF'>35</fil:BuildingMaximumLife>
	<fil:PlantMachineryAndEquipmentLife unitRef='Pure' contextRef='E13Q1' decimals='INF'>10</fil:PlantMachineryAndEquipmentLife>
	<fil:MotorVehicleMinimumLife unitRef='Pure' contextRef='E13Q1' decimals='INF'>5</fil:MotorVehicleMinimumLife>
	<fil:MotorVehicleMaximumLife unitRef='Pure' contextRef='E13Q1' decimals='INF'>10</fil:MotorVehicleMaximumLife>
	<fil:OfficeEquipmentMinimumLife unitRef='Pure' contextRef='E13Q1' decimals='INF'>3</fil:OfficeEquipmentMinimumLife>
	<fil:OfficeEquipmentMaximumLife unitRef='Pure' contextRef='E13Q1' decimals='INF'>5</fil:OfficeEquipmentMaximumLife>
	<fil:DepreciationExpensePropertyAndEquipment unitRef='USD' contextRef='Y13Q1' decimals='INF'>214406</fil:DepreciationExpensePropertyAndEquipment>
	<fil:DepreciationExpensePropertyAndEquipment unitRef='USD' contextRef='Y12Q1' decimals='INF'>212424</fil:DepreciationExpensePropertyAndEquipment>
	<fil:AmortizationExpenseIntangibleAssets unitRef='USD' contextRef='Y13Q1' decimals='INF'>136062</fil:AmortizationExpenseIntangibleAssets>
	<fil:AmortizationExpenseIntangibleAssets unitRef='USD' contextRef='Y12Q1' decimals='INF'>152799</fil:AmortizationExpenseIntangibleAssets>
	<fil:GrossCarryingAmount unitRef='USD' contextRef='E13Q1' decimals='INF'>5387075</fil:GrossCarryingAmount>
	<fil:GrossCarryingAmount unitRef='USD' contextRef='E12' decimals='INF'>5357580</fil:GrossCarryingAmount>
	<fil:AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas unitRef='USD' contextRef='E13Q1' decimals='INF'>-3097224</fil:AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas>
	<fil:AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas unitRef='USD' contextRef='E12' decimals='INF'>-2944726</fil:AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas>
	<fil:NetCarryingAmount unitRef='USD' contextRef='E13Q1' decimals='INF'>2289851</fil:NetCarryingAmount>
	<fil:NetCarryingAmount unitRef='USD' contextRef='E12' decimals='INF'>2412854</fil:NetCarryingAmount>
	<fil:TotalInterestExpenseRecognizedForThePeriod unitRef='USD' contextRef='Y13Q1' decimals='INF'>3386</fil:TotalInterestExpenseRecognizedForThePeriod>
	<fil:TotalInterestExpenseRecognizedForThePeriod unitRef='USD' contextRef='Y12Q1' decimals='INF'>1970</fil:TotalInterestExpenseRecognizedForThePeriod>
	<fil:InterestRateOnAdvancesFromMemberOfBOD unitRef='Pure' contextRef='Y13Q1' decimals='INF'>0.0100</fil:InterestRateOnAdvancesFromMemberOfBOD>
	<fil:InterestRateOnAdvancesFromMemberOfBOD unitRef='Pure' contextRef='Y12Q1' decimals='INF'>0.0100</fil:InterestRateOnAdvancesFromMemberOfBOD>
	<fil:AdavanceOwingToBoardmember unitRef='USD' contextRef='E13Q1' decimals='INF'>1354567</fil:AdavanceOwingToBoardmember>
	<fil:AdavanceOwingToBoardmember unitRef='USD' contextRef='E12' decimals='INF'>1354567</fil:AdavanceOwingToBoardmember>
	<fil:RevolvingLineOfCreditWithABank unitRef='USD' contextRef='I121030' decimals='INF'>30000000</fil:RevolvingLineOfCreditWithABank>
	<fil:AnnualInterestRate unitRef='Pure' contextRef='I121030' decimals='INF'>0.0690</fil:AnnualInterestRate>
	<fil:OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000 unitRef='USD' contextRef='E13Q1' decimals='INF'>4787285</fil:OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000>
	<fil:UndistributedEarningsOfHelpsonInMillions unitRef='Pure' contextRef='E13Q1' decimals='INF'>110.5</fil:UndistributedEarningsOfHelpsonInMillions>
	<fil:InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions unitRef='Pure' contextRef='E13Q1' decimals='INF'>23.3</fil:InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions>
	<fil:EnterpriseIncomeTaxRatesForTheYear2013 unitRef='Pure' contextRef='E13Q1' decimals='INF'>0.1500</fil:EnterpriseIncomeTaxRatesForTheYear2013>
	<fil:EnterpriseIncomeTaxRatesForTheYear2014AndAfter unitRef='Pure' contextRef='E13Q1' decimals='INF'>0.2500</fil:EnterpriseIncomeTaxRatesForTheYear2014AndAfter>
	<us-gaap:CurrentIncomeTaxExpenseBenefit unitRef='USD' contextRef='Y13Q1' decimals='INF'>0</us-gaap:CurrentIncomeTaxExpenseBenefit>
	<us-gaap:CurrentIncomeTaxExpenseBenefit unitRef='USD' contextRef='Y12Q1' decimals='INF'>564893</us-gaap:CurrentIncomeTaxExpenseBenefit>
	<us-gaap:DeferredFederalIncomeTaxExpenseBenefit unitRef='USD' contextRef='Y13Q1' decimals='INF'>-269011</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
	<us-gaap:DeferredFederalIncomeTaxExpenseBenefit unitRef='USD' contextRef='Y12Q1' decimals='INF'>-34312</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
	<fil:TotalIncomeTaxExpense unitRef='USD' contextRef='Y13Q1' decimals='INF'>-269011</fil:TotalIncomeTaxExpense>
	<fil:TotalIncomeTaxExpense unitRef='USD' contextRef='Y12Q1' decimals='INF'>530581</fil:TotalIncomeTaxExpense>
	<fil:BankersAcceptanceNotes unitRef='USD' contextRef='E13Q1' decimals='INF'>1180864</fil:BankersAcceptanceNotes>
	<fil:BankersAcceptanceNotes unitRef='USD' contextRef='E12' decimals='INF'>101570</fil:BankersAcceptanceNotes>
	<fil:Total1 unitRef='USD' contextRef='E13Q1' decimals='INF'>1180864</fil:Total1>
	<fil:Total1 unitRef='USD' contextRef='E12' decimals='INF'>101570</fil:Total1>
	<fil:BankersAcceptanceNotesLevel1 unitRef='USD' contextRef='E13Q1' decimals='INF'>0</fil:BankersAcceptanceNotesLevel1>
	<fil:BankersAcceptanceNotesLevel1 unitRef='USD' contextRef='E12' decimals='INF'>0</fil:BankersAcceptanceNotesLevel1>
	<fil:TotalLevel1 unitRef='USD' contextRef='E13Q1' decimals='INF'>0</fil:TotalLevel1>
	<fil:TotalLevel1 unitRef='USD' contextRef='E12' decimals='INF'>0</fil:TotalLevel1>
	<fil:BankersAcceptanceNotesLevel2 unitRef='USD' contextRef='E13Q1' decimals='INF'>1180864</fil:BankersAcceptanceNotesLevel2>
	<fil:BankersAcceptanceNotesLevel2 unitRef='USD' contextRef='E12' decimals='INF'>101570</fil:BankersAcceptanceNotesLevel2>
	<fil:TotalLevel2 unitRef='USD' contextRef='E13Q1' decimals='INF'>1180864</fil:TotalLevel2>
	<fil:TotalLevel2 unitRef='USD' contextRef='E12' decimals='INF'>101570</fil:TotalLevel2>
	<fil:BankersAcceptanceNotesLevel3 unitRef='USD' contextRef='E13Q1' decimals='INF'>0</fil:BankersAcceptanceNotesLevel3>
	<fil:BankersAcceptanceNotesLevel3 unitRef='USD' contextRef='E12' decimals='INF'>0</fil:BankersAcceptanceNotesLevel3>
	<fil:TotalLevel3 unitRef='USD' contextRef='E13Q1' decimals='INF'>0</fil:TotalLevel3>
	<fil:TotalLevel3 unitRef='USD' contextRef='E12' decimals='INF'>0</fil:TotalLevel3>
	<fil:CommonSharesAuthorized unitRef='Shares' contextRef='E13Q1' decimals='INF'>95000000</fil:CommonSharesAuthorized>
	<fil:PreferredSharesAuthorized unitRef='Shares' contextRef='E13Q1' decimals='INF'>5000000</fil:PreferredSharesAuthorized>
	<fil:NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable unitRef='Shares' contextRef='E13Q1' decimals='INF'>150000</fil:NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable>
	<fil:WarrantsStartRangeExercisePrice unitRef='UsdPerShare' contextRef='E13Q1' decimals='INF'>3.00</fil:WarrantsStartRangeExercisePrice>
	<fil:WarrantsEndRangeExercisePrice unitRef='UsdPerShare' contextRef='E13Q1' decimals='INF'>3.80</fil:WarrantsEndRangeExercisePrice>
	<fil:WarrantsWeightedAverageExercisePrice unitRef='UsdPerShare' contextRef='E13Q1' decimals='INF'>3.40</fil:WarrantsWeightedAverageExercisePrice>
	<fil:WarrantsWeightedAverageContractualLife unitRef='Pure' contextRef='E13Q1' decimals='INF'>0.2</fil:WarrantsWeightedAverageContractualLife>
	<fil:TotalIntrinsicValue unitRef='USD' contextRef='E13Q1' decimals='INF'>0</fil:TotalIntrinsicValue>
	<fil:NumberOfCommonShares unitRef='Shares' contextRef='I101112' decimals='INF'>4000000</fil:NumberOfCommonShares>
	<fil:NumberOfCommonShares unitRef='Shares' contextRef='E12' decimals='INF'>0</fil:NumberOfCommonShares>
	<fil:NumberOfCommonSharesPurchasedByOptions unitRef='Shares' contextRef='I101112' decimals='INF'>0</fil:NumberOfCommonSharesPurchasedByOptions>
	<fil:NumberOfCommonSharesPurchasedByOptions unitRef='Shares' contextRef='E12' decimals='INF'>75000</fil:NumberOfCommonSharesPurchasedByOptions>
	<fil:StockOptionsGranted unitRef='Shares' contextRef='I101112' decimals='INF'>0</fil:StockOptionsGranted>
	<fil:StockOptionsGranted unitRef='Shares' contextRef='E12' decimals='INF'>25000</fil:StockOptionsGranted>
	<fil:PercentageOfNoCustomerAccountedForMoreThanSales unitRef='Pure' contextRef='Y13Q1' decimals='INF'>0.1000</fil:PercentageOfNoCustomerAccountedForMoreThanSales>
	<fil:PercentageOfOneCustomerAccountedForMoreThanSales unitRef='Pure' contextRef='Y12Q1' decimals='INF'>0.1030</fil:PercentageOfOneCustomerAccountedForMoreThanSales>
	<fil:PercentageOfPurchasesFromOneSupplierOfRawMaterials unitRef='Pure' contextRef='Y13Q1' decimals='INF'>0.3400</fil:PercentageOfPurchasesFromOneSupplierOfRawMaterials>
	<fil:PercentageOfPurchasesFromOneSupplierOfRawMaterials unitRef='Pure' contextRef='Y12Q1' decimals='INF'>0.1410</fil:PercentageOfPurchasesFromOneSupplierOfRawMaterials>
	<fil:PercentageOfAccountsReceivableByOneCustomer unitRef='Pure' contextRef='E13Q1' decimals='INF'>0.1050</fil:PercentageOfAccountsReceivableByOneCustomer>
	<fil:NoOfCustomersAccountedForMoreThan100OfAccountsReceivable unitRef='Pure' contextRef='E12' decimals='INF'>0</fil:NoOfCustomersAccountedForMoreThan100OfAccountsReceivable>
	<fil:AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets unitRef='USD' contextRef='Y13Q1' decimals='INF'>-399992</fil:AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets>
	<fil:AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets unitRef='USD' contextRef='Y12Q1' decimals='INF'>-790092</fil:AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets>
	<context id='Y13Q1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001106644</identifier>
		</entity>
		<period>
			<startDate>2013-01-01</startDate>
			<endDate>2013-03-31</endDate>
		</period>
	</context>
	<context id='I130510'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001106644</identifier>
		</entity>
		<period>
			<instant>2013-05-10</instant>
		</period>
	</context>
	<context id='E13Q1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001106644</identifier>
		</entity>
		<period>
			<instant>2013-03-31</instant>
		</period>
	</context>
	<context id='E12'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001106644</identifier>
		</entity>
		<period>
			<instant>2012-12-31</instant>
		</period>
	</context>
	<context id='Y12Q1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001106644</identifier>
		</entity>
		<period>
			<startDate>2012-01-01</startDate>
			<endDate>2012-03-31</endDate>
		</period>
	</context>
	<context id='E11'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001106644</identifier>
		</entity>
		<period>
			<instant>2011-12-31</instant>
		</period>
	</context>
	<context id='E12Q1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001106644</identifier>
		</entity>
		<period>
			<instant>2012-03-31</instant>
		</period>
	</context>
	<context id='I121030'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001106644</identifier>
		</entity>
		<period>
			<instant>2012-10-30</instant>
		</period>
	</context>
	<context id='I101112'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001106644</identifier>
		</entity>
		<period>
			<instant>2010-11-12</instant>
		</period>
	</context>
	<unit id='Shares'>
		<measure>shares</measure>
	</unit>
	<unit id='USD'>
		<measure>iso4217:USD</measure>
	</unit>
	<unit id='UsdPerShare'>
		<divide>
			<unitNumerator>
				<measure>iso4217:USD</measure>
			</unitNumerator>
			<unitDenominator>
				<measure>shares</measure>
			</unitDenominator>
		</divide>
	</unit>
	<unit id='Pure'>
		<measure>pure</measure>
	</unit>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cphi-20130331.xsd
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- NeoClarus - iFile Suite version 4.2311  -->
<schema xmlns:dei='http://xbrl.sec.gov/dei/2011-01-31' xmlns:fil='http://www.chinapharmaholdings.com/20130331' attributeFormDefault='unqualified' elementFormDefault='qualified' targetNamespace='http://www.chinapharmaholdings.com/20130331' xmlns='http://www.w3.org/2001/XMLSchema' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xbrli='http://www.xbrl.org/2003/instance' xmlns:xbrldt='http://xbrl.org/2005/xbrldt' xmlns:us-gaap='http://fasb.org/us-gaap/2011-01-31' xmlns:num='http://www.xbrl.org/dtr/type/numeric' xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric'>
	<annotation>
		<appinfo>
			<link:linkbaseRef xlink:type="simple" xlink:href="cphi-20130331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="cphi-20130331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="cphi-20130331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="cphi-20130331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePROPERTYANDEQUIPMENTTables" id="idr_DisclosurePROPERTYANDEQUIPMENTTables">
				<link:definition>000230 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINTANGIBLEASSETS" id="idr_DisclosureINTANGIBLEASSETS">
				<link:definition>000110 - Disclosure - INTANGIBLE ASSETS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureNOTESPAYABLE" id="idr_DisclosureNOTESPAYABLE">
				<link:definition>000140 - Disclosure - NOTES PAYABLE</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureCONTINGENCIES" id="idr_DisclosureCONTINGENCIES">
				<link:definition>000180 - Disclosure - CONTINGENCIES</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDBALANCESHEETS" id="idr_CONDENSEDCONSOLIDATEDBALANCESHEETS">
				<link:definition>000020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_PROPERTYANDEQUIPMENTDetails" id="idr_PROPERTYANDEQUIPMENTDetails">
				<link:definition>000310 - Statement - PROPERTY AND EQUIPMENT (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_INTANGIBLEASSETSSFDAApprovedMedicalFormulasDetails" id="idr_INTANGIBLEASSETSSFDAApprovedMedicalFormulasDetails">
				<link:definition>000340 - Statement - INTANGIBLE ASSETS SFDA Approved Medical Formulas (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_INVENTORYDetails" id="idr_INVENTORYDetails">
				<link:definition>000300 - Statement - INVENTORY. (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINCOMETAXES" id="idr_DisclosureINCOMETAXES">
				<link:definition>000150 - Disclosure - INCOME TAXES</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINVENTORYTables" id="idr_DisclosureINVENTORYTables">
				<link:definition>000220 - Disclosure - INVENTORY(Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureADVANCESFORPURCHASESOFINTANGIBLEASSETS" id="idr_DisclosureADVANCESFORPURCHASESOFINTANGIBLEASSETS">
				<link:definition>000120 - Disclosure - ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS.</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" id="idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
				<link:definition>000060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" id="idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited">
				<link:definition>000040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONCENTRATIONSAccountsReceivableDetails" id="idr_CONCENTRATIONSAccountsReceivableDetails">
				<link:definition>000510 - Statement - CONCENTRATIONS Accounts Receivable (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureFAIRVALUEMEASUREMENTSTables" id="idr_DisclosureFAIRVALUEMEASUREMENTSTables">
				<link:definition>000260 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureCONCENTRATIONS" id="idr_DisclosureCONCENTRATIONS">
				<link:definition>000190 - Disclosure - CONCENTRATIONS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureAccountingPoliciesPolicies" id="idr_DisclosureAccountingPoliciesPolicies">
				<link:definition>000200 - Disclosure - Accounting Policies (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_StockOptionPlanDetails" id="idr_StockOptionPlanDetails">
				<link:definition>000420 - Statement - 2010 Stock Option Plan (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_RELATEDPARTYTRANSACTIONSMemberOfBODDetails" id="idr_RELATEDPARTYTRANSACTIONSMemberOfBODDetails">
				<link:definition>000350 - Statement - RELATED PARTY TRANSACTIONS Member Of BOD (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_PROPERTYANDEQUIPMENTAssetsLifeDetails" id="idr_PROPERTYANDEQUIPMENTAssetsLifeDetails">
				<link:definition>000320 - Statement - PROPERTY AND EQUIPMENT Assets Life (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONDetails" id="idr_BASISOFPRESENTATIONDetails">
				<link:definition>000270 - Statement - BASIS OF PRESENTATION (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINCOMETAXESTables" id="idr_DisclosureINCOMETAXESTables">
				<link:definition>000250 - Disclosure - INCOME TAXES (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINVENTORY" id="idr_DisclosureINVENTORY">
				<link:definition>000090 - Disclosure - INVENTORY.</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureFAIRVALUEMEASUREMENTS" id="idr_DisclosureFAIRVALUEMEASUREMENTS">
				<link:definition>000160 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_FAIRVALUEMEASUREMENTSAtReportingDateUsingDetails" id="idr_FAIRVALUEMEASUREMENTSAtReportingDateUsingDetails">
				<link:definition>000400 - Statement - FAIR VALUE MEASUREMENTS At Reporting Date Using (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONPOLICIESDetails" id="idr_BASISOFPRESENTATIONPOLICIESDetails">
				<link:definition>000290 - Statement - BASIS OF PRESENTATION POLICIES (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DocumentDocumentAndEntityInformation" id="idr_DocumentDocumentAndEntityInformation">
				<link:definition>000010 - Document - Document and Entity Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePROPERTYANDEQUIPMENT" id="idr_DisclosurePROPERTYANDEQUIPMENT">
				<link:definition>000100 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePRODUCTRECALL" id="idr_DisclosurePRODUCTRECALL">
				<link:definition>000080 - Disclosure - PRODUCT RECALL</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureBASISOFPRESENTATION" id="idr_DisclosureBASISOFPRESENTATION">
				<link:definition>000070 - Disclosure - BASIS OF PRESENTATION</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureSTOCKHOLDERSEQUITY" id="idr_DisclosureSTOCKHOLDERSEQUITY">
				<link:definition>000170 - Disclosure - STOCKHOLDERS&apos; EQUITY</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONSOLIDATEDBALANCESHEETSPARENTHETICALS" id="idr_CONSOLIDATEDBALANCESHEETSPARENTHETICALS">
				<link:definition>000030 - Statement - CONSOLIDATED BALANCE SHEETS PARENTHETICALS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_RELATEDPARTYTRANSACTIONSOwingsDetails" id="idr_RELATEDPARTYTRANSACTIONSOwingsDetails">
				<link:definition>000360 - Statement - RELATED PARTY TRANSACTIONS Owings (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetails" id="idr_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetails">
				<link:definition>000280 - Statement - BASIS OF PRESENTATION Basic and Diluted Earnings per Common Share (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureBASISOFPRESENTATIONTables" id="idr_DisclosureBASISOFPRESENTATIONTables">
				<link:definition>000210 - Disclosure - BASIS OF PRESENTATION (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_ASSETSDepreciationDetails" id="idr_ASSETSDepreciationDetails">
				<link:definition>000330 - Statement - ASSETS Depreciation (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINTANGIBLEASSETSTables" id="idr_DisclosureINTANGIBLEASSETSTables">
				<link:definition>000240 - Disclosure - INTANGIBLE ASSETS (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureRELATEDPARTYTRANSACTIONS" id="idr_DisclosureRELATEDPARTYTRANSACTIONS">
				<link:definition>000130 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_NOTESPAYABLESDetails" id="idr_NOTESPAYABLESDetails">
				<link:definition>000370 - Statement - NOTES PAYABLES. (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONCENTRATIONSSalesAndPurchasesDetails" id="idr_CONCENTRATIONSSalesAndPurchasesDetails">
				<link:definition>000490 - Statement - CONCENTRATIONS Sales And Purchases (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_PreferredCommonStockAndWarrantsDetails" id="idr_PreferredCommonStockAndWarrantsDetails">
				<link:definition>000410 - Statement - Preferred Common Stock And Warrants (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_INCOMETAXESProvisionDetails" id="idr_INCOMETAXESProvisionDetails">
				<link:definition>000390 - Statement - INCOME TAXES Provision (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_INCOMETAXESUndistributedEarningsAndIncomeTaxRatesDetails" id="idr_INCOMETAXESUndistributedEarningsAndIncomeTaxRatesDetails">
				<link:definition>000380 - Statement - INCOME TAXES Undistributed Earnings And Income Tax Rates (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
		</appinfo>
	</annotation>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd' namespace='http://fasb.org/us-gaap/2011-01-31' />
	<import schemaLocation='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd' namespace='http://xbrl.sec.gov/dei/2011-01-31' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_DocumentAndEntityInformationAbstract' abstract='true' name='DocumentAndEntityInformationAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_AdvancesToSuppliers' name='AdvancesToSuppliers' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_AllowanceForDoubtfulAccountsOnOtherReceivables' name='AllowanceForDoubtfulAccountsOnOtherReceivables' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_InventoryPurchasedWithBankerSAcceptances' name='InventoryPurchasedWithBankerSAcceptances' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_AccountsReceivableCollectedWithBankerSAcceptances' name='AccountsReceivableCollectedWithBankerSAcceptances' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_AccountsPayableForPurchasesOfPropertyAndEquipment' name='AccountsPayableForPurchasesOfPropertyAndEquipment' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_AdvancesForPurchasesOfIntangibleAssetsAbstract' substitutionGroup='xbrli:item' name='AdvancesForPurchasesOfIntangibleAssetsAbstract' />
	<element nillable='true' xbrli:periodType='duration' type='nonnum:textBlockItemType' id='fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock' substitutionGroup='xbrli:item' name='AdvancesForPurchasesOfIntangibleAssetsTextBlock' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_NotesPayable1Abstract' abstract='true' name='NotesPayable1Abstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='nonnum:textBlockItemType' id='fil_NotesPayableTextBlock' name='NotesPayableTextBlock' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_NetInvestmentInBankerSAcceptances' substitutionGroup='xbrli:item' name='NetInvestmentInBankerSAcceptances' />
	<element nillable='true' xbrli:periodType='duration' type='nonnum:textBlockItemType' id='fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock' name='PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_InventoryTablesAbstract' abstract='true' name='InventoryTablesAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_BasisOfPresentationTablesAbstract' abstract='true' name='BasisOfPresentationTablesAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_PropertyAndEquipmentTablesAbstract' substitutionGroup='xbrli:item' name='PropertyAndEquipmentTablesAbstract' />
	<element nillable='true' xbrli:periodType='duration' type='nonnum:textBlockItemType' id='fil_UsefulLivesOfTheAssetsTableTextBlock' substitutionGroup='xbrli:item' name='UsefulLivesOfTheAssetsTableTextBlock' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_IntangibleAssetsTablesAbstract' substitutionGroup='xbrli:item' name='IntangibleAssetsTablesAbstract' />
	<element nillable='true' xbrli:periodType='duration' type='nonnum:textBlockItemType' id='fil_IntangibleAssetsMedicalFormulasTablesTextBlock' substitutionGroup='xbrli:item' name='IntangibleAssetsMedicalFormulasTablesTextBlock' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_IncomeTaxesTablesAbstract' substitutionGroup='xbrli:item' name='IncomeTaxesTablesAbstract' />
	<element nillable='true' xbrli:periodType='duration' type='nonnum:textBlockItemType' id='fil_IncomeTaxesTableTextBlock' substitutionGroup='xbrli:item' name='IncomeTaxesTableTextBlock' />
	<element nillable='true' xbrli:periodType='duration' type='nonnum:textBlockItemType' id='fil_ProvisionForIncomeTaxesTableTextBlock' substitutionGroup='xbrli:item' name='ProvisionForIncomeTaxesTableTextBlock' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_FairValueMeasurementsTablesAbstract' substitutionGroup='xbrli:item' name='FairValueMeasurementsTablesAbstract' />
	<element nillable='true' xbrli:periodType='duration' type='nonnum:textBlockItemType' id='fil_AssetsFairValuesTablETextBlock' substitutionGroup='xbrli:item' name='AssetsFairValuesTablETextBlock' />
	<element nillable='true' xbrli:periodType='instant' type='num:percentItemType' id='fil_PercetageOfAcquiredByOnnyInHelpson' name='PercetageOfAcquiredByOnnyInHelpson' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetailsAbstract' abstract='true' name='BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetailsAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_NetIncome' name='NetIncome' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_Warrants' name='Warrants' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_Options' name='Options' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='num:perShareItemType' id='fil_BasicEarningsPerShare' name='BasicEarningsPerShare' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='num:perShareItemType' id='fil_DilutedEarningsPerShare' name='DilutedEarningsPerShare' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:sharesItemType' id='fil_WarrantsWithExercisePrice' name='WarrantsWithExercisePrice' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:sharesItemType' id='fil_OptionsWithAnExercisePrice' name='OptionsWithAnExercisePrice' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:sharesItemType' id='fil_TotalWarrantsAndOptions' name='TotalWarrantsAndOptions' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_PROPERTYANDEQUIPMENTAbstract' abstract='true' name='PROPERTYANDEQUIPMENTAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_PermitOfLandUse' name='PermitOfLandUse' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_PlantMachineryAndEquipmentGross' name='PlantMachineryAndEquipmentGross' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_MotorVehicleGross' name='MotorVehicleGross' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_PropertyAndEquipmentNet' name='PropertyAndEquipmentNet' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_OfficeEquipmentMaximumLife' name='OfficeEquipmentMaximumLife' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_MotorVehicleMaximumLife' name='MotorVehicleMaximumLife' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_BuildingMaximumLife' name='BuildingMaximumLife' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_PermitOfLandUseMaximumLife' name='PermitOfLandUseMaximumLife' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_PROPERTYANDEQUIPMENTAssetsLifeAbstract' abstract='true' name='PROPERTYANDEQUIPMENTAssetsLifeAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_OfficeEquipmentMinimumLife' name='OfficeEquipmentMinimumLife' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_MotorVehicleMinimumLife' name='MotorVehicleMinimumLife' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_BuildingMinimumLife' name='BuildingMinimumLife' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_PermitOfLandUseMinimumLife' name='PermitOfLandUseMinimumLife' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_PlantMachineryAndEquipmentLife' name='PlantMachineryAndEquipmentLife' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_INTANGIBLEASSETSSFDAApprovedMedicalFormulasAbstract' abstract='true' name='INTANGIBLEASSETSSFDAApprovedMedicalFormulasAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_GrossCarryingAmount' name='GrossCarryingAmount' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_NetCarryingAmount' name='NetCarryingAmount' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_RELATEDPARTYTRANSACTIONSMemberOfBODAbstract' substitutionGroup='xbrli:item' name='RELATEDPARTYTRANSACTIONSMemberOfBODAbstract' />
	<element nillable='true' xbrli:periodType='instant' type='num:percentItemType' id='fil_AnnualInterestRate' substitutionGroup='xbrli:item' name='AnnualInterestRate' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_INCOMETAXESUndistributedEarningsAbstract' substitutionGroup='xbrli:item' name='INCOMETAXESUndistributedEarningsAbstract' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_INCOMETAXESEnterpriseIncomeTaxRatesAbstract' substitutionGroup='xbrli:item' name='INCOMETAXESEnterpriseIncomeTaxRatesAbstract' />
	<element nillable='true' xbrli:periodType='instant' type='num:percentItemType' id='fil_EnterpriseIncomeTaxRatesForTheYear2013' substitutionGroup='xbrli:item' name='EnterpriseIncomeTaxRatesForTheYear2013' />
	<element nillable='true' xbrli:periodType='instant' type='num:percentItemType' id='fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter' substitutionGroup='xbrli:item' name='EnterpriseIncomeTaxRatesForTheYear2014AndAfter' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_TotalIncomeTaxExpense' substitutionGroup='xbrli:item' name='TotalIncomeTaxExpense' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_INCOMETAXESProvisionAbstract' substitutionGroup='xbrli:item' name='INCOMETAXESProvisionAbstract' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_RelatedPartyTransactionMemberOwingsAbstract' abstract='true' name='RelatedPartyTransactionMemberOwingsAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_AdavanceOwingToBoardmember' name='AdavanceOwingToBoardmember' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_STOCKHOLDERSEQUITYPreferredCommonStockAndWarrantsAbstract' substitutionGroup='xbrli:item' name='STOCKHOLDERSEQUITYPreferredCommonStockAndWarrantsAbstract' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:sharesItemType' id='fil_CommonSharesAuthorized' substitutionGroup='xbrli:item' name='CommonSharesAuthorized' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:sharesItemType' id='fil_PreferredSharesAuthorized' substitutionGroup='xbrli:item' name='PreferredSharesAuthorized' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:sharesItemType' id='fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable' substitutionGroup='xbrli:item' name='NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable' />
	<element nillable='true' xbrli:periodType='instant' type='num:perShareItemType' id='fil_WarrantsStartRangeExercisePrice' substitutionGroup='xbrli:item' name='WarrantsStartRangeExercisePrice' />
	<element nillable='true' xbrli:periodType='instant' type='num:perShareItemType' id='fil_WarrantsEndRangeExercisePrice' substitutionGroup='xbrli:item' name='WarrantsEndRangeExercisePrice' />
	<element nillable='true' xbrli:periodType='instant' type='num:perShareItemType' id='fil_WarrantsWeightedAverageExercisePrice' substitutionGroup='xbrli:item' name='WarrantsWeightedAverageExercisePrice' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_WarrantsWeightedAverageContractualLife' substitutionGroup='xbrli:item' name='WarrantsWeightedAverageContractualLife' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_TotalIntrinsicValue' substitutionGroup='xbrli:item' name='TotalIntrinsicValue' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:sharesItemType' id='fil_NumberOfCommonSharesPurchasedByOptions' substitutionGroup='xbrli:item' name='NumberOfCommonSharesPurchasedByOptions' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_STOCKHOLDERSEQUITY2010StockOptionPlanAbstract' substitutionGroup='xbrli:item' name='STOCKHOLDERSEQUITY2010StockOptionPlanAbstract' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:sharesItemType' id='fil_NumberOfCommonShares' substitutionGroup='xbrli:item' name='NumberOfCommonShares' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:sharesItemType' id='fil_StockOptionsGranted' substitutionGroup='xbrli:item' name='StockOptionsGranted' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_CONCENTRATIONSSalesAndPurchasesAbstract' abstract='true' name='CONCENTRATIONSSalesAndPurchasesAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='num:percentItemType' id='fil_PercentageOfNoCustomerAccountedForMoreThanSales' name='PercentageOfNoCustomerAccountedForMoreThanSales' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='num:percentItemType' id='fil_PercentageOfOneCustomerAccountedForMoreThanSales' name='PercentageOfOneCustomerAccountedForMoreThanSales' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='num:percentItemType' id='fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials' name='PercentageOfPurchasesFromOneSupplierOfRawMaterials' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_FAIRVALUEMEASUREMENTSAtReportingDateUsingAbstract' abstract='true' name='FAIRVALUEMEASUREMENTSAtReportingDateUsingAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_BankersAcceptanceNotes' name='BankersAcceptanceNotes' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_BankersAcceptanceNotesLevel1' name='BankersAcceptanceNotesLevel1' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_TotalLevel1' name='TotalLevel1' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_BankersAcceptanceNotesLevel2' name='BankersAcceptanceNotesLevel2' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_TotalLevel2' name='TotalLevel2' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_BankersAcceptanceNotesLevel3' name='BankersAcceptanceNotesLevel3' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_TotalLevel3' name='TotalLevel3' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_AdvancesForPurchasesOfIntangibleAssets' name='AdvancesForPurchasesOfIntangibleAssets' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_StockBasedCompensation' name='StockBasedCompensation' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_ChangesInAdvancesToSuppliers' name='ChangesInAdvancesToSuppliers' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_CommitmentAndContingenciesAbstract' abstract='true' name='CommitmentAndContingenciesAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_AccountingPoliciesPoliciesAbstract' abstract='true' name='AccountingPoliciesPoliciesAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_OrganizationAndOperationsAbstract' substitutionGroup='xbrli:item' name='OrganizationAndOperationsAbstract' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_BASISOFPRESENTATIONPOLICIESAbstract' substitutionGroup='xbrli:item' name='BASISOFPRESENTATIONPOLICIESAbstract' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_INVENTORYABSTRACTAbstract' substitutionGroup='xbrli:item' name='INVENTORYABSTRACTAbstract' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_AllowanceForObsolescenceRawMaterials' substitutionGroup='xbrli:item' name='AllowanceForObsolescenceRawMaterials' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_TotalInventoryNet' substitutionGroup='xbrli:item' name='TotalInventoryNet' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_TotalPropertyAndEquipment' substitutionGroup='xbrli:item' name='TotalPropertyAndEquipment' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_LessAccumulatedDepreciationDetails' substitutionGroup='xbrli:item' name='LessAccumulatedDepreciationDetails' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_AssetsDepreciationAbstract' substitutionGroup='xbrli:item' name='AssetsDepreciationAbstract' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_DepreciationExpensePropertyAndEquipment' substitutionGroup='xbrli:item' name='DepreciationExpensePropertyAndEquipment' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_AmortizationExpenseIntangibleAssets' substitutionGroup='xbrli:item' name='AmortizationExpenseIntangibleAssets' />
	<element nillable='true' xbrli:periodType='duration' type='num:percentItemType' id='fil_InterestRateOnAdvancesFromMemberOfBOD' substitutionGroup='xbrli:item' name='InterestRateOnAdvancesFromMemberOfBOD' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas' substitutionGroup='xbrli:item' name='AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000' substitutionGroup='xbrli:item' name='OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_InventoryObsolescenceReserve' substitutionGroup='xbrli:item' name='InventoryObsolescenceReserve' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_Total1' name='Total1' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='duration' type='nonnum:domainItemType' id='fil_AggregateIntrinsicValueMember' substitutionGroup='xbrli:item' name='AggregateIntrinsicValueMember' />
	<element nillable='true' xbrli:periodType='duration' type='nonnum:domainItemType' id='fil_WeightedAverageRemainingContractualTermYearsMember' substitutionGroup='xbrli:item' name='WeightedAverageRemainingContractualTermYearsMember' />
	<element nillable='true' xbrli:periodType='duration' type='nonnum:domainItemType' id='fil_WeightedAverageExercisePriceMember' substitutionGroup='xbrli:item' name='WeightedAverageExercisePriceMember' />
	<element nillable='true' xbrli:periodType='duration' type='nonnum:domainItemType' id='fil_NoOfSharesMember' substitutionGroup='xbrli:item' name='NoOfSharesMember' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' id='fil_PRODUCTRECALLAbstract' abstract='true' name='PRODUCTRECALLAbstract' substitutionGroup='xbrli:item' />
	<element nillable='true' xbrli:periodType='instant' type='num:percentItemType' id='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited' substitutionGroup='xbrli:item' name='PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited' />
	<element nillable='true' xbrli:periodType='instant' type='num:percentItemType' id='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd' substitutionGroup='xbrli:item' name='PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_TotalInterestExpenseRecognizedForThePeriod' substitutionGroup='xbrli:item' name='TotalInterestExpenseRecognizedForThePeriod' />
	<element nillable='true' xbrli:balance='credit' xbrli:periodType='instant' type='xbrli:monetaryItemType' id='fil_RevolvingLineOfCreditWithABank' substitutionGroup='xbrli:item' name='RevolvingLineOfCreditWithABank' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_UndistributedEarningsOfHelpsonInMillions' substitutionGroup='xbrli:item' name='UndistributedEarningsOfHelpsonInMillions' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions' substitutionGroup='xbrli:item' name='InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions' />
	<element nillable='true' xbrli:periodType='duration' type='xbrli:stringItemType' abstract='true' id='fil_CONCENTRATIONSAccountsReceivableAbstract' substitutionGroup='xbrli:item' name='CONCENTRATIONSAccountsReceivableAbstract' />
	<element nillable='true' xbrli:periodType='instant' type='num:percentItemType' id='fil_PercentageOfAccountsReceivableByOneCustomer' substitutionGroup='xbrli:item' name='PercentageOfAccountsReceivableByOneCustomer' />
	<element nillable='true' xbrli:periodType='instant' type='xbrli:pureItemType' id='fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable' substitutionGroup='xbrli:item' name='NoOfCustomersAccountedForMoreThan100OfAccountsReceivable' />
	<element nillable='true' xbrli:balance='debit' xbrli:periodType='duration' type='xbrli:monetaryItemType' id='fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets' substitutionGroup='xbrli:item' name='AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets' />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>cphi-20130331_cal.xml
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- NeoClarus - iFile Suite version 4.2311  -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.chinapharmaholdings.com/20130331"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDBALANCESHEETS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesToSuppliers' xlink:label='fil_AdvancesToSuppliers'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='fil_AdvancesToSuppliers' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashEquivalentsAtCarryingValue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_CashEquivalentsAtCarryingValue' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash' xlink:label='us-gaap_Cash'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_Cash' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent' xlink:label='us-gaap_DeferredTaxAssetsNetCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_DeferredTaxAssetsNetCurrent' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_InventoryNet' use='optional' order='5.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherReceivablesNetCurrent' xlink:label='us-gaap_OtherReceivablesNetCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_OtherReceivablesNetCurrent' use='optional' order='6.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ReceivablesNetCurrent' xlink:label='us-gaap_ReceivablesNetCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_ReceivablesNetCurrent' use='optional' order='7.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesForPurchasesOfIntangibleAssets' xlink:label='fil_AdvancesForPurchasesOfIntangibleAssets'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='fil_AdvancesForPurchasesOfIntangibleAssets' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:label='us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_IntangibleAssetsNetExcludingGoodwill' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='3.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_AssetsCurrent' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TaxesPayableCurrent' xlink:label='us-gaap_TaxesPayableCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_TaxesPayableCurrent' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CustomerAdvancesCurrent' xlink:label='us-gaap_CustomerAdvancesCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_CustomerAdvancesCurrent' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableOtherCurrent' xlink:label='us-gaap_AccountsPayableOtherCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_AccountsPayableOtherCurrent' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent' xlink:label='us-gaap_DueToRelatedPartiesCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_DueToRelatedPartiesCurrent' use='optional' order='5.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableCurrent' xlink:label='us-gaap_NotesPayableCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_NotesPayableCurrent' use='optional' order='6.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableTradeCurrent' xlink:label='us-gaap_AccountsPayableTradeCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_AccountsPayableTradeCurrent' use='optional' order='7.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent' xlink:label='us-gaap_DeferredTaxLiabilitiesNoncurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Liabilities' xlink:to='us-gaap_DeferredTaxLiabilitiesNoncurrent' use='optional' order='1.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Liabilities' xlink:to='us-gaap_LiabilitiesCurrent' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_Liabilities' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_StockholdersEquity' use='optional' order='2.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses' xlink:label='us-gaap_OperatingExpenses'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts' xlink:label='us-gaap_ProvisionForDoubtfulAccounts'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingExpenses' xlink:to='us-gaap_ProvisionForDoubtfulAccounts' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingExpenses' xlink:to='us-gaap_GeneralAndAdministrativeExpense' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SellingExpense' xlink:label='us-gaap_SellingExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingExpenses' xlink:to='us-gaap_SellingExpense' use='optional' order='3.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' xlink:label='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivities' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='4.0' weight='1.0'/>
	</link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>cphi-20130331_def.xml
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- NeoClarus - iFile Suite version 4.2311  -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.chinapharmaholdings.com/20130331"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DocumentDocumentAndEntityInformation">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDBALANCESHEETS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AssetsAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_AssetsCurrentAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash' xlink:label='us-gaap_Cash'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_Cash' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashEquivalentsAtCarryingValue'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_CashEquivalentsAtCarryingValue' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ReceivablesNetCurrent' xlink:label='us-gaap_ReceivablesNetCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_ReceivablesNetCurrent' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherReceivablesNetCurrent' xlink:label='us-gaap_OtherReceivablesNetCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_OtherReceivablesNetCurrent' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesToSuppliers' xlink:label='fil_AdvancesToSuppliers'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='fil_AdvancesToSuppliers' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_InventoryNet' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent' xlink:label='us-gaap_DeferredTaxAssetsNetCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_DeferredTaxAssetsNetCurrent' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_AssetsCurrent' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesForPurchasesOfIntangibleAssets' xlink:label='fil_AdvancesForPurchasesOfIntangibleAssets'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsAbstract' xlink:to='fil_AdvancesForPurchasesOfIntangibleAssets' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:label='us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_IntangibleAssetsNetExcludingGoodwill' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_Assets' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_LiabilitiesAndStockholdersEquityAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_LiabilitiesCurrentAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableTradeCurrent' xlink:label='us-gaap_AccountsPayableTradeCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccountsPayableTradeCurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TaxesPayableCurrent' xlink:label='us-gaap_TaxesPayableCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_TaxesPayableCurrent' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableOtherCurrent' xlink:label='us-gaap_AccountsPayableOtherCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccountsPayableOtherCurrent' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CustomerAdvancesCurrent' xlink:label='us-gaap_CustomerAdvancesCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_CustomerAdvancesCurrent' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent' xlink:label='us-gaap_DueToRelatedPartiesCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_DueToRelatedPartiesCurrent' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableCurrent' xlink:label='us-gaap_NotesPayableCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_NotesPayableCurrent' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_LiabilitiesCurrent' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent' xlink:label='us-gaap_DeferredTaxLiabilitiesNoncurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_DeferredTaxLiabilitiesNoncurrent' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_Liabilities' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_StockholdersEquityAbstract' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_PreferredStockValue' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_CommonStockValue' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_AdditionalPaidInCapital' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax' xlink:label='us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_StockholdersEquity' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_LiabilitiesAndStockholdersEquity' use='optional' order='5.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONSOLIDATEDBALANCESHEETSPARENTHETICALS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONSOLIDATEDBALANCESHEETSPARENTHETICALS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONSOLIDATEDBALANCESHEETSPARENTHETICALS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:label='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AllowanceForDoubtfulAccountsOnOtherReceivables' xlink:label='fil_AllowanceForDoubtfulAccountsOnOtherReceivables'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_AllowanceForDoubtfulAccountsOnOtherReceivables' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockParOrStatedValuePerShare' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesAuthorized' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesIssued' xlink:label='us-gaap_PreferredStockSharesIssued'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesIssued' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesOutstanding' xlink:label='us-gaap_PreferredStockSharesOutstanding'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesOutstanding' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockParOrStatedValuePerShare' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockSharesAuthorized' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued' xlink:label='us-gaap_CommonStockSharesIssued'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockSharesIssued' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockSharesOutstanding' use='optional' order='12.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Revenues' xlink:label='us-gaap_Revenues'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_Revenues' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CostOfRevenue' xlink:label='us-gaap_CostOfRevenue'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CostOfRevenue' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryWriteDown' xlink:label='us-gaap_InventoryWriteDown'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_InventoryWriteDown' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_GrossProfit' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpensesAbstract' xlink:label='us-gaap_OperatingExpensesAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_OperatingExpensesAbstract' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SellingExpense' xlink:label='us-gaap_SellingExpense'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_SellingExpense' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_GeneralAndAdministrativeExpense' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts' xlink:label='us-gaap_ProvisionForDoubtfulAccounts'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_ProvisionForDoubtfulAccounts' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses' xlink:label='us-gaap_OperatingExpenses'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_OperatingExpenses' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss' xlink:label='us-gaap_OperatingIncomeLoss'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_OperatingIncomeLoss' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract' xlink:label='us-gaap_OtherIncomeAndExpensesAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_OtherIncomeAndExpensesAbstract' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InvestmentIncomeInterest' xlink:label='us-gaap_InvestmentIncomeInterest'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='us-gaap_InvestmentIncomeInterest' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='us-gaap_InterestExpense' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherExpenses' xlink:label='us-gaap_OtherExpenses'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='us-gaap_OtherExpenses' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_IncomeTaxExpenseBenefit' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ProfitLoss' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease' xlink:label='us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax' xlink:label='us-gaap_ComprehensiveIncomeNetOfTax'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ComprehensiveIncomeNetOfTax' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:label='us-gaap_EarningsPerShareBasicAndDilutedAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_EarningsPerShareBasicAndDilutedAbstract' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasic' xlink:label='us-gaap_EarningsPerShareBasic'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:to='us-gaap_EarningsPerShareBasic' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareDiluted' xlink:label='us-gaap_EarningsPerShareDiluted'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:to='us-gaap_EarningsPerShareDiluted' use='optional' order='2.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_NetIncomeLoss' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationAndAmortization' xlink:label='us-gaap_DepreciationAndAmortization'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_DepreciationAndAmortization' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_StockBasedCompensation' xlink:label='fil_StockBasedCompensation'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_StockBasedCompensation' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts' xlink:label='us-gaap_ProvisionForDoubtfulAccounts'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_ProvisionForDoubtfulAccounts' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit' xlink:label='us-gaap_DeferredIncomeTaxExpenseBenefit'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_DeferredIncomeTaxExpenseBenefit' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InventoryObsolescenceReserve' xlink:label='fil_InventoryObsolescenceReserve'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_InventoryObsolescenceReserve' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:label='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccountsReceivable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables' xlink:label='us-gaap_IncreaseDecreaseInOtherReceivables'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInOtherReceivables' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_ChangesInAdvancesToSuppliers' xlink:label='fil_ChangesInAdvancesToSuppliers'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='fil_ChangesInAdvancesToSuppliers' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInInventories' xlink:label='us-gaap_IncreaseDecreaseInInventories'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInInventories' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayableTrade'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccountsPayableTrade' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccruedLiabilities' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable' xlink:label='us-gaap_IncreaseDecreaseInAccruedTaxesPayable'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccruedTaxesPayable' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable' xlink:label='us-gaap_IncreaseDecreaseInOtherAccountsPayable'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInOtherAccountsPayable' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances' xlink:label='us-gaap_IncreaseDecreaseInCustomerAdvances'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInCustomerAdvances' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivities' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NetInvestmentInBankerSAcceptances' xlink:label='fil_NetInvestmentInBankerSAcceptances'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='fil_NetInvestmentInBankerSAcceptances' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets' xlink:label='fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:label='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' xlink:label='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract' xlink:label='us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SupplementalCashFlowInformationAbstract' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestPaid' xlink:label='us-gaap_InterestPaid'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='us-gaap_InterestPaid' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxesPaidNet' xlink:label='us-gaap_IncomeTaxesPaidNet'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='us-gaap_IncomeTaxesPaidNet' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:label='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AccountsPayableForPurchasesOfPropertyAndEquipment' xlink:label='fil_AccountsPayableForPurchasesOfPropertyAndEquipment'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_AccountsPayableForPurchasesOfPropertyAndEquipment' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AccountsReceivableCollectedWithBankerSAcceptances' xlink:label='fil_AccountsReceivableCollectedWithBankerSAcceptances'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_AccountsReceivableCollectedWithBankerSAcceptances' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InventoryPurchasedWithBankerSAcceptances' xlink:label='fil_InventoryPurchasedWithBankerSAcceptances'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_InventoryPurchasedWithBankerSAcceptances' use='optional' order='3.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureBASISOFPRESENTATION" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureBASISOFPRESENTATION"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureBASISOFPRESENTATION">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePRODUCTRECALL" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosurePRODUCTRECALL"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePRODUCTRECALL">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINVENTORY" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureINVENTORY"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINVENTORY">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosurePROPERTYANDEQUIPMENT"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePROPERTYANDEQUIPMENT">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINTANGIBLEASSETS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureINTANGIBLEASSETS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINTANGIBLEASSETS">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureADVANCESFORPURCHASESOFINTANGIBLEASSETS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureADVANCESFORPURCHASESOFINTANGIBLEASSETS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureADVANCESFORPURCHASESOFINTANGIBLEASSETS">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureRELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureRELATEDPARTYTRANSACTIONS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureRELATEDPARTYTRANSACTIONS">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureNOTESPAYABLE" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureNOTESPAYABLE"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureNOTESPAYABLE">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINCOMETAXES" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureINCOMETAXES"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINCOMETAXES">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureFAIRVALUEMEASUREMENTS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureFAIRVALUEMEASUREMENTS">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureSTOCKHOLDERSEQUITY"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureSTOCKHOLDERSEQUITY">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureCONTINGENCIES" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureCONTINGENCIES"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureCONTINGENCIES">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureCONCENTRATIONS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureCONCENTRATIONS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureCONCENTRATIONS">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureAccountingPoliciesPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureAccountingPoliciesPolicies">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureBASISOFPRESENTATIONTables" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureBASISOFPRESENTATIONTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureBASISOFPRESENTATIONTables">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINVENTORYTables" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureINVENTORYTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINVENTORYTables">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosurePROPERTYANDEQUIPMENTTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePROPERTYANDEQUIPMENTTables">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureINTANGIBLEASSETSTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINTANGIBLEASSETSTables">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINCOMETAXESTables" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureINCOMETAXESTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINCOMETAXESTables">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureFAIRVALUEMEASUREMENTSTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureFAIRVALUEMEASUREMENTSTables">
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_BASISOFPRESENTATIONDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited' xlink:label='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd' xlink:label='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercetageOfAcquiredByOnnyInHelpson' xlink:label='fil_PercetageOfAcquiredByOnnyInHelpson'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercetageOfAcquiredByOnnyInHelpson' use='optional' order='3.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NetIncome' xlink:label='fil_NetIncome'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NetIncome' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic' xlink:label='us-gaap_WeightedAverageNumberOfSharesIssuedBasic'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_WeightedAverageNumberOfSharesIssuedBasic' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract' xlink:label='us-gaap_DilutiveSecuritiesAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DilutiveSecuritiesAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_Warrants' xlink:label='fil_Warrants'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_Warrants' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_Options' xlink:label='fil_Options'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_Options' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:label='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BasicEarningsPerShare' xlink:label='fil_BasicEarningsPerShare'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BasicEarningsPerShare' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_DilutedEarningsPerShare' xlink:label='fil_DilutedEarningsPerShare'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_DilutedEarningsPerShare' use='optional' order='8.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONPOLICIESDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_BASISOFPRESENTATIONPOLICIESDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONPOLICIESDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsWithExercisePrice' xlink:label='fil_WarrantsWithExercisePrice'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsWithExercisePrice' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OptionsWithAnExercisePrice' xlink:label='fil_OptionsWithAnExercisePrice'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_OptionsWithAnExercisePrice' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalWarrantsAndOptions' xlink:label='fil_TotalWarrantsAndOptions'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalWarrantsAndOptions' use='optional' order='3.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_INVENTORYDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_INVENTORYDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_INVENTORYDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryRawMaterials' xlink:label='us-gaap_InventoryRawMaterials'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_InventoryRawMaterials' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryFinishedGoods' xlink:label='us-gaap_InventoryFinishedGoods'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_InventoryFinishedGoods' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryGross' xlink:label='us-gaap_InventoryGross'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_InventoryGross' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AllowanceForObsolescenceRawMaterials' xlink:label='fil_AllowanceForObsolescenceRawMaterials'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_AllowanceForObsolescenceRawMaterials' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalInventoryNet' xlink:label='fil_TotalInventoryNet'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalInventoryNet' use='optional' order='5.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_PROPERTYANDEQUIPMENTDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_PROPERTYANDEQUIPMENTDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PermitOfLandUse' xlink:label='fil_PermitOfLandUse'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PermitOfLandUse' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BuildingsAndImprovementsGross' xlink:label='us-gaap_BuildingsAndImprovementsGross'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_BuildingsAndImprovementsGross' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PlantMachineryAndEquipmentGross' xlink:label='fil_PlantMachineryAndEquipmentGross'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PlantMachineryAndEquipmentGross' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_MotorVehicleGross' xlink:label='fil_MotorVehicleGross'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_MotorVehicleGross' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FurnitureAndFixturesGross' xlink:label='us-gaap_FurnitureAndFixturesGross'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FurnitureAndFixturesGross' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConstructionInProgressGross' xlink:label='us-gaap_ConstructionInProgressGross'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ConstructionInProgressGross' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalPropertyAndEquipment' xlink:label='fil_TotalPropertyAndEquipment'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalPropertyAndEquipment' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_LessAccumulatedDepreciationDetails' xlink:label='fil_LessAccumulatedDepreciationDetails'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_LessAccumulatedDepreciationDetails' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PropertyAndEquipmentNet' xlink:label='fil_PropertyAndEquipmentNet'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PropertyAndEquipmentNet' use='optional' order='9.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_PROPERTYANDEQUIPMENTAssetsLifeDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_PROPERTYANDEQUIPMENTAssetsLifeDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_PROPERTYANDEQUIPMENTAssetsLifeDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PermitOfLandUseMinimumLife' xlink:label='fil_PermitOfLandUseMinimumLife'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PermitOfLandUseMinimumLife' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PermitOfLandUseMaximumLife' xlink:label='fil_PermitOfLandUseMaximumLife'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PermitOfLandUseMaximumLife' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BuildingMinimumLife' xlink:label='fil_BuildingMinimumLife'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BuildingMinimumLife' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BuildingMaximumLife' xlink:label='fil_BuildingMaximumLife'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BuildingMaximumLife' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PlantMachineryAndEquipmentLife' xlink:label='fil_PlantMachineryAndEquipmentLife'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PlantMachineryAndEquipmentLife' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_MotorVehicleMinimumLife' xlink:label='fil_MotorVehicleMinimumLife'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_MotorVehicleMinimumLife' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_MotorVehicleMaximumLife' xlink:label='fil_MotorVehicleMaximumLife'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_MotorVehicleMaximumLife' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OfficeEquipmentMinimumLife' xlink:label='fil_OfficeEquipmentMinimumLife'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_OfficeEquipmentMinimumLife' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OfficeEquipmentMaximumLife' xlink:label='fil_OfficeEquipmentMaximumLife'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_OfficeEquipmentMaximumLife' use='optional' order='9.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_ASSETSDepreciationDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_ASSETSDepreciationDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_ASSETSDepreciationDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_DepreciationExpensePropertyAndEquipment' xlink:label='fil_DepreciationExpensePropertyAndEquipment'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_DepreciationExpensePropertyAndEquipment' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AmortizationExpenseIntangibleAssets' xlink:label='fil_AmortizationExpenseIntangibleAssets'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_AmortizationExpenseIntangibleAssets' use='optional' order='2.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_INTANGIBLEASSETSSFDAApprovedMedicalFormulasDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_INTANGIBLEASSETSSFDAApprovedMedicalFormulasDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_INTANGIBLEASSETSSFDAApprovedMedicalFormulasDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_GrossCarryingAmount' xlink:label='fil_GrossCarryingAmount'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_GrossCarryingAmount' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas' xlink:label='fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NetCarryingAmount' xlink:label='fil_NetCarryingAmount'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NetCarryingAmount' use='optional' order='3.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_RELATEDPARTYTRANSACTIONSMemberOfBODDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_RELATEDPARTYTRANSACTIONSMemberOfBODDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_RELATEDPARTYTRANSACTIONSMemberOfBODDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalInterestExpenseRecognizedForThePeriod' xlink:label='fil_TotalInterestExpenseRecognizedForThePeriod'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalInterestExpenseRecognizedForThePeriod' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InterestRateOnAdvancesFromMemberOfBOD' xlink:label='fil_InterestRateOnAdvancesFromMemberOfBOD'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_InterestRateOnAdvancesFromMemberOfBOD' use='optional' order='2.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_RELATEDPARTYTRANSACTIONSOwingsDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_RELATEDPARTYTRANSACTIONSOwingsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_RELATEDPARTYTRANSACTIONSOwingsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdavanceOwingToBoardmember' xlink:label='fil_AdavanceOwingToBoardmember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_AdavanceOwingToBoardmember' use='optional' order='1.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_NOTESPAYABLESDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_NOTESPAYABLESDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_NOTESPAYABLESDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_RevolvingLineOfCreditWithABank' xlink:label='fil_RevolvingLineOfCreditWithABank'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_RevolvingLineOfCreditWithABank' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AnnualInterestRate' xlink:label='fil_AnnualInterestRate'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_AnnualInterestRate' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000' xlink:label='fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000' use='optional' order='3.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_INCOMETAXESUndistributedEarningsAndIncomeTaxRatesDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_INCOMETAXESUndistributedEarningsAndIncomeTaxRatesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_INCOMETAXESUndistributedEarningsAndIncomeTaxRatesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_UndistributedEarningsOfHelpsonInMillions' xlink:label='fil_UndistributedEarningsOfHelpsonInMillions'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_UndistributedEarningsOfHelpsonInMillions' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions' xlink:label='fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_INCOMETAXESEnterpriseIncomeTaxRatesAbstract' xlink:label='fil_INCOMETAXESEnterpriseIncomeTaxRatesAbstract'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_INCOMETAXESEnterpriseIncomeTaxRatesAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_EnterpriseIncomeTaxRatesForTheYear2013' xlink:label='fil_EnterpriseIncomeTaxRatesForTheYear2013'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_EnterpriseIncomeTaxRatesForTheYear2013' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter' xlink:label='fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter' use='optional' order='5.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_INCOMETAXESProvisionDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_INCOMETAXESProvisionDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_INCOMETAXESProvisionDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit' xlink:label='us-gaap_CurrentIncomeTaxExpenseBenefit'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CurrentIncomeTaxExpenseBenefit' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit' xlink:label='us-gaap_DeferredFederalIncomeTaxExpenseBenefit'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DeferredFederalIncomeTaxExpenseBenefit' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalIncomeTaxExpense' xlink:label='fil_TotalIncomeTaxExpense'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalIncomeTaxExpense' use='optional' order='3.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_FAIRVALUEMEASUREMENTSAtReportingDateUsingDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_FAIRVALUEMEASUREMENTSAtReportingDateUsingDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_FAIRVALUEMEASUREMENTSAtReportingDateUsingDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BankersAcceptanceNotes' xlink:label='fil_BankersAcceptanceNotes'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BankersAcceptanceNotes' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_Total1' xlink:label='fil_Total1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_Total1' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BankersAcceptanceNotesLevel1' xlink:label='fil_BankersAcceptanceNotesLevel1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BankersAcceptanceNotesLevel1' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalLevel1' xlink:label='fil_TotalLevel1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalLevel1' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BankersAcceptanceNotesLevel2' xlink:label='fil_BankersAcceptanceNotesLevel2'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BankersAcceptanceNotesLevel2' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalLevel2' xlink:label='fil_TotalLevel2'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalLevel2' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BankersAcceptanceNotesLevel3' xlink:label='fil_BankersAcceptanceNotesLevel3'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BankersAcceptanceNotesLevel3' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalLevel3' xlink:label='fil_TotalLevel3'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalLevel3' use='optional' order='8.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_PreferredCommonStockAndWarrantsDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_PreferredCommonStockAndWarrantsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_PreferredCommonStockAndWarrantsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_CommonSharesAuthorized' xlink:label='fil_CommonSharesAuthorized'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_CommonSharesAuthorized' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PreferredSharesAuthorized' xlink:label='fil_PreferredSharesAuthorized'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PreferredSharesAuthorized' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable' xlink:label='fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsStartRangeExercisePrice' xlink:label='fil_WarrantsStartRangeExercisePrice'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsStartRangeExercisePrice' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsEndRangeExercisePrice' xlink:label='fil_WarrantsEndRangeExercisePrice'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsEndRangeExercisePrice' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsWeightedAverageExercisePrice' xlink:label='fil_WarrantsWeightedAverageExercisePrice'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsWeightedAverageExercisePrice' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsWeightedAverageContractualLife' xlink:label='fil_WarrantsWeightedAverageContractualLife'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsWeightedAverageContractualLife' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalIntrinsicValue' xlink:label='fil_TotalIntrinsicValue'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalIntrinsicValue' use='optional' order='8.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_StockOptionPlanDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_StockOptionPlanDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_StockOptionPlanDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NumberOfCommonShares' xlink:label='fil_NumberOfCommonShares'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NumberOfCommonShares' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NumberOfCommonSharesPurchasedByOptions' xlink:label='fil_NumberOfCommonSharesPurchasedByOptions'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NumberOfCommonSharesPurchasedByOptions' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_StockOptionsGranted' xlink:label='fil_StockOptionsGranted'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_StockOptionsGranted' use='optional' order='3.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONCENTRATIONSSalesAndPurchasesDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONCENTRATIONSSalesAndPurchasesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONCENTRATIONSSalesAndPurchasesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfNoCustomerAccountedForMoreThanSales' xlink:label='fil_PercentageOfNoCustomerAccountedForMoreThanSales'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercentageOfNoCustomerAccountedForMoreThanSales' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfOneCustomerAccountedForMoreThanSales' xlink:label='fil_PercentageOfOneCustomerAccountedForMoreThanSales'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercentageOfOneCustomerAccountedForMoreThanSales' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials' xlink:label='fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials' use='optional' order='3.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONCENTRATIONSAccountsReceivableDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONCENTRATIONSAccountsReceivableDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONCENTRATIONSAccountsReceivableDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfAccountsReceivableByOneCustomer' xlink:label='fil_PercentageOfAccountsReceivableByOneCustomer'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercentageOfAccountsReceivableByOneCustomer' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable' xlink:label='fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable' use='optional' order='2.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cphi-20130331_lab.xml
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- NeoClarus - iFile Suite version 4.2311  -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.chinapharmaholdings.com/20130331"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
	<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsWeightedAverageContractualLife' xlink:label='fil_WarrantsWeightedAverageContractualLife'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWeightedAverageContractualLife' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants weighted average contractual life</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWeightedAverageContractualLife' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants weighted average contractual life</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsWeightedAverageContractualLife' xlink:to='lab_fil_WarrantsWeightedAverageContractualLife'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BankersAcceptanceNotesLevel1' xlink:label='fil_BankersAcceptanceNotesLevel1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BankersAcceptanceNotesLevel1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bankers acceptance notes Level 1</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BankersAcceptanceNotesLevel1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bankers acceptance notes Level 1</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BankersAcceptanceNotesLevel1' xlink:to='lab_fil_BankersAcceptanceNotesLevel1'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PermitOfLandUseMaximumLife' xlink:label='fil_PermitOfLandUseMaximumLife'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PermitOfLandUseMaximumLife' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Permit of land use maximum life</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PermitOfLandUseMaximumLife' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The maximum useful life of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PermitOfLandUseMaximumLife' xlink:to='lab_fil_PermitOfLandUseMaximumLife'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_LessAccumulatedDepreciationDetails' xlink:label='fil_LessAccumulatedDepreciationDetails'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessAccumulatedDepreciationDetails' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Less: accumulated depreciation details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessAccumulatedDepreciationDetails' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LessAccumulatedDepreciationDetails' xlink:to='lab_fil_LessAccumulatedDepreciationDetails'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BuildingsAndImprovementsGross' xlink:label='us-gaap_BuildingsAndImprovementsGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BuildingsAndImprovementsGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Building</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BuildingsAndImprovementsGross' xlink:to='lab_us-gaap_BuildingsAndImprovementsGross'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AssetsFairValuesTablETextBlock' xlink:label='fil_AssetsFairValuesTablETextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AssetsFairValuesTablETextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Assets Fair Value</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AssetsFairValuesTablETextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Tabular disclosure of assets vair value.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AssetsFairValuesTablETextBlock' xlink:to='lab_fil_AssetsFairValuesTablETextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>STOCKHOLDERS&apos; EQUITY {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>STOCKHOLDERS&apos; EQUITY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:to='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NotesPayableTextBlock' xlink:label='fil_NotesPayableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesPayableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NOTES PAYABLE</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesPayableTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The entire disclosure of notes payable.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NotesPayableTextBlock' xlink:to='lab_fil_NotesPayableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PRODUCTRECALLAbstract' xlink:label='fil_PRODUCTRECALLAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PRODUCTRECALLAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>PRODUCT RECALL</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PRODUCTRECALLAbstract' xlink:to='lab_fil_PRODUCTRECALLAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Loss) income before income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:to='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestExpense' xlink:to='lab_us-gaap_InterestExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryWriteDown' xlink:label='us-gaap_InventoryWriteDown'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryWriteDown' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory obsolescence</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryWriteDown' xlink:to='lab_us-gaap_InventoryWriteDown'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesOutstanding' xlink:label='us-gaap_PreferredStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesOutstanding' xlink:to='lab_us-gaap_PreferredStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TOTAL LIABILITIES AND STOCKHOLDERS&apos; EQUITY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax' xlink:label='us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated other comprehensive income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax' xlink:to='lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BankersAcceptanceNotesLevel3' xlink:label='fil_BankersAcceptanceNotesLevel3'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BankersAcceptanceNotesLevel3' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bankers acceptance notes Level 3</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BankersAcceptanceNotesLevel3' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bankers acceptance notes Level 3</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BankersAcceptanceNotesLevel3' xlink:to='lab_fil_BankersAcceptanceNotesLevel3'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalInterestExpenseRecognizedForThePeriod' xlink:label='fil_TotalInterestExpenseRecognizedForThePeriod'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalInterestExpenseRecognizedForThePeriod' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total interest expense recognized for the period</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalInterestExpenseRecognizedForThePeriod' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total interest expense recognized for the period</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalInterestExpenseRecognizedForThePeriod' xlink:to='lab_fil_TotalInterestExpenseRecognizedForThePeriod'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AmortizationExpenseIntangibleAssets' xlink:label='fil_AmortizationExpenseIntangibleAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmortizationExpenseIntangibleAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortization Expense Intangible assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmortizationExpenseIntangibleAssets' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amortization Expense Intangible assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AmortizationExpenseIntangibleAssets' xlink:to='lab_fil_AmortizationExpenseIntangibleAssets'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_MotorVehicleMinimumLife' xlink:label='fil_MotorVehicleMinimumLife'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MotorVehicleMinimumLife' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Motor vehicle minimum life</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MotorVehicleMinimumLife' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The minimum useful life of long lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MotorVehicleMinimumLife' xlink:to='lab_fil_MotorVehicleMinimumLife'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:label='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Diluted weighted-average common shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:to='lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_Warrants' xlink:label='fil_Warrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Warrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Warrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount of warrants.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Warrants' xlink:to='lab_fil_Warrants'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BasisOfPresentationTablesAbstract' xlink:label='fil_BasisOfPresentationTablesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BasisOfPresentationTablesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>BASIS OF PRESENTATION (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BasisOfPresentationTablesAbstract' xlink:to='lab_fil_BasisOfPresentationTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresAbstract' xlink:label='us-gaap_FairValueDisclosuresAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueDisclosuresAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>FAIR VALUE MEASUREMENTS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueDisclosuresAbstract' xlink:to='lab_us-gaap_FairValueDisclosuresAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract' xlink:label='us-gaap_RelatedPartyTransactionsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RelatedPartyTransactionsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RELATED PARTY TRANSACTIONS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RelatedPartyTransactionsAbstract' xlink:to='lab_us-gaap_RelatedPartyTransactionsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Cash Provided by Financing Activity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract' xlink:label='us-gaap_OtherIncomeAndExpensesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherIncomeAndExpensesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other income (expense):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='lab_us-gaap_OtherIncomeAndExpensesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Revenues' xlink:label='us-gaap_Revenues'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Revenues' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Revenue</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Revenues' xlink:to='lab_us-gaap_Revenues'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalPeriodFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Period Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalPeriodFocus' xlink:to='lab_dei_DocumentFiscalPeriodFocus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Common Stock, Shares Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCommonStockSharesOutstanding' xlink:to='lab_dei_EntityCommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_CONCENTRATIONSSalesAndPurchasesAbstract' xlink:label='fil_CONCENTRATIONSSalesAndPurchasesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CONCENTRATIONSSalesAndPurchasesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CONCENTRATIONS Sales And Purchases</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CONCENTRATIONSSalesAndPurchasesAbstract' xlink:to='lab_fil_CONCENTRATIONSSalesAndPurchasesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000' xlink:label='fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Outstanding balance due under revolving line of credit (RMB 30,000,000)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Outstanding balance due under revolving line of credit (RMB 30,000,000)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000' xlink:to='lab_fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_RelatedPartyTransactionMemberOwingsAbstract' xlink:label='fil_RelatedPartyTransactionMemberOwingsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyTransactionMemberOwingsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RELATED PARTY TRANSACTIONS Owings</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyTransactionMemberOwingsAbstract' xlink:to='lab_fil_RelatedPartyTransactionMemberOwingsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_INTANGIBLEASSETSSFDAApprovedMedicalFormulasAbstract' xlink:label='fil_INTANGIBLEASSETSSFDAApprovedMedicalFormulasAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_INTANGIBLEASSETSSFDAApprovedMedicalFormulasAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INTANGIBLE ASSETS SFDA Approved Medical Formulas</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_INTANGIBLEASSETSSFDAApprovedMedicalFormulasAbstract' xlink:to='lab_fil_INTANGIBLEASSETSSFDAApprovedMedicalFormulasAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsWithExercisePrice' xlink:label='fil_WarrantsWithExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWithExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants with exercise prices of $3.00 to $3.80 per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWithExercisePrice' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants with exercise prices of $3.00 to $3.80 per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsWithExercisePrice' xlink:to='lab_fil_WarrantsWithExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_IntangibleAssetsTablesAbstract' xlink:label='fil_IntangibleAssetsTablesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IntangibleAssetsTablesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Intangible Assets (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IntangibleAssetsTablesAbstract' xlink:to='lab_fil_IntangibleAssetsTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock' xlink:label='us-gaap_ConcentrationRiskDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConcentrationRiskDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CONCENTRATIONS {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConcentrationRiskDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>CONCENTRATIONS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConcentrationRiskDisclosureTextBlock' xlink:to='lab_us-gaap_ConcentrationRiskDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Cash Provided by Operating Activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable' xlink:label='us-gaap_IncreaseDecreaseInOtherAccountsPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other payables.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInOtherAccountsPayable' xlink:to='lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trade accounts receivables.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:to='lab_us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit' xlink:label='us-gaap_DeferredIncomeTaxExpenseBenefit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredIncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredIncomeTaxExpenseBenefit' xlink:to='lab_us-gaap_DeferredIncomeTaxExpenseBenefit'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_StockBasedCompensation' xlink:label='fil_StockBasedCompensation'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockBasedCompensation' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock based compensation.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockBasedCompensation' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers&apos; compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StockBasedCompensation' xlink:to='lab_fil_StockBasedCompensation'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent' xlink:label='us-gaap_DueToRelatedPartiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DueToRelatedPartiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other payables - related parties</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DueToRelatedPartiesCurrent' xlink:to='lab_us-gaap_DueToRelatedPartiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash' xlink:label='us-gaap_Cash'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Cash' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash and cash equivalents</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Cash' xlink:to='lab_us-gaap_Cash'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityWellKnownSeasonedIssuer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Well-known Seasoned Issuer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityWellKnownSeasonedIssuer' xlink:to='lab_dei_EntityWellKnownSeasonedIssuer'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfAccountsReceivableByOneCustomer' xlink:label='fil_PercentageOfAccountsReceivableByOneCustomer'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentageOfAccountsReceivableByOneCustomer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Percentage of accounts receivable by one customer</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentageOfAccountsReceivableByOneCustomer' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Percentage of accounts receivable by one customer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PercentageOfAccountsReceivableByOneCustomer' xlink:to='lab_fil_PercentageOfAccountsReceivableByOneCustomer'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials' xlink:label='fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Percentage of purchases from one supplier of raw materials</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Percentage of purchases from one supplier of raw materials</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials' xlink:to='lab_fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_CommonSharesAuthorized' xlink:label='fil_CommonSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common shares authorized</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The maximum number of common shares permitted to be issued by an entity&apos;s charter and bylaws.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonSharesAuthorized' xlink:to='lab_fil_CommonSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PermitOfLandUse' xlink:label='fil_PermitOfLandUse'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PermitOfLandUse' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Permit of land use</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PermitOfLandUse' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount of permit of land use as on the date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PermitOfLandUse' xlink:to='lab_fil_PermitOfLandUse'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OrganizationAndOperationsAbstract' xlink:label='fil_OrganizationAndOperationsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OrganizationAndOperationsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Organization and operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OrganizationAndOperationsAbstract' xlink:to='lab_fil_OrganizationAndOperationsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_ProvisionForIncomeTaxesTableTextBlock' xlink:label='fil_ProvisionForIncomeTaxesTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ProvisionForIncomeTaxesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Provision For Income Taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ProvisionForIncomeTaxesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Tabluar disclosure of Provision For Income Taxes.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ProvisionForIncomeTaxesTableTextBlock' xlink:to='lab_fil_ProvisionForIncomeTaxesTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment consists</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' xlink:label='us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Presentation of the numerators and denominators used in the calculation of basic and diluted earnings per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:label='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CONTINGENCIES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:to='lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryDisclosureAbstract' xlink:label='us-gaap_InventoryDisclosureAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryDisclosureAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INVENTORY.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryDisclosureAbstract' xlink:to='lab_us-gaap_InventoryDisclosureAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract' xlink:label='us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>BASIS OF PRESENTATION</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract' xlink:to='lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InventoryPurchasedWithBankerSAcceptances' xlink:label='fil_InventoryPurchasedWithBankerSAcceptances'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InventoryPurchasedWithBankerSAcceptances' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory purchased with banker&apos;s acceptances</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InventoryPurchasedWithBankerSAcceptances' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Inventory purchased with banker&apos;s acceptances</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InventoryPurchasedWithBankerSAcceptances' xlink:to='lab_fil_InventoryPurchasedWithBankerSAcceptances'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Increase in Cash and Cash Equivalents</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued expenses.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:to='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:label='us-gaap_EarningsPerShareBasicAndDilutedAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Loss) earnings per share:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:to='lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GrossProfit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gross profit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GrossProfit' xlink:to='lab_us-gaap_GrossProfit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityPublicFloat' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Public Float</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityPublicFloat' xlink:to='lab_dei_EntityPublicFloat'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsEndRangeExercisePrice' xlink:label='fil_WarrantsEndRangeExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsEndRangeExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants end range exercise price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsEndRangeExercisePrice' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants start range exercise price.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsEndRangeExercisePrice' xlink:to='lab_fil_WarrantsEndRangeExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalLevel1' xlink:label='fil_TotalLevel1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalLevel1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Level 1</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalLevel1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bankers acceptance notes total Level 1</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalLevel1' xlink:to='lab_fil_TotalLevel1'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_INCOMETAXESEnterpriseIncomeTaxRatesAbstract' xlink:label='fil_INCOMETAXESEnterpriseIncomeTaxRatesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_INCOMETAXESEnterpriseIncomeTaxRatesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INCOME TAXES Enterprise Income Tax Rates</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_INCOMETAXESEnterpriseIncomeTaxRatesAbstract' xlink:to='lab_fil_INCOMETAXESEnterpriseIncomeTaxRatesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OfficeEquipmentMaximumLife' xlink:label='fil_OfficeEquipmentMaximumLife'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OfficeEquipmentMaximumLife' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Office equipment maximum life</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OfficeEquipmentMaximumLife' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The maximum useful life of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OfficeEquipmentMaximumLife' xlink:to='lab_fil_OfficeEquipmentMaximumLife'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercetageOfAcquiredByOnnyInHelpson' xlink:label='fil_PercetageOfAcquiredByOnnyInHelpson'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercetageOfAcquiredByOnnyInHelpson' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Percetage of acquired by Onny in Helpson</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercetageOfAcquiredByOnnyInHelpson' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Percetage of acquired by Onny in Helpson</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PercetageOfAcquiredByOnnyInHelpson' xlink:to='lab_fil_PercetageOfAcquiredByOnnyInHelpson'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock' xlink:label='us-gaap_IncomeTaxDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INCOME TAXES {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>INCOME TAXES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxDisclosureTextBlock' xlink:to='lab_us-gaap_IncomeTaxDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract' xlink:label='us-gaap_IncomeTaxDisclosureAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxDisclosureAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INCOME TAXES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxDisclosureAbstract' xlink:to='lab_us-gaap_IncomeTaxDisclosureAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesForPurchasesOfIntangibleAssetsAbstract' xlink:label='fil_AdvancesForPurchasesOfIntangibleAssetsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesForPurchasesOfIntangibleAssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AdvancesForPurchasesOfIntangibleAssetsAbstract' xlink:to='lab_fil_AdvancesForPurchasesOfIntangibleAssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:label='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Purchase of property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:to='lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables' xlink:label='us-gaap_IncreaseDecreaseInOtherReceivables'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInOtherReceivables' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other receivables.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInOtherReceivables' xlink:to='lab_us-gaap_IncreaseDecreaseInOtherReceivables'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasic' xlink:label='us-gaap_EarningsPerShareBasic'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareBasic' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareBasic' xlink:to='lab_us-gaap_EarningsPerShareBasic'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Liabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Liabilities' xlink:to='lab_us-gaap_Liabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentType' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Type</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentType' xlink:to='lab_dei_DocumentType'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalLevel3' xlink:label='fil_TotalLevel3'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalLevel3' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Level 3</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalLevel3' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bankers acceptance notes Level 3 total.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalLevel3' xlink:to='lab_fil_TotalLevel3'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter' xlink:label='fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Enterprise Income Tax Rates for the year 2014 and after</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Enterprise Income Tax Rates for the year 2014 and after</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter' xlink:to='lab_fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AssetsDepreciationAbstract' xlink:label='fil_AssetsDepreciationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AssetsDepreciationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Assets Depreciation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AssetsDepreciationAbstract' xlink:to='lab_fil_AssetsDepreciationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PROPERTYANDEQUIPMENTAssetsLifeAbstract' xlink:label='fil_PROPERTYANDEQUIPMENTAssetsLifeAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PROPERTYANDEQUIPMENTAssetsLifeAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>PROPERTY AND EQUIPMENT Assets Life</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PROPERTYANDEQUIPMENTAssetsLifeAbstract' xlink:to='lab_fil_PROPERTYANDEQUIPMENTAssetsLifeAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryGross' xlink:label='us-gaap_InventoryGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryGross' xlink:to='lab_us-gaap_InventoryGross'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_Options' xlink:label='fil_Options'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Options' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Options</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Options' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount of options.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Options' xlink:to='lab_fil_Options'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:label='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Supplemental Noncash Investing and Financing Activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NetInvestmentInBankerSAcceptances' xlink:label='fil_NetInvestmentInBankerSAcceptances'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetInvestmentInBankerSAcceptances' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net investment in banker&apos;s acceptances</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetInvestmentInBankerSAcceptances' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The cash outflow for the net investment in bankers acceptances.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetInvestmentInBankerSAcceptances' xlink:to='lab_fil_NetInvestmentInBankerSAcceptances'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableCurrent' xlink:label='us-gaap_NotesPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NotesPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Short-term notes payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NotesPayableCurrent' xlink:to='lab_us-gaap_NotesPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Current Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrent' xlink:to='lab_us-gaap_AssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherReceivablesNetCurrent' xlink:label='us-gaap_OtherReceivablesNetCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherReceivablesNetCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other receivables, less allowance for doubtful accounts of $50,592 and $49,881, respectively</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherReceivablesNetCurrent' xlink:to='lab_us-gaap_OtherReceivablesNetCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>ASSETS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsAbstract' xlink:to='lab_us-gaap_AssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_STOCKHOLDERSEQUITY2010StockOptionPlanAbstract' xlink:label='fil_STOCKHOLDERSEQUITY2010StockOptionPlanAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_STOCKHOLDERSEQUITY2010StockOptionPlanAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>STOCKHOLDERS EQUITY 2010 Stock Option Plan</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_STOCKHOLDERSEQUITY2010StockOptionPlanAbstract' xlink:to='lab_fil_STOCKHOLDERSEQUITY2010StockOptionPlanAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions' xlink:label='fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment in Helpson, a foreign subsidiary for the company in millions</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Investment in Helpson, a foreign subsidiary for the company in millions</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions' xlink:to='lab_fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InterestRateOnAdvancesFromMemberOfBOD' xlink:label='fil_InterestRateOnAdvancesFromMemberOfBOD'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestRateOnAdvancesFromMemberOfBOD' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest rate on advances from Member of BOD</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestRateOnAdvancesFromMemberOfBOD' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Interest rate on advances from Member of BOD</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestRateOnAdvancesFromMemberOfBOD' xlink:to='lab_fil_InterestRateOnAdvancesFromMemberOfBOD'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BuildingMinimumLife' xlink:label='fil_BuildingMinimumLife'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BuildingMinimumLife' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Building minimum life</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BuildingMinimumLife' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The minimum useful life of long lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BuildingMinimumLife' xlink:to='lab_fil_BuildingMinimumLife'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OptionsWithAnExercisePrice' xlink:label='fil_OptionsWithAnExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OptionsWithAnExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Options with an exercise price of $2.54 to $3.47 per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OptionsWithAnExercisePrice' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Options with an exercise price of $2.54 to $3.47 per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OptionsWithAnExercisePrice' xlink:to='lab_fil_OptionsWithAnExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PropertyAndEquipmentTablesAbstract' xlink:label='fil_PropertyAndEquipmentTablesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAndEquipmentTablesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>PROPERTY AND EQUIPMENT (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyAndEquipmentTablesAbstract' xlink:to='lab_fil_PropertyAndEquipmentTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_UseOfEstimates' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounting Estimates</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_UseOfEstimates' xlink:to='lab_us-gaap_UseOfEstimates'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInInventories' xlink:label='us-gaap_IncreaseDecreaseInInventories'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInInventories' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInInventories' xlink:to='lab_us-gaap_IncreaseDecreaseInInventories'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_ChangesInAdvancesToSuppliers' xlink:label='fil_ChangesInAdvancesToSuppliers'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ChangesInAdvancesToSuppliers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Changes in Advances to suppliers.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ChangesInAdvancesToSuppliers' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Changes in Advances to suppliers.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ChangesInAdvancesToSuppliers' xlink:to='lab_fil_ChangesInAdvancesToSuppliers'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash Flows from Operating Activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CostOfRevenue' xlink:label='us-gaap_CostOfRevenue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CostOfRevenue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cost of revenue</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CostOfRevenue' xlink:to='lab_us-gaap_CostOfRevenue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashEquivalentsAtCarryingValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Banker&apos;s acceptances</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashEquivalentsAtCarryingValue' xlink:to='lab_us-gaap_CashEquivalentsAtCarryingValue'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PreferredSharesAuthorized' xlink:label='fil_PreferredSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PreferredSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred shares authorized</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PreferredSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity&apos;s charter and bylaws.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PreferredSharesAuthorized' xlink:to='lab_fil_PreferredSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_GrossCarryingAmount' xlink:label='fil_GrossCarryingAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GrossCarryingAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gross carrying amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GrossCarryingAmount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Gross carrying amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GrossCarryingAmount' xlink:to='lab_fil_GrossCarryingAmount'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PlantMachineryAndEquipmentGross' xlink:label='fil_PlantMachineryAndEquipmentGross'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PlantMachineryAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Plant, machinery and equipment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PlantMachineryAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount of plant machinery and equipment gross as on the date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PlantMachineryAndEquipmentGross' xlink:to='lab_fil_PlantMachineryAndEquipmentGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryFinishedGoods' xlink:label='us-gaap_InventoryFinishedGoods'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryFinishedGoods' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finished goods</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryFinishedGoods' xlink:to='lab_us-gaap_InventoryFinishedGoods'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BASISOFPRESENTATIONPOLICIESAbstract' xlink:label='fil_BASISOFPRESENTATIONPOLICIESAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BASISOFPRESENTATIONPOLICIESAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>BASIS OF PRESENTATION POLICIES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BASISOFPRESENTATIONPOLICIESAbstract' xlink:to='lab_fil_BASISOFPRESENTATIONPOLICIESAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_IntangibleAssetsMedicalFormulasTablesTextBlock' xlink:label='fil_IntangibleAssetsMedicalFormulasTablesTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IntangibleAssetsMedicalFormulasTablesTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Intangible Assets Medical Formulas</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IntangibleAssetsMedicalFormulasTablesTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Tabluar disclosure of Intangible Assets Medical Formulas</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IntangibleAssetsMedicalFormulasTablesTextBlock' xlink:to='lab_fil_IntangibleAssetsMedicalFormulasTablesTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InventoryObsolescenceReserve' xlink:label='fil_InventoryObsolescenceReserve'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InventoryObsolescenceReserve' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory obsolescence reserve</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InventoryObsolescenceReserve' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Inventory obsolescence reserve</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InventoryObsolescenceReserve' xlink:to='lab_fil_InventoryObsolescenceReserve'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationAndAmortization' xlink:label='us-gaap_DepreciationAndAmortization'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DepreciationAndAmortization' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation and amortization</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DepreciationAndAmortization' xlink:to='lab_us-gaap_DepreciationAndAmortization'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net income for the period</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetIncomeLoss' xlink:to='lab_us-gaap_NetIncomeLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpensesAbstract' xlink:label='us-gaap_OperatingExpensesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingExpensesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating expenses:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='lab_us-gaap_OperatingExpensesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, shares authorized</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesAuthorized' xlink:to='lab_us-gaap_CommonStockSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockParOrStatedValuePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, par or stated value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockParOrStatedValuePerShare' xlink:to='lab_us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:label='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Allowance for doubtful accounts on trade accounts receivables</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:to='lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent' xlink:label='us-gaap_DeferredTaxLiabilitiesNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredTaxLiabilitiesNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-term deferred tax liability</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredTaxLiabilitiesNoncurrent' xlink:to='lab_us-gaap_DeferredTaxLiabilitiesNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityVoluntaryFilers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Voluntary Filers</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityVoluntaryFilers' xlink:to='lab_dei_EntityVoluntaryFilers'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsWeightedAverageExercisePrice' xlink:label='fil_WarrantsWeightedAverageExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWeightedAverageExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants weighted average exercise price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWeightedAverageExercisePrice' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants weighted average exercise price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsWeightedAverageExercisePrice' xlink:to='lab_fil_WarrantsWeightedAverageExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_FAIRVALUEMEASUREMENTSAtReportingDateUsingAbstract' xlink:label='fil_FAIRVALUEMEASUREMENTSAtReportingDateUsingAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FAIRVALUEMEASUREMENTSAtReportingDateUsingAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>FAIR VALUE MEASUREMENTS At Reporting Date Using</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FAIRVALUEMEASUREMENTSAtReportingDateUsingAbstract' xlink:to='lab_fil_FAIRVALUEMEASUREMENTSAtReportingDateUsingAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit' xlink:label='us-gaap_DeferredFederalIncomeTaxExpenseBenefit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred tax provision.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredFederalIncomeTaxExpenseBenefit' xlink:to='lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AnnualInterestRate' xlink:label='fil_AnnualInterestRate'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AnnualInterestRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Annual interest rate</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AnnualInterestRate' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Annual interest rate</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AnnualInterestRate' xlink:to='lab_fil_AnnualInterestRate'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_MotorVehicleMaximumLife' xlink:label='fil_MotorVehicleMaximumLife'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MotorVehicleMaximumLife' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Motor vehicle maximum life</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MotorVehicleMaximumLife' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The maximum useful life of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MotorVehicleMaximumLife' xlink:to='lab_fil_MotorVehicleMaximumLife'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalInventoryNet' xlink:label='fil_TotalInventoryNet'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalInventoryNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Inventory net</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalInventoryNet' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalInventoryNet' xlink:to='lab_fil_TotalInventoryNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock' xlink:label='us-gaap_ConsolidationPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConsolidationPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Consolidation and Basis of Presentation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConsolidationPolicyTextBlock' xlink:to='lab_us-gaap_ConsolidationPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock' xlink:label='fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS. {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The entire disclosure of advances for purchases of intangible assets.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock' xlink:to='lab_fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, shares authorized</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesAuthorized' xlink:to='lab_us-gaap_PreferredStockSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated amortization on intangible assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:to='lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock, $0.001 par value; 95,000,000 shares authorized; 43,579,557 shares and 43,579,557 shares outstanding, respectively</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockValue' xlink:to='lab_us-gaap_CommonStockValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityRegistrantName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Registrant Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityRegistrantName' xlink:to='lab_dei_EntityRegistrantName'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalIntrinsicValue' xlink:label='fil_TotalIntrinsicValue'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalIntrinsicValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total intrinsic value</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalIntrinsicValue' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total intrinsic value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalIntrinsicValue' xlink:to='lab_fil_TotalIntrinsicValue'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BankersAcceptanceNotesLevel2' xlink:label='fil_BankersAcceptanceNotesLevel2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BankersAcceptanceNotesLevel2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bankers acceptance notes Level 2</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BankersAcceptanceNotesLevel2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bankers acceptance notes Level 2</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BankersAcceptanceNotesLevel2' xlink:to='lab_fil_BankersAcceptanceNotesLevel2'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_DepreciationExpensePropertyAndEquipment' xlink:label='fil_DepreciationExpensePropertyAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationExpensePropertyAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation Expense property and equipment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationExpensePropertyAndEquipment' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Depreciation Expense property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DepreciationExpensePropertyAndEquipment' xlink:to='lab_fil_DepreciationExpensePropertyAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetailsAbstract' xlink:label='fil_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>BASIS OF PRESENTATION Basic and Diluted Earnings per Common Share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetailsAbstract' xlink:to='lab_fil_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited' xlink:label='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Percentage of share owned by China Pharma Holdings Inc of Onny Investment Limited</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Percentage of share owned by China Pharma Holdings Inc of Onny Investment Limited</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited' xlink:to='lab_fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock' xlink:label='fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Potential common shares were not included in the computation of diluted earnings per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Tabular disclosure of common shares not included in earnings per share.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock' xlink:to='lab_fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityAbstract' xlink:label='us-gaap_EquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>STOCKHOLDERS&apos; EQUITY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EquityAbstract' xlink:to='lab_us-gaap_EquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock' xlink:label='us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>BASIS OF PRESENTATION {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>BASIS OF PRESENTATION</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock' xlink:to='lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable' xlink:label='us-gaap_IncreaseDecreaseInAccruedTaxesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued taxes payables.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccruedTaxesPayable' xlink:to='lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss' xlink:label='us-gaap_OperatingIncomeLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Loss) income from operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingIncomeLoss' xlink:to='lab_us-gaap_OperatingIncomeLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>LIABILITIES AND STOCKHOLDERS&apos; EQUITY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory, less allowance for obsolescence of $1,779,729 and $1,769,984, respectively</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryNet' xlink:to='lab_us-gaap_InventoryNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Assets:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='lab_us-gaap_AssetsCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementLineItems' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement [Line Items]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementLineItems' xlink:to='lab_us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentPeriodEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Period End Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentPeriodEndDate' xlink:to='lab_dei_DocumentPeriodEndDate'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NumberOfCommonShares' xlink:label='fil_NumberOfCommonShares'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfCommonShares' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of common shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfCommonShares' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The maximum number of common shares permitted to be issued by an entity&apos;s charter and bylaws.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NumberOfCommonShares' xlink:to='lab_fil_NumberOfCommonShares'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalIncomeTaxExpense' xlink:label='fil_TotalIncomeTaxExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalIncomeTaxExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total income tax expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalIncomeTaxExpense' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalIncomeTaxExpense' xlink:to='lab_fil_TotalIncomeTaxExpense'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_RevolvingLineOfCreditWithABank' xlink:label='fil_RevolvingLineOfCreditWithABank'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RevolvingLineOfCreditWithABank' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Revolving line of credit with a bank</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RevolvingLineOfCreditWithABank' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Revolving line of credit with a bank</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RevolvingLineOfCreditWithABank' xlink:to='lab_fil_RevolvingLineOfCreditWithABank'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PermitOfLandUseMinimumLife' xlink:label='fil_PermitOfLandUseMinimumLife'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PermitOfLandUseMinimumLife' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Permit of land use minimum life</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PermitOfLandUseMinimumLife' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The minimum useful life of long lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PermitOfLandUseMinimumLife' xlink:to='lab_fil_PermitOfLandUseMinimumLife'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BasicEarningsPerShare' xlink:label='fil_BasicEarningsPerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BasicEarningsPerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic earnings per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BasicEarningsPerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BasicEarningsPerShare' xlink:to='lab_fil_BasicEarningsPerShare'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_UsefulLivesOfTheAssetsTableTextBlock' xlink:label='fil_UsefulLivesOfTheAssetsTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_UsefulLivesOfTheAssetsTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Useful lives of the assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_UsefulLivesOfTheAssetsTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Tabular disclosure of useful lives of the assets.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_UsefulLivesOfTheAssetsTableTextBlock' xlink:to='lab_fil_UsefulLivesOfTheAssetsTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock' xlink:label='us-gaap_ScheduleOfInventoryCurrentTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory consists</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfInventoryCurrentTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BasisOfAccounting' xlink:label='us-gaap_BasisOfAccounting'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BasisOfAccounting' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Condensed Financial Statements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BasisOfAccounting' xlink:to='lab_us-gaap_BasisOfAccounting'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract' xlink:label='us-gaap_RisksAndUncertaintiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RisksAndUncertaintiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CONCENTRATIONS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RisksAndUncertaintiesAbstract' xlink:to='lab_us-gaap_RisksAndUncertaintiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:label='us-gaap_RelatedPartyTransactionsDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RELATED PARTY TRANSACTIONS {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>RELATED PARTY TRANSACTIONS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:to='lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>PROPERTY AND EQUIPMENT {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>PROPERTY AND EQUIPMENT</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxesPaidNet' xlink:label='us-gaap_IncomeTaxesPaidNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxesPaidNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash paid for income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxesPaidNet' xlink:to='lab_us-gaap_IncomeTaxesPaidNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Cash Used in Investing Activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TaxesPayableCurrent' xlink:label='us-gaap_TaxesPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_TaxesPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued taxes payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_TaxesPayableCurrent' xlink:to='lab_us-gaap_TaxesPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TOTAL ASSETS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Assets' xlink:to='lab_us-gaap_Assets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment, net of accumulated depreciation of $4,511,658 and $4,273,373, respectively</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentNet' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesForPurchasesOfIntangibleAssets' xlink:label='fil_AdvancesForPurchasesOfIntangibleAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesForPurchasesOfIntangibleAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advances for purchases of intangible assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesForPurchasesOfIntangibleAssets' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Advances for purchases of intangible assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AdvancesForPurchasesOfIntangibleAssets' xlink:to='lab_fil_AdvancesForPurchasesOfIntangibleAssets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ReceivablesNetCurrent' xlink:label='us-gaap_ReceivablesNetCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ReceivablesNetCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trade accounts receivable, less allowance for doubtful accounts of $4,333,411 and $4,429,945, respectively</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ReceivablesNetCurrent' xlink:to='lab_us-gaap_ReceivablesNetCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CurrentFiscalYearEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Fiscal Year End Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CurrentFiscalYearEndDate' xlink:to='lab_dei_CurrentFiscalYearEndDate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentFlag' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Flag</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentFlag' xlink:to='lab_dei_AmendmentFlag'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_CONCENTRATIONSAccountsReceivableAbstract' xlink:label='fil_CONCENTRATIONSAccountsReceivableAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CONCENTRATIONSAccountsReceivableAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CONCENTRATIONS Accounts Receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CONCENTRATIONSAccountsReceivableAbstract' xlink:to='lab_fil_CONCENTRATIONSAccountsReceivableAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfNoCustomerAccountedForMoreThanSales' xlink:label='fil_PercentageOfNoCustomerAccountedForMoreThanSales'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentageOfNoCustomerAccountedForMoreThanSales' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Percentage of no customer accounted for more than sales</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentageOfNoCustomerAccountedForMoreThanSales' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Percentage of no customer accounted for more than sales</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PercentageOfNoCustomerAccountedForMoreThanSales' xlink:to='lab_fil_PercentageOfNoCustomerAccountedForMoreThanSales'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_Total1' xlink:label='fil_Total1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Total1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Total1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total bankers acceptance notes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Total1' xlink:to='lab_fil_Total1'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdavanceOwingToBoardmember' xlink:label='fil_AdavanceOwingToBoardmember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdavanceOwingToBoardmember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Adavances owing to board member</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdavanceOwingToBoardmember' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Adavance owing to boardmember</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AdavanceOwingToBoardmember' xlink:to='lab_fil_AdavanceOwingToBoardmember'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NetCarryingAmount' xlink:label='fil_NetCarryingAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetCarryingAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net carrying amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetCarryingAmount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Net carrying amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetCarryingAmount' xlink:to='lab_fil_NetCarryingAmount'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalWarrantsAndOptions' xlink:label='fil_TotalWarrantsAndOptions'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalWarrantsAndOptions' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Warrants And Options</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalWarrantsAndOptions' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total Warrants And Options</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalWarrantsAndOptions' xlink:to='lab_fil_TotalWarrantsAndOptions'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_IncomeTaxesTablesAbstract' xlink:label='fil_IncomeTaxesTablesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeTaxesTablesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INCOME TAXES (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncomeTaxesTablesAbstract' xlink:to='lab_fil_IncomeTaxesTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NatureOfOperations' xlink:label='us-gaap_NatureOfOperations'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NatureOfOperations' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Organization and Nature of Operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NatureOfOperations' xlink:to='lab_us-gaap_NatureOfOperations'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_CommitmentAndContingenciesAbstract' xlink:label='fil_CommitmentAndContingenciesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommitmentAndContingenciesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>COMMITMENTS AND CONTINGENCIES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommitmentAndContingenciesAbstract' xlink:to='lab_fil_CommitmentAndContingenciesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract' xlink:label='us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SupplementalCashFlowInformationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Supplemental Cash Flow Information:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='lab_us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash and Cash Equivalents at Beginning of Period</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Cash and Cash Equivalents at Beginning of Period</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Cash and Cash Equivalents at End of Period</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:to='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease' xlink:label='us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other comprehensive income - foreign currency translation adjustment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease' xlink:to='lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherExpenses' xlink:label='us-gaap_OtherExpenses'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherExpenses' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net other expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherExpenses' xlink:to='lab_us-gaap_OtherExpenses'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SellingExpense' xlink:label='us-gaap_SellingExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SellingExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Selling expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SellingExpense' xlink:to='lab_us-gaap_SellingExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stockholders&apos; Equity:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='lab_us-gaap_StockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Current Liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='lab_us-gaap_LiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesToSuppliers' xlink:label='fil_AdvancesToSuppliers'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesToSuppliers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advances to suppliers</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesToSuppliers' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Carrying amount as of the balance sheet date of advances to suppliers.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AdvancesToSuppliers' xlink:to='lab_fil_AdvancesToSuppliers'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCurrentReportingStatus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Current Reporting Status</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCurrentReportingStatus' xlink:to='lab_dei_EntityCurrentReportingStatus'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable' xlink:label='fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>No of customers accounted for more than 10.0% of accounts receivable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>No of customers accounted for more than 10.0% of accounts receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable' xlink:to='lab_fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable' xlink:label='fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of common stock shares to purchase by warrants outstaning and exercisable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of common stock shares to purchase by warrants outstaning and exercisable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable' xlink:to='lab_fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BankersAcceptanceNotes' xlink:label='fil_BankersAcceptanceNotes'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BankersAcceptanceNotes' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bankers acceptance notes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BankersAcceptanceNotes' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bankers acceptance notes,</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BankersAcceptanceNotes' xlink:to='lab_fil_BankersAcceptanceNotes'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_INCOMETAXESUndistributedEarningsAbstract' xlink:label='fil_INCOMETAXESUndistributedEarningsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_INCOMETAXESUndistributedEarningsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INCOME TAXES Undistributed Earnings</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_INCOMETAXESUndistributedEarningsAbstract' xlink:to='lab_fil_INCOMETAXESUndistributedEarningsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FurnitureAndFixturesGross' xlink:label='us-gaap_FurnitureAndFixturesGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FurnitureAndFixturesGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Office equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FurnitureAndFixturesGross' xlink:to='lab_us-gaap_FurnitureAndFixturesGross'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_MotorVehicleGross' xlink:label='fil_MotorVehicleGross'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MotorVehicleGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Motor vehicle</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MotorVehicleGross' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount of motor vehicle gross as on the date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MotorVehicleGross' xlink:to='lab_fil_MotorVehicleGross'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_INVENTORYABSTRACTAbstract' xlink:label='fil_INVENTORYABSTRACTAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_INVENTORYABSTRACTAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INVENTORY ABSTRACT</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_INVENTORYABSTRACTAbstract' xlink:to='lab_fil_INVENTORYABSTRACTAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract' xlink:label='us-gaap_DilutiveSecuritiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DilutiveSecuritiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Effect of dilutive securities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DilutiveSecuritiesAbstract' xlink:to='lab_us-gaap_DilutiveSecuritiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_FairValueMeasurementsTablesAbstract' xlink:label='fil_FairValueMeasurementsTablesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FairValueMeasurementsTablesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>FAIR VALUE MEASUREMENTS (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FairValueMeasurementsTablesAbstract' xlink:to='lab_fil_FairValueMeasurementsTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock' xlink:label='us-gaap_FairValueMeasurementInputsDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>FAIR VALUE MEASUREMENTS {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>FAIR VALUE MEASUREMENTS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueMeasurementInputsDisclosureTextBlock' xlink:to='lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AccountsReceivableCollectedWithBankerSAcceptances' xlink:label='fil_AccountsReceivableCollectedWithBankerSAcceptances'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccountsReceivableCollectedWithBankerSAcceptances' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts receivable collected with banker&apos;s acceptances</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccountsReceivableCollectedWithBankerSAcceptances' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Accounts receivable collected with banker&apos;s acceptances</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccountsReceivableCollectedWithBankerSAcceptances' xlink:to='lab_fil_AccountsReceivableCollectedWithBankerSAcceptances'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayableTrade'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trade accounts payables.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:to='lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProfitLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net (loss) income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProfitLoss' xlink:to='lab_us-gaap_ProfitLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses' xlink:label='us-gaap_OperatingExpenses'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingExpenses' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total operating expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingExpenses' xlink:to='lab_us-gaap_OperatingExpenses'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts' xlink:label='us-gaap_ProvisionForDoubtfulAccounts'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProvisionForDoubtfulAccounts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bad debt expense.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProvisionForDoubtfulAccounts' xlink:to='lab_us-gaap_ProvisionForDoubtfulAccounts'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GeneralAndAdministrativeExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>General and administrative expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GeneralAndAdministrativeExpense' xlink:to='lab_us-gaap_GeneralAndAdministrativeExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued' xlink:label='us-gaap_CommonStockSharesIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, shares issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesIssued' xlink:to='lab_us-gaap_CommonStockSharesIssued'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Stockholders&apos; Equity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquity' xlink:to='lab_us-gaap_StockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RetainedEarningsAccumulatedDeficit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Retained earnings</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RetainedEarningsAccumulatedDeficit' xlink:to='lab_us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementTable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement [Table]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementTable' xlink:to='lab_us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCentralIndexKey' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Central Index Key</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCentralIndexKey' xlink:to='lab_dei_EntityCentralIndexKey'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalLevel2' xlink:label='fil_TotalLevel2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalLevel2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Level 2</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalLevel2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bankers acceptance notes Level 2 total</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalLevel2' xlink:to='lab_fil_TotalLevel2'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_EnterpriseIncomeTaxRatesForTheYear2013' xlink:label='fil_EnterpriseIncomeTaxRatesForTheYear2013'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_EnterpriseIncomeTaxRatesForTheYear2013' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Enterprise Income Tax Rates for the year 2013</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_EnterpriseIncomeTaxRatesForTheYear2013' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Enterprise Income Tax Rates for the year 2013</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_EnterpriseIncomeTaxRatesForTheYear2013' xlink:to='lab_fil_EnterpriseIncomeTaxRatesForTheYear2013'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BuildingMaximumLife' xlink:label='fil_BuildingMaximumLife'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BuildingMaximumLife' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Building maximum life</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BuildingMaximumLife' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The maximum useful life of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BuildingMaximumLife' xlink:to='lab_fil_BuildingMaximumLife'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalPropertyAndEquipment' xlink:label='fil_TotalPropertyAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalPropertyAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Property and Equipment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalPropertyAndEquipment' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total Property and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalPropertyAndEquipment' xlink:to='lab_fil_TotalPropertyAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NetIncome' xlink:label='fil_NetIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net income</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetIncome' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetIncome' xlink:to='lab_fil_NetIncome'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd' xlink:label='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Percentage of share owned by China Pharma Holdings Inc of Helpson Medical &amp; Biotechnology Co., Ltd</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Percentage of share owned by China Pharma Holdings Inc of Helpson Medical &amp;amp; Biotechnology Co., Ltd</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd' xlink:to='lab_fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NotesPayable1Abstract' xlink:label='fil_NotesPayable1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesPayable1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NOTES PAYABLES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NotesPayable1Abstract' xlink:to='lab_fil_NotesPayable1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract' xlink:label='us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INTANGIBLE ASSETS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract' xlink:to='lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' xlink:label='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Effect of Exchange Rate Changes on Cash</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' xlink:to='lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareDiluted' xlink:label='us-gaap_EarningsPerShareDiluted'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareDiluted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Diluted</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareDiluted' xlink:to='lab_us-gaap_EarningsPerShareDiluted'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income tax benefit (expense)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='lab_us-gaap_IncomeTaxExpenseBenefit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesIssued' xlink:label='us-gaap_PreferredStockSharesIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, shares issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesIssued' xlink:to='lab_us-gaap_PreferredStockSharesIssued'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableTradeCurrent' xlink:label='us-gaap_AccountsPayableTradeCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsPayableTradeCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trade accounts payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsPayableTradeCurrent' xlink:to='lab_us-gaap_AccountsPayableTradeCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:label='us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Intangible assets, net of accumulated amortization of $3,097,224 and $2,944,726, respectively</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:to='lab_us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NumberOfCommonSharesPurchasedByOptions' xlink:label='fil_NumberOfCommonSharesPurchasedByOptions'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfCommonSharesPurchasedByOptions' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of common shares purchased by options</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfCommonSharesPurchasedByOptions' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of common shares purchased by options</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NumberOfCommonSharesPurchasedByOptions' xlink:to='lab_fil_NumberOfCommonSharesPurchasedByOptions'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit' xlink:label='us-gaap_CurrentIncomeTaxExpenseBenefit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CurrentIncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current tax provision.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CurrentIncomeTaxExpenseBenefit' xlink:to='lab_us-gaap_CurrentIncomeTaxExpenseBenefit'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_INCOMETAXESProvisionAbstract' xlink:label='fil_INCOMETAXESProvisionAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_INCOMETAXESProvisionAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INCOME TAXES Provision</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_INCOMETAXESProvisionAbstract' xlink:to='lab_fil_INCOMETAXESProvisionAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_UndistributedEarningsOfHelpsonInMillions' xlink:label='fil_UndistributedEarningsOfHelpsonInMillions'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_UndistributedEarningsOfHelpsonInMillions' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Undistributed earnings of Helpson in millions</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_UndistributedEarningsOfHelpsonInMillions' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Undistributed earnings of Helpson in millions</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_UndistributedEarningsOfHelpsonInMillions' xlink:to='lab_fil_UndistributedEarningsOfHelpsonInMillions'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OfficeEquipmentMinimumLife' xlink:label='fil_OfficeEquipmentMinimumLife'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OfficeEquipmentMinimumLife' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Office equipment minimum life</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OfficeEquipmentMinimumLife' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The minimum useful life of long lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OfficeEquipmentMinimumLife' xlink:to='lab_fil_OfficeEquipmentMinimumLife'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConstructionInProgressGross' xlink:label='us-gaap_ConstructionInProgressGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConstructionInProgressGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Construction in progress</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConstructionInProgressGross' xlink:to='lab_us-gaap_ConstructionInProgressGross'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_DilutedEarningsPerShare' xlink:label='fil_DilutedEarningsPerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DilutedEarningsPerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Diluted earnings per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DilutedEarningsPerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DilutedEarningsPerShare' xlink:to='lab_fil_DilutedEarningsPerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic' xlink:label='us-gaap_WeightedAverageNumberOfSharesIssuedBasic'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic weighted-average common shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberOfSharesIssuedBasic' xlink:to='lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InventoryTablesAbstract' xlink:label='fil_InventoryTablesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InventoryTablesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INVENTORY (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InventoryTablesAbstract' xlink:to='lab_fil_InventoryTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock' xlink:label='us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerSharePolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic and Diluted Earnings per Common Share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerSharePolicyTextBlock' xlink:to='lab_us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract' xlink:label='us-gaap_PropertyPlantAndEquipmentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>PROPERTY AND EQUIPMENT</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentAbstract' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock' xlink:label='us-gaap_ProductWarrantyDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProductWarrantyDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>PRODUCT RECALL {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProductWarrantyDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>PRODUCT RECALL</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProductWarrantyDisclosureTextBlock' xlink:to='lab_us-gaap_ProductWarrantyDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets' xlink:label='fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advances for purchases of property and equipment and intangible assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Advances paid  for purchases of property and equipment and intangible assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets' xlink:to='lab_fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash Flows from Investing Activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated depreciation on property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:to='lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued or outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockValue' xlink:to='lab_us-gaap_PreferredStockValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CustomerAdvancesCurrent' xlink:label='us-gaap_CustomerAdvancesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CustomerAdvancesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advances from customers</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CustomerAdvancesCurrent' xlink:to='lab_us-gaap_CustomerAdvancesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalYearFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Year Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalYearFocus' xlink:to='lab_dei_DocumentFiscalYearFocus'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_StockOptionsGranted' xlink:label='fil_StockOptionsGranted'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockOptionsGranted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock options granted</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockOptionsGranted' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Stock options granted</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StockOptionsGranted' xlink:to='lab_fil_StockOptionsGranted'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_STOCKHOLDERSEQUITYPreferredCommonStockAndWarrantsAbstract' xlink:label='fil_STOCKHOLDERSEQUITYPreferredCommonStockAndWarrantsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_STOCKHOLDERSEQUITYPreferredCommonStockAndWarrantsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Common Stock And Warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_STOCKHOLDERSEQUITYPreferredCommonStockAndWarrantsAbstract' xlink:to='lab_fil_STOCKHOLDERSEQUITYPreferredCommonStockAndWarrantsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas' xlink:label='fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated amortization Intangible assets SFDA Approved Medical Formulas</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Accumulated amortization Intangible assets SFDA Approved Medical Formulas</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas' xlink:to='lab_fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PlantMachineryAndEquipmentLife' xlink:label='fil_PlantMachineryAndEquipmentLife'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PlantMachineryAndEquipmentLife' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Plant, machinery and equipment life</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PlantMachineryAndEquipmentLife' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Plant, machinery and equipment life</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PlantMachineryAndEquipmentLife' xlink:to='lab_fil_PlantMachineryAndEquipmentLife'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PROPERTYANDEQUIPMENTAbstract' xlink:label='fil_PROPERTYANDEQUIPMENTAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PROPERTYANDEQUIPMENTAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>PROPERTY AND EQUIPMENT {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PROPERTYANDEQUIPMENTAbstract' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>PROPERTY AND EQUIPMENT</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PROPERTYANDEQUIPMENTAbstract' xlink:to='lab_fil_PROPERTYANDEQUIPMENTAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AccountingPoliciesPoliciesAbstract' xlink:label='fil_AccountingPoliciesPoliciesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccountingPoliciesPoliciesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounting Policies (Policies)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccountingPoliciesPoliciesAbstract' xlink:to='lab_fil_AccountingPoliciesPoliciesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock' xlink:label='us-gaap_IntangibleAssetsDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IntangibleAssetsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INTANGIBLE ASSETS {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IntangibleAssetsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>INTANGIBLE ASSETS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IntangibleAssetsDisclosureTextBlock' xlink:to='lab_us-gaap_IntangibleAssetsDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryDisclosureTextBlock' xlink:label='us-gaap_InventoryDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INVENTORY. {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>INVENTORY.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryDisclosureTextBlock' xlink:to='lab_us-gaap_InventoryDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:label='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Changes in assets and liabilities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InvestmentIncomeInterest' xlink:label='us-gaap_InvestmentIncomeInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InvestmentIncomeInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InvestmentIncomeInterest' xlink:to='lab_us-gaap_InvestmentIncomeInterest'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockParOrStatedValuePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, par or stated value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockParOrStatedValuePerShare' xlink:to='lab_us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AllowanceForDoubtfulAccountsOnOtherReceivables' xlink:label='fil_AllowanceForDoubtfulAccountsOnOtherReceivables'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AllowanceForDoubtfulAccountsOnOtherReceivables' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Allowance for doubtful accounts on other receivables</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AllowanceForDoubtfulAccountsOnOtherReceivables' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>A valuation allowance for other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AllowanceForDoubtfulAccountsOnOtherReceivables' xlink:to='lab_fil_AllowanceForDoubtfulAccountsOnOtherReceivables'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract' xlink:label='us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stockholders equity number of shares par value and other disclosures</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract' xlink:to='lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdditionalPaidInCapital' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Additional paid-in capital</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdditionalPaidInCapital' xlink:to='lab_us-gaap_AdditionalPaidInCapital'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccruedLiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccruedLiabilitiesCurrent' xlink:to='lab_us-gaap_AccruedLiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Liabilities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='lab_us-gaap_LiabilitiesCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfOneCustomerAccountedForMoreThanSales' xlink:label='fil_PercentageOfOneCustomerAccountedForMoreThanSales'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentageOfOneCustomerAccountedForMoreThanSales' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Percentage of one customer accounted for more than sales</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentageOfOneCustomerAccountedForMoreThanSales' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Percentage of one customer accounted for more than sales</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PercentageOfOneCustomerAccountedForMoreThanSales' xlink:to='lab_fil_PercentageOfOneCustomerAccountedForMoreThanSales'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsStartRangeExercisePrice' xlink:label='fil_WarrantsStartRangeExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsStartRangeExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants start range exercise price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsStartRangeExercisePrice' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Warrants start range exercise price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsStartRangeExercisePrice' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants start range exercise price.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsStartRangeExercisePrice' xlink:to='lab_fil_WarrantsStartRangeExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_RELATEDPARTYTRANSACTIONSMemberOfBODAbstract' xlink:label='fil_RELATEDPARTYTRANSACTIONSMemberOfBODAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RELATEDPARTYTRANSACTIONSMemberOfBODAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RELATED PARTY TRANSACTIONS Member Of BOD</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RELATEDPARTYTRANSACTIONSMemberOfBODAbstract' xlink:to='lab_fil_RELATEDPARTYTRANSACTIONSMemberOfBODAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PropertyAndEquipmentNet' xlink:label='fil_PropertyAndEquipmentNet'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAndEquipmentNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and Equipment, net</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAndEquipmentNet' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyAndEquipmentNet' xlink:to='lab_fil_PropertyAndEquipmentNet'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AllowanceForObsolescenceRawMaterials' xlink:label='fil_AllowanceForObsolescenceRawMaterials'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AllowanceForObsolescenceRawMaterials' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Allowance for obsolescence - raw materials</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AllowanceForObsolescenceRawMaterials' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Allowance for obsolescence - raw materials</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AllowanceForObsolescenceRawMaterials' xlink:to='lab_fil_AllowanceForObsolescenceRawMaterials'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryRawMaterials' xlink:label='us-gaap_InventoryRawMaterials'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryRawMaterials' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Raw materials</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryRawMaterials' xlink:to='lab_us-gaap_InventoryRawMaterials'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_IncomeTaxesTableTextBlock' xlink:label='fil_IncomeTaxesTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeTaxesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeTaxesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Tabluar disclosure of Provision For Income Taxes.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncomeTaxesTableTextBlock' xlink:to='lab_fil_IncomeTaxesTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AccountsPayableForPurchasesOfPropertyAndEquipment' xlink:label='fil_AccountsPayableForPurchasesOfPropertyAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccountsPayableForPurchasesOfPropertyAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts payable for purchases of property and equipment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccountsPayableForPurchasesOfPropertyAndEquipment' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Accounts receivable collected with banker&apos;s acceptances</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccountsPayableForPurchasesOfPropertyAndEquipment' xlink:to='lab_fil_AccountsPayableForPurchasesOfPropertyAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestPaid' xlink:label='us-gaap_InterestPaid'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestPaid' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash paid for interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestPaid' xlink:to='lab_us-gaap_InterestPaid'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances' xlink:label='us-gaap_IncreaseDecreaseInCustomerAdvances'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInCustomerAdvances' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advances from customers.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInCustomerAdvances' xlink:to='lab_us-gaap_IncreaseDecreaseInCustomerAdvances'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax' xlink:label='us-gaap_ComprehensiveIncomeNetOfTax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ComprehensiveIncomeNetOfTax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Comprehensive (loss) income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ComprehensiveIncomeNetOfTax' xlink:to='lab_us-gaap_ComprehensiveIncomeNetOfTax'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesOutstanding' xlink:to='lab_us-gaap_CommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableOtherCurrent' xlink:label='us-gaap_AccountsPayableOtherCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsPayableOtherCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other payables</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsPayableOtherCurrent' xlink:to='lab_us-gaap_AccountsPayableOtherCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent' xlink:label='us-gaap_DeferredTaxAssetsNetCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredTaxAssetsNetCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred tax assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredTaxAssetsNetCurrent' xlink:to='lab_us-gaap_DeferredTaxAssetsNetCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFilerCategory' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Filer Category</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFilerCategory' xlink:to='lab_dei_EntityFilerCategory'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_DocumentAndEntityInformationAbstract' xlink:label='fil_DocumentAndEntityInformationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DocumentAndEntityInformationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document and Entity Information</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='lab_fil_DocumentAndEntityInformationAbstract'/>
	</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cphi-20130331_pre.xml
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- NeoClarus - iFile Suite version 4.2311  -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.chinapharmaholdings.com/20130331"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DocumentDocumentAndEntityInformation">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_DocumentAndEntityInformationAbstract' xlink:label='fil_DocumentAndEntityInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityRegistrantName' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentType' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentPeriodEndDate' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_AmendmentFlag' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCentralIndexKey' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_CurrentFiscalYearEndDate' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCommonStockSharesOutstanding' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityFilerCategory' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCurrentReportingStatus' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityVoluntaryFilers' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityWellKnownSeasonedIssuer' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentFiscalYearFocus' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentFiscalPeriodFocus' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityPublicFloat' use='optional' order='14.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDBALANCESHEETS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AssetsAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_AssetsCurrentAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash' xlink:label='us-gaap_Cash'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_Cash' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashEquivalentsAtCarryingValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_CashEquivalentsAtCarryingValue' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ReceivablesNetCurrent' xlink:label='us-gaap_ReceivablesNetCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_ReceivablesNetCurrent' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherReceivablesNetCurrent' xlink:label='us-gaap_OtherReceivablesNetCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_OtherReceivablesNetCurrent' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesToSuppliers' xlink:label='fil_AdvancesToSuppliers'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='fil_AdvancesToSuppliers' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_InventoryNet' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent' xlink:label='us-gaap_DeferredTaxAssetsNetCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_DeferredTaxAssetsNetCurrent' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_AssetsCurrent' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesForPurchasesOfIntangibleAssets' xlink:label='fil_AdvancesForPurchasesOfIntangibleAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsAbstract' xlink:to='fil_AdvancesForPurchasesOfIntangibleAssets' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:label='us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_IntangibleAssetsNetExcludingGoodwill' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_Assets' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_LiabilitiesAndStockholdersEquityAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_LiabilitiesCurrentAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableTradeCurrent' xlink:label='us-gaap_AccountsPayableTradeCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccountsPayableTradeCurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TaxesPayableCurrent' xlink:label='us-gaap_TaxesPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_TaxesPayableCurrent' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableOtherCurrent' xlink:label='us-gaap_AccountsPayableOtherCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccountsPayableOtherCurrent' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CustomerAdvancesCurrent' xlink:label='us-gaap_CustomerAdvancesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_CustomerAdvancesCurrent' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent' xlink:label='us-gaap_DueToRelatedPartiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_DueToRelatedPartiesCurrent' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableCurrent' xlink:label='us-gaap_NotesPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_NotesPayableCurrent' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_LiabilitiesCurrent' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent' xlink:label='us-gaap_DeferredTaxLiabilitiesNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_DeferredTaxLiabilitiesNoncurrent' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_Liabilities' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_StockholdersEquityAbstract' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_PreferredStockValue' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_CommonStockValue' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_AdditionalPaidInCapital' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax' xlink:label='us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_StockholdersEquity' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_LiabilitiesAndStockholdersEquity' use='optional' order='5.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONSOLIDATEDBALANCESHEETSPARENTHETICALS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONSOLIDATEDBALANCESHEETSPARENTHETICALS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONSOLIDATEDBALANCESHEETSPARENTHETICALS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract' xlink:label='us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:label='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AllowanceForDoubtfulAccountsOnOtherReceivables' xlink:label='fil_AllowanceForDoubtfulAccountsOnOtherReceivables'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_AllowanceForDoubtfulAccountsOnOtherReceivables' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockParOrStatedValuePerShare' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesAuthorized' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesIssued' xlink:label='us-gaap_PreferredStockSharesIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesIssued' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesOutstanding' xlink:label='us-gaap_PreferredStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesOutstanding' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockParOrStatedValuePerShare' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockSharesAuthorized' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued' xlink:label='us-gaap_CommonStockSharesIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockSharesIssued' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockSharesOutstanding' use='optional' order='12.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Revenues' xlink:label='us-gaap_Revenues'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_Revenues' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CostOfRevenue' xlink:label='us-gaap_CostOfRevenue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CostOfRevenue' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryWriteDown' xlink:label='us-gaap_InventoryWriteDown'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_InventoryWriteDown' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_GrossProfit' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpensesAbstract' xlink:label='us-gaap_OperatingExpensesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_OperatingExpensesAbstract' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SellingExpense' xlink:label='us-gaap_SellingExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_SellingExpense' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_GeneralAndAdministrativeExpense' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts' xlink:label='us-gaap_ProvisionForDoubtfulAccounts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_ProvisionForDoubtfulAccounts' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses' xlink:label='us-gaap_OperatingExpenses'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_OperatingExpenses' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss' xlink:label='us-gaap_OperatingIncomeLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_OperatingIncomeLoss' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract' xlink:label='us-gaap_OtherIncomeAndExpensesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_OtherIncomeAndExpensesAbstract' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InvestmentIncomeInterest' xlink:label='us-gaap_InvestmentIncomeInterest'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='us-gaap_InvestmentIncomeInterest' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='us-gaap_InterestExpense' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherExpenses' xlink:label='us-gaap_OtherExpenses'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='us-gaap_OtherExpenses' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_IncomeTaxExpenseBenefit' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ProfitLoss' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease' xlink:label='us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax' xlink:label='us-gaap_ComprehensiveIncomeNetOfTax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ComprehensiveIncomeNetOfTax' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:label='us-gaap_EarningsPerShareBasicAndDilutedAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_EarningsPerShareBasicAndDilutedAbstract' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasic' xlink:label='us-gaap_EarningsPerShareBasic'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:to='us-gaap_EarningsPerShareBasic' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareDiluted' xlink:label='us-gaap_EarningsPerShareDiluted'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:to='us-gaap_EarningsPerShareDiluted' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_NetIncomeLoss' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationAndAmortization' xlink:label='us-gaap_DepreciationAndAmortization'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_DepreciationAndAmortization' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_StockBasedCompensation' xlink:label='fil_StockBasedCompensation'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_StockBasedCompensation' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts' xlink:label='us-gaap_ProvisionForDoubtfulAccounts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_ProvisionForDoubtfulAccounts' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit' xlink:label='us-gaap_DeferredIncomeTaxExpenseBenefit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_DeferredIncomeTaxExpenseBenefit' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InventoryObsolescenceReserve' xlink:label='fil_InventoryObsolescenceReserve'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_InventoryObsolescenceReserve' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:label='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccountsReceivable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables' xlink:label='us-gaap_IncreaseDecreaseInOtherReceivables'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInOtherReceivables' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_ChangesInAdvancesToSuppliers' xlink:label='fil_ChangesInAdvancesToSuppliers'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='fil_ChangesInAdvancesToSuppliers' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInInventories' xlink:label='us-gaap_IncreaseDecreaseInInventories'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInInventories' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayableTrade'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccountsPayableTrade' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccruedLiabilities' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable' xlink:label='us-gaap_IncreaseDecreaseInAccruedTaxesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccruedTaxesPayable' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable' xlink:label='us-gaap_IncreaseDecreaseInOtherAccountsPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInOtherAccountsPayable' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances' xlink:label='us-gaap_IncreaseDecreaseInCustomerAdvances'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInCustomerAdvances' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivities' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NetInvestmentInBankerSAcceptances' xlink:label='fil_NetInvestmentInBankerSAcceptances'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='fil_NetInvestmentInBankerSAcceptances' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets' xlink:label='fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:label='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' xlink:label='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue_1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue_1' use='optional' order='7.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract' xlink:label='us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SupplementalCashFlowInformationAbstract' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestPaid' xlink:label='us-gaap_InterestPaid'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='us-gaap_InterestPaid' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxesPaidNet' xlink:label='us-gaap_IncomeTaxesPaidNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='us-gaap_IncomeTaxesPaidNet' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:label='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AccountsPayableForPurchasesOfPropertyAndEquipment' xlink:label='fil_AccountsPayableForPurchasesOfPropertyAndEquipment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_AccountsPayableForPurchasesOfPropertyAndEquipment' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AccountsReceivableCollectedWithBankerSAcceptances' xlink:label='fil_AccountsReceivableCollectedWithBankerSAcceptances'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_AccountsReceivableCollectedWithBankerSAcceptances' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InventoryPurchasedWithBankerSAcceptances' xlink:label='fil_InventoryPurchasedWithBankerSAcceptances'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_InventoryPurchasedWithBankerSAcceptances' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureBASISOFPRESENTATION" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureBASISOFPRESENTATION"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureBASISOFPRESENTATION">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract' xlink:label='us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock' xlink:label='us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract' xlink:to='us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePRODUCTRECALL" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosurePRODUCTRECALL"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePRODUCTRECALL">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PRODUCTRECALLAbstract' xlink:label='fil_PRODUCTRECALLAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock' xlink:label='us-gaap_ProductWarrantyDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PRODUCTRECALLAbstract' xlink:to='us-gaap_ProductWarrantyDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINVENTORY" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureINVENTORY"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINVENTORY">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryDisclosureAbstract' xlink:label='us-gaap_InventoryDisclosureAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryDisclosureTextBlock' xlink:label='us-gaap_InventoryDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_InventoryDisclosureAbstract' xlink:to='us-gaap_InventoryDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosurePROPERTYANDEQUIPMENT"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePROPERTYANDEQUIPMENT">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract' xlink:label='us-gaap_PropertyPlantAndEquipmentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PropertyPlantAndEquipmentAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINTANGIBLEASSETS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureINTANGIBLEASSETS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINTANGIBLEASSETS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract' xlink:label='us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock' xlink:label='us-gaap_IntangibleAssetsDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract' xlink:to='us-gaap_IntangibleAssetsDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureADVANCESFORPURCHASESOFINTANGIBLEASSETS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureADVANCESFORPURCHASESOFINTANGIBLEASSETS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureADVANCESFORPURCHASESOFINTANGIBLEASSETS">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesForPurchasesOfIntangibleAssetsAbstract' xlink:label='fil_AdvancesForPurchasesOfIntangibleAssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock' xlink:label='fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AdvancesForPurchasesOfIntangibleAssetsAbstract' xlink:to='fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureRELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureRELATEDPARTYTRANSACTIONS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureRELATEDPARTYTRANSACTIONS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract' xlink:label='us-gaap_RelatedPartyTransactionsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:label='us-gaap_RelatedPartyTransactionsDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RelatedPartyTransactionsAbstract' xlink:to='us-gaap_RelatedPartyTransactionsDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureNOTESPAYABLE" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureNOTESPAYABLE"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureNOTESPAYABLE">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NotesPayable1Abstract' xlink:label='fil_NotesPayable1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NotesPayableTextBlock' xlink:label='fil_NotesPayableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_NotesPayable1Abstract' xlink:to='fil_NotesPayableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINCOMETAXES" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureINCOMETAXES"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINCOMETAXES">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract' xlink:label='us-gaap_IncomeTaxDisclosureAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock' xlink:label='us-gaap_IncomeTaxDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeTaxDisclosureAbstract' xlink:to='us-gaap_IncomeTaxDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureFAIRVALUEMEASUREMENTS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureFAIRVALUEMEASUREMENTS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresAbstract' xlink:label='us-gaap_FairValueDisclosuresAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock' xlink:label='us-gaap_FairValueMeasurementInputsDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_FairValueDisclosuresAbstract' xlink:to='us-gaap_FairValueMeasurementInputsDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureSTOCKHOLDERSEQUITY"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureSTOCKHOLDERSEQUITY">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityAbstract' xlink:label='us-gaap_EquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_EquityAbstract' xlink:to='us-gaap_StockholdersEquityNoteDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureCONTINGENCIES" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureCONTINGENCIES"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureCONTINGENCIES">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_CommitmentAndContingenciesAbstract' xlink:label='fil_CommitmentAndContingenciesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:label='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_CommitmentAndContingenciesAbstract' xlink:to='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureCONCENTRATIONS" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureCONCENTRATIONS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureCONCENTRATIONS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract' xlink:label='us-gaap_RisksAndUncertaintiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock' xlink:label='us-gaap_ConcentrationRiskDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RisksAndUncertaintiesAbstract' xlink:to='us-gaap_ConcentrationRiskDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureAccountingPoliciesPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureAccountingPoliciesPolicies">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AccountingPoliciesPoliciesAbstract' xlink:label='fil_AccountingPoliciesPoliciesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NatureOfOperations' xlink:label='us-gaap_NatureOfOperations'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPoliciesPoliciesAbstract' xlink:to='us-gaap_NatureOfOperations' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock' xlink:label='us-gaap_ConsolidationPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPoliciesPoliciesAbstract' xlink:to='us-gaap_ConsolidationPolicyTextBlock' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BasisOfAccounting' xlink:label='us-gaap_BasisOfAccounting'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPoliciesPoliciesAbstract' xlink:to='us-gaap_BasisOfAccounting' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPoliciesPoliciesAbstract' xlink:to='us-gaap_UseOfEstimates' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock' xlink:label='us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPoliciesPoliciesAbstract' xlink:to='us-gaap_EarningsPerSharePolicyTextBlock' use='optional' order='5.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureBASISOFPRESENTATIONTables" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureBASISOFPRESENTATIONTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureBASISOFPRESENTATIONTables">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BasisOfPresentationTablesAbstract' xlink:label='fil_BasisOfPresentationTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' xlink:label='us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BasisOfPresentationTablesAbstract' xlink:to='us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock' xlink:label='fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BasisOfPresentationTablesAbstract' xlink:to='fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINVENTORYTables" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureINVENTORYTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINVENTORYTables">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InventoryTablesAbstract' xlink:label='fil_InventoryTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock' xlink:label='us-gaap_ScheduleOfInventoryCurrentTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_InventoryTablesAbstract' xlink:to='us-gaap_ScheduleOfInventoryCurrentTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosurePROPERTYANDEQUIPMENTTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePROPERTYANDEQUIPMENTTables">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PropertyAndEquipmentTablesAbstract' xlink:label='fil_PropertyAndEquipmentTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PropertyAndEquipmentTablesAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentTextBlock' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_UsefulLivesOfTheAssetsTableTextBlock' xlink:label='fil_UsefulLivesOfTheAssetsTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PropertyAndEquipmentTablesAbstract' xlink:to='fil_UsefulLivesOfTheAssetsTableTextBlock' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureINTANGIBLEASSETSTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINTANGIBLEASSETSTables">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_IntangibleAssetsTablesAbstract' xlink:label='fil_IntangibleAssetsTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_IntangibleAssetsMedicalFormulasTablesTextBlock' xlink:label='fil_IntangibleAssetsMedicalFormulasTablesTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_IntangibleAssetsTablesAbstract' xlink:to='fil_IntangibleAssetsMedicalFormulasTablesTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINCOMETAXESTables" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureINCOMETAXESTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINCOMETAXESTables">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_IncomeTaxesTablesAbstract' xlink:label='fil_IncomeTaxesTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_IncomeTaxesTableTextBlock' xlink:label='fil_IncomeTaxesTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_IncomeTaxesTablesAbstract' xlink:to='fil_IncomeTaxesTableTextBlock' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_ProvisionForIncomeTaxesTableTextBlock' xlink:label='fil_ProvisionForIncomeTaxesTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_IncomeTaxesTablesAbstract' xlink:to='fil_ProvisionForIncomeTaxesTableTextBlock' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_DisclosureFAIRVALUEMEASUREMENTSTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureFAIRVALUEMEASUREMENTSTables">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_FairValueMeasurementsTablesAbstract' xlink:label='fil_FairValueMeasurementsTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AssetsFairValuesTablETextBlock' xlink:label='fil_AssetsFairValuesTablETextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_FairValueMeasurementsTablesAbstract' xlink:to='fil_AssetsFairValuesTablETextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_BASISOFPRESENTATIONDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OrganizationAndOperationsAbstract' xlink:label='fil_OrganizationAndOperationsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OrganizationAndOperationsAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited' xlink:label='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd' xlink:label='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercetageOfAcquiredByOnnyInHelpson' xlink:label='fil_PercetageOfAcquiredByOnnyInHelpson'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercetageOfAcquiredByOnnyInHelpson' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetailsAbstract' xlink:label='fil_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetailsAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NetIncome' xlink:label='fil_NetIncome'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NetIncome' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic' xlink:label='us-gaap_WeightedAverageNumberOfSharesIssuedBasic'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_WeightedAverageNumberOfSharesIssuedBasic' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract' xlink:label='us-gaap_DilutiveSecuritiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DilutiveSecuritiesAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_Warrants' xlink:label='fil_Warrants'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_Warrants' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_Options' xlink:label='fil_Options'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_Options' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:label='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BasicEarningsPerShare' xlink:label='fil_BasicEarningsPerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BasicEarningsPerShare' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_DilutedEarningsPerShare' xlink:label='fil_DilutedEarningsPerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_DilutedEarningsPerShare' use='optional' order='8.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONPOLICIESDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_BASISOFPRESENTATIONPOLICIESDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONPOLICIESDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BASISOFPRESENTATIONPOLICIESAbstract' xlink:label='fil_BASISOFPRESENTATIONPOLICIESAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BASISOFPRESENTATIONPOLICIESAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsWithExercisePrice' xlink:label='fil_WarrantsWithExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsWithExercisePrice' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OptionsWithAnExercisePrice' xlink:label='fil_OptionsWithAnExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_OptionsWithAnExercisePrice' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalWarrantsAndOptions' xlink:label='fil_TotalWarrantsAndOptions'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalWarrantsAndOptions' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_INVENTORYDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_INVENTORYDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_INVENTORYDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_INVENTORYABSTRACTAbstract' xlink:label='fil_INVENTORYABSTRACTAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_INVENTORYABSTRACTAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryRawMaterials' xlink:label='us-gaap_InventoryRawMaterials'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_InventoryRawMaterials' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryFinishedGoods' xlink:label='us-gaap_InventoryFinishedGoods'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_InventoryFinishedGoods' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryGross' xlink:label='us-gaap_InventoryGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_InventoryGross' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AllowanceForObsolescenceRawMaterials' xlink:label='fil_AllowanceForObsolescenceRawMaterials'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_AllowanceForObsolescenceRawMaterials' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalInventoryNet' xlink:label='fil_TotalInventoryNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalInventoryNet' use='optional' order='5.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_PROPERTYANDEQUIPMENTDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_PROPERTYANDEQUIPMENTDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PROPERTYANDEQUIPMENTAbstract' xlink:label='fil_PROPERTYANDEQUIPMENTAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PROPERTYANDEQUIPMENTAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PermitOfLandUse' xlink:label='fil_PermitOfLandUse'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PermitOfLandUse' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BuildingsAndImprovementsGross' xlink:label='us-gaap_BuildingsAndImprovementsGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_BuildingsAndImprovementsGross' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PlantMachineryAndEquipmentGross' xlink:label='fil_PlantMachineryAndEquipmentGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PlantMachineryAndEquipmentGross' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_MotorVehicleGross' xlink:label='fil_MotorVehicleGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_MotorVehicleGross' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FurnitureAndFixturesGross' xlink:label='us-gaap_FurnitureAndFixturesGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FurnitureAndFixturesGross' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConstructionInProgressGross' xlink:label='us-gaap_ConstructionInProgressGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ConstructionInProgressGross' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalPropertyAndEquipment' xlink:label='fil_TotalPropertyAndEquipment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalPropertyAndEquipment' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_LessAccumulatedDepreciationDetails' xlink:label='fil_LessAccumulatedDepreciationDetails'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_LessAccumulatedDepreciationDetails' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PropertyAndEquipmentNet' xlink:label='fil_PropertyAndEquipmentNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PropertyAndEquipmentNet' use='optional' order='9.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_PROPERTYANDEQUIPMENTAssetsLifeDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_PROPERTYANDEQUIPMENTAssetsLifeDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_PROPERTYANDEQUIPMENTAssetsLifeDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PROPERTYANDEQUIPMENTAssetsLifeAbstract' xlink:label='fil_PROPERTYANDEQUIPMENTAssetsLifeAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PROPERTYANDEQUIPMENTAssetsLifeAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PermitOfLandUseMinimumLife' xlink:label='fil_PermitOfLandUseMinimumLife'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PermitOfLandUseMinimumLife' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PermitOfLandUseMaximumLife' xlink:label='fil_PermitOfLandUseMaximumLife'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PermitOfLandUseMaximumLife' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BuildingMinimumLife' xlink:label='fil_BuildingMinimumLife'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BuildingMinimumLife' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BuildingMaximumLife' xlink:label='fil_BuildingMaximumLife'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BuildingMaximumLife' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PlantMachineryAndEquipmentLife' xlink:label='fil_PlantMachineryAndEquipmentLife'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PlantMachineryAndEquipmentLife' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_MotorVehicleMinimumLife' xlink:label='fil_MotorVehicleMinimumLife'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_MotorVehicleMinimumLife' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_MotorVehicleMaximumLife' xlink:label='fil_MotorVehicleMaximumLife'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_MotorVehicleMaximumLife' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OfficeEquipmentMinimumLife' xlink:label='fil_OfficeEquipmentMinimumLife'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_OfficeEquipmentMinimumLife' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OfficeEquipmentMaximumLife' xlink:label='fil_OfficeEquipmentMaximumLife'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_OfficeEquipmentMaximumLife' use='optional' order='9.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_ASSETSDepreciationDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_ASSETSDepreciationDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_ASSETSDepreciationDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AssetsDepreciationAbstract' xlink:label='fil_AssetsDepreciationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AssetsDepreciationAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_DepreciationExpensePropertyAndEquipment' xlink:label='fil_DepreciationExpensePropertyAndEquipment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_DepreciationExpensePropertyAndEquipment' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AmortizationExpenseIntangibleAssets' xlink:label='fil_AmortizationExpenseIntangibleAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_AmortizationExpenseIntangibleAssets' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_INTANGIBLEASSETSSFDAApprovedMedicalFormulasDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_INTANGIBLEASSETSSFDAApprovedMedicalFormulasDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_INTANGIBLEASSETSSFDAApprovedMedicalFormulasDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_INTANGIBLEASSETSSFDAApprovedMedicalFormulasAbstract' xlink:label='fil_INTANGIBLEASSETSSFDAApprovedMedicalFormulasAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_INTANGIBLEASSETSSFDAApprovedMedicalFormulasAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_GrossCarryingAmount' xlink:label='fil_GrossCarryingAmount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_GrossCarryingAmount' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas' xlink:label='fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NetCarryingAmount' xlink:label='fil_NetCarryingAmount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NetCarryingAmount' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_RELATEDPARTYTRANSACTIONSMemberOfBODDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_RELATEDPARTYTRANSACTIONSMemberOfBODDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_RELATEDPARTYTRANSACTIONSMemberOfBODDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_RELATEDPARTYTRANSACTIONSMemberOfBODAbstract' xlink:label='fil_RELATEDPARTYTRANSACTIONSMemberOfBODAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RELATEDPARTYTRANSACTIONSMemberOfBODAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalInterestExpenseRecognizedForThePeriod' xlink:label='fil_TotalInterestExpenseRecognizedForThePeriod'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalInterestExpenseRecognizedForThePeriod' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InterestRateOnAdvancesFromMemberOfBOD' xlink:label='fil_InterestRateOnAdvancesFromMemberOfBOD'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_InterestRateOnAdvancesFromMemberOfBOD' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_RELATEDPARTYTRANSACTIONSOwingsDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_RELATEDPARTYTRANSACTIONSOwingsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_RELATEDPARTYTRANSACTIONSOwingsDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_RelatedPartyTransactionMemberOwingsAbstract' xlink:label='fil_RelatedPartyTransactionMemberOwingsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RelatedPartyTransactionMemberOwingsAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AdavanceOwingToBoardmember' xlink:label='fil_AdavanceOwingToBoardmember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_AdavanceOwingToBoardmember' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_NOTESPAYABLESDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_NOTESPAYABLESDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_NOTESPAYABLESDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NotesPayable1Abstract' xlink:label='fil_NotesPayable1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_NotesPayable1Abstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_RevolvingLineOfCreditWithABank' xlink:label='fil_RevolvingLineOfCreditWithABank'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_RevolvingLineOfCreditWithABank' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_AnnualInterestRate' xlink:label='fil_AnnualInterestRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_AnnualInterestRate' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000' xlink:label='fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_INCOMETAXESUndistributedEarningsAndIncomeTaxRatesDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_INCOMETAXESUndistributedEarningsAndIncomeTaxRatesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_INCOMETAXESUndistributedEarningsAndIncomeTaxRatesDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_INCOMETAXESUndistributedEarningsAbstract' xlink:label='fil_INCOMETAXESUndistributedEarningsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_INCOMETAXESUndistributedEarningsAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_UndistributedEarningsOfHelpsonInMillions' xlink:label='fil_UndistributedEarningsOfHelpsonInMillions'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_UndistributedEarningsOfHelpsonInMillions' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions' xlink:label='fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_INCOMETAXESEnterpriseIncomeTaxRatesAbstract' xlink:label='fil_INCOMETAXESEnterpriseIncomeTaxRatesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_INCOMETAXESEnterpriseIncomeTaxRatesAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_EnterpriseIncomeTaxRatesForTheYear2013' xlink:label='fil_EnterpriseIncomeTaxRatesForTheYear2013'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_EnterpriseIncomeTaxRatesForTheYear2013' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter' xlink:label='fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter' use='optional' order='5.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_INCOMETAXESProvisionDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_INCOMETAXESProvisionDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_INCOMETAXESProvisionDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_INCOMETAXESProvisionAbstract' xlink:label='fil_INCOMETAXESProvisionAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_INCOMETAXESProvisionAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit' xlink:label='us-gaap_CurrentIncomeTaxExpenseBenefit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CurrentIncomeTaxExpenseBenefit' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit' xlink:label='us-gaap_DeferredFederalIncomeTaxExpenseBenefit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DeferredFederalIncomeTaxExpenseBenefit' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalIncomeTaxExpense' xlink:label='fil_TotalIncomeTaxExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalIncomeTaxExpense' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_FAIRVALUEMEASUREMENTSAtReportingDateUsingDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_FAIRVALUEMEASUREMENTSAtReportingDateUsingDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_FAIRVALUEMEASUREMENTSAtReportingDateUsingDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_FAIRVALUEMEASUREMENTSAtReportingDateUsingAbstract' xlink:label='fil_FAIRVALUEMEASUREMENTSAtReportingDateUsingAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_FAIRVALUEMEASUREMENTSAtReportingDateUsingAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BankersAcceptanceNotes' xlink:label='fil_BankersAcceptanceNotes'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BankersAcceptanceNotes' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_Total1' xlink:label='fil_Total1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_Total1' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BankersAcceptanceNotesLevel1' xlink:label='fil_BankersAcceptanceNotesLevel1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BankersAcceptanceNotesLevel1' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalLevel1' xlink:label='fil_TotalLevel1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalLevel1' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BankersAcceptanceNotesLevel2' xlink:label='fil_BankersAcceptanceNotesLevel2'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BankersAcceptanceNotesLevel2' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalLevel2' xlink:label='fil_TotalLevel2'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalLevel2' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_BankersAcceptanceNotesLevel3' xlink:label='fil_BankersAcceptanceNotesLevel3'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_BankersAcceptanceNotesLevel3' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalLevel3' xlink:label='fil_TotalLevel3'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalLevel3' use='optional' order='8.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_PreferredCommonStockAndWarrantsDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_PreferredCommonStockAndWarrantsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_PreferredCommonStockAndWarrantsDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_STOCKHOLDERSEQUITYPreferredCommonStockAndWarrantsAbstract' xlink:label='fil_STOCKHOLDERSEQUITYPreferredCommonStockAndWarrantsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_STOCKHOLDERSEQUITYPreferredCommonStockAndWarrantsAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_CommonSharesAuthorized' xlink:label='fil_CommonSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_CommonSharesAuthorized' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PreferredSharesAuthorized' xlink:label='fil_PreferredSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PreferredSharesAuthorized' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable' xlink:label='fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsStartRangeExercisePrice' xlink:label='fil_WarrantsStartRangeExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsStartRangeExercisePrice' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsEndRangeExercisePrice' xlink:label='fil_WarrantsEndRangeExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsEndRangeExercisePrice' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsWeightedAverageExercisePrice' xlink:label='fil_WarrantsWeightedAverageExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsWeightedAverageExercisePrice' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_WarrantsWeightedAverageContractualLife' xlink:label='fil_WarrantsWeightedAverageContractualLife'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsWeightedAverageContractualLife' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_TotalIntrinsicValue' xlink:label='fil_TotalIntrinsicValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_TotalIntrinsicValue' use='optional' order='8.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_StockOptionPlanDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_StockOptionPlanDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_StockOptionPlanDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_STOCKHOLDERSEQUITY2010StockOptionPlanAbstract' xlink:label='fil_STOCKHOLDERSEQUITY2010StockOptionPlanAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_STOCKHOLDERSEQUITY2010StockOptionPlanAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NumberOfCommonShares' xlink:label='fil_NumberOfCommonShares'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NumberOfCommonShares' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NumberOfCommonSharesPurchasedByOptions' xlink:label='fil_NumberOfCommonSharesPurchasedByOptions'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NumberOfCommonSharesPurchasedByOptions' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_StockOptionsGranted' xlink:label='fil_StockOptionsGranted'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_StockOptionsGranted' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONCENTRATIONSSalesAndPurchasesDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONCENTRATIONSSalesAndPurchasesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONCENTRATIONSSalesAndPurchasesDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_CONCENTRATIONSSalesAndPurchasesAbstract' xlink:label='fil_CONCENTRATIONSSalesAndPurchasesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_CONCENTRATIONSSalesAndPurchasesAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfNoCustomerAccountedForMoreThanSales' xlink:label='fil_PercentageOfNoCustomerAccountedForMoreThanSales'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercentageOfNoCustomerAccountedForMoreThanSales' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfOneCustomerAccountedForMoreThanSales' xlink:label='fil_PercentageOfOneCustomerAccountedForMoreThanSales'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercentageOfOneCustomerAccountedForMoreThanSales' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials' xlink:label='fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.chinapharmaholdings.com/20130331/role/idr_CONCENTRATIONSAccountsReceivableDetails" xlink:type="simple" xlink:href="cphi-20130331.xsd#idr_CONCENTRATIONSAccountsReceivableDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.chinapharmaholdings.com/20130331/role/idr_CONCENTRATIONSAccountsReceivableDetails">
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_CONCENTRATIONSAccountsReceivableAbstract' xlink:label='fil_CONCENTRATIONSAccountsReceivableAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_CONCENTRATIONSAccountsReceivableAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_PercentageOfAccountsReceivableByOneCustomer' xlink:label='fil_PercentageOfAccountsReceivableByOneCustomer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PercentageOfAccountsReceivableByOneCustomer' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='cphi-20130331.xsd#fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable' xlink:label='fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable' use='optional' order='2.0'/>
	</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E1KAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS At Reporting Date Using (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_BankersAcceptanceNotes', window );">Bankers acceptance notes</a></td>
        <td class="nump">$ 1,180,864<span></span></td>
        <td class="nump">$ 101,570<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_Total1', window );">Total</a></td>
        <td class="nump">1,180,864<span></span></td>
        <td class="nump">101,570<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_BankersAcceptanceNotesLevel1', window );">Bankers acceptance notes Level 1</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalLevel1', window );">Total Level 1</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_BankersAcceptanceNotesLevel2', window );">Bankers acceptance notes Level 2</a></td>
        <td class="nump">1,180,864<span></span></td>
        <td class="nump">101,570<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalLevel2', window );">Total Level 2</a></td>
        <td class="nump">1,180,864<span></span></td>
        <td class="nump">101,570<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_BankersAcceptanceNotesLevel3', window );">Bankers acceptance notes Level 3</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalLevel3', window );">Total Level 3</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_BankersAcceptanceNotes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Bankers acceptance notes,</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_BankersAcceptanceNotes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_BankersAcceptanceNotesLevel1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Bankers acceptance notes Level 1</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_BankersAcceptanceNotesLevel1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_BankersAcceptanceNotesLevel2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Bankers acceptance notes Level 2</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_BankersAcceptanceNotesLevel2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_BankersAcceptanceNotesLevel3">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Bankers acceptance notes Level 3</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_BankersAcceptanceNotesLevel3</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_Total1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total bankers acceptance notes</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_Total1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalLevel1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Bankers acceptance notes total Level 1</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_TotalLevel1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalLevel2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Bankers acceptance notes Level 2 total</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_TotalLevel2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalLevel3">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Bankers acceptance notes Level 3 total.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_TotalLevel3</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>12
<FILENAME>0001010549-13-000329-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001010549-13-000329-xbrl.zip
M4$L#!!0````(`'V$KD+6L\2-IVH``$P(!@`1`!P`8W!H:2TR,#$S,#,S,2YX
M;6Q55`D``RZ@DE$NH))1=7@+``$$)0X```0Y`0``[#UK<^(XMI]WJ_8_:&KW
M3KJK`K$-YI%TSQ9-2'=VTB&3T#L['X4M0-/&8BT["?OK[SF2;00X#PB=)AUJ
MJW<(ELY+YRUAO?OG[3@@URR27(3O]^RRM4=8Z`F?A\/W>UR*4J/A-DOVWC]_
M^=M?W_U4*I%S)MH!C1))2H2?\("1JX3'+(-!JF6G8MN$E$HXX[8?!010A/+0
M9_S]WBB.)X<'!_AU63*O/!37!_#@P+%LNV39I8J]EPX?\"`??G-S4_9&/*23
M$8W&="0"I$^6/3'&F16KDL^;FZ/0B&@(@ZS*`0]E3$./91AN)9\;?5/)QMH'
M__E\=N6-V)B6EF8%//Q:-,]N-IL'ZFDV=&GD/#WXN$_E##(\Y2O0G\C2D-))
M/F-`95^-3A\4"!46M.K8]?N0Z!'9A#`9%P_VX^@@GD[8`8Q@$??R"2)\Q!P1
MEA;FX2!_04%2HFH'^N$>*-1?WJ'4#J5:FTLV($K@APCU_9[DXTF`XE'?C2(V
M>+_G34:\E.E(^5;Z>^1`P0&M.SP6'E`1QCV83CP1QNPVOL19?]B5W^R]7VRK
M]-N[@\612],O@!'A=T+_F,:%<!!_R:K`0LQ#FYN8@VW!(Q\?GP1T6`1N0`/)
M-*2YL3F$3ACS>'K)AES&$0WC<SHNI*O]Z?2\12X^M2X_M\BG[MGQZ?G'JWUR
M>MXN:_!%@!:PM`%Y1(/3T&>WO[)I$1H++,JV:K5JU82Z,#$'VTZB"!GBTJ/!
M'XQ&]PBV5+*=7*IW35PD6(S'(KR*A??U"MP)D]TD1L-"ET*2D&L$^M'>'-)3
MT"+7!@_I,X^/81'@J_.3O5^J%;?>=-WZ''?W8%D@")UHU`9"AR(JE-\5X((A
MY))-1!0CF0!]0L.IB7`.RB++6C+Y_*N8QN#`"U#]P>0<%X43%Z#_6P1)&--(
MDU`(]ER84!<F+(#[G07!KZ&X":\8E2)D_JF4"7#_(-@[)BZ9ZTQ!3N";0GK1
M8.=-=6'2'4"U0=\)]C>["*@Q28%-W?=AF\K13"&_7!W/:V-'P5S2Q;IK56N-
M=P<FE-7`.LM`+:=9MQX"VOEOPJ]I`'S)5MRF430%C?DW#1*V,A>VW;`:M>H\
MPKOA;XJ49<YMRW;KUEIT7#*/P;A^P.0YBU-+6ED2-:?6K-?J[HR$0KA/Q+S,
M>*UFU]TYUA_&VXU'+-H,VX[K.DUGAOQNT)N@8)G]AE5O-A^-'G+5PY9_C<F9
M[(FK9#().'K"5;EV;;M9=P#O'0#71E9@T@V[5G&K]Z/*V#\-KX%5B"O`]\I,
M52I.S7*<VDR:)KCU\"SS4P%NFJ[]&"S';,!@[?P>O6U)R>*GZ&G3K38;AI'<
M`WLC-"PSWJR!>[!7IT`_7)=OVVHX=M.I&"YZ#N":J`H<L.VX4$\V&O<A,G7X
M1$072>2-H+"2W<$IY!GAD(/-ZEFK:V^S6@/E;<P;ROU(-DE3@:8WG5JE6:^O
M3%$FOXM(3%@43R\"R.A;H8_Q;(+IR#K6W70:#<<U7.5]T#=#1H$-6!6[T:RN
M0<2BH.!YY]8+$DS3/PKAW_`@6#UX.8UFP[5-5_0PELV2M2PCIVH[#;?Z!*+6
MM"#;;8*"U&QGT8)7!5[@'&H5I])L8JY^'VC/$U!OR`LZQ>#=BZC/ULY+FO5&
MK6)$F7N`;X2(@H5L5.U&S5F+A"AA_AFG?1[PF+.UO;]3A9*^,D=!,>0-X"\0
M@.78#7=5[!`/62:B=?EV[:I3-3`7P'P2SB*KA=ACYDX/H5Q0!I6XKA_D[6JM
M6K]3TTS@&R&BJ/YJ5AN-N^WM3A+:B8S%F$59?%Q;!G7(*VU#!G<`?C+R`MZ;
M5;?9J*Z&^CAA/7')`AHS_X)&3[%R&^H#MV:P?C?L39!0((`U"3@7\9--O5IO
MU!W3RQ0`?1+2@I*L7K.M>N7Q*#?@R6VG!OFU950P#[C1)WMO<"E.O=*H/!JC
M4=`8(\]%Z*W+LVTYIDMY",'FJ"G(7"$SJJQ)BC%BC74'O^::4C"@K86E:*7K
M3J52?02.BRCE6_7+UVL96F;VOP3N2>B665L!F;$1L!YCU8IK=A@6X:V/K,`#
MK8"JY?NPD"*DP07E_FG8IA,>TS6*)8BOEF.9C81BR$_&7I!=K87[DL64A\SO
MT"C$;6A(29)QHH(2V"_W^#J95LUJ.I:99SR,99-$%65>C:95K3CNVB09CW6:
M)L:3B(U8*/DU.PT]2&7.A,2ZLSL`A[>ZT&KU9L-QYBN!53!^,VH+I.E"X5AU
M&YNA59DDGH)@D<361CQ=77C5F@MEG%E:+$-]"M*B>-!P[=I<0O<`2B->M$)_
M$UPO]R(>PK$Y@A[5OUB)G&XTI"'_'T6/U1:A%`'WU1\P%>*2A(Q!_=D=G/`0
M2@9.`]S!9=@)D\=<>H&02<1Z0..'`#`5[5G^',1'/Y5*;'A;*OT\C(_P[PF1
M\31@[W_^;R+BHU[G/[U2Z^STX_GAGU"A\,'TB)R=GG=*GSJG'S_U#D,1`<]'
MY'/K\N/I^:'%0Z+^3>(CHN=^Z76O+EKMSJ$&F*'IXX?S;J]#;%(B'UI7IU>D
M>T(N+CM7G?->JW?:/<=A!_ULPL$$/Y%E$M<DYXC$M%^"HFLB#UW+*MN3V*"0
MCB='85].[D?];:6#'SA^,%6!T-`GYS2&I25B0+H3%JGO)5$T_]UV+4WI`<\E
MIZ"U\8P5N5"'K,BG])35/@%O5-XGE)RS:^I34))H(C3$?2)N`*QM6?^G,(7A
ME."^BXQ1Q<@9'W/P;^1-BK=:/\(AV5^-H[<(]D,$ZBY'Y-\\&@+GIS(`^N4\
MFGA$8P(/@:=P'N<GBJI-/K%@(H'US\SG'B0""@?^(Q\XE%'>*!2!&$Y)6P`K
M9_$<3>G<!;(,_$1HZ0(K20BV".0P$M`;B03@YPLF)@'[F4Z$/))X3B/I!]S#
MIUJD;W#0#.'%9=M`5B;WR%VM)8\ED4E?<I_3"!-Q"BN;Y9TD%@3B!P/I4*FH
M24^'E+^#7CZ[3=QKHMV0'#./C?NP9!5[GT"&Y>S?(VWT?S(9CS$H@P:@3$TM
M&+-H")`&0BO`)(%'4IF8-\)6>CA4WTMTL?CM_.Q!),9`#J@-KAXL6FI.`$8F
M%*P%OL+I,8O&4BT[4*.S4:5GH.2M8<24\U:/<7,#'WS69/F*ZIQ?IZ[Y+1MK
MDG_JC=A=W-V`$M'))!+7`*T_!6YF(8BD)R\5G6/ZIX@PYJ4V((QC5)ZJ'(A4
M)Y^(,);!L3.R7I._1GF?")#X,#3]XVGH`XH(PC)I4R@SQ#!AN4=?H%=]M^!'
M9I-FWH3\*7@8!U/"\?236D+E$U#ILV$U<%*?>8B'^M3R8:''(H\IM<+1YU07
M0;!NURP0DUSG(#,`_M4$@(]J\R9U.IC)RC@_!LSUMU-&([7>V8-]P@8#YL60
MY))_T3"A0$'%TCKQEG@!!:@##G1?@Z<3B00CTC)B\J"?2"@_I&3XK;(6,`?B
M<P"H6B^>/OT&0P_)&_Y6'61.(CH$:&BS@W0!>+X`1S`,QH&.`@(OUKZT:!BR
M#D-A+!C&B/=55%,&O3RZC"L-,Z89Z=.<<!(*H!(L*](+@X.T]8`;T=S,>,"@
MQZ9$;?7U@4VT?/\.<4"$AT@;W\EHF;1(/)VHR+C\%`,JK,Z(3W)1J"4,M9M3
MCM)C2:RF9TSI%8:H3(L@PC\632(.?"WH[,EIQ]16<!'`'\IE1*^90G@#7@;<
M233G83`$,IUC<X0-B*2B6PLRIT&Q0KAV28"+P$`*P5B"C,E8H.<%7PTJ1_H1
M9,0C]&_HHW"%?30(WD]B_%LI(-/(<:@OM4#0XP_45&1.S]X'FCG`XGJ%$;5'
M=60PXK%I?=G:O2XWF"5I8S#\`?4P0=62']/H*V[_#EF(A\+5=TKHL+P+^@<&
MZ"<>C`6_<\-`=^"_?2[P0/C\<]`^`,O!$V*")*1JY&AT\.@:8W2$#0UU9A6J
M'Q4^P0A%,AQ!+--YW66[3'JS)01###BX1$D6<D9S33,U@(SM3_!TB%X9>I&1
M(9E,>J!U<[EE[MC+.J>F'J@^.HTLZU4!-P?(9_FO<DH%Q&GO@LX;4*BXG,5T
M3)KIE#@N.F'+17/"D]E3[6/!5M+2M@?K(<'3&EG(#8_!@!+0?`U^HO=D%D%J
M$>(!<DFU:UE,,E(KP2"$P?`#*`9-C.S^`D9"ML(0\K^2D!',XQ2UN)P9[Y$Z
MH,=T"&LSH&7`O307:RELVOV13N83,%>!AYW<6TG-4T&L3KTA:`02H?(\/%7O
MTVF>HN<*`+D_"\'^V37W(0@A%GS^^TFW0][\#H('I<Q0=)4/FU'P5N6/B<Q9
MU1D32/%5N0K3Z$8TSX=C'B:P2*B8VB24#RA1SV,3M-]Q6OZAHB<!U2/!L6/V
M`?HIHG@@`BYPT7^'E661+I8Q.\(8K*;CQ]<E[.5VPEPW28GH`Y5<U2%F8ZFP
MBV`T&7`586WT.J(9#+(^E*Z25"-*1_X^8R$Z0_`A*LU1\R(?-[JU35*]\X]0
MP%``"%3<:<2@:%"Y#J26^B5469IJ>"G"6^H'1]2L_+^4K\KD8ZMU8:8DR"V6
M:.P6?;/4$.>A^6#"-)+E90:]7'"8C!5Q"Z0'B:]3G90GK=YBUJ>93QQR!W.C
M7$=)ISUF0P#R.XB$$OR)<GG*78%R>UG4HH$Z,*#S^YD?-D4/@6T,Y*8"],SU
M?UW&4!`\!TGHI061WHCUIEF!DWF.2Q:"^/J\7!1\(T@9P&\I\8-686S0/1RU
M%D$J='!5A5I&J$Y&8*FPF`$(JMT`Z0O&MKP;H7Y%`HJ@#](AJL#8NEW`EH*<
M!T5SQ6.HCOICE/_H*,/P$6*RQ/P\$*KX4"E'!AL'%DFPR!*0IM0:,HO/MD2(
MP#T1["/,-D54/V7,C&2;J@$B5#7,8*Y5,4.>E@T9W4HPFG`P':F<4LY`9A80
MM85A#72V[)HN54.@=(HT(Y<A_B@I[5PBK9@=3?,NCY$-+<I!BUTF0:P69.87
M7I<A%D8E'XW')_E^!IEM:*P<C)*0)KXR."\'_+#_OH'B<Q:H%KMW41*D?C9B
M0]1ETY_/F_<5`Y5)K1/&=S);-)LK"_V>_,E\^QA27=!M4!U,>V8A&XH0;(]D
MVSQ8E>`R8&_(T+9")N\+Q'G0-*+'3(#@%T3:BS!EHZJ$0N&4H58(P:^-4RLV
M`Y\1JF>#S%B=UV/*&,%?BAM<69-IM"[J@Q-`%P>4C.E7'7Q-<4UT4L.4T`@(
M.6`4.YDJPDNVDH)(*!\#'WLV4,5DT?3/U%%H$:H.P8.`LFX<KJ/B$.I5L>0I
M\NZ"WGQHA6$"8/1/-K&(.,&&G6V5?LU#A6K*,55<+[7'@9(`OL^I-)115741
M+*-=56,KKV*#8:XDD6Q-IQ&Q08"]`&QV41]ITM^_P:E<JK`IPD`%#TT<5K,0
M4?"!,>&MBB?[V=J+"0_5T@P,(]I7*A_"RDJ)[570F52]R8#R*)C>IWZ@1#QW
M((5!:-%&YQ,0.3.E<K;S""QDD++!NE\PAH)N)%-5U+J5ZF%%\P"VF/'!E=O"
MZD[UCO/L1,-5479,L4&C,BPOZX6:^HZ$+"K\:U/BY:#:FM55'<`R5K&I,)1F
M4TMD]B4&51TLTIW2P5U5#VH<.EQ,BM"]S*0P"R@14T6]-$-"YK)93IPJT*1,
MQA.MD+H-K;85C)05L]RQKJYP]^R.M#AUL6;`P/T\U6D8JEV/.R9J5'[:7E+A
MIX#O_1Q#$5%I72#G"P,_B;(]ML7D&PL]+TZ4=]"*[ZE8H_=`TD16M:AS:;WV
MG!'[%KJA?,R#!!<@.[Z&,B7ZC"-1[VAXO-9KH,P$9&YY8KZ/>:9"UY]B_XDK
M[Q.R.*UBLJ[G#>/#$0PK9=5=F"CWI)1P;A/5V%XU-"0KRC+FYFB:$4,#+RVL
MP)R&Z$!9:B\0'""]`'77B2&8%1XW!Y(!'HZ;H^)U*5-O+J>,E5QT)6>VP%+K
M5^^SH;&(TKVDK(+$+Q(Y2]>RI4BG]G/U].]<P<,M"E%:"C?<CT<I?M>Q](<Y
MJE)L-,$&;/Y_):M<=Q'Q[Z?'O4^'E::BXD/W\KAS66IWS\Y:%U>=0P_['A/)
M4K`>"X()]=4KJ?17EO%$3JBW]&1&;C1'52H2VU%D+([UY_BJ5.T"OE):/W1[
MO>[GP[\/+/Q?SL)9YZ0W^_*B=8QOU,D&@]1A8*O]Z\?+[I?S8^2W>WFH&@%8
M:^$^<S9#P7'+U9FH'+<V,09<*C[2$?-<Y<3TNA=+!.IY2Q3B4"`OY?>:!GP8
MI@SW11R+\;R'/8C]NZ1FUYO9X@A<FPQ,98MD:5>JVR'+^ZW94YOHCS7F%)^)
M3@,H"(XG:6+<4UGX9Y6%%YVD--9:?XQVAK4Q98!X]PQ6!:'+%S=XJ)=`7"6J
MY-N9V+<WL<Y\3;NSKBVVKN;#$OM.9E1KE)W7;4?8HGG`>(J6U-DB&[#+C>U8
MPP=DUG"WU@Q>>3#!QOPN@FS?XJ^RTNJW3"PF;W#S^6W:!7JT/]N%J&=9H%G;
MXQ]%/YLH^D3>./L-V]FO6/6WN_"T"T^OS@`,4P!+L&K[%;=)=C'JI6J`WMI8
MVI:X<S-BDR'L^59LJZ.6D5-&N`Q/2"G5_!FR:F7?K3?W7;=>;*&[6/5LL>H9
M=7U[P].WU73G'DW?Q:)OVG';0"#JZ`UJ,9CM1<O\Q.3A+NQ\NW[HSN.O*+"=
MN[]'8#M/NPV>5D7:T_/CSCE0I4Y=W.=[?Z<17O<C=U[V^\;`U6OP;?]$2H7?
M[JJ176S:V>4+L<M=1-\&_5PMHG?U6?G=AM/.BVR)%]E%]^>)[J]L4VQGI-\A
MU#?+/V"D5TQM_X9=]LN?[[-EM\U)P'=:P-WVW5-"ZG,LVH\<5'](I7_Z3IY5
M=MR,N1\F1&FFMC]$Z3,EZ<G'Y=\WOI)X]%)6ZTEGP#:>K+ZQRE;MASU9^2PZ
M\0.'NYU-/<VZT+AV8?6%*E56^>T"Z\M8KZUR`KO`N@NLWUM^W]NFR+<SKT<%
M5OT1WZCR<%6]VJ\+'_^2G?M_@3CC+&?EAR#S6[TD*'^7TD+W5;TT%%]GM_CV
M1OV:J/QU0'>_!"B]W(E'V9N;;M2;OV:OX*2`MY0=E3V\4R2[%_AL;=ZY%3]=
MV+W`YP7\('SW`I_79%B[=_A\'RO;O</G11E8H[&MEE2K82*[#2+<O<;G*4T'
M=SL6\27;@;4E,MR]RN<5!Y(-])VR7TCIFQ+8+=Y<AS>,1=S3KQ#_1Z5L6?AZ
M9?C0L-;HR3_"C)_QAQO;',&V^T@GL5UKWP)=V$6][QSUGM5<MCC0O61[V07'
M%Z`PZ8^-TGL;PX7PJ**C4W:K:72LUK]-=-P5>R_-]`O=@>/NHN<V1,]=S?CB
M[(E4[*>'TLJ/^-N>RO;\MF>UW_'V1$R#UQ(EMVB5MLBH[?J/'A&?8]U?LN4\
M(B#N3*?(=*JUQ\7#9SR8]9CF<<%9GG<'B2P-*9T<=J,A#?G_U!&BMGEM>ROT
M+XR+RKJ#_-+DV9W)Q_F]ASW0XP^!\+[^\K>__N5=!OPB$G[BQ6FW<UHP7-V5
M"']<LL'[O3_LRF_VWB](YD^E$AO>EDJ9.#=R55Q!0_V\V^L0)[LD&>]YOKCL
M'G]I]\AEI]TZ.RMJMC^@N+9==MR'`O&&SIP]"M=I=O,N;J/MY_?.4W(BA*_O
M-HR2(6GY8QYR&:=7<1J7)[=/CEO97WAM,E[SAU=1DE`-!<>G3J=A<;YXY33,
M).?JD0D@NUI5W<UJ7H,WT0H#W^P320-]YWTB5='_(1D$8LQ\'J1GV-2E[F/\
M!O0QF*K+EHF!D=Q0O&Y/WW4YN_*5@5=*-%9?A/E5BFIBGZI+J,/TAF=]7RSV
M(M*[,7$^VE<J0*2.H[5I0>B+-9F2-=Z>&8&QR.S"^8%(TKL\)<HK/887<?E5
M-?S[,^YB04(6_3][U_K<-H[D/]]5W?^`J\O49JIHC42]9^:V2DF<G53EX76<
MJ<M'B(0L;BA20Y!VM'_]=3<`BJ0H6XH?HFQ\F%U'$@F@T?WK1J,?6+!R)4'0
M:!2/)WX07W&)W?\2\PV%[X$\+;'-*$P%.WJ&L(D>S"1-!*>NOWJH5@'(:@FU
M7(;P((;W8;A>&-)<%SS*9MQ+069-:T)DD6":I?@!L)JBQ/4\UHWHZ;%I)H,(
M-G=S7^D=M+6E+3U)A&HPJ7]Y2Z_(>Y&+QY3!LTJC]P+UG5(_9$\0"^Y&-,6N
MAF2*4=3SN'_P^2+6?(E?+7CR35`[6(["HSK1HBAN?6.+'<TN[&(NO,T2;(.^
MB),*T4&HXTO0@DBX"'CX"L0F3E8LGH(^%!(DWA.FPZYA<=6(5]W5.8.QZXS&
M?=S=ZR2@IKZUW)WPZS4RT*;,$'/G\-5EC.VO\[$1S0))DHFS2S"6B,MM<].(
MQ3U/K0@W.6\C7&G`O7,3[3ON_IX&W$,/!5H0@XB5;JEL/D@+K'Z[8.7HKT2H
MQ=ZE&-`\CQ/B&:47`"-)CR$*+Q-Q%<29#%=HV/LW`1WN0YQ=SMEDF0#X=]N&
M^`C2F)I5U#TST"$2N<P#,L`+$\4A+]R.TV\/==?UG)>IL[5IY>RKEVF5:("E
MV$9Z#\;X`I\F"L02<8D-:9$E84E7@40F<]8@IPT#/X81*(1]L<0.TZ&X!%@R
M/;%7!A?+^J:L]6'J88SH1:'L*T0QMMR.JT0F1,-]+`O5?!<T7`P[EZ':KLAG
MP=YX()9E59_9(?,3;M=;B@>NXF^;6@OL"=63O*QD6%7)7%!CXR0AV$+K+&^*
MKF74V(Z#WV3Q/4:4P`3CT66`IHONMP[(^6^1Q+_A2T!J"/"C&'F/!XG!Q"T#
M;+X-12P29*P",!<3@'8]$]Q;%^7UP>WVLU7I*/;.*(ZF'L*Z[(2]^_CGZ<>+
M3^=??^#8=;^-JN]YG)SZ2&H)%C2>,A0'YMD_VY-N[GDR%?_%9DI/;U075;Y;
M2L_`59ZDQT_JZ;;&M]TTN/TFW31T1K?7,Z)%'3CSH$D.X/%14*S=I&BB$4AH
M(ZAVJ*#9-:ZNS=@?B":W<K"_'#0);H=]*P=:#MZ`,;N8P@EN!U'8^9[?:E^K
M?1M!L1VT[X$N7Y^]*O[!1"XK!`^A>@\D!,]>#]]?$I=5NH>+/3DO7N58)+.'
MZ8-S\,,547[`TG/,'3G=4=L9M[M6B.Q)W`K1/O'Y;:<S'CFCSIV*L%HKXH!6
MQ-O2];)%0.L5:!8_/P8<'BPW<.`,^F.GW7=W3X:P@F<]$5;P?DS<ALX8+);!
MJ&>ME2;*J44VZYFP8';+B:OOM+MC9]SO6XO!.BNL7-U1FD9.!WNSW;G$@+4(
M#N6_^%3,0L'DM^1J]RH\%AJMR6&A<6>X?-EQAL.Q,W3'N_?=L2)FK0\K8EO%
M:0"V_*A7+T[6^FB$]5$N<*2+E]R84VKB;*C8$<M3;VS<64,,E..Z9KEQMD>+
MJ_<?Q]'M.NZ@[;CNELMH*U_V-L7*U]Y2-7"Z_;'3WR'$0_UIJDZM$X5ORORM
M5FM:BB1=G84\2B>1?_I7%BPQ6;JI*<,]=H+EFLY.SR^^LLG'-^STGU_>G7T`
M2Z%.U]]?*NW6-H,5V_4!AEZ/8W:+2A8(LU4WYA>7YU.3]SL<UH#+;GF__:'-
M^STR`]PJ9^LZ.+SKP.;]6CFP<F#S?JWVM:ACC\9/%()LWJ\5`BL$-N^W@5N_
M;\3+F4@6`=4/#'4)20MG]B1Q<#8^(J?V#[C!>[VQTQMN21RPHF9%S8K:_8G:
MT`%KW4;D-H3;]K5/7F5!B-<K%BHM5!Z<>8\[1+`6'UVGUX7_>C9IV$J8E;`'
MDK#.V.FX?6N#-(3)]O:18`21PQ;<FP>12"HQ*A8W+6X>G*6?(&X.`#='SG`P
MLI:)E3`K80\B8=U1QW';8VN9-(3)]K5,/L1IG+`K,0^\T%[<6)@\/`<_/9B\
M!40[O:$S&N_1@-Y*GY4^*WT%";K+PRA][9$MN-(4!MR[X,ILAKU-K3/%HFAS
MF/@84?1N+FJWZXQ[0VO#6.FSTG<`Z7,==VA#5)K"@/O:,*_C2*:);A(.7RZ3
M^#(1TI:_/RR:VKR`9P"MK.=TW*'3'=LR+5;<K+@]N+AUG<%HY/0'6\X*UEII
MA+5RQR)S-K6Q(9AJ#X3'#Z.LTW6&X[$S[EC_BA4G*T[W($[==M]QK0G2&([:
MUV'R7DCY*^.>ERVRD&-Q-U\L$^$%'%TH%B0M2!Z<I9L)DCM?E;_L.?U.QQGT
M1[:VOA4G*TYWM#E`G-PAV!W#KJVMWQ".VM?FR#T<I4*S>4U@AT4BM7Z/AH#F
M<?F2;<GO??%T[+BCD>/VMR0>6$&S@F8%[7X$K=WM.*/Q[3V*U9^FW/Y]UI3;
M4O3]YB)SZ\7D\VY6P?L".?Z5R328K>Y(CT./O2V*Q93@EU@CKIP"[14?D=ER
M&09"LG3.4S;G5X)-A8#W\,!GLSAQV#1+&4`#B^*4K036]E\L0X'N'WS9,N0>
M_!E$:8QC^^JUK3JV_H3=&;$9P'HZ@637<?(MB"Y9G*A&`=P+PB"EKV`YF10.
M"U+\UR*^R@>Z,;.;_I6[IH1?.YDW!=<5OAU7E5'#@HAQV+:$H^"?A/!^-N5`
M20;#JRD*V+L%^;]@=K,L9&%P):3I=,"E%$!U+G7/`UGM>'!(AMSLMM#MCVO4
MS4[=%MQ!$>F/K]?"@;1H@T]G#UF`=()R8>W&![,;QX/&,CP^?'#R/7:]W1R"
MWP<SP4Y`=?)$VKNOAFR]K;=[W%#VB$S\'-&KUP;$&K8M6C5CJVWU38M1%J,J
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M(T%^DA@]@ISHQ9(N>Q;"#SP>8B`,YCQ)QI?+A.)0X)-"O`N;KNBYUV_?3#!L
MY?4\B'B+O<D2#&W9C;?AA8JUZ47Q8LFC%?,#GP)OXFG*\;WX_L*P:CIJ@@Q_
M7YDP"0&\+Q'P@5!_L6M!T3RT2%RX!PN3P2S`527Q@G'_BD<>A@3%&P1H/2LV
MF9C=WN0#("%?Q$D:_-N0#;?-YZEF@GQG,'*(-@]CBW0(49``D_C!5>!G/`Q7
M+/"!\6`'*#JG)KQH)AQV#6?..8VK1A,1[D\Z#Y(4X[7H>KDVTND=14_QE(6"
M`U<G\+]Q!".MV#*&?<<A*?:+,V\.0B&0?V\/<]J@B!=G(:S0\[+$O"&".<%$
MDP7S,X&S50-(\[TO%LB?,PW_?I)=2N)8>CE03&I>+Y!8;@[=8A.U$V5ED(@0
M/D#QBS%JK"+OI"HZW8'3'KA*573Z+F9\Y]/91QN5M`O[4*5-NEKB!T!R/R9Q
MIC@[CH\1"Z`Y!13B"GQ@+$UEX!->7!HHJ"#V;Y;!)Q?A>%&`0X&$`IZ$#>$H
M#5ODD_8P@$>"1`4$IFOI!,J6!!0E2T0DCQY1F5B\^#"(G-$-N..5E]%$9@#W
M$5@C(9`#/L?G6JPP<:+?_W1Z@]^D68...YQRJ8,.HZ+$P6PD2%2$_X@PZ))+
M&"6,KX$A?0&3IO!.7Y!^`9'#@P&P%[_B04@HLN#)-W@.9LESCB:)P+1=$#2C
M&6IGF,]#OT7.@0@M]DZ)OL>39(7C*JZM!P000T\(7U:@9):E&6J?XI*D@XLO
M4!RL)XFT`=447T8*8?42\*TR!Z'J3$R$9H%XMPP-V"&5(&9A:EZ[WJ&R,IZ#
M*/L"`8W0G%"3MK^Z=C3W@BA3*A39#':*344D9D$J%6ROWXH;`=JXL'[$IL+:
M_1^P(IZ9GD[KH/F-\,1B"BRA/P6<WM0#.DP:""GC$-"[@@^UNG]K:&]->.VX
M6^,>V"V\=MQK'2C`UJ6)W.R[ZXR&37)\]-JW.HM<3=Z#9O<TREOD'@7-QDUR
M$@]&K890[;$#6HTS(4?:.M_!TW(O-X'[1Z,&D6RP2P;@D^;^HE%QBP#L>$]F
ME:U5MLVAV0[*]D!I)%;SXLG&*MV&*-U#2<&SU\!XDK>:MWF;OV^,RC\2=//E
M+CR^0(_=[J!F=;L]2#>&E^]4%H3UG>YHZ+2'_2=;5Z<)W&\/THWE_O[0Z=^Q
M&Z35Y8?D@$FA*'#QQMJJ<ZO.CY"=[ZO^:-=ICX>.Z_:>;#G?)LB!5>Q-E`/V
MTG7&O9XS=`=WK+[[!/4Z+:KY^_^18F6>QP'],;;D:?O>-RGX^)4_'_?HXCKN
M:.R,^ITG>W!O@%0<N2_^.4I%K^."5.Q;O7:=B[-#2@VEX,R"\->)SE9X&R=G
M6>+-N13RTZSZAF:EX@R8#K?MPQ9/WOPY^?CZ]#-[^^F<G7TY?_W'Y#/\Z]-;
MFZT3FVP=%B<^QO;&&-UO(I>CC`(Q3)H.Y0LL>)3-N(>1OJH^K8I@AG^8#!T5
M=;L9V$O73:;`+#))`J^1@$3I'(/#Q1+#;3$XF4_CA*=Q@D5S35CR4G->7<Y0
MBTW"=!YGE_-*9@B.BLD`5&\WSQ'1KZS)<\#`4QVA[%,,O(F"-I-5BXJG_Q)>
MNO$E!E3731?G=+(]V#4V17O+<X?_HT!L73F7Z@&WV.=XL2T>7!:BU'7Z1_T;
M>2B1_@NA2+^$E4:I+$73$^42X8G@2BA62(,T%&IYUW'Y&1/TKC]4J1=(=N"D
M(!&W9%,\-5$Z2X)8R1&R.YKUQ.\U;%3B\W4""Y&O4`(Z#('"?V5(28RB%Q0<
MJ`HP7XDP5@69880\;KXV64"EK_GZ.Y`6RH`I)+IIIKH4$<S:RP6^-N'I<V!X
MMK0&4\-:@.Y464\Q<A^L"4??EEE'Q%BQ3*I,+8J]II=J_N3%A_+BU2]EAF20
M193Y666/Y".2(-:D\IGD*5Z0I36J)65)F&8K-0AFH(3F?1JVMHV0IZLI"=1T
M+Q&+MIF`4.WT#0*;OVT9`R]5<>=YB=?$2,HV6FWN.]"+E_EZO8_`"U=QB%EW
MO*#M9"J6NEX[/4>,J850ZA01V+H9H*-."S29.U6Q`_0VJB#/:U*[2#E1&Q)7
MF)F&7YDS1C&!J)26ZH5!1(_*-/-7)I$1AK["JE^&7H8R)?U<?E0M6:=>`(<#
M]!BQ3/DWG1<9`\*0G`$+AS.5:X,$4>5W"QP-:GF6ZGRARCA%I>;HS"G,#U(8
M(K/I(D@1_$PBCY$B7BMM*/$ZM8QT<!`*?RV?^##L3\06F'+LH?5*!>]I>;2L
MJ4BOT4(06)">H!O_P$]T'A#E&(DEI:3"+-3\M@I_<3KX\V)FL?E1BWU9YL^8
MW*,MG.`4$I^ES(A7"^-Z(L',5@\!LY)R!JN-3(*GFKG`-6\?JB99*Y!&MIS-
MO%O,!/7T1DW%VF((]-*^4V88L@\8#26)*6?T;DMZ7:O,YX5R7R)?"P[J]&UV
MZ(;RS>T$(+7FNCH&?8GI](*D5[\X5Z`&)#9LRY)&:[$//.*7E(6),A+`'!1.
M87)F)O.LS>IV4NN'1%S"WXEN^A`4CAZ8,088#M"(>?3U:UR*!-]&_E(?UJOX
M*\L)MN88Q&2^"?CJ2)#;XX6Z`@[:$P)3"2,O_P8SR4'J\`2L-`E\BVFH@%VP
M-PZF`P:S\E3!:$AP^1J[S8R<ZJ\H`5/OV.8"BIF-2+19%OG5S$:]?;,,Q%IY
MC\U'2[Y:D#6^`"J9QPICJXTFM*>M<5A9/1!TZ-FIKAL%5*,Q8ED8!3</R(J[
M5MWS'(@EVEOK*=0FANIE4D^@\@ERK4EIZZ/-],$UAGD>L!3\+`0M5R;$TECG
M^.KBOM;)2;'DA!(O?"\J<KDNX4!E*HQ;A!*;JQF0SRV;/"9(=S#EUO``'B=G
MG/0RT%ZKB>VU-F!<>J2X_W2&#R)\(Z9S`WP(.L/R:]P:E,QHE8]'G+W@*QJT
M.*0Z->1*^(_X&@Y1B:/K=A`VX*YE"5<G'&VR55A,VT;FI;5&`'!Q4`)7YL="
M84_M9-8VB<!%PNB!2IXE,,`2!B04LKB:@L3D^%R0<:*B_EDN!B3':A_VEMCG
MQ<@;.<]E0,(<\G@*1UVN#2`@<45=H?&'%)85:^C%P.EWQDZ[W689FH':%BX<
MPZ\X`!4HTF4.*VLW4T$O;)6@.B_9FH*___(#?MU22:9SY?,YXTFZND!?/J<)
M-+8TT[#H#SX_?3^Y.'W#SB;G%U_9Q?GDX^?)ZXMWGS[NZOY]<JQ^$:>(64:G
MQ=>ZJ@MGTY@GJ&+I:$QUC5YTG&Z_Y_0'0UW59?U/8M3=Z@04Z[DXZFQ7T;`*
MFT"H\/9"%O=O[7"$DP].5QVDN><IT:2*'3$ZD_'4C?4'\`*('IGRD)!=SH71
MS#-@S_+-5WY9]2N<I%-1N?CY!1\@HN&8AF13K,03D(=;4CD4L&QT_9).J_T3
MFJUT\*GUIRGRYT^;^CKP[(NNTQT-#*''PW:U=,7^M71J:[/M(<_YO=#'&`YN
M9VI_FB7MHR*WX">?0=:_3EZ]/WVF]SN?(O;)2V,2P;81P:(R*]W-<!:):V`R
M](RA+%&+/E1!\`LR4M`KJVV'*8^^&8?J^@1R_N$5#@0*#O\K\'SQO@#>((Q\
MD_S(L@"A]R0BPT<+TJ`U!DEZJ0KZD.+L=/H_&95Y=OZ:76*!FHCJL1:<9?I>
M!(0^3E)5+FO]RG;[IY_AR)!#GUI*9<F(35AA"WU?*,65>F2F,:%Z28YFY,I.
MT7U(H@K'"?35X*G<M#C2-AVV@%3]1)31@$B61:FY@D$"*:=TG*5PPH[PESF4
MX;S6I\?MNP:X4=X6]O)%SQF.AHX[ZO]<"][U8%6Y)D*+V8<1`"ZX.87*0ITD
M+`Z6%F98GM>6(;">FN(F'()L_T(1/?B(]O*$]A+Y2.:,%-0K@RTJ`!EM0SL]
M,SLWQT[\(\`_WO(@87_JVE,TH2"'S&D^M?(SI`V85@?USZPQ^96IR85;!19S
MHBR.A%R!=<6V*GX/U'J$/&$,NDHAD@P60:C+X>DB=SS-D@!-!*=<S,HP*7!A
MF7F*\K6[-5.T[GWM,YHA"571+#BH\DRI<Q'DCJU@@08ZH4=2Y&8]:>/;D:)0
M^BR@MK+J'*=.P/1B?!W)5[A2]XWK7Y7-$D5?58NP.&4#D+H8&?VL5<>2ZN!0
MJ_@K%5OQ;'[!OS?U/#"F4JVO/WTX91>3_SM]KG$?;\1,)$KODS,EY=_S]KK`
MZ6'`IWC=:GRO"\$EQ7UDY(03$5?.?WA*L5;Q/D#=PZ+@\N\:F6D,#=`KK?#U
M;54J%DLX.2=8D'4&DQ*DC7'0S3L&5/+*!P0S34.,BT"E).`Y#,N(F&^6=<-Z
MR)=;J,<)OPSY-<F56DNY/%X05>:O*D4J88)OPLS7[EZB"GG&4=\\NWN+`,`G
MF%*C9]CAB&P:H/4?(ES*2KF_HHV&U7.#2^R6/94!X&("IT))80;H!N/>7UD@
M`U4P4*%WSF1%OTJGTV[U&>B!D+PA50<.\@FZK<W$R.%_C7=BVMD81%>`D[1Y
ML%8]9V*5\CANM]4UPSC:UE/5(G,^Q8@F0.Z`'H"UT9M5R)1#UDGNH08#ZDOK
M<XO-A(^V(O$UUK@L"*6)%U"-PY7S1Y<=CB-]EYA3ON2AS_=`LRUZ@_!;JHT+
MYT1B>#+EKP/L!%[R<%'!V2E=R%+$4UJ9*5TI;D[U)5:`)(\L6(;(7$10U-EF
MEU':E/TG5=`&:O!Y3":P?HE1R5KS@W7?`LVK0EQXT56V/G5D4;&FH\$`FG$!
MWPP(K,Q5T!+=:H&GCR&YKE9W,>B8^ZX14,I8]3O7,6L8Z[1:(O%2\K3!?QZF
MZ,'D?F-SXUHNS:J&`.2G!B*7C!WXBNYLV1)3_=:+I<645O',C%5U,VH,%HW:
MAKF!238NC11W@8B7^5C)`@8Z*$T&C+5,0`**G$)ZX/8*E&[/E(/<OP)EJT_A
MT8VL/WED?3>:D"CG]IM$LN-(+NQTQK<2;1IR.#@\9N;!Z/&(!X=?F)"AGKL+
M20]5&>ATC9/JB,?@C,?.`2?K#E`/4V-@!U@Z4+9*0S#J4,SQ%6S-6]C`8N;^
MF/FXHO/L-/JC]U36%0:M:!S.G'@\HCVB&=$D+N_T?VJ`&6"Q[,&QK*?N*S'.
MWZ*:1;4GSN^WHUHYW_I!6TYNO01H;!?*"Y4P<Q5(2N7#R/FBVWC=*,:$M1O_
M7-4'=\!+E$WW7[]3AV<[N?^ZHT%!1A[1_;=#Y^ANN]<@Q''=9G2.O@VFCZWV
MR.$I-C:*#;B^X`:K:^K4#"=/KQET/927Y^*&0-/[<0):<++@U`R*C1M;&&G8
M;0T:0<$CZ]31)!'HM(X"-JP0-%D([JE1A]6YAZL%]UH%L^R,85://P"$/1[%
MFHQ:CUK&L.E_L9/:3ZVM8075"NKNS4<&/6<T[MZI]8BU3@['.29%Q)HG]H1U
MU(Q\,#/BI3L8.^U.9_<6)4V2H*=C.5@9.EH9VM+\I^=T.^X=>Y]8R^)@S)1?
M*>GR)WGBS<NIB,0L2'\VI5!^P--KS1`+H8WD^L<XB5F;PPI,(RAX+`)3[[KH
MMIW^:$OKH:<=]'<DT[S?V,1B5:-J_2)*:5^*A*=46RG&2L44PHAEI]!F66;)
M,M:U&E_T1JXS&(S*G02H[T:>O,^I.HRN$HYQCE24B!*9`ZDJ;^K,=G[)L:2+
M:CU2G8*?):9\N$F*_BOC"=9=-W6V=+;SY@I401Q8Q#76^).FJ0.6X*#J7&R!
M%9*H_FF<8.&F;U3*>\XC^M9+`NQPH7I+Z!SW8J[ZYA`Z3=M,5)70:+''W^U&
M<1JR!=`^HVH%IO"GJJY&@;$.E2'`I$L?ZQ<OX!<AE0>:8AD6+)BM?T;EADZX
M[ZO*)_A1EDSY_[/WI<UM(TFBGW<C]C_@Q1[MCJ`X.$G`GID(699ZM&M;&EF>
MCOD($441W2#`QB%9\^M?9N$@0((D>!?([.ANTR10F965=V5E^;RR-@ZS'J'9
M+]A@(.6^B#?_#)\K'4N[TJ6/;;4GMNM,FWKQ%HU#+^W'DK=OJK14Y+V1!X,P
MR7'(&SG4MAU<UB>HTE`(.U+QAE1?TA8TV%'BUI\DM3=7"=%A2)'+#:]N+F\?
MI']<?OY^+7VYOOSV_>'ZR_77QM=-G9P,W$R[8X&RXXU2TK9NO('.CZPM#S![
MWH2Y:$527#&07FB3=O?!'B:<45'5H8<T!-FQ2YT^WL&3V,8C'?+GHH</Z,Z!
M.TE[KO#K(7@+O]A^9BB#63NLO,5F`:K4001[%*;]ZU$S3AMG%G=*9&/P5J4(
MBK?N\K.FT@4KIZV"I,<@_[+4/ZR#-VVXH+=!2M^F[?!8A!Z'"U+G9"V4B@M*
M<+)^C/@!/<;V#W?L_BOK$I:V-@F>(A:^9$V94(C2=FFN/_=DXL\]BT8-%FV*
M4A(5EZ)X>"51U@6=CQM/9\0K^J?KCOUA%G2:BO(K2-Y+GW%`22F+TM^!B5)-
MB!VB<`5X&]F,TJE1QM8V:4^6#$9IU0!$-QM7+8][-T>43`>CO<OQ2#L]H0']
MHX(&`LT;T-6"[,R\@$T@^65<%>0[13>>FC7B@H!M^9^P,4T8!NDM2;RQ9.GI
MC..`H^Q\GEIYGM_GEQ1,P`0;S:1C`<)XUQ=@X@?Y:!Q-Y"C>Q:>V(=TK[S=4
M$NKL.JJ\6QA.'/\<!P[P2`?[%0VR1DX#.QI)0UCQ[&JJP`N>.<U*5(W98.2[
M?R2LVK6IC`'BEG43P\Z<L\V"2LQ7B$H$WBB_/(5WORONM/@M<9[Y!Q@1!`W[
M/L$@Y]7+J^RG<!$OT6]&K`N)3OT!_W?PZLN7%0T&;!)S)R%MMPB*&)L]10O[
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MUVR%7=BW+*SJN4"R0#;A'.1@E6M$2=$61(`?LZWV21#5;+.3RTL18-LYO$5-
M2B2EHYARQ^SI)'CD5Y#4':-M#WGJ%+6>CU1M8'%(0,CDG(=P[,/D-`R*M>X)
MQL1:MQ5\Q/M1G*H#?H@U./'`MR5L3'$OB=W)^"`D<Q3U"B9/K0]ZSU6FSB#F
M%4`\R-RT4#2.&/'2-O#^XBV!B"9(NHG.QA"G"4&R!F;R<"03)1E\8MZ8"#1K
M$JT<CFH"[<H1KY%..S#-R",^MC(D/X4\8N(T,4E&UH.\%/*(Q:4;\1KI-/*(
MR2,^=S^%/&+BM,.0C-H';KVS2NT#R?R14B+S)P#91*):*TA&[0-;:`NI?:#H
M)I':![98)[;]#(T`NF]?[0/G+O\@B1`DQ2INO;$`XD`=!$]CJZ'UQU+.0!:H
M@R#9!#$(2!T$SSLO2AT$6^SR4A!XH#1'>SHIK#KY*BL=HR\W/Q=.4DE.!XGD
M&3=:$$&B**0]3:E:WQR1])`](LFAWH/4>["-WKD`76G:'C*WA(TI8B:9/`\'
MA022XF7!Y*GUX3+)U'E&RP+(#MFBDY.;K6/E]*/]Y+'B;X[[LA4Q/DCI+OOW
MQ[MO]Y=7U^^K#/I4)5/=+OF?_Y1$%\^V/7F/IX[XH:/2F:-;?Y+$T2<W&G@!
M?O<(W/K1"P:___4__OW?_IR_^2V&;T:!Y[`PNOXC<>.WKT',:MZ2!H&/#/_`
MAG_YZ9^*]G?EI[\B*O_OXH(]_[BXR%';%RF^WCU>2XHB74C?'N^N_N]O=Y^!
MF;^E6\[2]=^_WS[^LXY&NUN>#Q*L_T44!Y/HO2'+J,OJ^'D?H.LX`SXDE;%Q
M<2X2'Q;2<WWV_LFS![]/7[P/V9"%(7,DVW>DJV`\#GR)+SY'."FH)C3]2G4I
MOR51[`[?FA:F+*'IXXA),>9<)#_A1;O!4+*3>!2$[K^`7M$(]'(DN9%D&1U9
MEO&__$MX<I"2,D)2<MK6/30IJ,^?ZTH(<^9+:6R_24\,`$4)?`=H1RQTX?U7
M-QY)43(820Z+0"O;6&(?=;+WF3]@\)<HMF-XZP65`/R5%R;#GW\DH,B'[B!]
M1PI"R7/';IS]U8Y@R)B%8V`8!ZT8\P"%-RD&[(!%)K;_QA?F/Q6]]R&2G@([
M='`ZCANR01R$4?>L&&5CX?O5#L'`Q]'9B]HEEX8O=@C,G)7&:YTRNTDC&YRQ
MC%Q2``8L!IG"(T0H6NP'"P=NA&88)%::)#".'3'X3;*?GT/VC,>,`(!BS`I@
MA:/3*J6JX,;YX"B7+HB4!"@\(^!A&(RE_]*Z,![`A`^F+$U`2_#!.]+KR(7)
ML!\3D`F8V9ND]-)Y=:7+N':JQ?1PKK;TRE!6F7-AO[#0?F8SB"#V`%2O`*UY
M"XR^[?J(,!KJT![$(/H@[4,^@MQ5I3=FAQ&GHYWI.Q<>=/W(':1Z@X.22:8;
MR?2W0N&GG^[XR2<2<03CX@=@>%FZ];'\TWUATKUGI^?"W+,CR9TO?0U>T@-!
MBLI5@=Q99&0_YD;V4VYD)=L))B#J'<YMH+**TT5J-ICD@C:)2IZ\9$\F(8!T
M4C#\F<^!_WSQ",9^=E%JXJ%W^%:.5;]V*;,?S0\_YSKP&51119?C9_O)]2"H
M0-7YC%HOT[?!)'-B0#^##AK$N1?4R14R3(`-7.ZH9-X,GSXHP2&N`1:7)C[.
M&T;&/]AXX@5O#)T?9THY>`/4891X,6K<#CI`X-B!;GT=!>!8>1YX7&`(6*/7
M9PP)_OPG&)`3/WF*7,>UT6%+O;L:FDF#),00'YPLV_."UTB"J4B,1UV2#6;!
MX2"2"<Y)7^%K(I0P2)Y'<S:F;ZQR43/J+[6AZNPHE87CMNN),3]=55@]KBBG
MW%:=N;`V91^@8?7!%7C%__D!./&PZF[L\A"">_;<H5A`*,F!A\&&X\_Q*&1,
M@I6+1\#>0%YG9JF%I>I^?,=:;PHI#6$,$'KJ`"4^"'#P[//P#9A_POPH523@
MIL%G=)8\'BZ!`%39&N0QUTBX).F/G,57Q#K[L:4UY)XF?1JG;BH)'PS]W9@W
MI;GTG2O@+B`9!)'`H#O+^NS74TLS06INGPSY@W1U]_7Q]NLOUU^O;J^_G;'C
M]53QP*YA\8(Q>/?,?W'#P,=%EV9\L*?*JQ?2],MO8-+0[+E@J[C!6A!'!6"2
M\WP"2"/`=!)NSP%C?/S^X2KU7+BT@L6K.@DN-YZ_@<7ETCA!H^]QJ^LZTX'A
M=4Q]\%0&3")TH]]1Z.&=MPE\Q3&,H@`=!N:D&9,!!X!Z-\,0-$.&TG=P'!@Z
M[O`TMVV78P8B;W/+C>J!#^_Z`R]Q,-H"'?PL!8A_E#I4DP"<&H3;D5A.9,31
M`_/IE<F=HC[T$@S'TKED."`A8$:93S!X`]T$AMC'2`ZP2GV(&4J#9@)/)$H-
M2(GL6>+(=B`4C#"%8P^'C"_!TYN4#EJ`+3!/:1KDU';<"G;%HE5'>`:?,N03
M@[=PJ$&1H`+D)MDB>O9K.F_P)A(O3U<A*UVX_C#]P@[?I'&:K(;?"B(`)C@)
MU-7I`*"KTI-$]E,8V)D/'/)UPT]C!NY<ZC;%]@\^<F6]8#*P[IE+EOA#^R4(
M>?J@/"DO>(+IC.U!&!2K.;13%Q!I:WM1,$?=1?[[=%T$,1B'@GT+2^:D;-19
MHBY"]L+\!-.<DL.0UKY=519%?B;G"1CG@?GPX),KO7OX\K$(.,:`.S)^RC3I
M*,!^Z<)GKR-_/J5:I\1,01+GZ`'$+@1=P,'XMQ+_(=@O'],A9X35S;@/WRB/
M.JQ]D#,N/`<F&K!((S/;*\$OB56WSM"O9[)GK#UW+U..?`"U)NS.CC9CSZ^N
MOSX^7#[>WGT]5X->X_`&/K`H`("(-<1CED'"8R\,(Q6Y:_PWW[I(OT9)&S#W
M!;5=MR[&A^'GVI1TT)%>`&"<6FZ(40"4O!C4.2W131`V"]6:$I:3-;(]S"(T
M'5Q=Q1=::51:GOKER?,@N7<%!(V2R<1SYPBJZ1GWA_8KN`<Q>([H#.7OK[5N
MS:$J>E=9!O6(^8[E46H3"U0Q65_M&'Z[&]Y-'5P!@]`BR+H+GR'*^%>:7T"G
M(,4?EZHT@Y)MJPO`KL!+M:7[D0TH27^#D!Z=U@[FAKJXV?.5O=B.#60()T&8
M.;G!*PRKR"DKWOD02=V"ZQ)Q-T'ZC)N\P#GOICE<?*22M+6ECYB7BD;2/]SP
M&69^&WF`?U0%`WHIYLY9$OI5F'^S`6=?^AOS)A%,_0MS>%C!8>!_TD<WB-E@
MY`=>\/P&;B!,Y7-<P2E[=P:M$GPI2*E;R2_R\"+WGE@P\5CN,CZP2?($00G^
MFI)T)I'-W<L"6%=:0G>^EK.I71[A%MOVX!AB2`O4L:.RJWL6CO]2E7#GU_D6
MBZF=9MG'8QX*V!+2M,P%8-6>8:1AIEA!ZTTPAX^I[5&V2XO?\QH(_+;Z-E>M
MGYB'&7:^;YR)$PP3)9A-@*^XOF;AN,CYY_$P>CF^=/D,JIQ+%O[,$[6XCYVB
MY7"LIYLR_72^M4[7(X\8:F>':<Q\VP;#[LI^SBBE%L=S;/\6A+AED,E`>9<\
M3_5G6?OR7I&2HR6"?3AD;<]-%I.5]..M[R28Y05]=67'-BBHA!4:?09?_MV,
M'IF^--4FTF^!R_=VLC1_7D>#3%].$'QQ?1=@\^7#R(Z%F-W(HLFO:7+$@W5[
M85XP*7CN`6/8,7\!QD>V>9<I'<QD0QR<AZUN^BUN]O/USG_H2(SG+3"M_;^V
MGV`"1I-3GOA9&G@VC#IT>0E1Z`8)9D92&K'H3T])Y/HLBGB^A$L+>C:..^3U
M1[$T`!2>`WSTO?3._1F<'7!=L"HA]5WRH-@M%N`#/`;/E3;_2D%V^3&<.CP*
MSX)@C-PG;M6X0,\_G7I>/*>8HOY6(,Y3A0.,LM.%P8=2Z8ER/VTZ!Y[B>\MW
M!R4')=]90(X)%D_%\<*)=J7+/$59\RL:5%B=D3N9[CK@$F:I.JXH!RQ)\W7Y
MI-(5!JMLUXW(FRU-0BP?F>'9F]OK,K>"BH#Y(5U&^;[M*V@9AEL@90W#]U;3
M+4H7QP9`$<<[)62!`Y^*Y*8J"6!)\"`$A.!?`)FF(8XF2T^A[8,7#-HBS/(H
M#@J$^Y3PK!YG0)8"QT>=+"F)&G_(7\7)I6_GF2`W2P9C!L=.+<.B&K9L[<Y+
M#>9.VA@$'S.;24[YL1W^SF!!GYF/&?`TY8M$A^6=X3\00$SL\ZK!5P:\`W\^
MN<%@Q,;5WX'[8%C7XYO^L&P3%Y1EMGL?NB]HHT,6VZZ'A@W<_W0G+MW,QL1<
MD94KI<!!$"$H`BZ79GS&\IKF;%#:3^""7B=DB"9O6/Q4\2T+Q=Y-?6I[P+-V
M3N'U<H-;#.A._5^NE&J02[4+*N^\?"NWZ>@TVV^XT0Y*6#90G#!0>DMU+,A*
MNJDG/>+A`-"T)2]D6A*:#C^Q0[[#/#-D2D)^N,!.5<NLDY%)"1HA-(8?@3'L
MI.3=W\.3+L]M^M+_)A">IO4K@"TN9S[W-/W#4A-VQ0`77G+*Y?`RSW>B@KS.
M=0+Z*O#C=:&MLEV$&EL]S0PC$MS/L\>@ENVWPD4O&`!\?[Z_RUY<!Q.DN.4#
MO_]Z<W<MO?L5"`],F8.XXSILBL'/W'],HF*JJ<<$5#PK55$6NI%=^,.QZR>,
M5XQD(L%UP$7:ZHWA1HR3&[EQXMGIDZ#8^::)A'W@AX'G!KCHO\+*LC`-EM$[
M0AO,7\>/M0GP^93`;)*;G\#A/]WCKM2;T!O8A:=909S3XZ,=N3SHN`?MA-ML
M_)?:/=MI1@&7#+-%?-%XR2K*+A=H'A*E&Y'<S/.2'=!\>-:(;[K@>Z'#MR^X
M`&99)QP%I`(&@?`Z,P_I+FN^X"NV4LMA_O?NMZ[TR^7E?=G_X'6H(5:[HB*.
MTA&KHSD@KW:8;=Y5)C@H"(>>5]ULL\W;M`8M3U.GM4]%4F:^G(MKBU>N)RY2
M'Z=:V'4)9J^\#\T]HD%NHFP/Z9AM#4V5;IGT#,OOBQVO07G]STO-U%C*8>(/
MLNBGV/O+HIE<3>3[@-TZ2YOO+*:5XKS0)TW8\+7P[&*#L);+L`2<,TM1A5W:
MCI^F'H"Y`P<8`3@V8RC/36L<W7EHV9#5H>R"\9COY!_#XJJ,',(O8(#3`QM!
M5"2(\['QP3H*UDD"XI1)0R[Q":IH1##;*@4&!K<$"(;!(28GQJSD6=O\@<#G
M`<NPDI>8`L]BA!QO3I@4<1"=J*BCKXC%S/ZO7=KRS?;N[:Q6HH8S"AK&O+R4
MIRD15W2%WHJ43LGUF:5#2O:TH@(&J]VWKZ2Q%]J8BC'Z'H&A`C_''7/N$MG\
M7$YU_13AQO5!V1$FH'>6JATNTL1(!/0+<*'0R$SU3F$9\NWQ"/Q7'\2/>WZP
MB&/[=X:19(8<-QI1E(SS`E8>!T_K,5(Q0LD;IQH?TW<+1#7+N#C%=D16*YOM
MKL<+7TQ!.9E_R_FS9MY%S5,M4IFNBJK*JE3\.:L0T/BD1SIRGH6U\YPL"9/7
ME&*,7%"KEH^K[%GAW&L[Q/+)Z)Z%WS!.:9,GA7Y3&KU^<KT$B9W/AA^;R<\[
MXK2:<W@Z*"L/5,ZOHKY!S9ADE5;@[+H\">NS.-.B>8@U=UIG>M)P)F-;RN66
MN"$W"OGD*CA-D;&]05(4MCZC,F>9;`3@@L<L+^;##"6O@G)P/'RN@L5Y>2*/
MO!@/Z_$YM3E=4DM2=L$S28=U0S.1'PXH+!A^D413PY(O1?;J4\&>SL(5?"_0
MKE%*A7)3!$.MZ_:60;,3C/:*_UW(6<>^M&N!9LFEE@17=Y\_7]Y_NWX_0+]K
M$K%LV`&$DQ,L(/.?L\'ETB_1Q![,_3)%=_.>\)JNK.SV<,`.&49/C':(G!^6
MM)?I6_GB5*[C$ZG;B*+I8M#R:%?19C'+(T\1?N%U*'6E=*6U3C_NY+(%$JST
M$&DP.8!4'>L>PW,7L>MJ51=)E\#29:VFV)'$J&=VU?.6(ZS!7"$\M;<""R0#
M2M<48PU7T,P4MKM9[\R-28-[0LF"'&'QU^UM]Y7%TCM,?O^<98$:ZS,R40=9
MH`V:#TKOU(ZIJ!U-[O],YHG,T]D)0$D40!+D7D<SK*UNF"`;=4P.2+<VYK8E
M%FY&[-*$'6[%A+9:^[N&7M<Z1M_J&$:_>9]HLE5[L54'Y'5QS=-^.5U=PNED
MB_::<=N!(;I.-ZAY4]EL+WK:,>L]F9W]Y4-)XZ]),%+W2PA&FE8$3<LM[>W7
M3]=?`2M>=;%,]U;:4I.6/9H-/.P-&*+=LD&VB6P3R:5X<DD6703^7,^BEYO0
MTX83:9'C:Q&R[H>Q[F>V*49">@13;ZV^%+Y]EMYJQX6)^<F?XVS9B>P$'&D!
M:?MN&Y-ZB$4[9:-ZDDR__4Z>W%6-?'(G8Z+228EOHM*:DJSR<?Y\XYG8H[:L
MUE8U8#MW5M_)7;EWLI65!^&)$S9W)%/;21<*%YG5EC)5'OF186W'>@FE!,BP
MDF$]-OV.+5/2_L2KD6%-/V)'E=51]7JG"YLWV5E^`G$ZLV(J)X'FOIH$%;V4
M9K*OV9VO\5R?N;1-5-$.:'$3H.PF"3?,.S>]\BY?TP:2_!:]O%3V_4*24`,?
M8?U.(8XN4`.?%AP(IP8^YR18U,/G.%)&/7Q:)6"F*:HD]7KHR(I`0FKCLTW2
MP1!C$=LL![(@-*16/F=L2':0=\I/2*5W8[`?>$T.7F<2NH.T7?A_:5U9QO;*
M\,&4-\C)-Q#C`Q[<$-F"B5W2*2F&W)&!%\CJ'=GJ'51<!#9T;987,HXM8)CL
ML%%V;Y0_8QZY=52[AIY91[V_'^M(P5[;1+]6':@&64\1K"?%C*V3)TE3MC>E
MVBF>[='$.=NSWCG>QR"VO7.QD@*MDD!"K?1/W2(>8MW;+#D-#"*)3IWHZ+UF
M]K!:F#6](V_%17B52_/XA;UWP])5BB)?DW<5^`Y>->A(-\65A=^F5S5R@JQQ
MSW#BVXG#[U(=%`.OOIJ75TD5=Q!/DC!*[/2V1W[Q8>)EUR*&[#F[0JVX,;5Z
M<^NWHE$@?_XZOV85;_MSHPB+K=[A6]D4]/Z'Z2_Y=^:'G[O\RG(;R.GR:RJG
MMS'[05R](#)=!KQ!KU3@53O)97<L3V^]G-9U30D8A%(P=N-XAC;\MO=:XG3+
M=V;.W&E<NH5Y^E!I[@#<<]D+2Z_9G5:XE2?-R](<]D>"-U[F=W+BXV5R99?E
M,4XT"8CL,1M+P?CES1%;BT&B$2]Z>\);,.W\HN3?LCM@4Q*F176K!LIOX,1U
MY#,,&>`_6YR7T>I_[$D0?8BD2]_':S8?^`6<>!G\#4Q24N2+_RMN`7YC=HBW
M]\(8G]B`\:L<-7Y;O*(")AZ>T\ZQ+#$C_)N6&2@Z?U9;?M'B8:_\.TP1)7#"
M9DHC9$,/ZR%!^H`9$:?T^W?XJAMQS1OX'K\7.$4.7L'+@O&'T@L_\SMC._G:
M!Q/7SXHRI_+1X2SOP\I&D1WRRX0S]I:&MAMZ;\O8#YC(+11([?W"LS):O5LZ
MFHI25\HNO(<IY"/E#\>\)FS,:\(R5BQ*6#AOI7,`6<SGX7*UY;@#FW=9+2Z>
M3L?E-^F.[3>4.KR/=L!G-</OB,@LPVNUU\S.F<6*T?PV&#$'5-G=<-;4\C.D
ME[Z3'7IY1.,LX@VT=&DHU1R+$FP)LZ=`-<?MKURAFF,!!(LN#3UE$:."X_9(
M5[N/3)^V')U&M;$8:[@J3][B,\XG+P14:2S@XM.EH8*;*+HTE,S369LGNC24
M;!1=&MHRJT5=A\_`5AV0U\4U3Z*W&B9;M&'&;0>&B"X-/58^E#3^F@0C=;^$
M8*1I1="T=&FHJ"LC3DWU0>JVZ5HQLDTDE\)]HDM#3]NBTZ6AI$7$TB)DW0]C
MW<]L4XR$]`BFGBX-/=Z&'5T:*M@"TO;=-B:5+@W=SJB>)-/3I:&MOMF'+@UM
MTVIM50.V<V>5[C8C<T<RM2_IHDM#6\Q4=&EHN]9+*"5`AI4,Z['I=VR9$NO2
MT&ECG0U;Y_#V.T/7>W^?7UUYQ5.`_,WH5Q:RKT%\FS7&NO4?1^QJ>F7EW3`;
M<Q9D2]KST'6=U#I'L%U]:IUSK!0DM<XAP:+N.>V5,NJ>TRH!$[K#MK@WN%`#
M';IZ1:A.\Z<N"-1$1\#%I^LZVVO!Q"ZFI.LZ1;%Z!Q47@0U=F^6%C&,+&(:N
MZSR5E11@AYBNZQ3#>E+,V#IYHNLZ%_&+0+?9T76=;5@E@82:KNLD@R@$"=LG
M.IM>U[GG<J8%-Y;=^B\`,0C?KI(0N6(7-5!;USL52$G9=7AXC^2P>J?CXNJC
MZ:<I^><KDG2S;E.\64523TT%X?`U25K76N4HJ89(CI)BKCX(R2=UY,()D>R7
MU0J*R2(E0TV04"&H=JP]OZDVG-Z;N<%F.,G!^G(@DKKM&R0'F1Q4;G;=S78X
M65^ROH)0K('U/5+L>/:F>,,Z-!*"?9C>(PG!V=OAW=6@D=$]7NKLP7Z5QC:L
ML&M[S3MJDB:C8/H`RFO'W9?V>&9=4LV.9LH=2]9(B"@2)R%:I[Q`[BB6V3&5
MK;JWD!=Q1"_BQO7=:,0<Z3D(''(C*"L@&#\?0AT>K;2QU^D95D<VU.:U'"1X
ME(D@P=M,W/H="SR6GJF3MR*BG))FH\P$*;,5$9?1D36K8QD&>0R4K""YVE*:
MS(Z"3=VW/B%!'L&Q\A=W3^"LLVC`_`&30A:Q\*7Y(4)2C>1RD&ILK"[?*9U^
MW^KT5:MYPUX2,?(^2,06BE,/?'E3KQ<G\CZ$\#ZJYS.SLU=+SS3E=3;\K*94
M')BANC-!')1V;;,LQ;:U>G7W=1R:UE%[<D=5%VQ&DWS1;@K)U]I2U>MHAM4Q
M&I1XI!^7W2.P_$!KY13L?1A,6!B_W7NV'U_ZSO4?B3L9XSM'/O^:(R;9OB.Q
M'*NEAV$+NBUHP*_W^S4RU>RXJ]&GXZXM\SO))E'$?/R(F8Z[DAR0'-!Q5[*^
MI'4H(CQ1%43'74D(2`CHN*N`2[]NH<<]"\=NC-D5#S,O241E'A1)')^-6Y3+
MW:1?HFYU]/Z">GD2-1(U$K7=B5J_`]XZ%:(*PFWK^B<?$]?#[152E:0JC\Z\
M[:Z,J]6/:D?7X#^=SLJ2A)&$[4G"%*NCJ`;Y(((PV=HY$BR6Z4AC>S!R?1;.
MU*B0WB2]>726/D&]V0.]:7;Z/9,\$Y(PDK"]2)AF*AU5ML@S$83)UO5,O@1Q
M$$HO;.0./-JX(35Y?`X^/36Y0HDJ>K]C6FM<&T?21])'TE>2H&U>1NF33>HS
M(@H#KMUG9#C$J\LIF4):5!PF;J,6W2Y%K6H=2^^3#T/21])W!.E3.VJ?2E1$
M8<!U?9BKP(_B,!G@S<02_#@)@^>01=3U_;C:E,X%G(%JE?2.HO8[FD7=24C<
M2-SV+FY:IV>:':.W(%8@;T4(;V7+WFITM%$0G4H!8?O5J*1HG;YE=2R%\BLD
M3B1..Q`G338Z*KD@PG#4N@F3SRR*WDOV8)",$\_&YFX.FX1LX-J80B$E24KR
MZ"PMII)LO%7^3N\8BM+I&2:UE"=Q(G':TN<`<5+[X'?T-6HI+PA'K>MS%!F.
M2J/9HOUM1_)93'D/091FNW+)U.EZ77UJ=533[*C&@H,')&@D:"1HNQ$T65,Z
MIK7Z:M[TXWR7^=4-XWE_^:'KO?\>L6'B?79?6'0W?!RQRRAB<51M1K]9=_G2
M,OR61+$[?&NZ$$LZSG\JY1PD-P+,QI.$=YKW)1O`AS:NV(7G^DQZLB-X(GAA
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M>8]:L224(E5;03-+)/^I9W8%H=JA]WKSZN)"TYY^+;$(W&^:`I&LUZ2J\:2Y
MO^Q4K!"`AB$D&5LRMN+0K(&Q/5*%%5G>\[B3700I:&!TCR4%9V^!=W<I.UG>
M8Z9O?PF#*)(&=AB^N?ZS9(^#9)T<+MEV"J2%X>6MCCI)1D<S^QVYO^#Z1++I
M%$B?-O<;_8ZQY0T79,N/R0&7I49'8,C#V/W7FHV.R)R3.1>&G7?54T7KR%:_
MHZKZR;8H$D$.R+"+*`?2.[5CZ7JGK_:V["AT@G:=3TK\]?_*XK,)T`^Q)*>=
M>Y^GX.&[F1PV=%$[JFEU3$,YV<!=`*EH>2[^'*5"5U20BO4[\JQ?A%BJ71P$
M8_9H_V#BMN/Y[CLLE`9)B(PEQ?8/R;-?\3HE;*ES_W#5X1^N@O'$]M^P7P]6
M,;ZZGB<],2E*GGYC`W@MX$^E%8AHE_D^R21T(P9#(1'XR"'$X@WJ$U5=KI&N
M9O6)78,+CY#5B2TK6!8AC%(-D4C6CM!34>H:2U6)]N39H(4.:9?,PQ$O#%X!
MH9QZ:A.2'FO?^'JJ)U-C(8&UD!Y`3QYN-[G-_8M.NJC@G\P.-RBM(9VY7&<>
M5G3.SJ(?O!E%5G]&HG$\=^)P1#N@&R$2ERO&?PO@!I`NV[LNTWE\;0_Q>])J
MI-5.F]]7:[7Z;-R"M%J1>+L/@Q<W<@/_)@C;D(1['#&\OCS%&0_UEK)FK'P>
M.&MU723:EK>XWA"O#P#VZ2**@TGTWI#EKK)@^W55'L]0ZA13HSR>9O9*S"Y6
MAVM-U@52':HJ1N^,4]MB.C[%K-Q"`=>7\EEU9_?%R-;H8M#U6.F:QU'(F#0&
MHS**).8[H*Z;'DMN7'9"RHF4DP@4LX3=_^YKW9X0%&S9@4R11$#IMD)MD!"(
M+`0[.H])-O=X)3]7:57*Z=:QM4&%'8YB(FNM@U:KB?Y)NJB_)9M\#1)4$M3&
M9TQ[>L>TM'W?3$7>R9XXYQ,;,O!/'')/*,)J-2,?S8UXI_:LCJPHS4^BBB1!
MI^,YD`RU5H86G/'6.YJB;GG$E3R+HS%3L:44Q+97/D'S[HGY;.C&/TOLQX3Y
MT:HR<7)#2(6VANL/$8F1ST$"(P0%VR(P]:D+3>X8YH(3YBNJ]QK5YA65?.EY
MVQO;#?]A>TGZV+6H)7SY*=DD8I$T!)R1!1*&QV/'S(Z2D/'JO?3+K)3OR?9_
M9R&G[7\J>N]#)-F#`9O$MC]@DA_$,)(;2Z/`<Z)NW5H\-AL#!$,*V2`(L2S%
MCH%P42R]CMS!*+U4Y(<[QL.Y):P70LMG.6*>,W/L-[N_I`RH1`8[PDDWN13E
M_<(J0\=]6;H#N*@44:\K]VU4BJ@K2M<HE]X*=JI8Z=6=ECZ:@5(%:2!W6DZP
M&"03BF9*VL.B!603B6JM()FJYT6NU=)7H<ZYF&I7%H0#CU5E@VZ9Q/TRZ4OJ
MW^"5A^!LQ+NIO2'S1TI)()()13,R?R?+:9N;OV.=_"!;^.&!3;#%-`3!GR"0
MEKY'\%$L*W@LYA#%).YR8^83BP:A.RG:B9_T#HP(.K&)]3T2@XMCBI?KOM!]
M'L5;J#[^?HTL5!-Z)`Z'$(>>L+Y`@T.@`LC"_OR`S^R%>9*R@1BL/MA[P&(*
M//0OPC*N4AVRL,WK^E;7;(5=V+<LK#J(1;)`-N$<Y&"5:T1)T19$@!^SK?9)
M$-5LLY/+2Q%@VSF\12<7):6CF'+'[.DD>.17D-0=XRPO>>H4M9Z/5&U@<4A`
MR.2<AW#LP^0T/JUV@C%Q2RYDY(?43M4!%^"NN;8'OBUA8XI[2>Q.Q@<AF:.H
M5S!Y:GW0>ZXR=08QKP#B0>:FA:)QQ(B7MH'W%V\)1#1!TDUT-H8X30B2-3"3
MAR.9*,G@$_/&1*!9DVCE<%03:%>.>(UT6GLO;":/F/P4\HA%)IM(5&L%R<AZ
MD)="'K&X="->(YU&'C%YQ.?NIY!'3)QV&))1^\"M=U:I?2"9/U)*9/X$()M(
M5&L%R:A]8`MM(;4/%-TD4OO`%NO$MI^A$4#W[:M]X-SE'R01@J18Q:TW%D`<
MJ(/@:6PUM/Y8RAG(`G40))L@!@&I@^!YYT6I@V"+75X*`@^4YFA/)X55)U]E
MI6/TY>;GPDDJR>D@D3SC1@LB2!2%M*<I5>N;(Y(>LD<D.=1[D'H/MM$[%Z`K
M3=M#YI:P,47,))/GX:"00%*\+)@\M3Y<)IDZSVA9`-DA6W1R<K-UK)Q^M)\\
M5OS-<5^V(L8'*=UE__YX]^W^\NKZ?95!GZIDJMLE__.?AJ[W_C**6!SAN2-^
M["AZ!"RO'X$U/WK!X/>__L>__]N?D^CBV;8G[R\]+WC%?=F;(/P4)$_Q,/$N
M!X,@\>/H@0V8^X(SO$I"9$0I\=WX@0W_\M/W;Y]^D@:!C_S.O[A6M+\K/TD.
M&[@PN>@O/]U^O?GIK[JF:;JB_/E/&X';$Z+J/)JZ:EFZL0V:G.Q+WKKS[^(1
M"Z<O1VL3TY`-2\T6>"U(^T"PAHB6:2H;HU=0?C!(QHEGQ\SYQ"8A@+"Q?!P^
M>PP_7/K.Y1B/$/R+?W\?!A,6QF_WGNW'\-OU'XD[&6_$JH:B]`RSQ`,[PN3P
MTZM9&[6O:7UMSY.[<0$I]ME]8<ZM']O^LPO+F^JB$KSRN&NODB9;?575IQ-9
M'^8^49ZGO&KI>E_M[0SA^Y`-&:@=YUL,JOS>#N_";S&^P37]/0N_C<!G*"$9
M.?F73>@K=V6YI*Z;0=L7@O/4W#5Z_/?H,HE'0>C^BSE3M-)?FJEE_L\BK&9!
M[!";>?KL&I?;*$HVH\H*'-*!=P2_AD]V`OTNB2.04`>/J^V>!*71=XG)VL18
MA,=5,!X'_D'43`-0>T%MI8+9`K%=J!9K3IZ7`-@5(O-$V2$:FRL473/ZEF'T
MER!1(]8;(E#C0>T&_)8JI0$6#<1Y!SIE"T0>V`OSDZ7AQ3]K)V^JNJ69)9#Y
M2.L/K]8,K_1DL]?7E!7C7P51?#?,?EI[#CU%-?2J))6&VQ!0[6SDOJEJIMX$
MTJT/W\5!^/9K"*[II^!UF9-;/R^M9ZFF58J@Y\?<!F3=#.7&P'X)@RB"$&;H
M+HN;ZB=VH1@]TY)+<6%IM(V@U,W%T&1=T_NK@7QCG@<"=?UCPOQH??8S%54V
M2CQ1'6Y32'4S,BU=[LF-(/W"?!;:'H:<SABBHR@.(>YY89M.LJ]9$.^6:+E\
M_)WA4D>&7K^GR^IFN,#RO[@1!(`U690-^%BQ+*WB"BX>?3=HU-%#4V79,C?`
MXF["D%(%!ZU/`477%,,HJ?>Y(;<`6*N"06\891EH"/#6'P1C]AD4P/JKK(&;
MIAM6#<SIJ%M!K5U47='Z9<.\"BCJZRC&_%'ZP"T>!X-OUE]3P^Q5S4#=L-O#
MKA5M2UX;=/KEIHKM`CP@O6)C*^-M#*MN=A?]OJ'UF\'B"=V-Y?+"E,T*QY9'
MVQ!._8QZ9MG$+H8SY=J;,!A?P<BNGP`W9VP=^-%'-@Q"EC[W:/]@T?4/4.1!
M",ZN';[=QFP<?0U\Q"D,N-W;F,-!HDU%4\SR2NP-.R&H4*MA-'`P=?E81(#W
M,T;Y"/9[$S=2!6U1W@=;,.[6L&L9'[Q+PUP3>.I[;F2$5/`R-;E?,?+96)N`
MJ)N2:LH]K:PT%H#@,@Z1Z21D(Y@I.%KIW,';8.ZSGV[@#=X><:_='F0;'_QO
M'N>B2^>W)%7K7QD$3T"R>Q:Z@0.CA,R.V">6_KF!(V[U>[/*Z`"(BD>=6H[5
MY;ZA')L\-?#RMS=PORT+(_]*OF31Z#O!HE9L-,LT=75])*[MT`<5&>5)SX]V
MY`X:I%@7$$/NRB6WK7;P'8&O31QL"?V3ZR5Q.8>XV^EGP^\,A?5)4(<!L,4V
M<<F<3:B,MR&D1I9A,:#RQO?,?O?Z^2]#UGLE)VW)V#O!H=9)ZAFJJC7'`2LU
M>+X66)XYJ`I`#VPV?3FM^Z@?;1M@M<FRGFY:*P%.J9#N>.W*D].4?D\I$WGI
M\#M#I=9,:KJFJ.OA@E0KTJ5W3U'@L6@`MI,]L(B%+^M[,D7F=]7(VX-?D`5N
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MUBMO9.\"+Z[09YARDSVUOK*4[>O`[!JS6A=9U[35!FT]Q*Z2*`:W,LPMP@;F
M395U9:E*G86Q2Y1J-9=B6>5\R)H806QY94<COHGI,.?CV_<(O>]B^^MR$+LO
MFZDN19'[?;T:QS:$M0\4:^525K2ROE@30W0S>'`^W3E+>P9^NRR:!:Y/MRP>
M6#GPCE"H=R=-I=?7UT&D2&/;;_QNH,?@<O!'XH9LDP,`"Z1/KQP`:`YI'PC6
M[\]9Y3KY#1%<P(3I&FPGDA>Z#);(6,GP-;#V@6(M#4%K6#U+W1>.-ZX/3+L=
M&5=KC!HH^T!N15'9ALA=#X=L$-\-KW\,>`SU8,?LSL>1@&?Q#^3;%]MCFU3Q
M\-BYE+A=`]9^D*S?;U3[VBZPK']D1SMP?57NEXMSU@&V'RSKE:*FR+JY-S0O
M@<?#\`W8.;V@;LUC9;)J]>65V,T`V3%:=8Z)(9OE,L=CH%5;OMV?V28X!F+U
M]16*99:WA-9'+"^?N+==9P-O5]&JB<KI8)M!J9MEWS!Z-25--4"*HA'\#0S!
M!H5IEF8H<P4KY3&W`5F?A=$-L[\2(C^?6PW\;H+P/@E!.4<LNAOF?M96WJ8"
MD^]E+O#:T/:$9VTN1@=ET=\5GJ6CX8'G@=%CSJ]N/-I!6*-IO5[/,*J(-@:W
M)T3K@\)>3]:WQ;/8SLE78%=T5%73XH6;ZT#9+5JKJ+8V5F#\\4(%^YG=#?G^
M_=VKC_[JU0A<U7OX8FS_+?#P'$X$.N%N>.?[;].8]+,[=BNE!`"VT1D^I9N>
M"=L9"AM/Z&_,FT2!_X4Y[L#V+L>3CVX0L\'(#[S@^>TJ^!P?>'H-$*I.-ATZ
M"W1AX)0^V3`[P'WI^-54"!J-+>H[*N.L.?+2>H[Y@7-#]RO#*]>8<_G"0ICG
MUP2O6<L6*CN4-U,P5'?*K7YB\^?<FD+;"XJUND,SU"U01+K^"EZ=O4D\FO%8
M_OYZ`R[9SI\;\(Y?(KDQ@MGK:PVW!+WR<"N(GM52K7GD<DMF7`1TGPAOQ9I+
M$4:*<WZ=K5/;M@)OX<`[`+NXZFXUU(P:^YCN@J%W`GKYE%=!SD4>G9WK'V"T
MW(C=A^Z`;2(IBC$U@`L'WAYT;42Q%NA,D^`#E_[6TU:-`O3B@7<`NS:%H,CK
M`.<=K7/Z0%`UIY'76.S^=-H+AMT6;*URZ\F-P$[C\<RO?[!?O]@Q"UT8:^T4
MDFIJIFS)E1*9FG&WA#R?ZM-D!?M[]3:"BSV/HA%S?@D"9_TI0^!KR89:`[DR
M[K:@Y^?<MS1YIO*@.6!^@GOMN6J&K%F647>0G@^X*:R:!06/'1M[+(4TV\RM
M4EVY#1M?*/V^U5>M^7YQBT#L#I]Y6@`V/<LR]0VPX9)?4&YYWF[!DFMJ3U;5
M7DF3E,?;$%+-@F,<Q<NAEL,!RPSA^-WP,[A@WY=N62Q(<NN6GN]^SXRU$8RZ
M=HU]6=$60\@9^F/BID$Y:.3;\20,7AC?4MY,-%5=4_5RL<C2X7>$2$U#.5VQ
M%-58!PU.)]PU_V(/1J[/PDH6<S-J]'3%[.-61H/!=X+$/"5ZJ,)D:ST4O@3`
M[_]@(W?@L<UFKNA],\\@SHVV(9SYR0$4V5P*)5__FP0\ZC@)&4SZQOV!GS;E
M<%6SRG70"T?>`?P:QH9_RA4JS:!?@9L5APD_\W>+?2J?X;$-YZ\K@(!5W@5;
M//A.D*A3TJ99V:1:A0+RQV?X9F%#S]AV-['/13O49@!VA4N-;2YZEZZ)2=V.
MS2;VV5)-4\TSD`L&W0IH3<,U65-,2V\&DEOR-3?#%F@VK6]9EM(O>0A+M[TV
M@URCZS0-_/M>8[@S-O\+../C9/S9'98<B::I<EVN]2-*8RX$:__8'&Q_`=CI
MF-,<5&;?MYJFFL&K&6P>T#83TXP90#4S6FRK-X.IR*M\@`KXLCG=BJC&O'FN
MHVOE]VUHJ]3X`W7TO1L.W0$K)K_5'#.]NWC(A5"WF:E1#[5FKF4+D!UWW$D!
M@XJ5`7GJLAF,G>)47ZVNZJJ^&4[ET[_9\[/MI]<O\M!Z<B_O2+]Z_)WA4I]V
M5<%XK8\+]Z3RJB9X,=G`;AJ:V9?[&<_6#+@QL)H&SYK1-_*X8!FH!;W$9^GP
M[>;3Y>6$!XU.MEU]$X3XX@8^8]&<?3<('&HN-3YGT;5]QS/A-<5;\1H6L)B&
M4NR'+UC^]0#59AE47D*Y'$R61:JT!GM@@^#9QU;`,/W'$4MK4S>H>#*KJ:H&
M0':-5ZVBL?KRQGCE3Z<ET/F9(FQA]86E.Z$?[SXM,Y<+=KF[LB(714T-0.P2
MH07;?ALB=.G8_(&[5^"VQ^!C8(?.F#^W03ACZ$8>52P>=UO0=?',>H`?V$O@
MO<#/G\%QO1M>A:`]8KYYAE5?2X#?*JHB:W+-9DW>L'OU\-/I^WXRY6=<K67K
MO@@T;OCFV;'Y$:?.XG2/_Z/M(7T^)>S_%W=%37'"0/C9?^%;GS@2N+-7AW:F
MZK5STZHSU3[T$0]49A1N`+7W[YLE"00((00LCN/<8;+?MTLVA&2S^1T'L,M>
MPO;7Y1G7R2#H>OV1]&5L1&F,6U(GI2%M:W0G+F>7,5_;^#)Z>JJO*6J/[S%:
M,)ZZ(+701+[)C)7ZRK)CW;S<95$0^>F!]DF0*L6'^"]SIHZ[<*MH15/<DOP&
MFL@^C;(J7Q^TEHS6^Q/ZJ8.P.YPF6N`5]P(]C&&4EI!6YSX7.PA]:LXP:B56
M?>:1'D$U57(;<3^,4O)4)#KS^[A&3'@&G&]A`&F6IS*+U4S?J(<S-;4A.8`T
MF`ECF'HA<_MTBAP!V)$O?;76PJ-QTUD5-WV5Y`9GKV&\1FN^H4$N<PRD9`R!
M\(H/-'OP"@/@<2I1&4-$JBDWY,DU^!F^A@;$E5:A,L<#2X_1T88MU!^GGB!B
ML-A.\C*A"H6<]_`3*GD\O(G/-+`K<XS45!`T6+B&(^F;S'T';W+'`YMXDRNQ
MI+%Z@HC!8C6\J1+*CL&9]/"G;KG"NB,_V&O*$^V4DJNY)A;$W3H!Z#;A6YC.
M#CPXDKV`P512'+#0T'J*&WV>8JCM)"1:$<$WN9^2%]?X(>R(CQUX[IF[:(8&
M=R"TF&SB8%(>ZP8/J?QVA'0]?'\J,LL&&15,'Z=S@I?ZN_R%N*;1VA-Y,U.R
M:0"TYAS3*,ZBG=D&\<;,HB"JR]N*-JYVGBUYGF#I[GW4Z3^%F!&8BEYS,%*Y
M#_+LH!6NW:6O`K\-,2DC:7#Q2FE[!:.B<V,7OT,+[>OE>PPBD6>.)5U,J%15
M88F[+*^2,O$6W41<3*A?)FEX^^C'-WXMS:?^-#F6;NG4`).2O([#D2SE<^<P
ML=IFJ8,FI5GN8H<Y=R*%)_*\OI>'3.N;TUW*S*F']VY4.VRZQ--2;6]NAVVU
MY2TRFJQ$*PG''J"JHTI(#\(N9K(60AJ_3)J::7<W:@@G++>PE:#>/`L0V#PV
M5L%R/Y$?'JPP!OH_*-"1'@VAZ11@@,=1P"T&EX\\4B7*#\7G(R\*X.L]<8CC
M;/<8/H>?/SSF^?[4MM_>WA99N%L\)*_V^?8':16(/&/0R<F2O!%7U:A,6Q#J
M[<L54?(E@]'O!2P,P>2[A;`%I^]65VFI,`Z$,JX%9W3R:Q2@$NK93+.6EEOL
MHA5&L^A)QG'D'N1,@Y4%?1&_IJ_!9K;[5.=/[X`)?V=N]HY%?LW84[><W4L<
M#2]QS+T$\FG-?(^P^3W:S':/:FW,V$/XJOKL&F!DN49]%'_7F%D#9!7-2%<#
M>!@7]-DK#2W^'/H9&1)]R8J+GLV_%]6A2KTN/,CK%:,L63KXXRGY3W]M8=*$
M2@DB2#S)=(-RY#T14NDFU!`:.$<,J5&Q$'81QLES%,O$2?3EDIJU/+MB*=.J
M&%+6C;(G?^36\.R_=^D3^?`/4$L#!!0````(`'V$KD+U0T1Z=`4``'HZ```5
M`!P`8W!H:2TR,#$S,#,S,5]C86PN>&UL550)``,NH))1+J"2475X"P`!!"4.
M```$.0$``-U;47/:.!!^;F?Z'WSI`T^.X]#>-9GF.BXX+3,4&$Q[]]81]@*:
M"LDGR0G\^Y,(;@VU;)QK#]$7P/;N:K_]).U*%J_?K);$N0,N,*,W+?_\HN4`
MC5F"Z?RFA05S7[UZ>>7ZK3=_/GOZ^C?7=0;`.@3Q3#BN@V\Q`2?*L(3<AO/B
M_++M^X[CNEJ#8/KE6G],D0!'M47%S=E"RO3:\^[O[\]74T[.&9][EQ<7;2\7
M/'OV],F3C?#U2N`=A?MV+NY[?W_H1_$"ELC%5$A$XZVBP-=B<[_/8B0UL/HF
M':.$OG)S,5??<OU+M^V?KT12<'2&R4XS\0)3E"X07Z(%(SJ>XCQF2V73;U^T
MVWY!51MO&)7O5+9Q\:^NKKS-TZ*T,I?(K^)%ZR^]AX=[TKC"G:^Q5OP^>2"8
M,P)CF#GZ^^.XUR@.GE;R<,(_=X:#;CB(PJ[Z$0W[O6XP";MO@WXPZ(31^S"<
M1&?.!MJU7*=P<R;P,B60WUMPF-V<Q>D"N[EIS=#S`RU[W]#$B,09V72<OKK>
M:1-6$F@"2=ZJ=O[GP=4^;9TB+"XZTB*Z:S/>*J)O%0F>(3'=D)8)=XY0JCWP
M/2!2Y'=TG'SWPM_VY>?;VY\#(4"*3L8Y4)DW0-`4R$VK7,9KZNCW-*GA\SE(
M[G3'$A,696E*L)I1]IHW214=*-`7\%U?$(]S@^KGAKN6L9]O)3R1+9<;:ZZ:
MYI:Y_HRSI2D<>9O,[+"3"=4V2[5=1%H.XPGP[?Q[#WB^D`\7C2/[8[I`!XE%
M^$^&[Q!1@$0@.XCSM>K,GQ#)P-`G:I2LY>A0T.6475I$604QIQ%^4Y#;E@2Y
M"S-0`)()6CW@&8"LGBBK-*RGI!)N.5,O+&&J1^^4EXROE<L&:G9$K.=B%U!Y
M\%]:$ORA7``?0PQJ+IT2J!\E%0K6$U,%MIRFWRVAJ0E#)TI.(U[^L(27!U25
ME?>/+KEO&1]E/%ZH9:88SGI4K?#F6$6MU)4&BG9T$%-%7H?:[B)]WU_5P<-5
M3#*]Z'S'6'*/"3&FO@-4[>.N&7*[Z_419REPN1X11&5`$[WR2)=J=C(7+)4J
M]K)5C?01!;]=\/9RD-UE<1^C*2988JC9X"D1/%8VC&.>07*PYV;Y8_<A,X2=
M_F3&:W<^4JM$$".TUM56-45EDJ=!3BE&NQ--)Q.2+8'G14\U-2;ITZ#'B-7N
M;24UY%E&9=ZQ-BO*VDG.J'$:5%5BMCN)=C.8L#&HL$(R0KP^)54HG`9958CM
MWHH:,'E@4BJ3/`UV2C':O?6T-_HG'"4U]%1IG`9-E9CMWI$J`*Q?+UCP<J;@
MS8#1^-`W-.5J%O6NFI<T!MB/6#98B//P!9$ME7?!XX`FD63Q%WTF!+C06R!R
M73^4RM4L(JH2EX$]V]>Q!Q/UBU!3)M5D8+WV]N'VU?7_<CHLFJC/#^%@$@UO
MAZ-P'$QZZFDP4$(?1N/PO5+H?0I[`W49?J0H2U3DDA]ZBNQQ'EARVNQQSA_I
MG7(*7$6)SL-5"E08"Y'OY8ZWP7^']9'86\:[+)O*64;R$M"\P6]6.?;48B1@
M;Z^_`K3=\_X[H`HA4?-FD"PQQ4)JO'>PQ6O@K$[K)&BKA6YWH14!(=\0FK+U
MKM!)\+(/K,DVIB5IN1-$[V_[P[^BGY]_2YJR,-&6>'F\$Z-JQ.\=>QT!QRSI
MT9@#$M"%A^^*DZ4'FSC2Y!#.9A#+X2Q<Q0M$YS!&$H:TW',#S$8FCCVQ/(;6
MXIS3+%YVIW1]YDMYO*E*U/!^N_XH0`7A5@UF&JM!',0JRU5M:S4P<.J\-XF5
MW>6``<G7C/M8ULL,_**LE\;*[I>H!B3ZW+3X+ZR7&?A%62^-59-WL<::<_M`
M?^B_,JH[_P)02P,$%`````@`?82N0BU^;=8"&```&9@!`!4`'`!C<&AI+3(P
M,3,P,S,Q7V1E9BYX;6Q55`D``RZ@DE$NH))1=7@+``$$)0X```0Y`0``[5W?
M<]LXDGZ>K=K_P3?[D"?'<3*YG4EM;HN6J$1ULJB3Y&3G:8HF(0L7BM""I&S/
M7[\`1<HD!8"@1(I-E_(0VU(#[/X^L-%H_/K'/Y]6WL4&T0`3__.;Z[?OWEP@
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MJT3FRO:\GR]B93^%SVOT^><`K]8>2C];4K20ZI$JS@GYR*GX&Z_MZFB=EDP1
MZD3WZ))]BGS>I&O4453[\3KOZKITT<*.O+!&C??KKE5?LK)QG0#O55V#MG%%
MERNTND>T3E5S]6;T3)4L:JCC5:YBE;%+_^@3)V)8A.E/PW=-/\3A\]!?$%8\
MU&K9SGJ)+]/*8[6UZ\Y8Q)H.]C'_=,3^S#T4/87(=Y&;/I;KWZ3%L5)7`JWJ
MQK]GC?OF>&;VV2\S:S3L&W.S?V.,C''/G'TUS?GL4/0U:CXY]AHZ<942G3SB
M9!5YX_%^FM`W6>/?9-_+A1W<QV]2%%P^V/:::W!]A;PP2#_A,%U?OKM..N:_
M)1__,0OM$/'6,+?O/90^P;/OD??YC43HJF55&5%HR'X-RM1]$6Q)92,(4!@8
M]T%(;2>4J%L0RJKZTC@-FE>:>=^TNL01YW4N]=1IZ04E*R5TZ6.)5..+*&!/
M)VNNI^V]N2#4170;++>*>R^BE/LY'?B+LJVR(&XV^PSL&0B.B)X=+"6XQU\!
M@%G22K)H;ZT`":[Y[PAO;(\9$!AASZ;TF?5"WVPODOGRDD+=(41EN9BJ]^U1
M-44.8MJRWC,8HS"Q4,*06+8;Q$CL%//QH3T^K'"):!52%`6ZP8S*8C$]OQQ"
MSWY(OL#>'X:[X2F18$YFT7KM842+L9M,"C:X4MO$B'YLK\$/_0VS@=!GQKND
MB>=$8.,NMDH,^G^W!WH?+1"SP9W;3UN32MV,JD0W*%':+&;H[T`&"CH#A(ZP
M4+!+C/NO]3OX`:&3B#I+.T"!M1CZH>T_8-;=;/51^/R2@@!0+_/_9::#BTDG
ME*P1#9\GGKU-!K*`>LW'_O(N0ED$*$=ZYH*+4(L-B&EI/CE>Q+.,7PAQ'['G
M23MRC:+`V=(SO\;`M<[^1-F10$=>[:]:#&%'V+[''@,+!>SUG87$^<&S[BS>
MYJ]R^%R2Y],NWH$$K#X4X'J=C.IZ^5E%@5:9JMH<)?S!S^$:CD,B/PPF]C//
M',RI[:*2B%E1`@IG.D&TRG"(--$(N?LFRDF2R'>+(IG1X#P?&Q&CM"VIJ1%)
M=H@4H:'@`NS"VQWG1RNYM5R)#M&C-!Q<1-V+@I"L$$V'V6J*9-(=HD=J,+B`
MO!^A.9DBCT6L[L2FY5V.HD"'"%*9#2X%/2:A9J<CDNP0*T)#P>6;M:.S;H=E
M^O'803GHVF=G,OJ.B>_H3M&(BT'AJ?*HM!P0<#%U1L_R%ZF[S.3,!!=)5T[%
M04V^'4-1]21<BT'UA":O>JRU:KF82++E!&D55H2&@DO=],AJ1?Q2+O;$.D3$
MOHG@^A+#=?%6FXF-W:'?L]<XM&63;#+I#G$B-1A<#S-%(3,=N:9-?;[+PG"<
M:!7%(S`6M&`'R]=2EA;L$&$Z,(#K:S)*;E--9+6F:,FWH6W0T'?("HU(P"=X
MK06+/.6YMTJU=(C5R@"!2P3MVZL=^'6)*)&9X!(^93'L@;/CW0W,RP'1>Y_J
M-=I^6;USR`*`XK:]1.=W;S\RZ7@C[2>'^"%Z"DTOEOO\)D`/*\$@_NJ4.S[%
M6Q\GQM0<S[^:\V'/&!VS[5.K^C;V?FHI=MX`JJOJWJL!=P.HYY%'/HTS(+1/
MHOMP$7GI_-O+9HR2:<=*=71@]5)%4&H<KDL6+ROTL?SBQID"2P=4`)BB0^"`
M-Y#/#HM8*.W@^&P#]KN'8J1]UU@1&N(_X\^E"X/+AR+'50^X'=0/);B<PH#C
MC49LC.46%QMGK,Y:)VD/!U34`>8/@0=<[B&?_IW8U**Q]6Z<@YP@.F,!G%[J
M6UJX`USJP@`NL9!7/-8R,*)P22C^$[E:O.T5ZAQ?^V:#2SJ(%!X&052)HZ1`
M1_E)S06WY$2DK!6%_)`Z/FJM0%"V5$=9RAD.;D5*9I*L8E^E4[(#E&D!(*;M
M-Q"T:791JA+=HDFW<[I^!X@?9=<DD^XB+^I.Z1K&D@?=+DE9I(OL:'1&U\4T
MRGD6HHES)V=S]O^M.9[/K($U,:?&?,B^-<9,Z'8R-;^R`L-OYG#,_C3O?#MR
MV=#8K?5\RL,T@'&.Y6&ZGZ<[7M]TQQ1MD!])U^+NONZ`MWXQ!>!RP2"T%HF"
MTLXR*],!O`M&@9M4V!TU]9TR]]4GC[)TL$"P`_"+S`.7LO]"21!,*%E(U_ME
M)3J`>LX@<-ES:XVH';)HP'Q:(S]`90<9R^4[0(7"6'!I\1GRO!=-95%!7JA5
M"DI;4FY44;`.7/_[!?G,'(_/?;HK!B0W)<0;I.:CK%1W""JU'USGS5SL!O-K
M+P1+&J0)<$61[G"EMAQ<#[]GFVY7TR%*!#;"[?I?UI^7,9&1[%)WGS40W+QJ
MO-AJJR%?3:,9AJD+=8&<$K/!S;'RT5,0<KNV6@_]$%'VB6*(*!1OUXEI-;;B
MH%%L-KB8+55-':,5I3K'1\%(<(%8;%-9WYZ3Z1@%!0/!!5@OW=V`6=HC/NL#
M(]8-)OTA\8,;M"`TV7<6G^1E/C%KF>;8M^ES[+/YD1"L)$/1BWO0$F?7W!,[
MT)<U"CBX%2P[*Y)7X(8-%>79.IET9V@5&`IN=<HVO:B(X#,"'0`^:PZ\I2:R
M#;QL](WP@[_=T^(\SZGM!ZP'V:Z@C__R8F=@N/\?;2.J=+OO!%%,7%8+17:`
M^FC[4]5UGN+Q'6@HIZ,"Y.J:HMDE^^M5)3I`MM)@S:4U)^0G/<`A7=1X8P?8
M8<VOC[V([ZI0#_!U2W>`-VT@)!RV&$D+5:_"6+O\5&R"I:0!'/,7]4Q,T^0H
ME7XM+.VLUTL*G!<:-KW0L&?,O@Y&UO=9\RL*!8^"MW10H.1YC:"NJGNO#]@U
M@OP^.#M8QA.3K&7=/-\%?(OI;D+&8+'X9GM<BSH,.J"B#D1$A\`#KN=E1I1.
M'.9E6F7F\"998*Y\,K%%4K(;^`O[]B44J4J\`L*4@-0X=2(^=23>",+B.>3R
MP2L;N8J84`AVF`"5^>!F3%[5VJ%Z7IQ#%A6UN)@E/=>\VN1$6:E7P&,I,#6N
M?!4[P=VR<^L^8*8'#O(=-O8*$-T4`^]2\0X34@X%N*5)Q31XQM;D'.&2\+U"
M!1UF]A"X`"YO*BJ_?UR;-LN"HJWR6[TAJWD500-N+"`P6GW,786"KXK-1H^[
M$_>)O:7M/Z"`M:3D!K`YF47KM8<1%1T^J!3O(!?E$(`;(NP;FG;F\GMIU&4Z
MR)LF&.!&!W(/GKWWM7+WEBO\JN@4PP-NDYQ0\<)EL558+19];9SN0=.!(4>B
M=O;"V:J4YLJ^1D[SX'1@;!&'7`4G4RT:+19^5;2*X8&X$KB@>/%B6VU.]PJ^
M*C[W80&WA%@_!7+T5.UKR/54@0O<>RM1?KO5JX;I>55%W9V>5\+3>,8@GGE^
MV8IW8_L_$)VQ/@*M0Y&KU2L#\4W4:(9I#D$#E.9OEDA\^H#0242=)7/X@;5(
M3\G/'I#/?B\>LRX@[;CZ.D[HD6""VPO)8C>N;#`GAL,TIZCJ1105*N@P]8?`
M!2Y#J`_!T;WI:^"Z"ES@$HH2Y0?89^[K"*Y%%70W8A+"`>Z]-1<+Y(36PGQR
MXBF)*;/8\KD]S.'P']SI;&P/R1<#5:JB`WQ6@P3<VRE6M-(NRTI5=(#1:I"`
M2_2+U3>8UZ'TF3D8Y97J6F4[R^$>".!R^O&T;FR>[7'E!QYY'/H+0E?;9;GJ
M'(-NZ0X0J`T$P`S^]C@*?HF\-*>;$6F7C&KM372ZSM9.B$MZT@-$N(8L[)(G
MV(N"W:5DWV9PX_S4)GZ("_OU91#CNX(@N(\#QR-!1%&)[SNZV@XXQ>.AJS&_
M+DGQY6?BRI-3HK1>Y3I:Y:ZN!KU+[%6'L/G,[?Y]Q,3SV,`'N=]QN-1*L5>O
MXU726@'"QF=*=HOLTQ:FSZ9VT5=%HCY@>KF;\[$"1QXK\$+9C3$;SJS!9&K.
MS/$\OG3GT`,$U)6>_*@`M3HM0#V96OV[WGQJ]HS1Z'B0\]6U"&]>D1:`'8Z_
M,5ZMZ>_'@_I258N`OBC13BN=F-/Y[\:X;_[?W7#"S]6HI;'NU]INF]W7IY6F
M.S?&7X8W(].8S<SYK(X67*BQU89<T*4%A(W^-V/<,V<#:SJYF_:^&C.3]07U
MXZ[YG!;9T-2P!8ZFYHB?XS,QV!LYGQKCF=&+;_\[GA5IS2WR(-6I!>3'UMR<
M38S?#<;_\6CG:FL1X9P>K7AU?DOEW/B768M#?ZFL55_^HD8+D`Z,X?2;,;HS
M;YF?NIMNC_LZ'EQQM2W"+%:H!<!G<ZOWOU^M4=^<SGB(-*\ANA;4V2+4`FU:
MP+EGC>?#\1=SW!O6X2WRU;6(;EZ1=H#ML9<GN4BX%F2S];4+;5:3-H+J;5:6
MR4Z(AQV,@O1G#8&TO.XV@V>Y5C"R=G'VL0;XY57#RN`E2K69;JH+\F*%$%)/
M[<$K2LW4A;2B;F#)J#:;=SXA4%\K%]8+*#W5)N:[P55]<!>KA#%X;`]DX="J
M+KA5E4,;3IZ:`D'OW4>AC;V#<5?4>'*P%;JTM!KV?/)XA<4<$T0=OFKP`5F+
M^(H#Z]'G&TQZO`%,X@;P-6D`0]^Q%I;O/[]L"1WA%=Z_#:*^>@$OKZL1O,87
M8E75\RORU@'Q;Y&+'=LS5NL;3$+D+'WBD8?G'AF%=5"N\Y17U@"T@&U\`5>L
M]5;I9!LH4WG;-A,%9>RJ"W6!K!*SSPNPV@J)"K?R9&[>Z9'5BOC;^W=JCYLJ
M/19"<%5)X7,$!C\"VUUY(3M@)/X.N&_-&`%N4\]WA!^6_**O#:+,^X\C;FC2
M7P?#((A8/Z"X=TZ[.&"*JD,!;@=0[._P!LV0$U&=LY,4!3K`E,K<&G?XBUW2
M=YM2>W\W?NXKP!CF3:AQ][P8+2NN6P16^@UPK'8&@-N6+O%72>RS=5M6%`:A
M[?,PJIH'E]8"F*Z#@:EQT[KX+8C[C>)]F8)W0BP'&'*%<35N(Q>#NA_DRV"5
M20('5FJ@WI[3\T"\_H'XQ!H-^:*E^L?:Q9HA#*>+.IU'S/!'S&ELQW=1FD^(
M.CA`$XH=D5^4RP+WC`HC&Y\O2`)"_FC#+T-8(0P<8I69C2?AYR2TO91DPW?E
MHPB9)'!TI0:><^PGZ=IW:]F.[,CWZCEYM[VGP;F3AM1)UW7T4G)(PM1^O&5*
M46Q[\NL-1+*`_6&)D>!2YCL]!PS%8(G<+X2XI6SDA;M$1\%,<,GOG:)?J/PR
M^()0E_!/S&H\L6UX'GGD9ZT,",U=$2OW.=K%`..M;WKCR?(X*MSQOG_`GE@&
M.+8"H_12Z><@]\@@5[1WX,AX5U7ER4-?E3+G*!A2%"Q=:K?"H;48V;Y[MW<8
MMD@"N*O;,PA<['H3X>TKQ6\P6:TIV<06!:K025T&,"6:1C>_I)3?'W)K<\>&
M:.Z<21'L.B4`@ZYE<..Q["UA@M_0$CL>DH&\+P,<5H%1X&X_&$24H<8W1?/S
M()_X;TKG(I<'3(:&L>!6B_2('X0T<KA&0W]"R0-35DF-JD0'R%$:W/B*CWC4
MHWDZLUP6,,PE1C:^^F/$R#0<)UI%'E/3[:,U10Z.#W1/Q@`"I#4*`8=<Q^S&
MCR0742[.5L@D@:,L-5#OYMQSYJ*!S,7VFL417AR[T46O<A#9C'VUSGF-SN4U
M;EGC644KSF)YBB,K#-U)*LP\Q:[=W,/MIPH89X0[AG'6S,;S%FG>1-V`15+`
M414:UGA.8O=495L5274%SO+66>-DF3S))/,"Z@+`02XSM\:$0WE*3>T19)+`
M$98:V'BR(/=DI7>0278)VG(O46.:P%HLL(-V[XJZX2J$@0.L,K/Q=$#QX<H6
MK!#N&,;E[?B<%Z@Y+[`]BT^0]#HT%R"O\.3C?[DJYS$__#%_EC?S:8U\OEE"
M*_NO6Q*X=]0&H/F;%5>$AOC/K"9#/[3]!\R:Z#:C)J!!IQ1P"K0,U\L:G'NJ
MHS>8Y,^/G0WZAK&.UYZXR0EG`T+Y+$YP]!:4RD]J89-*91W/G1[\3B^>3._9
ME#[S2S]7_!!\@6<520'WI$+#3G$E<#JOFW7E11^N>'E$_=KQE0(GJP[8&L^E
MCU%8^J+LRP!'7F#4>?_J2<(+V3UQMVA[ULV-U3\RK*CPA).'$Q5T.X<1\,.(
M9(=0B"@*PF3@,D4.>?#QG\AE3GJ^1!-$,1$=K%RA,'!O6@6&QF.15(\IT]KR
M#7<37\(^8"9E7C(!'7KE@#.A:?QY*-UJ7V<]\D(-=7/YRL'T<'FUSIT;_,[-
M<.W8?<3,S<D-L:F;]T[9P9I<&+C+5)FIUUF=_>21?C)[L_&Q!]0)ZSJY%Q1J
M<79Z\)W>%&V(MV',\IJM18\B%X?Q46(WMO]#X/A*"@!W?F7F-I\Y]/WH9>S`
MPU91Y[(O!!Q7D5F-9^HR)P/?V![OT_H1NF,>C0IIGM[>?'BW_2=:[7)X9<"Y
M.0:F<Y+P1'.0NYL5&3$X""F^SQXHS+?#Q_=2S.TG_G(=/Q-YX/-:F(\\4--S
M\`$_^!`RNKM>;.C?8L^3G":J712X<]:'X`2)Q/1*O]U-8L:`4(0?_%ET'V`7
MV_1YF]SLD=7:YC>.*1@ZJCK@K!T'5>.!4<9IFCPD6U/,%QAEW:3DUIFJI:'S
M5`6(QK<5R538-I3?D4UY$0$CF@6!DZ%K?N/[D;04^85%%L8B%";_*E;P&GC)
MP'$^$_#48X())1L<'+^&7E5EFY']GC+GX!U2\%[3L481I7'`E/B89-[\!OFL
MN<ENORLI!-BSZIH-[N#!/EH@IK([0$P3GM.KPI=FX0[PI@O#:6[8*#Y>OKRF
M(`<8:85QY[3C24*,@3&<?C-&=^:M:<SNIB8_R&9FA%.TYHMS_8<^,^DNX+\<
M%W=4?L[)@Y'*&IXC%$@1BNPN1_\'HOP0-K0.^;S'F+!AC<!U2@2!^TZ9>8TG
M"F.G?2WK@JZAXY:JW_RI/$*"1FB#A.@IQ8%CJC:U\<Q:3*D4V.RWP'',&=)X
M(DS!VOMJ#?0]=&#5IC9^),\+KR)@L]\"QS%GR`EN8Y:R)LJ3*\6!`ZLVM?'3
M=UYX%0&;_18XCCE#SM<OG^806)HD2WIDM2+^+"3.#\-WTULSCST%5J_VTQ\#
MJZ?7>:0(?Z28,,CO;`^,*%P2RC=R"1RA1!"X3Y29U_S9K^DKH@&M7!8XN@HC
MF]^L'FUWN65<T%:+.9E$U%G:`;IY3CU2LA"4[P'WW>2B:(%WJ*]>X,35!%[C
MH]M4!681#:>V_X!TKXN7E0!.3*G!C8^,4PU,WZT$N%B^(W!+C&U\<)P^_SO"
M#TM^-L@&45L?<V6QCD"O-KWQ<;9$C1X;:/"U<1$;48G/"-4LV$T6]LP_S2A\
MR)Z*_0`[WVPO4LSTYJ2`(RPT[#PZ/\GH/`YLK/BY_&CR(T?CDMI./OJ6Z'$>
M;<,?;1?B[CCD+A^#;,6`^SFQ:8V/LT6/38<P[LWS]C71Q5A0L(.HB\QO?#B>
M<4K!%QY2"#,=(BG@"`L-.Z_2.DG_W;/&/7,\GQKQN3(SVT-\UV/:OH_-KFO6
M?O+^75.O<W\/O[^?L,$LJY>-J*S%F/2B("0K1`W'X0=1QN>EW1**YDO;CVD6
MY88KU@#<FU8&Y!27M.TTLGQT+$=:572()#U(FK^>/J/2SA/RP^Z8?K-HO?8P
MCX*F]N,M,XYB6WBS[@&5=(@I75C.L4L+L4OR[@13Y""\X5;4&KS(JV\Y>I$K
M=@Y?NA6^[#/)AI<OG4.)NRTKW2$_6PI$\SD/P@;\R>,"4:]\_>Z=2$]1%N30
MJH`3=CA$YP-S9=UC\CG_[Y[%&>R3_P!02P,$%`````@`?82N0G_=E;C*/P``
M9-X"`!4`'`!C<&AI+3(P,3,P,S,Q7VQA8BYX;6Q55`D``RZ@DE$NH))1=7@+
M``$$)0X```0Y`0``[7UK<^/(D>!G;\3^ASKOG*<[@NJ66MV>Z1E[-RB)FF&8
M$F62ZG''QH8#(HHB=D"`!X!2RX[][U=9!8!X5Q6R"*+O9B.\HY90^:K,>F3E
MXT__\67CDB<:A([O_?G;LS>GWQ+J+7W;\1[__*T3^B???__AX\G9M__Q[__Z
M+W_Z7R<GY);ZEZX5[$)R0IQKQZ5DOG,BFL`@[]^\.S\[(^3D!$:XCO?K#_#_
M'JR0$H;+"__\^W44;7]X^_;Y^?G-EX?`?>,'CV_?G9Z>OTT^_/V__LOO?L<_
M_N%+Z.0&/)\GGY^]_=O-9+Y<TXUUXGAA9'G+>&#H_!#RWT_\I14!8W*4I/8+
M^-=)\MD)_.KD[-W)^=F;+Z&=(73EN#DTR[7C6=NU%6RLM>^"/,,W2W_#8)Z=
MGYZ?GV6&`G!-J92&Q'(Y^_CQXUO^U^S7#)P=I9]GH7]X*_Y8^-II(">5-9O?
MW_TI\%TZHRO"<?X0O6SIGW\?.INM2W\?_VX=T%4U.#<(WL+XMQY]M")J@W`_
M@G#/_@C"_;?XUQ/K@;J_)_#E_6Q<2]G''"PQZ&U7--[1P/'MD=>.V,+HCJF>
M1U80(>C.C.^,\@5;;6@KFC,CNZ/6CRRW';7[D8):L:#"+R;LIQS1]$M$/9O:
M"=D`I\&..1J^4@#@!+*_S,+\UH45U`^^S4KBV^5V[9PDZQCGDRU^?__%"@++
MB\)?J/.X9J0/V8Y@/=)+WXL":QGM&!_.BB:0.`M__E9CX-LLF3`Z1VA`0W\7
M+(OPV7_^KD\<E]RW$LD!@F]A2V.X8+.DWLG]_-M_3S"1YQ@5L00NLMPC(R[#
M]J>W>TK[Q9OM+W<;ZD5\\SP8C\-@2?S`ID%\[LBR;`7+Y!?L1PG-\1=O&?(E
MW48GR=3PX:O`WVCI64*'KRWAMV8,Z<+R?F6+U'`)S,!.>^M'-)S0)^J>59A/
MX^<HHU$A!&,J,7QBI0B(!Q@(1T'.3!F(*3YD9H'AIVMC4)%)U@34M:R]XK/C
MQ,:)IJN)Y=GW(;VQOCB;W:9FUVCX&*7T<B(P*B^@$W]%V*]MLF,7CXW`8'1+
M,,.$3-\7ZSWUC)/53JSYG#O?>V27IB=J#\AV_1(Z2[8A6&%(V:;!/K6)XY%H
M#?;![D<N;!OV;LGE\K`+'8^&S(J8?)CYL"_%L8:L_(`POBV7OB&C+Q:<T$+V
MUZ6[LRD7YX`-=L15:\`(@QL8#5XX(/I_=LX6>!GP?_H,=T!`E"'@7.T"SXEV
M`<U_&P-G\`!RQ*EQ'2981DSD#]C(E<-L/`,[#VCE?(&?0X&37?ZVNXBAW<.'
M7X?^*GJV`OJF3ZN#7'^R:X.J*;9?&29,(=C2L]OL7#@57]%M0)<.U\LK&EF.
M&U:L$`J#4"N%.E&8%0.P_`!;2H*'V!E$[!\<DZF%PRQ/*@M(C(LM%<3:^#N/
M+P)9%@?P+Y=R;L%@V%=!Y/Q#L/\JH$(HD4^V@;^E0?3"5AR&)2K:?6+!J5'S
M->,U6X:LB*RMD#Q0ZK$%9ND_>LX_]DL4^][?4!(R+BA`ZI6AJL]7UF!U+4/%
M<+/.I945/G!6=N')HV5MP>EU]I:Z49C\!DS\[.3T+/:C_5O\Z[]?)`OXT+/'
M&S:C3USFX4^!'Q9M7&U,:Q/7(@EU#(X1]$6OM!A/U*K%9+3?#H;\('%M.<$G
MR]W1<&$]N*,%_1)=,""_5FP%D@&H;4"-&(R""`P$4!".P]1J;XYTZ4IO/;"U
M)B"V$RY=/X03$EOFXP/A$S#V!!3T:FU5DTYV7=51L^[6U'G$D,,;!+N_C=A^
M&+W`W>TJG8DZP]$?CUYKM4G%F-5\,;W\R\_3R=5H-O^#M?7#'\GHK_?CQ6?R
MS[/_,6%B!^4J2OW8.JSUQ;Y:BZ:XW[14SO9[#_=[W%DOS+1K+:?^.]1.TX@:
M8PFWT\5H3NZ&GX<7DY&IS05-K<KM@?W987M)?EL13K>M0-VK+:51)MF=1$%[
M$'ZVV?3J_G(Q&UT.)Y/A0\B=V%4NMLKO<-ZU)M0HQYH`3`3D/LUY(\LY-XI<
MW-T=&L;\UCMAA_9KQ@F\=#C>CIWKI^R*S0TRO*`K/Z#BNX7UA8:C+XQB)EG'
MLX*7,;LLA[=,,O!&XKN,OL>QQ_8L&A8UK0N,Z(-)!^+`:/\KH.QUXJIXX*0D
M_XJ`F+X81(?R+)X4.M.O+HU4X!]]V5(O+.IOW5<&C*$2+4:!$Y"$"IC]T]=*
MELLZUB#J+O7BB1V,_.#EE\!AAV'_V:M5C=*'!K2C#CE.06*HQ'\(V8?ADK))
MZY^:U/%>UI1FR7>G+'<,%@T":O.KU'QML3F>[B((\@-'7HWFR$:AU4B1+-29
M,4%!.(X!"3D6XN_1]$W!%*52U#:MV>I.]2:.]>"X3N10<!>7K_(UNB<=AE8^
M5<(PVK>8+H83,AD/+\:3\6+,+N##VRORU7AN5$545$6]R>M.%S/O85.(#KCT
M-]N`KMDV[CS1_=GQED;3%3L<UJBF+A2TIK8D&_4<D7F+%H$4RRS2^-[1-WUM
M*:BB^J(F^"`Q@><5GIO&SP\5$WAN0KDD,73G'<0$:O&!C`ELY*=',8'G17O0
MT[+VBL\#X`O7JED:HW'M!XLU%6D(%6:@,1AE%/I$H@X.@(V'Q65OS-G(%8B4
M@]"5+<=IRF0.PZ74RV^0VZX-2E]B6?-JJ[V(N(I,:%6,D.%GL^$\N%0\;E<%
M5RB,PD58J).%.M=D`\MB/&2/*(Y6,!9[898IF1GAF>L\_$)=0+D8#%UM;&\N
M-S[[\!-=.TN7WCA>0[!ZW9<HLY"@QY@"!TV>!&RR$<"-1J@;(%XI/#TFO2(\
MG?P6GOZUAJ=+E">['"A97G=>AD(&V>UN\T"#Z>K*<9GL;57GJRX4M)>A)=F8
M)2B&G:88GNQ3##<;MH?UWU?;4FA%CP-JLO'IO!6[6?HG(RFY)I0E@64ZI=;T
M=K3/<'B.,?1J72VR794#:\ZC%3KA='7'9B(1&H3+TK`A($D^!NG;4B0)Y>`:
MSL=S,KTF=[/1?'2[&"[&TUOR2B!ZW2=M4!9'WB>D-47=[;QI5/8^-K1.U92&
MH/=4%8(PBG8]',_(I^'D?D1N1L/Y_6QTP]1MWA<-TQ%#<4M4GYCN]&LF$M'N
MK"!Z6;"5,F2T0%"11,>DP]!ZIDH81M=FH\EP,;HB=\/9XC-9S(:W\^$E+&R]
M4S=5:1153F^>NE.[6QI=6N'Z+O"?''8+O7BY9]?7L7?M>):W9,?!(2/SB;^V
MUBB@!@"T*NH3BXIJIQ$!="3!1QY>2(J+Q,A>^J:A^D(JZFK;*>U.:_G3J7@M
M'7IV[*:3+96206CM5",*HY$<0Q*7^RI^RGC]0]\T4$T01:W3F9XNM^4GZNUJ
M5[_TSP:VV3PBU'8J8/5-+XHLEO?(*F'JSG5(EV\>_:>W-G7$-+,?BK/+?O7W
MJ_B^?<W.@)8K'L*NV>^*4]W\;>MY5R(!Y0"+@1,!G0CPA,/OBV8H"2%1$XV)
M.)3.C+R([?B7W(.H%.ZJ.`BE1>I$8=1)8"$"31+P*C"1:?^<J'J"R:J8[G2U
M=V%=3F\OV95ZQETX\[GE\I#&.S;5:ZO^.*,S$N7.TB0/HUQY5(3C(@P92;'U
M1:]:"";KWFHU<>TU+*.T%Y8+(597.WKO,5&QO=9WG]CO)XY'IZO+@-I.-+NY
M.#\5_U>A=`A@*#W$,X$Z<^^QDP>!GM@[2G9```D2"@A#Q)^&EYP(\HJ10<Y/
M!XP*^%^C8[9_PI"]170@E*Z-&B_8K)V;LI7VIE_C<+JA_/GOF9?8J=]@=$:C
MC+L%F8=Q-!*!K$\JV4(V61UL/8?ME6Y\NQC>_C2^F(R&\_EH,9]?7PV'6U[%
MR;YABL[.[-=^`/'O3<K7!@I*"1%DHW(24[1$X"6`F"2828R:)+C[I)L(D65U
M%#W5!NJ-.]%Z](4&2R>D=X%34I+F;\U4%:\CP41,`WEFT`F-P9,MP.=A8=^<
MOSD]A<*'[(?O3R'\603%&*\KCN%.O92X02Z/%3=1*ZG*8N+-NHA8Q`OAKM*P
M"LD`W-*L1`RR=$`2Q!P7RNMC,(6:'')+J\:L=.=/OP0VH>P]V//,"7]5KR.G
M-!3MA]<AT*#+PW#).--<-%:+R[/2%ZMI(XKBBX2^RAW]Y3XN1]/^Y;X*P*%>
M[AN(-?YRG^(B>V1]TU5],2F^W4LGM=/*8`&U0GI%Q7\9<?#R.UPN(;8U*5I7
MH[.*@TW4Z](@$O^F'Q<;[$\X;SM!5-3,TIZN8VIB0MB,+JGSI*6'%4,/H(7U
M!*(R@@/+II!BSF%#;FP,_&O0QWJ1R+51-FG=Z>)57&`GK1X7!\!<4(^NG+J0
M)MDHM`8JDH6*4TB**/6YWJ"B'(H:IS4_[6_L_)GZ@FFT#>5$&(+$6U*\J==\
MB+JA-R/':`:'3*!UJ4@O3&`W+DK=DJZ4M//X&/!NC)GT'8^I'#NF#7BV9/1R
M(IBDFZWKOU"H3K#9>7%9R3=DL79"LK%>TFQ02"WE]>X!5,BEY`=DYT%GJ"T/
M*Q[DVYRPSZ`(0.`L(24N-R).W[3L_]Z%$8\7@D14D?L9A'$)J9STR3#<TQ\!
M;=2E(J$4TEH9*';>MAB&YS7UR-)RE[Q!"SMX>^Q<#L/((^7<B8.YGQ[,K?1P
M2B!-]C'NGV([;$>*R(9&:]_NS8XD5Z"L-T;%\CK<;79TX6?>AYC$+W=LH?)J
M-YKZ`?@]1DJ,N?,U.2%)QY^M0-47=5*71FF349R;#IU\S,;KG'CP)[R3+H,`
MY82#Q8AGK\,/L!:S995*$D&/XL3*,%QR4I5$>MCPQU^HZ_[%\Y^].3M$^QX[
MW83AC@:%Z9)_;R#H44**@7A'P'#R*Z`@"0XBD/1%192E40YR5)H95#].\)Y:
MCW2Z*M^T+EZF'KUDAPYV,BXJC^YH;,=.73(QBK5'QUL8E2_=_$SD06<[@=1@
M4\]#\"D[`AOEM^L#7@N9%3I;MM-A,T:7QI5"Q7J&:[[;;ET'JC_,K.<;=EX(
M'*NR]64+(,9,4(]H<Y:X3?`2F'ZND6&,FM^?K&=V!XNQ'\(DS?.M9YFF^#^F
MB>K)L,Y2VV@\(@M`9!KP)(/ACEUQ`RC/5V&4-1_B8OP;D:..UKDR.U8*VY3I
MX"G7:4_M\:HY/)0YQ]>6MRZ.&\@^4.+``8I[-2R/-Y>*7H0+)21,I0*HCP77
MC8<7UWKNCW-=+L]<#H."'AIKXEZ].>6^,-FNW="V4NC1?J"V[,8=E:E[<EMN
M,V^%;$O@#CF;K8"]4MT:L32T&#>67Q,\6E[L9!UZ]KX54$.TG'P,+EM&E224
M4RV#1%0<3-'T23&499%+W=";'\1*!S$:(8-\[0>9IE$+66=(M7&X55&'--1:
MF2""('<B4)&%[`7PJ*PHM"IV=Z56Q?6,]FLIU9%6;H'55\HN6Q3!^A2]W+&)
MBJ"X1%*B5!9RJC#00*,B5>*0AL:Q%$K`,G4(G;!__FYUH91;%>E-68=]M)=K
M:N]<=L$<68$'Z5?L5,*/T5#T;LEHC6MR-NX`6&CX'MLX-G!*O*\*"(LJ+[',
M%N,`IDR45+:IYV\<3_PB6XHY?8<60Q^`5C$B+A1+8V[ZER)B2/*EUM<F-*C+
MS($-.\*#)4/*O.B_^4B]I4-#G1P"+2`&L@G:$(W,*UB,;W\:W5Z.1SV,Q6\C
MCG)4?OM)/$(3S3U-D@)E32/,M=6L)P>7R_II=+N8SC[WYCBKP7AM<TW91'18
M\2YS*V4:'_JN8R=7U.RV.%W%9?HL=\Y^0X652`KC&8&-KY]GDD6,+E>66.Z;
M6AN55JD6GWF-P.2CQM:8O,O8D/HJFH?-]\W#JMXQE8<B<U3U",1EJR9]C)/W
M.END/C]P=,ECP[Y=G#%'RB&XE/E2S'+;?<ZNGL3RV;MM-+?;$#\X?+'_C/9A
M<Z(@7S'/HNXLK@/"2,B@+L'8',0$+MQ!TU!#_L.HWZ&&NH*J"DEL-[5'SOX*
M=M3.=!BN/:@K##U,]E<-@1A-C:$FK1'[XY!N(PBEG*_&J>I.`R5N%\FI774T
M6@\UR<2HXBOH??RZPA77NQK7FD(IJF6KR>M.,W\*V#S<!7Y]YF'V"[2&5:##
M:!$'1[8<7M_TIH+5HF[4BO:P8?UWNP?765Z[OE6<\^IO#(3O5Z`T$+(OH!(.
MMB_3W\AS.3"_5L[X<F<CSYXQH5'5DF?5WQLI>]9("D81TJ)@E)VW`T!1J`QF
MNL09FA/E,F=A9`51)4^].;8I"Z:JJIF"NB&;P?/^\F<5&I_]*[Z=>QX-JCH#
M[V#.X9$SH\W8]6F4Z:EP4&0],M!6EH8D4F6B:TVM$$2IB7J54F"*I%Y.;T:+
MX=]&\Q%T9V?6"_>2.&9F9D7-Q?8T1B.+HFJ3B7M``G2$XR-[A)E0*<)Q]DEW
M6H@H7_RTY50B`E9Y7G\:$W,CPMMKNHXW?(P+4942@8I-+;2M3F/X3;8?-\."
M3@9"10?RD]\ZD'^M'<CE^I,+258T1&368)*GR/`$4#INZGDO8^]GZF[#RFHR
M"H/P68%*1*&S`/?IJ0(/+QC(,($9Q;B,YOP9XTHIQP_)W5$R^I0D5,K@T]#&
M3E\:Q):N'J?6.,3$RX*4(&-G.<.5;4W1WEC1-LM`7RQ#1P`5KR"*ZG14JY#&
MQ]6/.(1-'.IZ\Q5HE#Q"3G$JVA])AO83CW"X]H,T(7NZ*E8U;[@I:P)`'57:
M$8MZM;WZ-+R]9.OK]71&[NYGES\/YR,>M59J*]*KDV\[264W>LR\=IAS9+WP
M:+B%'Y]&:A-3:E8[#0#X'"1M8E$G[GC6>*9Q95Y27Q2VO7Q*:4DM9_/H=;GW
MY6K4HV%*`P]5C[N".)3KB'LMOJ[RQW5R4"S%73M+1PZ#J=&UZF\/$^)B0J,X
MH+XI42.W2I$JQU(5>6B>T0@\PX%V\4/>'FC?%$,AGLY8V)QNF_8%`UN8JM*?
MC31CSR+"S';:?QT`]F6FZQBMZK%>%JF)E_?SQI?W<U,O[^<&#98_6I^;?WG7
MHK'URWM,OGB![\V!ID82U4_OYZ;4L.Z9E5TE%VOZF5H!&_*>G<:'JZBR**DF
M`)0RMR,6&4!7]^S.'P?A0?&%X26`6)2-!]2F+.-P#,N,YP",=VU,[827M3>,
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M2@D_T:>T9/K#]B[MT)0LJQ*VS6E)^\7XED8"-TS5V%,J\B$?@UK`E4G"5@MP
M4BP0EW?P>AY&^5+9&+C-^;MHQ?0LO55[-8SG6.[5#J(LM^S>HJFC'781!Q]A
MW(>WN05<U9?XON#UZ%'+_=H/HI.(!IO8"1KW?^N+'BFP7VKL+1-_=SHC;F?-
MVI+_!JTGE2CQKOT88'RI[IMV5#)=U(L&07=8G:X02@!=Z!O5HV$`OHZ<E!BC
M,2(#XO)L&I=M:_S9!;8VV]\]1)"OD_:[8O>A;SZ<#CY\?,=/F]^\_SCX_ONS
M`23<;"F<K*C[TC<%E$NR5#A.<5Z[7JPDER13H:#-2%$^9![)V3<%:0[65)$N
MHNGU8GKYEY^GDZO1;`Z.P\5G]LDI[[,K;O(06=?@+=8;CVN1W894U/DG@Y`(
MC/!T=4I$2VV!E`#6OFA4:S'EFBRWGU)<><KD7!\G&@VO_8`ZC]Y\]Q`ZMF,%
M+^(-#5H_6Y"0=..X;HW3$04.7<82RPC61[V_!L84#(@%&RH00<*4BO3ZN!2$
MP(!-3(K)>I==B$.E!N:!Q7*,PIA8T1:+99JQ&<PRP*Z;C`IX,I]Z:8X"X_F&
M0N^XZ>IB>E5I[RKCD(:M01K.@@4B$C!,T"[,BG&)EI("&YR$&3YS9FJ8.;D]
MFF&R>Z/3$%3>NK0UM+T97<0%!FX<KZ$R1=57*!-I0(L*_X[!LE78,UZ#`DFS
M4O&)F.R*XA/DM^(37VOQB0;%R=J]U,C0;^Y0TGKHR2K1-7QLXF6^@0@#C_6B
M7#DT@\T5:^/NH'=O/KR'OK'?G+]Y_YU:VZ'N^9,M$X?A\TAA`0VRJH@4D&HD
MJC<DSP[,-3#C'K6F^#?Y(&Q72$6B#A#W]DI@>MTGK5$72*%5HM8T=><KO0^A
M&5@8.=#HO2[8K?`1VE=:C13E*Q4^=SAWI7#[HC;-7!<]ITVR/F9F<!*)IU,B
M/SOF`/G`%209"9CLS<E-BW5Y]F_M=+3?M"[74+DU'*=WQ(7/XZX<&E1Y.AL_
M1VU4*H1@E".&#]><!`.<;\($1Z/.'(,1V2$.Q5#7NZZ*4++[K;J>=1AV0R,(
MN>-=DVTH5,96>GOLQ<W&L[%VDI?+%H#P03NMB4<9'82/08QB[&A+T?4Y7K.]
MJ$KQ/\B)[K)1:QA-5S/*]I==;>^GW#<&VJQ6H$0I&P,(=]=`@.R;6E7R6VZ3
M6BOC;J/:,RV@ADR)@^"%Z>LGRZW7CN9!1B+2Y43AZG[TO#^=GBBJPL55)PCC
M!*$K&@34YH5'PN$N6K/SZC^H7>G[J/L6Z?*0D(#R="3`A3^,Z4D*WEBQ61/T
MZY2I]G;)\Y?G>PPOI1MP;9!MD==7?I#])8]+R7P?,L3N"[$B_I`@,HF2EN].
M&.YH\!H\B1LG$OYZ\A#_GA>W!3\D;Z226."2(07O//CD'UY<Z[E?1UKI-.7]
M1TJJWM[N>'I=8M%#GLY587%57Z%LK0$MQLI$-ZAE##=.3S-E7TB:99:E37O7
MBMO`?U9EI;J"V"2@?MY-\AR8]:E69>RJC,!M&&KDH+8-0%'[!&ILYS#'B%[6
MZ!80UW%''KE%6"$$7L!>8%M1OQY7%>666]!U%/((J>_7CN>$:VK_Y/NV-`4^
M_[&Y5/A*(C!FE``DCP"Q+RJDQG=M9GR#]!$Q.</Y>#Z]OIN-YE";83&>WMY-
M)^/+\6C>\!JI,@H7LZ-.%NHJ!VB@KG(6$4DP]45O-`62B_/0G2A4D&2N2/,-
MM2%VZ-H/-CO7"L4K:%UOA!8`L&&3+8A%QD_&&),R+S%.DB`U&#5Y(-ZDFST#
MO;,"8J<YY+#IXS@_0BAE"^D58BI;ZS$N58%O$],'N%^'2\K8G-&0!D]5@5>-
MGZ-3#62$F"EWXV<00'PA8#"9(6"""Y4,@';<'".P7R:18N"^FH9U=^S-E3;S
M;'9;#2+G'\G<5)U]FT:@#\`*Y&`L)0M>%#;,(.B+:FG(HG@R5IZ;3M]^18'%
M27U%L?PW)EYLRRCQ]4IXI<PDYVA+`\=O=%P?Z0&VS'G%VVJ=M#O,H4]><D=?
MMM0+I2__]=_C,^AEI.`"HY-W>QI#[]VKO93_4MJ[VEQT^0:_V?@>SWR5/)ZI
MC##P/B\E!_=:#^!%<O-`[S'M.*_W4FF4W_(59^<H*G9G!=-@SLZOU.8/P$FO
M"+FJU8XTJ7(R\LRIWI9=;-EV&')<Y`F0]5CY9')I4$*U>>NPRD=2?87=H*_B
MVBMQ&'BX+T<B*5FD!0-?(Z0-R:BP>%F%&H^P/<NF^]]DJMST38U;2:]4F*3]
MC'=Y'Q6O_0OK2Z;Y"A1J;-1FZ3`#-U,UPC`Z.X$VY[R.FYV$BD36%^+&^'I7
M,4E5)N5KJLYL':K7SHC'S'SR768`4#'!<<N1^_7?H;KO-*+&:)``3%+(1(#N
MB^)(><]VYE&0>WOG\"]6$%ALX?N%.H]KMJ\/G]B=YI'*LG.5AJ&<Q3J$830E
MP4.>8T3$$I@*.:VFW,>F^9*YD4WPU[5#64=&6<>ROE:V-YSKX7CV:3BY']V,
MAO/[V0C25>?#:$:WX&OT'J_8*?D^A,"G^L=R?1@HDVI-,BK@@B$E'"O)HB7#
MB*2("6`F''6?U+"UO+(ZB9SC[D^<UY1)V'+3;D"Q<^N">G3ER,Z=DL'&3I]J
M1.*>2#(GSRWDWX1L@>U-T%D[@=0=0'6F#='TR?-V@&1?6*AB3:SX"-?DJ18I
MZE;-H?(Z-FE5*%,G!!S%LO.`+N5=+[KUW.?Z44FTI+V2WOCLPT]T[2Q=>B/2
M&VK*4=5]B5)7"7J,SG+0Y$G`3E,W3-:F,D"\3M9)17VJD]_J4WVM]:DDRI.U
M?B7+0[:M38-4;FG5T;W\#;Z%;15*C,&+:O?[."*/&LL30-$KK4N0SWPAKUS_
M6627+7F";L`,+?B51J]Y1H#(#GNP7.[D#M>41CP_`/[B[,M=I/7:^0/-/O)%
MF&5:QST$.^?F'4(N6^R(2P&])(A"\@H>LI=Q'EI`-Q9;7AC,-0#=6D"G%[</
M903#SW[Z!+Y\88H[((Y8LVCPNE>&6#NWI3:]]?K?Y8.D%_JN8_,9O6,_+5_J
M0HF5AAAX@I03A'M[S,#G*GQAA0XWA#L(#HSMJB\:I2.6\M.CZD0A+B5)95,_
MN&,SN[9"&DY7Q4C=INAT70BXZTP[<E%WG:M/P]O+T9Q<3V?D[GYV^?-P/N*Y
M$>/;Q?#VI_'%9$1$IX(WY)]G_V/L'G0X5MF1**03`_Q^!;RJG*@A;9H=(//1
M^?L*QY"TG5`EMM4T;E^<KWNU?[649>YZB3'I[O:^?4ZX1LB79!!Z_U,CRDP%
MA:\E]DM-)L7M3V>FNE,Z2#:,Z`3NV46#&"[94K-S(3Y((8"^!2"T<K8G'K6#
M[D'G(NWAOE!:2_NFN^U%5M1G[(0?)<JQL6)1\3.3\8O&JA+%P8JA6"N_.7US
M>GK&8Q9YI.*/Y..'P>GI*?ROO)#^2-Z?#SY\]W'PX<-WZ5_9E:/\6W\7A6Q.
MA>>JS^W-ZD3<$/?8LKY1^V"<&7UTX#70BVZM35%?:C\S$(I3C=A`),X>,`'(
M?5$*&>?E.)PFF:-=CE'@>*&SK%ISZKXRX7:L0HMW/#H)7'E(=(<T2Z]#NK0?
MR3U7Q7^%@ZY>5Q"5(42OYGT?8]ZE=D+9:O^N0FL;/\?5@E`@!%4$HM24.FXL
MS%&0=\9ZNACB0Z;;&'XZ+VNA()-</0ME+6NO^-FTTCA$HJJL?X4-J(Y$F8,F
M><82B&-<$"7#D1VF--4!N)/9BR$NNS8=34EEK:B5GAJM,02/&4N&Z\IQ=^PV
M.+("#Q[7[V@0'\CANG%%(\MQF[JBF()LNE81ACWS]8PX-5R18WI(0A!OV).D
MN?6M;X]AN4K*(N'U!E'GD#+M8@O4(YVN.)[ILP=EP"_7CF?=L5]LK)]]$7XR
M]I;3U=2#+I=)7\R)"!RI,`\S<'$U$TVRAG(GIX3`VP9W9Q`?:(&:LIP:(L@A
M"3V$$03?`DDDTZDU)LI8,<:N)23;#SN55.<E'$U*.U?HT;RM(184=BKV(L=R
M,VM7^`L-X+@\%G%M]MB+6^;NA"9,5^6ECP_D!:N:GL8/B0VW^!Q>#*@E*2$/
M(OBX\U8X69\9A7&`HJ`QB6E<[LD$<[/CW9QF=W.C;09[(D"%NG,[MU1W+B_4
MHCS+0NO5\W8'DL^M7EV9<'>O.W"-8?>9YD([A8_0+SO52#&+Q'PQO?S+S]/)
MU6@V%Q7O>>/$Q>>^:&LSZ\7WEB:!=UB/*7BTO/CU,1=^QBX`V?"ZZ>J:[=X>
MNRJ[O"`&+$+A5;K*R$(0C:/!5W\Z$./F+ZV&0LSZP'AC'%HE]WVS[4-)KU1K
MZZ`&<\RNFL/E,MCQ&A`TO+->8(>L6334QAZ@RV8#B<BP&``+&9;L&+85@/L3
M2]A*'O(6G-(Y.T+Q06EERJHOS14<-%NE\A4`>IT6JH2N@7'J!5LW^J9<#3*H
M+3=X_*J5F6HU;/WE,3)KWV62"Y7.ULK#T2JF2RBJ:M%X>#&>C!?CT9QW,?]J
MSN>Z0BHJ9KOI/$)+DW(J7^4GYMJ7&$KD2^$-TBRV3$VW7'EP?T6^.1M\]]W'
MP7?O/O*7'?CG'S\./G[_OM]Q>4T99_)IZK#H(`]8C<O#21:ZZF_Q102;2$"%
MBL;IC@)![RKT-O)=*O,GEWUW2I/>12:.1\?LQ[J#5L6':'6I1XYR/R50R7\"
M7,(!_U??5*:>]Z*^R"1_J(C?J]B%?<<KJ8\\^ZI<&*7^.U3,;R-J5'A0#)@(
MR&0$$08]*C0B93X;]ZL@^/;O<;>\<^ITE?6N5SRD57Z&>@%K0HR9^MNT%6SN
ME<74NQ.6['9=;?,/1O_O=*!MDF;V$4BN?NC0]WSEJ0H3J/[.1/A[-6H3`?#<
M`P$%Q.*F!X9CX-L3KF(&(3.!N+K&O@Q&D2,H;O$@RH1Q)>?=.9/TS.;/(:K0
M<N!]$.R(:6KD>#OXU]Y;TRMC:11Z1>A]DZ:V-Y<9??+=)R8F.*8PBV1R=J)?
MG&@]A`CH"KN1#$`9D!HQ&$M*,1`7#IFP%G,DY)EA(19Y8'A,694Y;F3FA>6J
M:]57DTS6!G2T#A4>R7;BZ6K"EI[[D-ZPU:2^7EO#Q]A`1@D1R.A$!IW7-X/U
M=<?6T(W`8+1TFQDFE$Y7,?45U=O(;]7;OM;J;7+]*81$*IDB)D>-:5`Q_*AB
M4:C^#IF5UH`:EXX&T?J'B^E#$Z[7\MW;=Y-[Y?(GNWQ3.<X@94:91!KO[V'P
MQ`!'R9T'2^,^\YS8NX"?)]?0*#.I+BW`]<I<&D6=3VN3ZF=[([GG2S`49`BG
M*S8Y<5D;652OTC"4">D0AK&H^V0/>J)I)4%Y%8YC<M(NX'57RV>OK$)'6%DC
MT5?(#CW_RS6U=RZ%\E'QXU7\)M%H9]K#\:\$FH0:>="$<USHA/VK>J,KC=)K
M0JMYZTXM><W(Z2KN>\4VEQK]*W^'5K1:U+@B-^S$[\$](8W_(_L`P+YI5ZT(
MBFHD$7]W^C)SPE\ANN.>\<;==CS:H_GUNWD,6H^42$+IU/3V<G2[F/'`VWG?
M=$B)_:(^:4Q)A[I%>>&O.RN(7A:!Y86,%O#^JH?3ZT#`ZYT^N2@/Z&@R7(RN
MR-UPMOA,F#;>SH>77"--1\(?B+'&(/=Z[GIG;_K2*5E?6S7MLJ2HJ/9PQV8I
MRI9\4#=&+1`&RHWJ$XSRQ\ZF=R/050CQA'C..^CH9-H4#\55HRU6L]8W.VPC
MFG)EU;8JVFFFB'A`A#0!QVZ*72U]:"('I`8YZD!EA6NR9?"XIV__.MR_1L/U
M_%<D>#1*OSN%8:A!P'?0J\R&`@/W(:3FBE("T&`.`G]YE':-(FD`0"N8/K&H
MH"0:$:Y\]_%+4HJ'[!'U30?U1534S;83VIW.9K.@FONT5WV)UL(&],83V_JF
M7@V\%_5(*ONNH^]K="3^HZ'X>A.:L)@NAI.X643?%"#/977X?.^N(?7'H,8A
MA[MF&#H:W556%1SP1U+HQ9&I(&]GJQ)"OL_[P8>SL\$?/WPO\GW>#]Y]=SXX
M9__K=;Z/BD25S^VMCEV8AD`5SZ**`SMH_V-D#U/O_M)M$QR3KZ6&F.SZG51/
M4/J-;8[G"%Y2YXE7`8"C:^-YL/I;`\[=!A)0)X'`LBFLX_"0$[*5.<%3F=-I
M^[N'")[LTP%BH3\_/Q^\/SM+%OKW[SX./K[_T.^%OE&D91>I=%H/E8@5([MV
MPJ7E?J964)^+5?LI*AU+1H")S$X!G`#T7F9ER6203<Q2FX5#J<N0;2PV;"[7
MKE5\/2__':48E:A0FWL"D`#$/LU_):O926\0:_LS7_ZE-WYM#_=K44.A:>6A
MJ'.?+H'FGKU)@HSLL?5%8=I()GL::C=W9JHYW_J7NS#R-S2(\5*;'<IN_(`N
MUI8WM]S*/%!=",8J-&N0B\QVR%08]GRRC+$F!Z$XJG_#$).(8280W6_L!G)`
MCO5J*QOA_)@5E#6D5U<K65N_D3FH9Q7V%O\!GV5Z9L(Z."2C.:1:9*FU3GJH
M:3+3)TW-\U[*W3PSYTNR^'U[^NQXCPO_PK<"=G:!7.I*_U'MQTB?D8P(G)_(
MBGTH_G.<ROL`&(A`8<XW9(()N3](8"GP(F>E>P^03!QYKX^:9B'*6,!+8Q"\
MP*,B3_"IT._R-[@"%G4HL0_%RQAJG*IDK'(%AEZ9XFK2W7F=B3K><T4FFO4#
MN;O_PD!;['0_].SIED?=U6WW%5_B]_]Z]/@Z$PELPH"3&+K14P*.>+5C@RX3
M1SDRU`NB=(:0:5%[=<Y$'/%<DJ8V6/7?HE1:2@(J.>CV<GHS(HOAWT9S\DK`
M?]TG59!RGU4&Q1GH,$S,@A3SZ6J:5EFI>6&I^!`?]E6+'*,QV>+@_&E$H.&-
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M`:6FH)M:0-?4"YTG*NX0UWY`G4=/1#TLLPF$C!7^+U>LGO9_[T3OR%L:35?L
MZB%FL-B*I&8!ZPP]OG](QX)"75%X_;!EEM@D`>H$WO6`X+C,YO*%1'LBB952
MV3<3[%K^I88H1]'4CA>"N'QH;6.>W#=F3*J($NM0%[7S%$K@'DV)BQQ7:EJU
ME#N\.%&7P7RLKI!<\Q'^&E2)%'7;$1`3?>B=7Z::X](-ID'.7;:5T.R\=,A>
M2X?MKI2%GG13XDCZ=S?6;J#4OY9)F99.S6'X%1^:;-IE,@"?/S,E<=`9''W3
MGWKV&QIOM8Z4;TZ"6OC<5>,PQ:SP!%=]922]J0*MD5RFR"=A`MATUE)+FF6O
MHY?Y5WUBI04<'RR7QZJ$:\H.6;85\0</JXK77E5Y;!!85:I2K7(=*K!_Q#MX
MQ`8U2ZK(0C&Y7=$(I)^CPOY5",&8A8"?+HDI!B)0]$5G5$61S1)0GQ1$S),_
M7241JF%5B.K9Z6E:NB\355ZQD+8&A8N@0C*`NA?ZO)YS@KTVR/GL],WI_XXS
MH(N9<\8BLSJ0@S2`Z\#RZ#SB"RG37&"8$>LPUJ,+#NNB!=+"3Y)H+UZ2>)^I
MJ$8.06R>/?I"@Z43UEF]$;@FNX#A6$.M!Z5>6[S&>]QQBYUEDNQL:+/UG,2*
M^2E%HF["GJ8#]1L[O("D"T6'@NI\T3`I[(;^928L#=.:@B=(#-/\B%M(CZA8
M'VH^1#:G:$*.L>"+%GD?W5(N,ZTZ#@9]LI%F,>1;1\C5!Q&%RJ,T>9#FO6<[
M810X#SNV+2>]*IJ"4E6'XF)4-0DT%K*:PT82='W2(5W1Y.)96TU>=Y[+ZZ2A
M$EN\K^-V2C\%?ECW@%;_/=J/*24%]:!<:"75%_U29K[HS%2<B/8KUHW//OQ$
MU\[2I54:4?T-:@VJ18F9>0Z4/`FHIG97%*5Z?9\V6?K)(R#C7DW1WPW\F+UR
M5]9*)KLJ2O0&L\U^&MTNIK//PXOY8C:\7#3NJW7?(C=2"0FXG3,&3A+H?9I[
M*>OYG5%)_-UMA5>.NX.24'.ZW`6.0L..A@'HS5!.#,J5O5I1T0W2CO&0,$74
MNQ=BN2R*FZ/JS+1?:*XM)^!ACS?4@OKGO&^.-+],911J\=$@"Z,_U\/QC'P:
M3NY'Y&8TG-_/1B(SI(_I9QHBR2Y/VE/5X9F]@K2QM]U%&BU@]&#@S_9M2#Z$
MAAIN/'$POAH[3]0PUQ>K0PFG=,]IKZB(>([2X\BE[[ILRZ0V-.46KJ+YWE54
M&>VA#0,7"]*69%2D2/E5C2P3M*([NZAO(T+0LKY"<P$EAV1<6@'E0`+H/,BD
MK1!S(2@XC>^T5TPN8GWL):3'5?MY]=F:G5-QL(F>,AI$HD+]\K5VXP8,_8F"
M:B>1BLXSVO/6:07_E1--ZAVOF0],5.<O(,/F+,0=R46*3M_TILQN1:'\2N%V
MF+PBBA6D(?*U"2RE[_!)+'6H\>'#?@*ZM^D+M<R7<EJ:!=_I2O'DA.PX<NT'
M5W'=\V0EJU\[ZH>86$VD!.%>RJ&)QT.4Z%#O]B45`52L.(I3TIUF_40]IN/N
MT+.']L;QX+'2`B]:<PJ5;!1:OQ3)PJA8C(('^U@Y)+U=N!2E4M0[K=GJL(1$
M,=)H'(8[:M>H7-W7^#(1S62@"D.(\#,.>Y#$GSD<?-]42R*%4G4`E=DX9I)?
MC195?'B`I#YSAZG:E+Z^Z4^]$.29?,?KI0/MW3-Q.?L.8E=TY2R=^L8ZTH$&
MNNRH$H?1L@0+H3V+P=(70[E-CMXD=;E:,2+`P[BHB'JO^<C`*E6%%)=N'$,D
M_\EA_E??=*>:Y?)Z5"_H`^?/,:3L7#;V;/KE+[2X9=5_9R)CKAJUB50Y`9EP
MT(3![HM62)FO2(YK$CRRV/*$/E'W7<4;4O:O^*+*>33X`PF'1]X9K9VL3V/;
M,/6$?!+)VD1T_1A3(8A2O>0JI6BOA4S%:;`-G)"F]7=G;"6$OH>+-85>83"D
M0D$5!Z)T5X\XY+(58R("%6&X"$?&\PHAX/(%6L$!0E-J;YX]F4488[-KP]`3
M5=9FVN@I(F5IY[@V.V?>6%^<S6XS<595^8Q57^&2E>K1HORO,5BR$7")RP`;
M2U/"T:P22IV0O0LIM`@%ZB'RT?6]QQ/7>:+V@&S7+Z$#C1Y%\UKXU":.B+#V
MH,RJ2YAJVCL1,_FP"]EE`L*P/1OV$NA^2]FY0"0?,X8ME[XAHR_69NN"D\=;
MNCN;$D880_40,QP.&&'+-0,4E+I8PS]%%3"0(:]@L4K"_?/?QL`9/(`<<6I<
M9^-`]$'D#]C(?-K#H`!H%6<.")Q0;V\70?&Q%#[\.O17T;,5],?Q+E&<7%:7
MS,B01[>DQ7:VNW;=0:[R6_RQKHD$_"$OUVE]I)(^TSD#:ATS]!DYRKFO21BE
M4Z!<HU`]BL1>6:'.^[]A>Q+E46##$.3Q!P<G3V5'8GH0^JX#N3LVV?+8`Z9H
M!&(HT@.8J$4\(!Z-1(-U?E"+H#'&8+_JBT^A7`N4/HU$=B&/0HO\>/=B`]G-
MU1=5!&&G8EQ'O5K*2W(NM#FJ4C4S747Y>\7TV:/VQ<LEVXNM._:+C?6S+[9H
MAGBZ^IFZV]#W;J@-)X3A9GOAL.OC<NWYKO_X<NE/HN(SU:&P&.M.:IAMC-7F
M^WCR9S'B`V50CX'31@1Q)*$.[BSP;4P@B2DD?V#'K1])CDIRZ;\9$$;I(1J>
M'D&(>DU1T<)L*="NEX\#3DI=K]6#6#2FM!:[RL91C&<-Z4?5WR&+8C6@1FWG
MT\5H3NZ&GX<7DWYUF&ED.5^(22KN#H-[?-]^=ER(_!@S+?8>'>C8S:^[^T0*
M2<*C'@Q\X$\;DG'9M8OA[4]CIG!D.)^/^I=1TTHBI1"@]K/8G;J*#-7I:O1E
MN68D4O#63;WJ1A0UVJH%`JVL;0@VD\*;8.0>7+;-P\^\/@!@[9L&MQ%348';
M3VR'^AM'&K!3`S\L\(SDVH"VNJ_Q6ME,!D8!8U"]4[!FCDNZI"+Y3C.3Q.M$
M'(]Y03VZJHT]JOO:1.Y1$QFH/39U9)`'`96\BF-L>Y,VKBB&B@PC^71TF2A`
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M",Z#G:FLG&+HBZJH2J"F@+)D+MJK1V5EYO0%;^S=L`-$S;:N/!2E-KH$8E0H
M7X\[R07+/A(['MG$"$WM[8=@4+:[&V.T:Q/2%5;6G-KI:WO3$G6WT^"T&\=K
MB(AN^!AE/G(B,`93+"U.-@*^T3AI,RPHA4O'U%>$2Y/?PJ6_UG!IN?YD5PE5
M0^RR0(3'EJT=;TL^]MA)X)%-0V.G@J81!@I%2,G!%8O8@P?#VL8(^J)1&F(H
M5XM0G);V>T[\AE=\VJO8<.J^1.TV$O0&WESWAY4M6WVX4\+4/F.`>+WV!EX:
MMIT4D<M'0!/KR7+<)*29LCT@"6PLM/1BH^)_[SR(IQ9MJ7B0M+T+DECI(.W:
MF8#W["+@0$"(UE9$GOV=:Y.U]43)`Z5>#BS;_7:;!#`\-?'DTI*W*(8G0KLM
MU]W77-_Z;".,'+Y=5HY09*)7.XU$@[+;C)+Y=;?'_$*=QS6C9_A$`^N1)KZP
M['/;A<4./C4;CO)P].ZC2R@J^P\`D><8XXDE4!85=J^G?5'%MK(J[E?M9A7A
MJO*>V)K@!R_29@)U7^(<5,WH<;ZII'=)']L$2!C/N:14!'^\4+,[WW66+[(&
M`+)1QD//:LC"KTVP@R<'HU'V8)247).=C_H0IE8C'5FX6N.L=5J3E.<AWK'I
MB;+)B)*`<ODX$]5)U4A#Q1_-IG>CV>(S&=Y>D=%?[\=WT)"A;SJG+(J*8J4Z
MT]2IWH&7*6Y%^Z+>_D1AH`G-4R0.J7I7]Y<+,AM=#B<3T_U-S/+0V-0DST@/
M;4=1$!7&HZ5JB*XE]A-OJW#M!\F;?3A=5>6(5Z1^5!PP<?!PW4Q,L((QJX0`
M?FE/XCVX:WF;K2.0]_PZQ8@M8SU.NA*'M-])(I:MY=CD<,+I^O1O1,"Y7BCF
M;*>[[?261I`^P]_9;8CWN0\I(P[N.R&XFX80/*C2&;$%(/1VVYYXE*>>H237
MKO_,5@JF321%1_;X>M=0L;VHBIL;=J([#5C?EWS=!G3I\#6._>Q2^`$JHF="
M:6N/O#4:;PR\B5!XHXRB=M%,H+*=(0:R$ZNWBKZ9BFEI5@3@'T!OCI5DQ!OU
MU5ZYRE\:3BO*H3>33Q2*?*)O3M^<GIZQ4T]`G@#)C^3#X/3T%/Z7^,"M7;3V
M`^<?U/Z1>'X^`PE>='KL(V^08G,F4L4L=AD-S"9G0X/DJ-6<?E3WM8'XWT8R
MS%Q"X&BQC!'UYN"L*(%RR*_"3!RJVO95?,&Y9M=PRX7"G]?L-\7;;].7J(K;
M$O2HV(`8-!&P"0`G''I?]$5!`-FZVTH3T-Y;PA>P.*'A)W#-E/)BZ[Y">38:
MT&)F?RYB(`1<\B@`FW(_(&F6.16T:>_:.]#`?_;.+]45A+(NII=_^7DZN1K-
MYO"^L/B<;L29]COL0!B[&9O>C=O#PBD^E@4S![IL'R;"L)$$7:\4#BNKG%J:
MF6]4-^WDCI.]RQ2]7O/KJ^%P"PE.U(ZKIEW[`0RL::^-!8KMMVV(*5,7[%PF
M<"EYF``E)"$E+?27$&.P&W>'8E%HSWUX\73NJS8FXD+S;J/VA"C0"KZ-FR38
M/^ODJ$D;D0S`E4U5(@:U-0&&VNP&HTDDYIB15B+%,=5Y"5$EP>2J@6KH',(4
MXKB2X>U5&E72<+)K_!QG!@J$F`^@(?]\9R2:P20'LAB&'L<!J8HAI^?**H4Z
M'T(V@.,]\G`VAX;)?QMT76$0]GRG2!3R_!9C(0EX\BKYJ5?QL>KR*)PJM&;I
M>&6&U&/'5$8:+S)TH.BQ4L5;TP%DAOEH7'U[7[Y70QBR&D=&PLA,65(<#J]C
M0@U##-B.G"`CB0QOS%N+&<HE9I*0WS_[D+-?-@Q55>JTBFM`K9!>4?'?L3?=
MTL"";?#2VCJ1Y4KBIS0`F*CUJDDL*EXJ+D_M>(GC!6Z&KF,].&X_@Z7TY5-1
M%[;5;':[A(?1)BW$-([;!#4LWY6?&UFZFPA!+=LQ+(4N4<=:_)I8KUKXY)-P
MK$B@.RN8!KR=MLV#1&J2\#4'&XX7DA%IYL4I+DD,L4-^0$*.3D01]4T%]:33
M'!JD-H<(IX'K^L\0/W+M!U?^[B%:[=RDFNW4FT(YF!E=4N>)YVA6.1#T`."<
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M'9K)P$7?)J!YMML)VQN6`GK?-%0BA%+.@<ID=)J9$^RH/=G[`*2-)&J^-Y$[
MTTP*\JT'@).XVTWOUCDI\Q6Y*RH3T9TFE2F1;-T-`]"Z)"<&Y4>+:X)/>NPY
MDTN@J%&J\V&F^_/4HVDN@CBO4IN=86_\@"[6EC>WJB^.VB",]6W6(1CEN\CU
M$88+49)[DEP@X^*M&X89KCP>@2*NQBZ0A^19KX>R&=X[#_)H*;^Z=L?Z6M[>
M0),@Y'ED!=$,'@M&7Q@I3DCO`J>D,2HC4.:G2`[&VA(4X!H,(A+P7IXTQD*V
M@,:481GD1E2>Y(#J'AJ_3L9D"X0"5[UY6-403=;VM2RJO:G/1I/A8G1U-YPM
M/B]FP]OY\'(QGM[.;ZBX`U],KQH"P'1&HY:`%F1BEH,8'>'X2!8A$1C)=$48
MSC[I6`L19?6M]50BSH$5E5AN:650;<V7N%-=,WK<PU.FKD(*G/>.,W8^PU,O
M+1)=2,](_>IKZO*V6^S<187?'@YC.[;TQ@T(MJ+>%J\R$9!PM]VZ+W"4>_1]
M6T0;A#1X8LM8.(@;$#`J7'#3<T\D^RW[)2_5;$,K!%`[4:QY%VQ]*'/$*T97
MN?FWH@H*H<Q:_(VS3!O<YH^+R0/#CU7M_+)5,GYKBG#H<W*S'N>.PRJK@)G7
MS.E#R&@/V>E[26?6\PW3B\"Q7-D;9NTP8R^7,L+,O5?Z&4SDA)VQGIFBQ]@.
M\4II@C/IVZ01#H_Y/"B34MVCH)IF'B%@M<&ZFK\U%Z)JVHYF?50D):YK`SMQ
M*E-793WN-TA#7L2[+F"Y^5MDI74)"2;<PQR\J173",7R@]^#N[.R#\)P=$E;
M_T%&+A&$".9Z=:"02BA?1EY)K]!Y54ES;WDIRJH3AC8,$UE7^B0;2,)*^[JK
MEC4UF#-_.*854N0%\_O8*!*'*K'S/\1$D0?+^Y4&?[#8]>?'$&XKS`)XY:8^
MF5YK(5:DJ[75]DZSUWBP+SS@UYY<,I^8R$<K(41M4%`WE1<1!F-S8NA]4:@F
MKBLRLVKD?,R$DV*1M5HED0X\0())'7&X:)W*6GF].1[H2T.>1M(\5UTV9]QL
M`[JF7N@\47&LN:71=,7.-C5ZUS3"0'-&*3FHI2L+/FE:U\^<$@5)E/LS*LY,
MI^J55*D289'3?2G5>OVJ'V)"P:0$(34LK5$V^`IZK*G(HT+/%&>HTTC$[/&/
MA]Q*8Q%K1YB(1I21@]$R#B^Y\_3F+*_!?$4\HMID=*=15W%*%%L]1=X^%,QO
MU*BF$6B-4B`'HU$)>!)97WK6Y$-#`D6U4IZ10]4L%OE)UX[+U-F*Z*,?O!3F
MN.XK5*WB!K08)8FSK3A<D@#NBYI(^,Z6)Y;*&]'`.O;9@*>!8QE[*TA"XPT!
MZB-BE(;A6EMK$(9:2)):UCR&02A,!E5?M$57)+G>Q\J3E>5VPGYBOTM^Q?[?
M`[L)LM_\7U!+`P04````"`!]A*Y"T./)I$4?``#@"@(`%0`<`&-P:&DM,C`Q
M,S`S,S%?<')E+GAM;%54"0`#+J"242Z@DE%U>`L``00E#@``!#D!``#M75MS
MX[BQ?DZJ\A]\-@_SY/%X)Y?=K>Q)T1(UHUI9U)'DF<S3%DU"%LY0A`*2ON37
M!R`IB:0`$)1(`9"=AXS7;H#=WX=+HP$T_O'/YU5P\0AP!%'XZ[OK]Q_>78#0
M0SX,'WY]!R-T^=-/?_WY\OK=/__W3W_\Q_]<7EZ,`>H%+DZBB\L+.(`!N)@E
M,`:;.B[^\O['C]?7%Q>7E[1$`,/OO]#_NW<C<$&^%4:__K",X_4O5U=/3T_O
MG^]Q\![AAZL?/WSX>+41_.%/?_S#'U+A7YXC6"KP]'$C?GWUK]O1S%N"E7L)
MPRAV0R\O&,%?HO3W(^2Y,36L_I,77`GZ7Y<;L4OZJ\OK'R\_7K]_COR"H@L8
ME#[C+6'HKI<N7KE+%%`\H_<>6I$ZKS]^^/CQNE"45MX0E;TB.2[7/__\\U7Z
MUZ(TJ<Z/M^+%VO]ZE?VQ(@T%ZFRQ)OS^(2,8HP!,P>*"_GLW'3;"X8H6NH(^
M_KV/O&0%PGCSKQ7Z=AC#^&48+A`I3IG\X2(U[I?X90U^_2&"JW4`-K];8K#X
M]0=OO827F\HI1W^6KOMJ9]$:@XB(I;\?D5^4/@N>8Q#ZP-]\F%K0I<U4K5RO
M`'E%5=X%M(4C_*X(P;M]"$CC_%WT">L^BK'KQ9MZ`O<>!+^^DRYVU53%8E.,
M@/?^`3U>^0!2A*[I#U3]Z\L/UWD_^S/YU>_9YZ?@`=*OAO'878&*PERQHH)%
M;BU<5M;%WJ9*\F-*[#MN3\@EKM8N)O5=$M8#?U-Z@=&J`8`;)9#`AHLD(MJ@
M-2WH!N\N$/8!SL;LD^"_,61.JF7@7OJS87B736/C_..I<9X`#!&QP>^[L0CP
MLIRAR%>,95/P\5046$0EGZHU"-P'!O3EOQL&><4X-M1_.174F=H]H@YV@R&9
M5I]_`R_<8;TJ9QCT'&/9%/SU5!3T$DP-'<#(<X-OP,7\,8<K:A@1?)/97/SM
MQ-T!K58HG,7(^SXC;B2(G"2F7C=U)?E]0U3(,'YD8&`S]??3,D57P+A'6LX#
MPOQAJRQE)!<50]G@_W3B;I+UXBE8(QR3-C$C."81OX.PQ8VD@V<ZFY>?3\O+
M%Q0D!$2<-1H^(54Y(YG8,Y:S3/MP6@Z^@B#X+41/X0RX$0J!/XRB!&`N%SQY
M(SGA&L_AYN1KZ)WC,2"_8?40GJ1A?'`-YC!Q\E5VIEBV_)3CHBAK-!LEHSE\
MG&S)G=DP2>X#Z`T"Y%9CD6P9P_!G&,G!?;O^_L?5GG$C\HNV@^\]9]RWQS.[
M3WZ8.:-AWYK;_1MK9(U[]NRS;<]GAX;>)6I6$'B7T.J85K]PH_NT0271Y8/K
MKK.F#X(XVORFV@?R7_].'3F0QB+=^Z"Z!.<('=5!6U"5$`6&Y,?JV"D05-1Q
MQ2C3;BHRKJ,`_.$,6%$$XHBS>\,1T@7YO4931+]JF*;(YZLP*0*JLHIY8#>=
M?0[V3-2.BIX;+3G(IW_2`FA.2RGBG=FA);SVOQ/XZ`;$@,B*>R[&+V1J_>(&
M"6^"JBED$B4BVSO:*3R<K"GP`-&6S&G1&,2YA1R.V+*F4,.QM*.-P\,9<>(E
MP$UH$10PA1N1S2UN-[+/N5C^(SV>%,W1+%FO`[@?@.1)Z0XOU[J.]@\/;_3#
M\)'8@/`+89[3S$LBNB//MJNCK<+#8>^#!2`V^'/W.3.I=K`1E3"%%*'5'6T2
MMK1PD%DP&,-#Q;(6=PC%`_T`X4F"O:4;@<A9#`DZX0,DTTZFCV#LKRFH!>YU
M\T"=\=IYJ!.,U@#'+Y/`S6*GQ+U>TW@`?ZH0%M&6)3F#M?-7JTV(:&D_>T%"
M@ZF?$/*?8!!PIW2)HMKS)0=`1Z?FCIU7A!.*_MB+1RV%#NT(NO<P@#$$$>G"
MZ8DDNL%`O&_:G>.7F@B@='$C@K/R8&@W^Q14EXO="@HHYJIID^0PJ']\U_(\
ME(1Q-'%?:#1ACET?U/C/@A+ZL";C4HM,UY$HG`!_WT0^31QYTTCBF:W=^$?6
MR&#3FL3DL"2-HH5IJG;N=J6'IY'31H-;J811!`E-U\Z_[B51C%8`;Q;>8I)X
MTD81Q#59._>\GX`YFH*`>*_^Q,7U4X^@@%$4B0S7+CP]1K'DY,.2-(H7IJG:
MQ:*E/373731YW^SH&RRM[-X4]!VCT)/=PF$7TX>IQNO4>DBT\[`+>M9W)I.Y
M*1FJG5_=.$2G;U#N&)*:!^<4NM@3G'?W5&O1\3*6I/+0:1->F*9J%]`IW+\5
M'O:KBAE%Q;Z1VLTIEN_#3)N)"_UAV'/7,'9YVW`\::-8X9JLW4PS!;$+0^#;
M+@[IA1/+\Y)5DJ[(B/L"/<@_?UE;T"C*9(#0;LXI*)D%H-"*`+T$800?P3#T
MT`J,4$0W@9T%\4+Y,;E&M1C%:V.(M`L/[=LK[02:117+4.W"0'7^[(%[Z*J9
M:FDMQ8&DID^=[I8H^[+DQ)K:X_EG>S[L6:-CKHI*5:_FOJB4:KH,<.-D=0^P
ML\CRYDQ<G/JVI'&E0W@?1EZ`HH3\J?&RN'G-JJ^G'GB35HO1_F`>F7=9<R2T
M6VB^W216S8`5!.B)[O(-$.ZCY#Y>),%F@W9WDZ=F9[I1';KPMM?D2KYO,UA:
MI)5SYEV@CQ-6[UU5>#J@`JU).@00_6([Q54R@=B#*<#DYP"D2(>^M:(YOOZ3
M_IY[FKQ^97I<]5JWA/;!U"[,-(`AC,&(++G]Z@GU@M5%ZS@MXH"*C.#^$("T
M"T>5]P6(N^?@U'H_=?LF`*=^H-2N"+>P$6S*`J%=K*FL>.:V6TF\1!C^!_A2
MS.T5,I"Q?<.UBT.Q%$[S!#9A*2]@+$,;@[4[F\12EI\%6;:4L3Q)9#Y6>'2I
ML(?:<,Z2*6D$:5(0=)2=MQ7B)*<J40G3B)*=I([/W=LB0\(IBB=M)C/BR>GX
MK+TMLE(_->F8GO](?B0FI5U"7Y6)3&=S\O^W]G@^<P;.Q)Y:\R'YJS4F0K>3
MJ?V9%!A^L8=C\I_V7>@F/EE)^JTF/#U,`UT2HQZFO9G;/F_;'J]HVV,*'D&8
M<(]J;_^L"]K"\7EGC'8X]U`4.XM<0>X$690Q`O&*6=IM+FSSE7W%9$3NHR=>
M4)@A:`0!+`.U"]U_PBB*)A@MN$=!BQ)&X%XR2;LHNK,&V*6OXMC/:Q!&M8=<
M^/)&D"$P5[OP^`P$P4Y3GKM3%E),0FUK*GD]%?NTFXD_@9"8$]"=4'\%P_2!
MV1@^`C$C=:5,HJ@6`>VF<3+0/D+ZNCKCD`,W$"XH8A);8MNUF^OW;).=<HPB
MA6&EOD[`[HI"'1<%2;,F_J*)VNVSIH>P,@WI&1M)ETQ<R`QZ:@S7;L^5KJ:B
MF-J5:3T,8T#`%:7P9HJK'LJD&EQU&<DV7#O_;:.:V%^K2AG(2,5,[9RRU*:Z
M6;XD8QP)%1.U<[9VT]Z`6-I#(9D+$S(=YO,B"J,;L$`XOZ28)H2SGXFU1',8
MNO@E';EI-A%2DH`8I#-IS9#7W1>-F-,ZA5R[<RU;*_).<$.6COPH'D_:(&(9
MIFIW9B4+.PK\^8*`$=`7#=+O``KOSC=9CP/X$&9W7[R7.7;#B,PCV2G[]+^"
M#&K__Y/,M]K<$,_>G26U8.!&H`^R?T53Z"D^;T13.1T96IZYJ9I=DY9!5,((
MNH4F=_6"]N$,;3)_;`X\WK@1]$@#[,,@H7<OQ$M^V=)&,"<-15?O;K?,8A/.
M5#/4L!G6TJ9A%*"J9VZ:)$L;Z?/A:6M_39A`ET.(/6OV>3!ROLZZ/VW(^)2.
MQPH9:KZ='Y15=6\J>CL_>!H&Z%.#;K1,-RE)1[EYN8OH]=/MQHQ%?/#'+*^/
MV/DYH")=&!3Z08<`I"/+M9N(91G%W!S>+"O<U6\L*J2E>,6_<K.?0Y*HQ%E0
M)H2DQ2T4=G:2]&H(\>*`3Q>N9-7*XD(@:#0%(@"TVSDYLQ-%[72>0XX:*3S@
MLDF.WVR3HJ[463!9"TV+YV+90^'V8+IS'Q'+(P^$'EE81@`_5M<4M>)&4U(/
MAG8'EJK!\(*M>1KJ&F>^005&<WL(8!H>>JHJOY_@39IG1E'%##=OS&)F6>!H
MMS)@&"U.C=>@X)GQV6F*//;<V%NZX0.(2%O*'Y:;HUFR7@<08%;*0J&XD6S4
M@Z#=@F'?T,VDSG_H2%S&2.8DX=!NK<`?QXM/"S>>YDJ%SXQ0-D#:7:AC*EYY
MC[@)K]6BY\?J'C@&+$!RM8MO&C<EM53V/%DMPV/`2B-UOBH#33//M%KXS(AE
M`Z3C.>&*XM6WDZ59W2MX9HSN`Z/=`6/YH,C1F[FJV6UMHU`:,.WZ+D?Y[$I8
M"UOXHHI,WL(7`M1Y#"'=F]Y=VKMQP^\`S\A,`=8Q:\"5*Z-G;Y1HBINH@@0L
MW;]1D8_L`X0G"?:69-B/G,4FUWXQS3[YN9JJG4';<?493^F1<&IW;Y)X<539
M:(XLCVB.0=,G+1I48#3YAP"F7=Q0'H*C9]7S8+L)8-J%&3G*#V!(AK`CV&95
M8++OQ`1$N[YK+Q;`BYV%_>REFQ538K$34GO(H$/_H0//HQL`_J&A1E48P6@S
M4+3KH6Q%&]W(;%2%$9PV`T6[+0"V^A89>3!^(8-,_JQ]`S*K90UF<0\&?K3_
M8KUY>&.4@<15/=,[;1]$-QRG\F=+_^_79]0`B#&"G8&#FH`=^DH;0'IN((7'
M#:CQ@P`]#<,%PJN,HYH7?B5+&]$$I*'0+@RYR8(R<2'O&F=)1#4=S=H<*[53
M9JF.9\<VF6NHAL2#Y^_=5`5-)F7?:NU"1QN;:/X@\N-N31SZC!75[G'LFA'P
MZ&I5TRX].QX'7HL;=9S(<7FCMS[BR8H6-ZY#,7MM->IMO+@YB-UO">P_F8V"
M@*RC@?\5QDNIW9OF=9PIL0U`['P;;GNS8]/&Y/F4+GIF-,I#5A,0/%$NBYU%
M-]9L.',&DZD]L\?S]`VH0[-6B"M5D)]"K)"BS&OXP0WSV[L]%$8H@/[F9N^D
M@(NSR!NB&VQ=@=K\RJW4K2HEW3'*[YB>D_9S0]3\W@5&K,^H3@#;9GLJ9:5K
MG0^^1](P0D.6FA$H1&=./FA.ID[_KC>?VCUK-#I^N"Q7IW2@+*O2CC]1JI,S
MA/'EU%VF]Q,O_NIB[(;QB_P`(U%0T9!1RT7EWGRM_>?3H8?C+\0O<*;?CN_,
MNZJ4=N2=&NJ>'4@]8NF(C:B$ZJ?VY+N_L(CR8]^UG##?X3OSSD_&Q(D]G7^S
MQGW[_^Z&$YJ\KI5)?;]6U7/[OD;*9E?V:;>:,:*^G#IW@:U8(\=!O@K%(XDT
M?Q67H@%&YS.^#,=S:_QI>#.RK=G,GL_:\#$J-2IV-2K:J.F"GQ#RGV`0,$Y,
M2_L@S>I0MZO,T:S>.:DOJ7AD.8C%RDYT/3KG,[A8_2_6N&?/!LYT<C?M?;9F
M]LP9M#_D2'Y'Z4`DJ6.7-V*JK4\0[FA80:<7>:I?Y0TDA]2@,-IQ&$?B2SH"
MJ,YG5)G:(YK+>V*1Y<)\:HUG5H_NF;0PCG!K5CIR<+52,\-/0>#&P)^XQ%LN
M//M2M_]36TR1P\+32]YQ:5*#8@=&EKNBS]((H/,99<;.W)Y-K&\6F9N/'UE*
MM2D=34J:M'0U&L7;+"C7`J>"+=?6_>Q"Y2(/@2VGT`\0HK>]9LVVKN8<E8)H
M0L^YM>?6O^Q6`@F[RA3'$':**#XBW&##@E]"]3GG)C$!01'E&Q:UG##/.Y_Y
MO#FPAM,OUNC.OB5+VKMI]MK.\8,!NUJEPP);)35]:^!"G-XVVJE7YY`+BR@:
M(K8ZW0*7*I0E%5DG3>*(S>I0/(C(\%8<11H"=#[#RFSN]'[[[(SZ]G1&-PCG
M+9R&8-2I=$!AZ*/H'OZ_$QB_U+V>6192]B(9:>@48=)`,XVHJRP_6LB75_UV
M(9.3\OMETE"<S[C0<\;SX?B3/>X-VUASE*M3.AJ456DI$3I:K6"<IV[JH9!>
M*P"AQT\U)UE(W0/-N691537Y$:!A)0HC!?+L59YT;@22;C$%T@]ZQ+.>6BT%
M^2OUJ>[C15T41<!A])TVC;O0`SAV82B1>E)<1MEP0+0)8YP22#5L,@A(%%4=
MO)?AJ=SS9?`X'U\@OZ](9"<H@'2`V_S;PA$#?MUJCQ7P]6KU)BWC`Z+C`_6%
M5"6,<V."FK/(4P6CD)L8;E]0Y6$!:19*R>`8QFJ7_J)T?RNUZD5BM.87,8XE
M,0#:Y<2X<2,8.8N=K1R2]N6,8X9AJG8Y$^\BTL'M*(8K-^9FN:P(&4=$U4CM
MLAS:+@[I?#T!>$8F<"`WCM65,HZG6AAJ4AGJD&%@GKY*UTF>@;QJW;(-Y&JU
MXR_F8V;Q%G96O\!=K"^C*KKL+8&?!'3PJ;1LJK)'%F-]&"0Q?0A(<.SDV-H4
M#@/2;)8"T8>BUGE:H`DB/2J&;D"#8BA,=8J^`@S&*!Z&7I#X-%GR?`GH:^K)
M)H=`KFW5&"'G77_-E#;1.>HU_K&ZV]IMS2/5"O6XN=WJG+&]S%L[4_`DE<\/
M6\5Z"::=I^&$4%-<86^OX88][M>AH=L>`^OV<5O]5U"W=C>N6^W5K-1_M1U<
MHI!NMZ@/OCNM1?^69TGJNO0IO;F[""R28`0?Z=4GXC[D=Y[JW#*I8L8P(@^$
M?IY2^>YC>PX3LUZMKJ&W[#Y5;OW5>U'"`JVEZBQ_Y1;XT'.#`<*K)'#SCXHZ
M:L,*E#I),@SL$G(V`T8W;ZEP'Z*]/ENM4I<;'RWWU&W2<XE.RI-MK7^6/R#N
MBCQ9I;VN!LU=A^-:VGW(B;[$%9'J2?=N@KA<.1/0ET1`-_>$>;VCK?%.5+E^
MEUI:'0-95QCJ1T.94FUEH4@GY>T'TZ_8PJ03X@(*^V@#K+>))6JLU\,98>QB
M]4'LPN#@OBFH44&'%&C33B,O9E`F"\W="2%!'ZPOH^P22)[;.6W:W)L>)2&%
MO5(:^_+MCK*-VIWCXC\*PR-B)ZC+>S:E]L-$OV!<]ZXCP/3\KOL`G$6Z]^4\
MA?1)UQX=1B;I,/(Y'T:(7^4LG#!\V3W&/H(K&(/JTU[MU:L+9WO-;>MWM@.?
M=C1_!L$Z0F$>-;!6ZQN(8N`M0Q2@AY<>&L5MD"[SE;-K`E+0=O[&3:IUIG3^
M`#M1.6N=N8(\?L6%S*"KQG`]WJAA^&>5LRV%<PN%8P_M.ZF-/JN')]M(Y99.
MI1VGA>CL6DLUJ_;:S'"=6^;QS<%^U0[V&,190)+1KW=_TP4[[K19,$.[1OL5
MP(<EZ9;6(UGD/H!QLKH'.'?&HF$4)62*IQV8TY2EBVM-4G,PM+OUDXZN\!',
M@)=@*'%#6%#`"*Y$!K=X"8@],.4O&[%>L=S^26L4RT:T>%V'$\U<LZYR%O^B
M/5I;$VJNR&@SA.?^5C9X.4D<Q6[H\Z\#-JU%:\(.AH9-[M_:ZPGI_%$],\^Y
M<K,OIS7H`O/8L/Z]/5@YEQ$8P/(DM8>6:R(;W)_41UPFSFA(DR.U'U2IUJQ'
MW*2J56>AD<V'FH4]]DJI7B<;&]+@X?\6KGC5X8J-0TV?;[>?`?9@!"88>JQI
MB"^K"[:UZP:&F9U#G'OA]--66(>Q0%A[D$6&=K[!-4>Q&VQH3D]`\)9O/$GM
M\>6:J,?^U?8>YY&^TUX]"CRE/1U:.AZ]J=:ZF<VG5F\N.JO-E54]^9KA`]5B
M_>;YO!+/IZVG)O+[QU/WZ9;HBZ$;\$A@R^K"@S#\Q#%37SH&,(31$OCT(<U:
M/LK"9A%2,52[[9RMHI\PBFJ9R(3,8B`WK/.M&BL(T!-]BG&`L',?$5LB#Y#_
M%(P\TL6T1ES>^,ZW?U)G>\O\&+!<M'T9[=%EF*5'_C16ZH@C%Q*B*A6L*43J
MM'3(D_$%45X,D;AJ/]>,188,XF_KC%>RSN">O%[!V%F,W-"_BU@QOZJ$+CAR
M)Y$]D[1KQC<)S,9B*_2'JS5&C]D]19%K*BZC-2F29G=_RX"F[KEUZ9P(<"G9
M#`MXF1):PRYE<N>KA5M$!+^`)?0"P(-Y7T9[8!EF:9>B>9#@$-)\^(3W`7RF
M/PF'&+Z\UG1(F*O="3.:`3_&2?JN^#"<8/1`E!62(RIA!#U"DSL_)9:N+%EY
MQG@+9Z:LUD#7F-GYB;$1H=/RO(2F=(J!WP<$(0^F^.0+20;6$H6T!UW&\)HC
M9=WDGF3'A7B2VN/,-9$-[L\:Q(BRW"(CN#CV'J1<Y9K$C?85ZS""M/U6TUC2
M?D'540V#HTI<%M[B2V_QI5TPYA:&<)6L:$.I#S45A75!5S;J5#+TY"B[SPU0
M+@@;AW+1T,[C1YOXE;@1LZ2TQY5I6N>QH>U7A>V5)64.H/4MM,5M87ZXCS<6
MB`MH#W.=P2T&?NK#F^)Q@2>I/<9<$SL/VI2^+!PC>))F@5L_5K08KG$6"^B!
M;7\1-UZ!L/80BPSM/"Q3_;BP%0N$C4.YOBV?.CZ3O4/`B,X=&I/A5Z@@#L-7
MILT<P<7Z1:]A\X55K^S-B+'4H_T65WG5<95BT["?UR"D=]FD=K=D2^J".W?&
MD8:@<S*L%<)QGMXXUZ3ZX@EKD)0HI3T)4J;K\=!!]46BV:!O6>OT&))?>9#F
MZ#N"C;^DY!9A8RW;NF<H_6'A#<3FM:B>_LQP/H[@Y\TK>=5>27J:I^=B_$+&
M'3(U)$P/A"6E"Y[<B8YI6O>>Q>Y827&FK4ZQ@A[*<CR.KU1[NMH`KO,-I3&(
M:SO+OHSVV#/,TB,'Q-0>67.[/[&F\V_SJ36>63V:?&AV"[(L=C=._TC/K\$7
M%'A\#;1KIX%+?%#@X34IK=J%,,.S.X"/-X_N57MT^8W<&!!$XGR!/P4>>@CA
M?X!/YLKY$DP`AHCU`DN#PKJ@SYW4F@#1.2L;/:9$:R>T_$=Z(ST:$),*/9FU
M9I8JIST7DN;K$7;BC;G.$RW4D;]1KEPC5Z.L6$M>!DC]_(F+XY<Y=L/(32^9
MY&TA_:#(RVA06O6T9HB7T9R/-R_C57L9EN^F8WC:..;H!KG87Z7-A16^X`OK
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M:CX,;V$00/9#"])%=4&>.S7*@W""C8E'XCM1;;</F%L#A`%\"&?)?01]Z.*7
M;+.DAU9KESYT+N#HJ.JTY^TXL#IW30M#L4V=XC6&]'!O<1:6FQ=K2^O/5!,H
M.K\VS5,A:RK?@(MI$08GD@6UIT,6@,[O6TLI\A?BO%J+F!G+;EC!>3!3`$2/
M[-Z%[CW!Z!%&Q]\-%%6I=GVUIT[KL\7V"W+3P[ZX:O?<N*42%_&WY=$K61ZU
ME)8TP3AU1_.Q.S_G=`-"L("\=^]K"NG"#'/.DC5<.Z;Z8`&(ROX`$$UHU+H)
M8Y*%C6!.%HC3//%8_3S_4&1%3FNL!>;I$5H?6,/I%VMT9]_:UNQN:M.4A#,K
MGH(UO?H1/O2)=7<1_>$XKZ[Q=Q2X>HUU;*?Y2W]6X!0VKT.UIV*&IW@P-V_N
MXRMQ'SGY^=SP.\`TMS58QW3+-3V)P^BX'$%=4.5.:CP#3W.MXIKG'5SKC]S&
M@.Z3;C(I&H%'P,1/**X]JF)C.P\LIZ1RH2W^57LD2Z9T'@<6\/9CLT;ZH_[0
MBHWM/./FCED6M,6_:H]DR93.LVD*>&-M%@G%M8=6;&SGR35WS+*@+?Y5>R1+
MIM3DRSS52QLX#_KTT&J%PEF,O.]6Z']U,7;#^-AS<Y*UJWAK0TZS=IKP;.[T
M?OOLC/KV=$;?>9A_J_F\8&%_>%VJUY)F+/"/YNIMH?^J%_IY(R%C$(BL)%XB
M3"^U,SHR1U`75+F3&,_`[E_FV/1#"7#YLMKC*S"S^RQ*27;GOS#295K,T23!
MWM*-P,W+9N#+KQ'06&?HV\\`>S!B#/'MU:L]=2W!UWEP8J,"L0C'4S=\`/GW
MP01#CT5@70GMJ:DUF1_8N%AO>N0H`X2K<*9MFKDD_4XJWS9I=N@WHHPM;PQA
M'',[CXULOO\5P(<E37WW"+`KC[JPF#'@BXWO/,S"4:.'PM3C3LABFOWZ@V1!
M4WG8`^`T09@A^2H,(^A]<8-$<!ZC)*4]QDS3]`C.I!Z$DVI!7V<Z,AC#J4U!
M\(6C25?!%B+RH?+)1@$647G5ZW93@RH2G+P%4EYU(*6RF$K74?5+RTQ,%T1E
M5XJY<4HPW:Q,_9N7K"_*HLPH:"3N+``ZC[04QK[H$_7QF&$LEI3V&#--T^-P
M:\\9]^SQ?&JE"11G;@!H.H1-`SAVMTNR=@4.EZ1F+47`Q1\3N%ZR)57/\68X
M70UY>'.W7K6[-0'8HT@\`&<Q1KTDBM$*8,OSZ*L#:5;F6X3!?.F&:4MB[;DT
MK$$7'K@366-(3DJ2$X)C69*JPBB:Y$#IW+LKJK0=<&E2;:+?+%FO`TB=T*G[
M=$N,P]`-ZIB2K,0HKF2!T=%US!M7-`4>@(]T(&_5=^17K]QYY*O6A?>X_S5I
M]U%05+738J+_6,_$FP/YYD#F0_M^8[EY*4S--9-=76E=\)>:Y6JAZ#[HAYS%
MYG,1RRNZ_O"!I2<K#'AH5=I3=CA(!S^-DO^%_M\]<8/(;_X+4$L#!!0````(
M`'V$KD+[M<$8'!$```JX```1`!P`8W!H:2TR,#$S,#,S,2YX<V155`D``RZ@
MDE$NH))1=7@+``$$)0X```0Y`0``[5U9<]LX$G[>K=K_@,W#>O9!EF4G,TDV
MGBGJ<*):6=1*<C)YFJ))R$(-!6IX^)A?OPU>(@40!"5+U&YQ'B:RT-WHQH>C
M&VA`GWYY7MGH$;L><>CU6>?\X@QA:CH6H0_79\1S6N_?O_O0ZIS]\O/?_OKI
M[ZT6&F.G9QMNX*$6(C?$QF@6$!\G,M#;\\NK3@>A5HMQ>.82KPP$E5#OHX7)
M]=G2]]<?V^WG>]<^][!Y_N`\MJ&@?7G1Z;0N.JVKSEE,OB!V2O[T]'1N+@DU
MUDO#71E+QV8:>N>FLV*<5Q=7C,_P?9?<!SZ^<=Q5'R^,P/:OSP+Z1V#89$&P
M!<;9>(6IGR/(%/N&^X#]L;'"WMHP<<7Z0[US/$]7YX[[`"07G?:OMZ-9V!R)
M@<\VH;^+R#L?/GQHAZ4)*4<9ME\L^JK-BN\-#Z>2H91(Z`GU?(.:.7K+SX,3
M$[]K1X4):>"U'@QCG=(N#.\^I(T+!$#28"76Q?+=MO^RQFV@P"XQ4P:'*O`X
MM)7P05?[RR>#4L<W?.B$[$_X>[TF=.&$?_SE$VNBCTD[3?$"A>W[D8FZ?N.1
MU=K&;^+OEBY>7+\QUTO22K#];>WB<U`N(7$=&]@*VY<5MX'%@ZX6:C3:5)R(
M,%R3D\+A#T*<-79]@KT4Y#?MUS')PHNJ)@$+H>14#;*-^ZH&`0NV3]$6T["K
MV@(L9F`?N+LQ&7.P`;$/=]-A3E[9#!GI22SWMS[Q3-OQ`A=/IOID,)U_U\;]
MP7_NAI/;P7@^-^YM[+U!Q+I^HTP=:1FKN>FH/U]<7%Q>7<!JM9$"?R2"$$A"
MJ2CT0R3LGY_:VV*RT@,/6SK].?R\/<ICSIBDB"L_D-1XMO`5,,5?)1@=%+?A
M>*Z-/P^[HX$VFPWF,Q%:'(T$HTZ'PVC#CB+^!I4R5,;Z?#";:-\U:#01(KER
M&1IO.31"5A3S-DB4(='3Q_/A^/-@W!L.A(,C3R##XCV'18ZWP4*,!312?S">
M#?KP8::/AGUM/NAWM9$V[@UF7P:Y.4N!5H+0Q25#:`8-&P87$4"1/)05B&*)
M*!+9`"<&3K3(][%O$#OC$\B()%!==;:A*O($8F&-*U"`TO;B/KOI:]H:',A'
M;-UBBX".+,H&-3T.O!UX99B^W<:4\QP0JP$E5:"X#I14TJ!=CO97&!7Z]+L`
MRZT2&5(7/%(Q]WF#017GNZ??#N;:KV+7(ELL<RS>"5QNQHE"U@:&<ACBSEL<
ML&Z3R*+42P$<,7<3EZIBHO6_AD[;C3Z=W$U[7[398*;?J$2KBIRR`<4CF`A%
M(!6E8I%^PZ]1YPVX%1SYV1S^SSPUP*BGS;[<C/1OLSMJ!!;QL57BV9<PRUS]
M'Q5=_4T5#&Q6"0IK03^D]32C>5?`F<>NS8=0"DX[K%B3Z>`+,`R_#J(%;)=^
MH"Y3UCTX5U2I>VSJ#J.07.W)FMST&Y5^TX,F36`T32>@OC?%)B:/;/WD?%=5
M!@GB[[B`,B\4)5+11FSCZJJOYS?:</I5&]W!8-%F=]-HS!3[6S)RF>_U([=R
M,TDH%(6RLIHC@BI;H)F!4+`'FJ60N58?1)N@&>8&CE+/.)J(@';BV,0DV$O^
M%7K#Q=2R<73!>\"I()1(0#\DGYI15`#;S'?,W_4UTV%B&Y1;N0K*)="\Y3:I
MH=8+%`I"D23$1#6+4QDVT\&(^7`3;3K_#M,/.`Z]<`JZQ:M[[.J+KM[G\*K`
M(]L_>[>-82P7A8)15C**1"-]@4!X@^HNIPZ:YV'?&Y$%[SJJD<NPY,9CP4E$
M)!4QL0V*92AVM=D0@CD(GV8,$#82..@D-+*E[:=MO$(Y+'S+2FH@VFD;6[:#
MNDTD`TF^I=TX[]7WMJ6[VM*]$-YEWYSV-`#L%/@JA[S26$HYV&U0$J,D;'+-
MG^*UX[)(IP^+Q)W'/FRO/94Y91X]=YI:M&>A^2BM`;$J4%A'LU;MX$Y,]-&0
MI5VIN!7;M+*5ZX.:>Y&(;+`KG4H=,V!-F?RK46M`?>*_#.G"`7:F7&8^5:&6
MK791_FK,G?UH4`M%HE!&5H/:+IGAJCGATN6/WZ,21UX-1`H0]>]Z\^F@IXU&
M!=AD"&3#AT]RC7E1Q-R`40:&8/T102(BDP'S$P>,<&%J\"G#9S;7>__^HH_Z
M@^F,S3%S86@EH)+-93PZ60'_,-:.]R\4R6D0*CPU%J=\3[0I].XO@_D0)J!\
MLK@2@VQ470E.C8ORQ%%>;H-CM6UY_8DQ*>_(Y\EE&[A<*I!D,SZ2VCCM.P1<
M7<,C)KCC?6('/K8&ADN9@`EV>\YJY=`9R.7WY_<5)`O5WJN%:F%]H?L?UXB2
M*M$:NRBJ%(6U-AUC+S^G>/>XF%@&,'\7L6"OO]E.EH(6);;V,5AMDE`5;IP6
MD\BF7F[YC*]Y9.4T8VKWV[RRXQ@AI6PT\7=)^?LYS4A2A:K(;Q&!54@K"RGX
MR_+%?DT#EQBN[#UK?J=86"J;[KBCY]QE[%ES=ZIB:O#,@+D&/,%)X)I+P\-\
M=*!(+SN=X3;TMQ*#0Z$(I*)4;(-C:9:.BQ?8=;$5N^PL>PV:\)OAN@;U>1P5
MZ64X\C>&$YFI"Q_FT#$D$[D-D.472M.TCHGK/!)/Y!S*B&3S)3?T<DD@J:@&
MI0HHW5&+>/'[:FGL#'U^2($5SXWG*32WZ*KWCA)D^'(!>`[?7#V;F)N-SZ@J
M!'6AL++_QQ[PJ9UY^0S^R#V+]HFL6!X`BA[F&SEF6")Y*H[]U4K>BVNQKUJ=
MR]95Y_S9L\X0%;Z45_#87+NJ`MOOP['J/[#J.S\J5<^]+[>'!@X=[ZM$YL&Z
MRHID7N)C"KPKJEKX=)]*;2&C\#&_-K9]+_FFM7G>KT@%Z8N`RJILOPW)/BA4
M+GU7,JH\?@(246+;+.B\/O/=@#V%R!Y-_+@&?!R+#:;K,RMP0\W.4/ALVUE$
MP:86^C"$N8=1G;&9[FQ![-]DF0/:/7`9IG^&C/A34BLSX?I,C=<+X"/Q`_;M
M9]<)UHE*!)11,^_>L-E8!-OP/?%%1D?#U<_;#%X.S)/N"V^U9CTR@=[<F07K
MM4VPZR5&"8M>TP83?+#7,<*VG2<F\\9Q^TYP[R\".[FWIU/=7V)W<WMO8U]%
MKJ/`)^ZSQ:8/Z2-4Y[@O21!B?2/^LFO0W['+;D3B=3AYIT:KTY^DN?P=SYYC
MV]CTR^S>@?$X77W7%I@8+ZP^Z+MI^*DO)M'[CR]L'OHC(&NFVG8+5&!\A1:H
M/A]OS[#;,U5>\2%X<O2!0+W1/0OEV38_QZD*W=?DZ&G<CSY^]KLV1)W%$[)<
MHWDBX%7MS$@][%H[=L!YCSMBIVQQ+2`^<.<L1RJK5Z;E>*75P:IG4AUCGRT+
MGL]J'=(=YL+8YG(YAT=E`@T/+IAA9PZ%O6_8Q8`(A(]V8&&(6.=+F/]7ZR"*
MK/0%?Z8<,LZ%V!ZTBEKF7,Z;B(YSRD9F(7FM1K!S^W!)V\3Y:N8H,)[4BBA:
MM"LJ''=H!4&''[EW'@8/?$0>V=($HR=>DZJ-C\@@-5''18M;;'=!JDS(X5':
MUF#KO<=(H:IX515Z;.3B#4Z\*VB%_,?`*U]Y=6@*^8^PF"=;_=`3]C5$4=9Q
MN]:-0=ROAAW@6VRPTWI6Z6Z=3$G2$<*7</RFRH0:#"I'*R5"JIJQM9W$3(!B
MDWFI?)=C!;[Q@/6%9L)B"(%[]T6G]&5(OV![[;'&B#N4`F6]CM!^.92E[M)K
MB3_-C98PFF'31"Z\B;XX38V3T^M$X<W?IZEO]&I-JF[ZYZ$C^VCXAWU1'#V8
MVT%:-D(0%-:J<$%<F1Y-%!4?9VH*8^/BKLKV7@?/,)$2#T]<8N+MOBL@J%7Q
MN),RM30JU%Q&4:OJ<\<W[*1=89+>&GZ%Q;6N8<)W>DH6)CG/*9["P:A<$5]?
MC`QJW7DXXV'DOSY)W4&>?VNPI!3LYK800$,O[5ZE9*=HVZWC.^Y7O"2FC7/6
M"`I.47_1Q@ZX,;)]G[#XE8>\4.MU(%K-],4"9LI4FUOCF:R"%7L\*YU?)13U
MZ9WM$`*E"XOKT[@;D#!W3*"ML*@^3;>F08'",HK36[[29^9V6L@$W*<S7`DM
M&ZY9BA,9KKS2A<4G,%QY;85%IS-<>85E%#7J7>BAY'0OH:KW_$[]AYE*S_9V
M$76*/E#HGO4@KGF!)M-6+`<FL5%8=(HV@%,FMD!0<%)'E`KOYE;<YZXD\9`;
MQ1JE@6$/J8\AVO99.KKJ[K:`\<@'6F5)_17/MY3%U6;F@+7VVB4>SM]6V-W2
M<HF'['Q%M<.4/%_B[]APV6401:M4A=5NT%M8;K4%$+ZF81FA->V#ASMOJ8:#
MYS6F"IL]F5T[GK>V@9:>LNX^L@0B#NLU3;$-O<*:&*[_,G<-ZD&=P!RO*$_Y
M*4SL+542<9HY])81IHB&RLZ=KF.XUBI4?Y-#6DQQ4DX'_P97R372BGUU#_FO
M$KX4;?!GTQ&UP%\Z+OD36XI&%3$?5..TW7946L)_4+W'0>1L9N".-)@[27IU
M]R5!7P]\)IJYZ!`M1@="3!?5K-K7J>MU%N^",\BD^AG,+>#1T@=<[>`K?^97
M*.4H-@RHM;<%!3*.HO\W3!Z6L!9IC]@U]C-#+NJ`6S$%"O0<&LZC$#XI;;9(
MK>&$U;/NQ@X<6]H\8H;Y3M5<OSSG,:>]D"J]1]9]43TQ%LYKA<+J]AW8SRQM
M_5S3WOZ"5.;1(=P#L`-KFVDC[S,;Q,J>@9#SL&%$R9LS92&$,OMQLHTDV9$T
M2GH<.[W`\R'P=..KA=B"P/K6<?%\:=#0@%RJ9!6V4[%1IW@G(]7X3L7*M)/=
MN,X*5$_N>^N+J?%T"X&M2PQ;:*<J9ZVG(LH_VE$V1'<0=)*Q?G0SS]O<S`MO
M*VZ2',6E_T.FC/`CMCMR@Q*:DS0K].WR5N2^.DFE)>U\J8#%Y8F:M6GX2QZ+
M4U5:TLY7"EB4'QW4C<45C\4K*_W:3ZS([]Y7NZE_HC?)0Z^[RP(X=O494R_F
MSOCD@M*3-*6W9!LXWI!*7LB1T]3J\[`@C?CQFT1LJP.H,&6_V5P:ARAPUFI:
M\4];EYFFPGE2)QFZ^V!0\F?TCA1+R<>1M*HG%@IRCFN8Y,?6*IJF).G8QZ'Q
MSV1JW1G$\SWURP?)66@A?_WO:^GWG@/!*T2`)JX4X_&/;A6+JF6=CO=3XR<M
M5/+@<_NP6;[Z]-_I(:>,'6+^>KK="'O,.0U8DJ&/+<&/#"A:IB+HR(]9A5Y<
M5I&J#U=)!-3C,&5UB?-0]NB,RM)J>H=NQ79\_LRJ5]E%CX%4D730G<!L)J*>
MNK)L0R^34ZG^D(>*K)J6L<T4D&WU[>:69#JK8OH*%=731''^`+M-T(V$]P-\
M1RWV%.:C8S_"]R-"L;[HA35.;[M7%]%_JI[H'A74E)Z7+NTY?P5[V'U4/:J5
MBZAQ*R6_N_@Z&XL*#XA8SLH@5#!"'QY<_`#C)G^L?:N6918//KF,`UNPE60P
MQ8P,.G4FVV".W17+/?4JF;6+X./:FDL/V<<VH:`#VS)V]$5TI%U)<Y[MX/<)
M-S_(JW!]4$1\V!M6RH>.8;/I3Y0E>_38+QI,PE\T^!+_HL&0FNP8E;VFDSPI
M.2(KHIX!\$IUG5)SQ,\*Q;Z"MEIWB>-C<TD=VWEXZ3DC_U"-HU1S/:YXD@85
M^IVQ!SW%IO-`62)HE.H_">57S*M2$5C/TBUTE<('1]B1CNI%JA(A!TSO$]X2
M2CO9D-Y"914RR=3%'="F[,NW<<T:]!58V>@,C"`6`2BCSL-./PPVV52T<[\J
MCKO!D<]FXE]?K[C=H2[N6/,UKP-[_"W-^MEA'BZ5>,#>R_R8I")/E+'4N;@0
M:5C!3=I-?$W;.\)#6-$&5/C[1[MM_.Q7!VN83^WH)UC@XW\!4$L!`AX#%```
M``@`?82N0M:SQ(VG:@``3`@&`!$`&````````0```*2!`````&-P:&DM,C`Q
M,S`S,S$N>&UL550%``,NH))1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`
M?82N0O5#1'IT!0``>CH``!4`&````````0```*2!\FH``&-P:&DM,C`Q,S`S
M,S%?8V%L+GAM;%54!0`#+J"2475X"P`!!"4.```$.0$``%!+`0(>`Q0````(
M`'V$KD(M?FW6`A@``!F8`0`5`!@```````$```"D@;5P``!C<&AI+3(P,3,P
M,S,Q7V1E9BYX;6Q55`4``RZ@DE%U>`L``00E#@``!#D!``!02P$"'@,4````
M"`!]A*Y"?]V5N,H_``!DW@(`%0`8```````!````I($&B0``8W!H:2TR,#$S
M,#,S,5]L86(N>&UL550%``,NH))1=7@+``$$)0X```0Y`0``4$L!`AX#%```
M``@`?82N0M#CR:1%'P``X`H"`!4`&````````0```*2!'\D``&-P:&DM,C`Q
M,S`S,S%?<')E+GAM;%54!0`#+J"2475X"P`!!"4.```$.0$``%!+`0(>`Q0`
M```(`'V$KD+[M<$8'!$```JX```1`!@```````$```"D@;/H``!C<&AI+3(P
M,3,P,S,Q+GAS9%54!0`#+J"2475X"P`!!"4.```$.0$``%!+!08`````!@`&
+`!H"```:^@``````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>INTANGIBLE ASSETS SFDA Approved Medical Formulas (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossCarryingAmount', window );">Gross carrying amount</a></td>
        <td class="nump">$ 5,387,075<span></span></td>
        <td class="nump">$ 5,357,580<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas', window );">Accumulated amortization Intangible assets SFDA Approved Medical Formulas</a></td>
        <td class="num">(3,097,224)<span></span></td>
        <td class="num">(2,944,726)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NetCarryingAmount', window );">Net carrying amount</a></td>
        <td class="nump">$ 2,289,851<span></span></td>
        <td class="nump">$ 2,412,854<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated amortization Intangible assets SFDA Approved Medical Formulas</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AccumulatedAmortizationIntangibleAssetsSFDAApprovedMedicalFormulas</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_GrossCarryingAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross carrying amount</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_GrossCarryingAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NetCarryingAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net carrying amount</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NetCarryingAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueMeasurementsTablesAbstract', window );"><strong>FAIR VALUE MEASUREMENTS (Tables)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AssetsFairValuesTablETextBlock', window );">Assets Fair Value</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The Company uses fair value to measure the value of the banker&#146;s acceptance notes it holds.&nbsp;&nbsp;The banker&#146;s acceptance notes are recorded at cost which approximates fair value.&nbsp;&nbsp;The Company held the following assets recorded at fair value as of March 31, 2013 and December 31, 2012:&nbsp;</p> <div align="center"> <table width="549" style="MARGIN:auto auto auto -0.75pt; WIDTH:411.55pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="243" colspan="5" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Fair Value Measurements at</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="243" colspan="5" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Reporting Date Using</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt"><b>Description</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right"><b>March 31, 2013</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Level 1</b></p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Level 2</b></p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Level 3</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Banker's acceptance notes</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,180,864</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,180,864</p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr> <tr style="HEIGHT:13.5pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Total</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,180,864</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,180,864</p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="243" colspan="5" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Fair Value Measurements at</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="243" colspan="5" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Reporting Date Using</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt"><b>Description</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right"><b>December 31, 2012</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Level 1</b></p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Level 2</b></p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Level 3</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Banker's acceptance notes</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101,570 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101,570 </p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr> <tr style="HEIGHT:13.5pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Total</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101,570 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101,570 </p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr></table></div> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>&nbsp;</b></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AssetsFairValuesTablETextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of assets vair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AssetsFairValuesTablETextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueMeasurementsTablesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueMeasurementsTablesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EHBAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONCENTRATIONS Sales And Purchases (Details)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfNoCustomerAccountedForMoreThanSales', window );">Percentage of no customer accounted for more than sales</a></td>
        <td class="nump">10.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfOneCustomerAccountedForMoreThanSales', window );">Percentage of one customer accounted for more than sales</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10.30%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials', window );">Percentage of purchases from one supplier of raw materials</a></td>
        <td class="nump">34.00%<span></span></td>
        <td class="nump">14.10%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfNoCustomerAccountedForMoreThanSales">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of no customer accounted for more than sales</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfNoCustomerAccountedForMoreThanSales</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfOneCustomerAccountedForMoreThanSales">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of one customer accounted for more than sales</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfOneCustomerAccountedForMoreThanSales</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of purchases from one supplier of raw materials</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfPurchasesFromOneSupplierOfRawMaterials</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EPH">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>INCOME TAXES Undistributed Earnings And Income Tax Rates (Details)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_UndistributedEarningsOfHelpsonInMillions', window );">Undistributed earnings of Helpson in millions</a></td>
        <td class="nump">110.5<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions', window );">Investment in Helpson, a foreign subsidiary for the company in millions</a></td>
        <td class="nump">23.3<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_EnterpriseIncomeTaxRatesForTheYear2013', window );">Enterprise Income Tax Rates for the year 2013</a></td>
        <td class="nump">15.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter', window );">Enterprise Income Tax Rates for the year 2014 and after</a></td>
        <td class="nump">25.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_EnterpriseIncomeTaxRatesForTheYear2013">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Enterprise Income Tax Rates for the year 2013</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_EnterpriseIncomeTaxRatesForTheYear2013</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Enterprise Income Tax Rates for the year 2014 and after</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_EnterpriseIncomeTaxRatesForTheYear2014AndAfter</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Investment in Helpson, a foreign subsidiary for the company in millions</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_InvestmentInHelpsonAForeignSubsidiaryForTheCompanyInMillions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_UndistributedEarningsOfHelpsonInMillions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Undistributed earnings of Helpson in millions</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_UndistributedEarningsOfHelpsonInMillions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>PROPERTY AND EQUIPMENT</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 4 - PROPERTY AND EQUIPMENT</b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Property and equipment consisted of the following:</p> <table width="477" style="MARGIN:auto auto auto -0.75pt; WIDTH:357.4pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>&nbsp;March 31, </b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>&nbsp;December 31, </b></p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Permit of land use</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 449,474 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 447,013 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Building</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,432,442 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,419,125 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Plant, machinery and equipment</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,418,768 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,381,209 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Motor vehicle</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 147,890 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;147,080 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Office equipment</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 223,947 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 222,273 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Construction in progress</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,127,396 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3,688,567 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10.05pt; MARGIN:0in 0in 0pt"><b>Total</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13,799,917 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13,305,267 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Less: accumulated depreciation</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;(4,511,658)</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4,273,373)</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt"><b>Property and Equipment, net</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9,288,259 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9,031,894 </p></td></tr></table> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:" align="center">&nbsp;</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Construction in progress consists of machinery and construction supplies that have been paid for, but are not yet completed and placed into production.&nbsp;&nbsp;Once the machinery is working or the facility is in use, it is moved into plant, machinery and equipment and depreciated.&nbsp;&nbsp;Depreciation is computed on a straight-line basis over the estimated useful lives of the assets as follows:</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <table width="359" style="MARGIN:auto auto auto -0.75pt; WIDTH:269pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">Asset</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">&nbsp;Life - years </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Permit of land use</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">40 - 70</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Building</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">20 - 35</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Plant, machinery and equipment</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">10</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Motor vehicle</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">5 - 10</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Office equipment</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">3-5</p></td></tr></table> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:" align="center">&nbsp;</p> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:" align="center">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">For the three months ended March 31, 2013 and 2012, depreciation expense was $214,406 and $212,424, respectively.</p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-107760<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13-14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391110&amp;loc=d3e2921-110230<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>19
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F
M-V-C-F(T,C`B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7
M96(@4&%G92P@86QS;R!K;F]W;B!A<R!A(%=E8B!!<F-H:79E(&9I;&4N("!)
M9B!Y;W4@87)E('-E96EN9R!T:&ES(&UE<W-A9V4L('EO=7(@8G)O=W-E<B!O
M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V
M.6-F-V-C-F(T,C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#8P
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].1$5.4T5$7T-/
M3E-/3$E$051%1%]"04Q!3D-%/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0T].4T],241!5$5$7T)!3$%.0T5?4TA%15137U!!/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].1$5.4T5$
M7T-/3E-/3$E$051%1%]35$%414U%/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^0T].1$5.4T5$7T-/3E-/3$E$051%1%]35$%414U%
M,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970P-2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D)!4TE3
M7T]&7U!215-%3E1!5$E/3CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O
M=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P-BYH=&UL(B\^#0H@("`\
M+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M("`\>#I.86UE/E!23T150U1?4D5#04Q,/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`W+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^24Y614Y43U)9/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`X+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^4%)/4$525%E?04Y$7T5154E0345.5#PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970P.2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DE.5$%.1TE"
M3$5?05-31513/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#$P+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA
M;64^041604Y#15-?1D]27U!54D-(05-%4U]/1E])3E1!/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#$Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4D5,051%1%]005)465]44D%.
M4T%#5$E/3E,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,3(N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y.3U1%4U]005E!0DQ%/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$S+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^24Y#3TU%7U1!6$53/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$T+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^1D%)4E]604Q515]-14%355)%345.5%,\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,34N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y35$]#2TA/3$1%4E-?
M15%52519/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#$V+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M0T].5$E.1T5.0TE%4SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q-RYH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/D-/3D-%3E12051)3TY3/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$X+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^06-C;W5N=&EN9U]0;VQI8VEE<U]0;VQI8VEE<SPO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970Q.2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D)!4TE37T]&
M7U!215-%3E1!5$E/3E]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C`N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y)3E9%3E1/4EE486)L97,\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C$N
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y04D]015)465]!3D1?15%525!-14Y4
M7U1A8FQE<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970R,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/DE.5$%.1TE"3$5?05-315137U1A8FQE<SPO>#I.86UE/@T*("`@(#QX.E=O
M<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R,RYH=&UL
M(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@("`\>#I.86UE/DE.0T]-15]405A%4U]486)L97,\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,C0N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y&04E27U9!3%5%7TU%
M05-54D5-14Y44U]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713
M;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C4N:'1M;"(O/@T*("`@
M/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@
M("`@/'@Z3F%M93Y"05-)4U]/1E]04D5314Y4051)3TY?1&5T86EL<SPO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970R-BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D)!4TE37T]&7U!2
M15-%3E1!5$E/3E]"87-I8U]A;CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R-RYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/D)!4TE37T]&7U!215-%3E1!5$E/3E]03TQ)0TE%4SPO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970R."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DE.5D5.5$]2
M65]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#(Y+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA
M;64^4%)/4$525%E?04Y$7T5154E0345.5%]$971A:6QS/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#,P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4%)/4$525%E?04Y$7T5154E0
M345.5%]!<W-E='-?/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E
M($A2968],T0B5V]R:W-H965T<R]3:&5E=#,Q+FAT;6PB+SX-"B`@(#PO>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX
M.DYA;64^05-315137T1E<')E8VEA=&EO;E]$971A:6QS/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#,R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^24Y404Y'24),15]!4U-%5%-?
M4T9$05]!<'!R;W9E/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E
M($A2968],T0B5V]R:W-H965T<R]3:&5E=#,S+FAT;6PB+SX-"B`@(#PO>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX
M.DYA;64^4D5,051%1%]005)465]44D%.4T%#5$E/3E-?365M/"]X.DYA;64^
M#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3
M:&5E=#,T+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX
M.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4D5,051%1%]005)465]4
M4D%.4T%#5$E/3E-?3W=I/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,U+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^3D]415-?4$%904),15-?1&5T86EL<SPO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S
M-BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DE.0T]-15]405A%4U]5;F1I<W1R
M:6)U=&5D7T5A<CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970S-RYH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/DE.0T]-15]405A%4U]0<F]V:7-I;VY?1&5T86EL<SPO>#I.86UE/@T*
M("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE
M970S."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D9!25)?5D%,545?345!4U52
M14U%3E137T%T7U)E<#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S.2YH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/E!R969E<G)E9%]#;VUM;VY?4W1O8VM?06YD7U=A<CPO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970T,"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/C(P,3!?4W1O8VM?3W!T
M:6]N7U!L86Y?1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O
M=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T,2YH=&UL(B\^#0H@("`\
M+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M("`\>#I.86UE/D-/3D-%3E12051)3TY37U-A;&5S7T%N9%]0=7)C:#PO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970T,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D-/3D-%3E12051)
M3TY37T%C8V]U;G1S7U)E8V5I=CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T,RYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@(#PO>#I%>&-E;%=O<FMS:&5E=',^
M#0H@(#QX.E-T>6QE<VAE970@2%)E9CTS1")7;W)K<VAE971S+W)E<&]R="YC
M<W,B+SX-"B`@/'@Z06-T:79E4VAE970^,#PO>#I!8W1I=F53:&5E=#X-"B`@
M/'@Z4')O=&5C=%-T<G5C='5R93Y&86QS93PO>#I0<F]T96-T4W1R=6-T=7)E
M/@T*("`\>#I0<F]T96-T5VEN9&]W<SY&86QS93PO>#I0<F]T96-T5VEN9&]W
M<SX-"B`\+W@Z17AC96Q7;W)K8F]O:SX-"CPO>&UL/CPA6V5N9&EF72TM/@T*
M/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@
M;W!E;F5D('=I=&@@36EC<F]S;V9T($5X8V5L(%A0(&]R(&YE=V5R+CPO<#X-
M"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S`V,#!F
M-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,`T*0V]N=&5N="U,;V-A
M=&EO;CH@9FEL93HO+R]#.B\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F
M-V-C-F(T,C`O5V]R:W-H965T<R]3:&5E=#`Q+FAT;6P-"D-O;G1E;G0M5')A
M;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP
M93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@
M(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@
M8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@
M='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO
M="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\
M8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%3D=!
M13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A
M;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY$;V-U;65N="!A;F0@16YT:71Y
M($EN9F]R;6%T:6]N/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA
M<BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M36%Y(#$P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/D1O8W5M96YT(&%N9"!%;G1I='D@26YF;W)M871I;VX\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT
M:71Y(%)E9VES=')A;G0@3F%M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^0TA)3D$@4$A!4DU!($A/3$1)3D=3+"!)3D,N/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!4
M>7!E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XQ,"U1/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U
M;65N="!097)I;V0@16YD($1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/DUA<B`S,2P-"@D),C`Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UE;F1M96YT($9L86<\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/F9A;'-E/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@0V5N=')A
M;"!);F1E>"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C`P
M,#$Q,#8V-#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-U<G)E;G0@1FES8V%L(%EE87(@16YD($1A=&4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/BTM,3(M,S$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!#;VUM
M;VX@4W1O8VLL(%-H87)E<R!/=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-#,L-3<Y+#4U-SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y($9I;&5R($-A=&5G
M;W)Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y3;6%L;&5R(%)E
M<&]R=&EN9R!#;VUP86YY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@0W5R<F5N="!297!O<G1I;F<@4W1A
M='5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y997,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET
M>2!6;VQU;G1A<GD@1FEL97)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#Y.;SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^16YT:71Y(%=E;&PM:VYO=VX@4V5A<V]N960@27-S=65R/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y.;SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&]C=6UE;G0@1FES
M8V%L(%EE87(@1F]C=7,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/C(P,3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D1O8W5M96YT($9I<V-A;"!097)I;V0@1F]C=7,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/E$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V
M.6-F-V-C-F(T,C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#8P
M,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P+U=O<FMS:&5E=',O
M4VAE970P,BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T
M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E
M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P135*04<^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS
M=')O;F<^0T].1$5.4T5$($-/3E-/3$E$051%1"!"04Q!3D-%(%-(14544R`H
M55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY#=7)R96YT($%S<V5T<SH\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S
M:"!E<75I=F%L96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`T+#<U,"PT-C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#0L,#(Y+#<P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%N:V5R)W,@86-C97!T86YC97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,3@P+#@V-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P,2PU
M-S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E1R861E(&%C8V]U;G1S(')E8V5I=F%B;&4L(&QE<W,@86QL;W=A;F-E
M(&9O<B!D;W5B=&9U;"!A8V-O=6YT<R!O9B`D-"PS,S,L-#$Q(&%N9"`D-"PT
M,CDL.30U+"!R97-P96-T:79E;'D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C8R+#8Y-RPV-S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV-BPQ-S4L-3<P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!R96-E:79A8FQE
M<RP@;&5S<R!A;&QO=V%N8V4@9F]R(&1O=6)T9G5L(&%C8V]U;G1S(&]F("0U
M,"PU.3(@86YD("0T.2PX.#$L(')E<W!E8W1I=F5L>3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C4U+#(Y,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@P+#<Y.3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^061V86YC97,@=&\@
M<W5P<&QI97)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#$Q
M.2PW,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XT+#@Q-BPS-30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DEN=F5N=&]R>2P@;&5S<R!A;&QO=V%N8V4@9F]R
M(&]B<V]L97-C96YC92!O9B`D,2PW-SDL-S(Y(&%N9"`D,2PW-CDL.3@T+"!R
M97-P96-T:79E;'D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,S
M+#(V,"PR,C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS-BPS-3DL-3$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y$969E<G)E9"!T87@@87-S971S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY-30L.3@P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.38W+#8W,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T
M86P@0W5R<F5N="!!<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$P."PR,3DL,C,T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3$R+#4S,2PQ.#@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%D=F%N8V5S(&9O<B!P=7)C
M:&%S97,@;V8@:6YT86YG:6)L92!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,Y+#0V,BPR-C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.2PR-C,L.3<W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A
M;F0@97%U:7!M96YT+"!N970@;V8@86-C=6UU;&%T960@9&5P<F5C:6%T:6]N
M(&]F("0T+#4Q,2PV-3@@86YD("0T+#(W,RPS-S,L(')E<W!E8W1I=F5L>3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2PR.#@L,C4Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2PP,S$L
M.#DT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y);G1A;F=I8FQE(&%S<V5T<RP@;F5T(&]F(&%C8W5M=6QA=&5D(&%M
M;W)T:7IA=&EO;B!O9B`D,RPP.3<L,C(T(&%N9"`D,BPY-#0L-S(V+"!R97-P
M96-T:79E;'D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,C@Y
M+#@U,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(L-#$R+#@U-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5$]404P@05-31513/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-3DL,C4Y+#8Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V,RPR,SDL.3$S/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D-U<G)E;G0@3&EA8FEL:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E1R861E(&%C8V]U;G1S('!A>6%B;&4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L.3<X+#8S-CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L.#0Q+#@V
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^06-C<G5E9"!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,C0P+#`P,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(P,BPQ.#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)U960@=&%X97,@<&%Y86)L93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3$T+#(T-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-#(V+#@R
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3W1H97(@<&%Y86)L97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L,#$T+#8T-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$L,#DT+#@X-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^061V86YC97,@9G)O;2!C=7-T;VUE
M<G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-S,U+#DQ-SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M.30U+#DX-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3W1H97(@<&%Y86)L97,@+2!R96QA=&5D('!A<G1I97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,S4T+#4V-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,S4T+#4V
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4VAO<G0M=&5R;2!N;W1E<R!P87EA8FQE/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XT+#<X-RPR.#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#<V,2PP-S,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L($-U<G)E
M;G0@3&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$R+#8R-2PS,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ-"PV,C<L,S@S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;VYG+71E<FT@9&5F97)R960@=&%X
M(&QI86)I;&ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$P
M+#(X-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/CDU+#DV,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^5&]T86P@3&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$R+#<S-2PU.#8\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PW,C,L,S0V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E-T;V-K:&]L9&5R<R<@17%U:71Y.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5F97)R960@<W1O8VLL("0P+C`P,2!P
M87(@=F%L=64[(#4L,#`P+#`P,"!S:&%R97,@875T:&]R:7IE9#L@;F\@<VAA
M<F5S(&ES<W5E9"!O<B!O=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@)#`N,#`Q('!A<B!V86QU
M93L@.34L,#`P+#`P,"!S:&%R97,@875T:&]R:7IE9#L@-#,L-3<Y+#4U-R!S
M:&%R97,@86YD(#0S+#4W.2PU-3<@<VAA<F5S(&]U='-T86YD:6YG+"!R97-P
M96-T:79E;'D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0S+#4X
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C0S+#4X,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^061D:71I;VYA;"!P86ED+6EN(&-A<&ET86P\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(S+#4Y,"PR,#0\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,RPU.3`L,C`T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2
M971A:6YE9"!E87)N:6YG<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3`V+#`Y,BPP,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,#@L.3`T+#,R-3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C=6UU;&%T960@;W1H97(@
M8V]M<')E:&5N<VEV92!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$V+#<Y."PR,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ-2PY-S@L-#4X/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!3=&]C:VAO;&1E
M<G,G($5Q=6ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30V
M+#4R-"PP,C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ-#@L-3$V+#4V-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5$]404P@3$E!0DE,251)15,@04Y$(%-4
M3T-+2$],1$524R<@15%52519/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$U.2PR-3DL-C$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`Q-C,L,C,Y+#DQ,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q-%\T.3@P
M7V$P,3-?-CEC9C=C8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,"]7;W)K
M<VAE971S+U-H965T,#,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5,14%%/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,3X\<W1R;VYG/D-/3E-/3$E$051%1"!"04Q!3D-%(%-(14544R!005)%
M3E1(151)0T%,4R`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06QL;W=A;F-E(&9O<B!D;W5B=&9U
M;"!A8V-O=6YT<R!O;B!T<F%D92!A8V-O=6YT<R!R96-E:79A8FQE<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T+#,S,RPT,3$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0L-#(Y
M+#DT-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^06QL;W=A;F-E(&9O<B!D;W5B=&9U;"!A8V-O=6YT<R!O;B!O=&AE
M<B!R96-E:79A8FQE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-3`L-3DR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-#DL.#@Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!8V-U;75L871E9"!D97!R96-I871I;VX@;VX@<')O
M<&5R='D@86YD(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-"PU,3$L-C4X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-"PR-S,L,S<S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-U;75L871E9"!A;6]R=&EZ
M871I;VX@;VX@:6YT86YG:6)L92!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,RPP.3<L,C(T/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#DT-"PW,C8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E
M9"!3=&]C:RP@<&%R(&]R('-T871E9"!V86QU93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`P+C`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,#$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!3=&]C
M:RP@<VAA<F5S(&%U=&AO<FEZ960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C4L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E9F5R<F5D(%-T;V-K+"!S
M:&%R97,@:7-S=65D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4')E9F5R<F5D(%-T;V-K+"!S:&%R97,@;W5T<W1A;F1I;F<\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@4W1O8VLL('!A
M<B!O<B!S=&%T960@=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,"XP,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#`N,#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@4W1O8VLL('-H87)E<R!A=71H
M;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY-2PP,#`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^.34L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0V]M;6]N(%-T;V-K+"!S:&%R97,@:7-S=65D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,RPU-SDL-34W/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#,L-3<Y
M+#4U-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V]M;6]N(%-T;V-K+"!S:&%R97,@;W5T<W1A;F1I;F<\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0S+#4W.2PU-3<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,RPU-SDL-34W
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^
M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-C`P
M9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C-F(T,C`-"D-O;G1E;G0M3&]C
M871I;VXZ(&9I;&4Z+R\O0SHO,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC
M9C=C8S9B-#(P+U=O<FMS:&5E=',O4VAE970P-"YH=&UL#0I#;VYT96YT+51R
M86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y
M<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*
M("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E
M(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T
M('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.
M;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@
M/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15!8
M044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P
M86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0T].1$5.4T5$($-/3E-/3$E$
M051%1"!35$%414U%3E13($]&($]015)!5$E/3E,@04Y$($-/35!214A%3E-)
M5D4@24Y#3TU%("A5;F%U9&ET960I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2979E;G5E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#@L,C0Y+#,X-SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,38L,#@V+#<S,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0V]S="!O9B!R979E;G5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XV+#$R-2PT,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,"PW.#(L,S@T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);G9E;G1O<GD@;V)S;VQE<V-E;F-E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#8Y,BPX.34\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'
M<F]S<R!P<F]F:70\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L
M-38X+#DP."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XU+#,P-"PS-#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3W!E<F%T:6YG(&5X<&5N<V5S
M.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3
M96QL:6YG(&5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XX,3(L,#4T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.#DT+#`V,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1V5N97)A;"!A;F0@861M:6YI<W1R871I=F4@
M97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<S.2PT
M,C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XV-S8L-#`R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y"860@9&5B="!E>'!E;G-E+CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,3$Y+#DS,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,C`L,#DX/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!O<&5R871I
M;F<@97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M-#,Q+#4U,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L.#DP+#4V,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^*$QO<W,I(&EN8V]M92!F<F]M(&]P97)A=&EO
M;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L,#`P+#0U.2D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M+#0Q,RPW.#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^3W1H97(@:6YC;VUE("AE>'!E;G-E*3H\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YT97)E
M<W0@:6YC;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4X
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C8Y,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^26YT97)E<W0@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH.#(L-#0U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#<W+#4S-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!O=&AE<B!E>'!E;G-E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X,"PX-3DI/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-S8L.#0W*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M*$QO<W,I(&EN8V]M92!B969O<F4@:6YC;VUE('1A>&5S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@S+#`X,2PS,3@I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPS,S8L.30P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);F-O
M;64@=&%X(&)E;F5F:70@*&5X<&5N<V4I/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR-CDL,#$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH-3,P+#4X,2D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="`H;&]S<RD@:6YC;VUE
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#@Q,BPS,#<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#@P
M-BPS-3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D]T:&5R(&-O;7!R96AE;G-I=F4@:6YC;VUE("T@9F]R96EG;B!C
M=7)R96YC>2!T<F%N<VQA=&EO;B!A9&IU<W1M96YT/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XX,3DL-S8W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#`W+#4Q-RD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;7!R96AE;G-I
M=F4@*&QO<W,I(&EN8V]M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XD("@Q+#DY,BPU-#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`R+#,Y."PX-#(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^*$QO<W,I(&5A
M<FYI;F=S('!E<B!S:&%R93H\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0F%S:6,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^)"`H,"XP-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#`N,#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1I;'5T960\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^)"`H,"XP-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H
M=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S`V,#!F-S$S7S!B,31?-#DX,%]A
M,#$S7S8Y8V8W8V,V8C0R,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#
M.B\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C-F(T,C`O5V]R:W-H
M965T<R]3:&5E=#`U+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z
M('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C
M:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-
M151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT
M+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V
M87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#
M;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B
M;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%0E%!1SX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY#3TY$14Y3140@0T].4T],241!5$5$(%-4051%345.5%,@
M3T8@0T%32"!&3$]74R`H56YA=61I=&5D*2`H55-$("0I/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@
M36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,CQB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#87-H($9L
M;W=S(&9R;VT@3W!E<F%T:6YG($%C=&EV:71I97,Z/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!I;F-O;64@9F]R('1H
M92!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BPX
M,3(L,S`W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,BPX,#8L,S4Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y$97!R96-I871I;VX@86YD(&%M;W)T:7IA
M=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S4P+#0V.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,V
M-2PR,C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E-T;V-K(&)A<V5D(&-O;7!E;G-A=&EO;BX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU-BPT.#D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A9"!D96)T(&5X<&5N<V4N
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,3DL.3,P*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,R,"PP
M.3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D1E9F5R<F5D(&EN8V]M92!T87AE<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,S$L-S8Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,S0L,S$R*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YV96YT;W)Y(&]B<V]L97-C
M96YC92!R97-E<G9E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M+#8Y,BPX.34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D-H86YG97,@:6X@87-S971S(&%N9"!L:6%B
M:6QI=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5')A9&4@86-C;W5N=',@<F5C96EV86)L97,N/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU.#DL,3@V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-"PQ-#$L,30V*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H97(@
M<F5C96EV86)L97,N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q
M-S,L-S8S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#(P+#(T-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-H86YG97,@:6X@061V86YC97,@=&\@<W5P<&QI
M97)S+CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C<V+#0P-2D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY
M-#0L.30Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y);G9E;G1O<GDN/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+#@Y,"PX-#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@S+#,U,2PT-3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4<F%D92!A8V-O=6YT<R!P87EA
M8FQE<RX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R,BPT,S`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M+#<R-2PY-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%C8W)U960@97AP96YS97,N/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@S,BPU,38I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3$L-3$W/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-R=65D('1A>&5S('!A
M>6%B;&5S+CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PY,C(L
M-S@P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C0T,RPV.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D]T:&5R('!A>6%B;&5S+CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,3$L-S$U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4T+#,S-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^061V86YC97,@9G)O;2!C
M=7-T;VUE<G,N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,C`L
M-#$X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(Q.2PY-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DYE="!#87-H(%!R;W9I9&5D(&)Y($]P97)A=&EN9R!!
M8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#$P
M-RPW-#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XT,#$L,S@P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-A<V@@1FQO=W,@9G)O;2!);G9E<W1I
M;F<@06-T:79I=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F5T(&EN=F5S=&UE;G0@:6X@8F%N:V5R)W,@86-C97!T
M86YC97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R.#$L-C<T
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^061V86YC97,@9F]R('!U<F-H87-E<R!O9B!P<F]P97)T>2!A;F0@97%U
M:7!M96YT(&%N9"!I;G1A;F=I8FQE(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,SDY+#DY,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@W.3`L,#DR*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4'5R8VAA<V4@;V8@
M<')O<&5R='D@86YD(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH-"PS-S,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH-RPY,C8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@0V%S:"!5<V5D(&EN($EN=F5S
M=&EN9R!!8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@T,#0L,S8U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#$L,#<Y+#8Y,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!#87-H(%!R;W9I9&5D(&)Y($9I
M;F%N8VEN9R!!8W1I=FET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D5F9F5C="!O9B!%>&-H86YG92!2871E($-H86YG97,@;VX@0V%S
M:#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<L,S<V/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-3(L-S,V
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F5T($EN8W)E87-E(&EN($-A<V@@86YD($-A<V@@17%U:79A;&5N=',\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<R,"PW-C`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W,S$L,#0X
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V%S:"!A;F0@0V%S:"!%<75I=F%L96YT<R!A="!"96=I;FYI;F<@;V8@
M4&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#`R.2PW
M,#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT+#`U,"PX-30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-A<V@@86YD($-A<V@@17%U:79A;&5N=',@870@16YD
M(&]F(%!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PW
M-3`L-#8X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,RPS,3DL.#`V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U<'!L96UE;G1A;"!#87-H($9L
M;W<@26YF;W)M871I;VXZ/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-A<V@@<&%I9"!F;W(@:6YT97)E<W0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q,2PS-#8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-2PU-C<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@<&%I
M9"!F;W(@:6YC;VUE('1A>&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+#4Y,RPU,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR-S0L-3@W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U<'!L96UE;G1A;"!.
M;VYC87-H($EN=F5S=&EN9R!A;F0@1FEN86YC:6YG($%C=&EV:71I97,Z/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8V]U
M;G1S('!A>6%B;&4@9F]R('!U<F-H87-E<R!O9B!P<F]P97)T>2!A;F0@97%U
M:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-3$L,#8T
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,30T+#`U-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^06-C;W5N=',@<F5C96EV86)L92!C;VQL96-T960@=VET:"!B
M86YK97(G<R!A8V-E<'1A;F-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,RPS-C8L-C4U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-#`V+#8P-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YV96YT;W)Y('!U<F-H87-E9"!W
M:71H(&)A;FME<B=S(&%C8V5P=&%N8V5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#(L,C@Y+#8Y,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-#`V+#8P-#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q-%\T.3@P
M7V$P,3-?-CEC9C=C8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,"]7;W)K
M<VAE971S+U-H965T,#8N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY"05-)4R!/1B!04D5314Y4051)3TX\8G(^/"]S=')O;F<^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY"05-)4R!/1B!0
M4D5314Y4051)3TX\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0D%325,@3T8@4%)%4T5.5$%424]./"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\(2TM96=X+2T^/'`@<W1Y;&4],T0G5$585"U!
M3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@
M,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SX\8CY.3U1%(#$@+2!"05-)4R!/
M1B!04D5314Y4051)3TX\+V(^/"]P/B`\<"!S='EL93TS1"=,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z
M.R!T86(M<W1O<',Z-3`P+C%P="<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/CQB/CQI/D]R9V%N:7IA
M=&EO;B!A;F0@3F%T=7)E(&]F($]P97)A=&EO;G,@)B,Q-3`[(#PO:3X\+V(^
M0VAI;F$@4&AA<FUA($AO;&1I;F=S+"!);F,N+"!A($YE=F%D82!C;W)P;W)A
M=&EO;BP@;W=N<R`Q,#`E(&]F($]N;GD@26YV97-T;65N="!,:6UI=&5D("@F
M(S$T-SM/;FYY)B,Q-#@[*2P@82!"<FET:7-H(%9I<F=I;B!)<VQA;F1S(&-O
M<G!O<F%T:6]N+"!T:&%T(&EN('1U<FX@;W=N<R`Q,#`E(&]F($AA:6YA;B!(
M96QP<V]N($UE9&EC86P@)F%M<#L@0FEO=&5C:&YO;&]G>2!#;RXL($QT9"`H
M)B,Q-#<[2&5L<'-O;B8C,30X.RDL(&$@8V]R<&]R871I;VX@;W)G86YI>F5D
M('5N9&5R('1H92!L87=S(&]F('1H92!096]P;&4G<R!297!U8FQI8R!O9B!#
M:&EN82`H=&AE("8C,30W.U!20R8C,30X.RDN($-H:6YA(%!H87)M82!(;VQD
M:6YG<RP@26YC+B!A;F0@:71S('-U8G-I9&EA<FEE<R!A<F4@<F5F97)R960@
M=&\@:&5R96EN(&%S('1H92!#;VUP86YY+CPO<#X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP
M:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SXF;F)S<#L\+W`^(#QP('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L
M.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.CL@=&%B+7-T
M;W!S.C4P,"XQ<'0G/D]N($1E8V5M8F5R(#,Q+"`R,#$R+"!#:&EN82!0:&%R
M;6$@2&]L9&EN9W,L($EN8R!C;VYS=6UM871E9"!A(')E:6YC;W)P;W)A=&EO
M;B!M97)G97(@9F]R('1H92!P=7)P;W-E(&]F(&-H86YG:6YG('1H92!S=&%T
M92!O9B!I;F-O<G!O<F%T:6]N(&9R;VT@1&5L87=A<F4@=&\@3F5V861A('!U
M<G-U86YT('1O('1H92!T97)M<R!A;F0@8V]N9&ET:6]N<R!O9B!A;B!!9W)E
M96UE;G0@86YD(%!L86X@;V8@365R9V5R(&1A=&5D($1E8V5M8F5R(#(W+"`R
M,#$R+B9N8G-P.R9N8G-P.U1H92!R96EN8V]R<&]R871I;VX@;65R9V5R('=A
M<R!A<'!R;W9E9"!B>2!S=&]C:VAO;&1E<G,@:&]L9&EN9R!T:&4@;6%J;W)I
M='D@;V8@=&AE(&]U='-T86YD:6YG(&-O;6UO;B!S:&%R97,@;VX@1&5C96UB
M97(@,C$L(#(P,3(N/"]P/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z.R!T86(M
M<W1O<',Z-3`P+C%P="<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,
M24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P
M:6X@,'!T.R!415A4+4%55$]34$%#13HG/E1H92!&;W)E:6=N($EN=F5S=&UE
M;G0@26YD=7-T<FEA;"!#871A;&]G=64\:3XF;F)S<#L\+VD^*'1H92`F(S$T
M-SM#871A;&]G=64F(S$T.#LI(&IO:6YT;'D@:7-S=65D(&)Y('1H92!#:&EN
M828C,30V.W,@36EN:7-T<GD@;V8@0V]M;65R8V4@86YD('1H92!.871I;VYA
M;"!$979E;&]P;65N="!A;F0@4F5F;W)M($-O;6UI<W-I;VX@*&%S('1H92!L
M871E<W0@=F5R<VEO;B!I<R!T:&4@>65A<B`R,#$R('9E<G-I;VXL(&5F9F5C
M=&EV92!*86YU87)Y(#,P+"`R,#$R*2!C;&%S<VEF:65D('9A<FEO=7,@:6YD
M=7-T<FEE<R]B=7-I;F5S<V5S(&EN=&\@=&AR964@9&EF9F5R96YT(&-A=&5G
M;W)I97,Z("AI*2!E;F-O=7)A9V5D(&9O<B!F;W)E:6=N(&EN=F5S=&UE;G0[
M("AI:2D@<F5S=')I8W1E9"!T;R!F;W)E:6=N(&EN=F5S=&UE;G0[(&%N9"`H
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M:7`@<F5S=')I8W1I;VX@:6X@=&AE('!H87)M86-E=71I8V%L(&EN9'5S=')Y
M(&ES('1H870@82!F;W)E:6=N(&EN=F5S=&UE;G0@96YT97)P<FES92`H=&AE
M("8C,30W.T9)128C,30X.RD@<VAA;&P@;F]T(&AA=F4@=&AE('=H;VQE(&]R
M(&UA:F]R:71Y(&]F(&ET<R!E<75I='D@:6YT97)E<W1S(&]W;F5D(&)Y(&$@
M9F]R96EG;B!O=VYE<B!I9B!T:&4@1DE%(&5S=&%B;&ES:&5S(&UO<F4@=&AA
M;B`S,"!B<F%N8V@@<W1O<F5S(&%N9"!D:7-T<FEB=71E<R!A('9A<FEE='D@
M;V8@8G)A;F1S(&EN('1H;W-E(&9R86YC:&ES92!S=&]R97,L('=H:6-H(&ES
M(&YO="!T:&4@8V%S92!O9B!T:&4@0V]M<&%N>28C,30V.W,@8G5S:6YE<W,N
M/"]P/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP
M:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z.R!T86(M<W1O<',Z-3`P+C%P
M="<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..FIU<W1I9GD[
M($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4
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M($UA>2`R-2P@,C`P-2X@5&AE('1R86YS86-T:6]N('=A<R!A<'!R;W9E9"!B
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M('-T871U<R!O;B!*=6YE(#(Q+"`R,#`U+CPO<#X@/'`@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M0554
M3U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G/B9N8G-P.SPO<#X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN;W)M86P[
M($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SY4:&4@0V]M
M<&%N>2!H87,@86YD(&-O;G1I;G5E<R!T;R!A8W%U:7)E('=E;&PM86-C97!T
M960@;65D:6-A;"!F;W)M=6QA<R!T;R!A(&1I=F5R<V4@<&]R=&9O;&EO(&]F
M(%=E<W1E<FX@86YD($-H:6YE<V4@;65D:6-I;F5S+CPO<#X@/'`@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%
M6%0M05543U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G/B9N8G-P.SPO<#X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN
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M=&AE(%5N:71E9"!3=&%T97,@;V8@06UE<FEC82`H)B,Q-#<[52Y3+B!'04%0
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M;G-O;&ED871I;VXN/"]P/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z.R!T86(M
M<W1O<',Z-3`P+C%P="<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,
M24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P
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M<RX\+W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13H[('1A8BUS=&]P<SHU,#`N
M,7!T)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF
M>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%
M6%0M05543U-004-%.B<^/&(^/&D^0V]N9&5N<V5D($9I;F%N8VEA;"!3=&%T
M96UE;G1S(#PO:3X\+V(^)B,Q-3`[(%1H92!A8V-O;7!A;GEI;F<@=6YA=61I
M=&5D(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N
M=',@=V5R92!P<F5P87)E9"!P=7)S=6%N="!T;R!T:&4@<G5L97,@86YD(')E
M9W5L871I;VYS(&]F('1H92!5;FET960@4W1A=&5S(%-E8W5R:71I97,@86YD
M($5X8VAA;F=E($-O;6UI<W-I;VX@*'1H92`F(S$T-SM#;VUM:7-S:6]N)B,Q
M-#@[*2X@0V5R=&%I;B!I;F9O<FUA=&EO;B!A;F0@;F]T92!D:7-C;&]S=7)E
M<R!N;W)M86QL>2!I;F-L=61E9"!I;B!F:6YA;F-I86P@<W1A=&5M96YT<R!P
M<F5P87)E9"!I;B!A8V-O<F1A;F-E('=I=&@@52Y3+B!'04%0(&AA=F4@8F5E
M;B!C;VYD96YS960@;W(@;VUI='1E9"!P=7)S=6%N="!T;R!S=6-H(')U;&5S
M(&%N9"!R96=U;&%T:6]N<RX@36%N86=E;65N="!O9B!T:&4@0V]M<&%N>2`H
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M,3`M2R!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,3(@9FEL
M960@=VET:"!T:&4@0V]M;6ES<VEO;B!O;B!-87)C:"`Q-"P@,C`Q,RX\+W`^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z
M;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^
M)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..FIU<W1I9GD[($Q)
M3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%5
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M($UA<F-H(#,Q+"`R,#$S(&%R92!N;W0@;F5C97-S87)I;'D@:6YD:6-A=&EV
M92!O9B!T:&4@<F5S=6QT<R!T:&%T(&UA>2!B92!E>'!E8W1E9"!F;W(@=&AE
M('EE87(@96YD:6YG($1E8V5M8F5R(#,Q+"`R,#$S+CPO<#X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN;W)M86P[($U!
M4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SXF;F)S<#L\+W`^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z
M;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^
M/&(^/&D^06-C;W5N=&EN9R!%<W1I;6%T97,@/"]I/CPO8CX\8CXM(#PO8CY4
M:&4@<')E<&%R871I;VX@;V8@9FEN86YC:6%L('-T871E;65N=',@:6X@8V]N
M9F]R;6ET>2!W:71H)FYB<W`[52Y3+B!'04%0(')E<75I<F5S($UA;F%G96UE
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M=&EM871E<RX\+W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13H[('1A8BUS=&]P
M<SHU,#`N,7!T)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0[(%1%6%0M05543U-004-%.B<^/&(^/&D^0F%S:6,@86YD($1I;'5T960@
M16%R;FEN9W,@<&5R($-O;6UO;B!3:&%R92`\+VD^/"]B/CQB/BT@/"]B/D)A
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M:6QU=&EV92!C;VUM;VX@<VAA<F5S+CPO<#X@/'`@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-0
M04-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G/B9N8G-P.SPO<#X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN;W)M86P[($U!
M4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SY4:&4@9F]L;&]W
M:6YG('1A8FQE(&ES(&$@<')E<V5N=&%T:6]N(&]F('1H92!N=6UE<F%T;W)S
M(&%N9"!D96YO;6EN871O<G,@=7-E9"!I;B!T:&4@8V%L8W5L871I;VX@;V8@
M8F%S:6,@86YD(&1I;'5T960@96%R;FEN9W,@<&5R('-H87)E.CPO<#X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SXF;F)S
M<#L\+W`^(#QT86)L92!W:61T:#TS1#4R,"!S='EL93TS1"=-05)'24XZ875T
M;R!A=71O(&%U=&\@+3`N-S5P=#L@5TE$5$@Z,SDP<'0[($)/4D1%4BU#3TQ,
M05!313IC;VQL87!S92<@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$
M,#X@/'1R/B`\=&0@=VED=&@],T0S-#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,C4V<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T
M9#X@/'1D('=I9'1H/3-$,3<Y(&-O;'-P86X],T0S('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$S-'!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R
M/CQB/D9O<B!T:&4@5&AR964@36]N=&AS/"]B/CPO<#X\+W1D/CPO='(^(#QT
M<CX@/'1D('=I9'1H/3-$,S0Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F
M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#(U-G!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$=&]P/CPO=&0^(#QT9"!W
M:61T:#TS1#$W.2!C;VQS<&%N/3-$,R!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3,T<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C
M96YT97(^/&(^16YD960@36%R8V@@,S$L/"]B/CPO<#X\+W1D/CPO='(^(#QT
M<CX@/'1D('=I9'1H/3-$,S0Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F
M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#(U-G!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$=&]P/CPO=&0^(#QT9"!W
M:61T:#TS1#DQ('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@
M,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V."XR<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C96YT97(^/&(^,C`Q
M,SPO8CX\+W`^/"]T9#X@/'1D('=I9'1H/3-$,B!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q+CAP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X\+W1D/B`\=&0@=VED=&@],T0X-2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-C1P=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M
M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E
M;G1E<CX\8CXR,#$R/"]B/CPO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H
M/3-$,S0Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#(U-G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^3F5T("AL;W-S*2!I
M;F-O;64\+W`^/"]T9#X@/'1D('=I9'1H/3-$.3$@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8X
M+C)P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R
M;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#L@*#(L.#$R+#,P-RD\+W`^/"]T9#X@/'1D('=I9'1H/3-$
M,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F
M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC
M;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H
M.B`Q+CAP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0X-2!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@-C1P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,BPX,#8L,S4Y(#PO<#X\+W1D
M/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,S0Q('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG
M+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@
M<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#(U-G!T.R!P861D:6YG+7)I
M9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT
M.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M
M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@
M,&EN(#!P="<^0F%S:6,@=V5I9VAT960M879E<F%G92!C;VUM;VX@<VAA<F5S
M(&]U='-T86YD:6YG/"]P/CPO=&0^(#QT9"!W:61T:#TS1#DQ('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8X+C)P=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIR:6=H=#L@3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$
M<FEG:'0^-#,L-3<Y+#4U-R`\+W`^/"]T9#X@/'1D('=I9'1H/3-$,B!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P
M9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@
M=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q+CAP
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0X-2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V-'!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H
M=#XT,RPU,CDL-34W(#PO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$
M,S0Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#(U-G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$=&]P/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN
M;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^169F96-T(&]F(&1I;'5T:79E
M('-E8W5R:71I97,Z/"]P/CPO=&0^(#QT9"!W:61T:#TS1#DQ('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8X+C)P=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1'1O<#X\+W1D/B`\=&0@=VED=&@],T0R('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG
M+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@
M<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$N.'!T.R!P861D:6YG+7)I
M9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT
M.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$=&]P/CPO
M=&0^(#QT9"!W:61T:#TS1#@U('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F
M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#8T<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1T;W`^/"]T9#X\+W1R/B`\
M='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1'1O<#X@/'`@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z;F]R;6%L.R!415A4+4E.1$5.5#HQ,'!T.R!-05)'
M24XZ,&EN(#!I;B`P<'0G/E=A<G)A;G1S/"]P/CPO=&0^(#QT9"!W:61T:#TS
M1#DQ('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#8X+C)P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1'1O<#X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R`M)FYB<W`[)FYB<W`[(#PO<#X\+W1D/B`\
M=&0@=VED=&@],T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[
M(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B
M86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U
M+C1P=#L@=VED=&@Z(#$N.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R
M9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D
M:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$=&]P/CPO=&0^(#QT9"!W:61T:#TS
M1#@U('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#8T<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N8G-P.R`\+W`^/"]T9#X\+W1R
M/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1'1O<#X@/'`@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!415A4+4E.1$5.5#HQ,'!T.R!-
M05)'24XZ,&EN(#!I;B`P<'0G/D]P=&EO;G,\+W`^/"]T9#X@/'1D('=I9'1H
M/3-$.3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@
M<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#8X+C)P=#L@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1'1O<#X@/'`@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`M)FYB<W`[)FYB
M<W`[(#PO<#X\+W1D/B`\=&0@=VED=&@],T0R('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG
M+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@
M<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$N.'!T.R!P861D:6YG+7)I
M9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT
M.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$=&]P/CPO
M=&0^(#QT9"!W:61T:#TS1#@U('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I
M;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V-'!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$=&]P
M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@
M,&EN(#!P="<^)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M("TF;F)S<#LF;F)S<#L@/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@]
M,T0S-#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@,C4V<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SY$:6QU=&5D('=E:6=H
M=&5D+6%V97)A9V4@8V]M;6]N('-H87)E<R!O=71S=&%N9&EN9SPO<#X\+W1D
M/B`\=&0@=VED=&@],T0Y,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD
M;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-C@N,G!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#XT
M,RPU-SDL-34W(#PO<#X\+W1D/B`\=&0@=VED=&@],T0R('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$N.'!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#@U('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P
M9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@
M=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V-'!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,
M24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX]
M,T1R:6=H=#XT,RPU,CDL-34W(#PO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I
M9'1H/3-$,S0Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#(U-G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^0F%S:6,@*&QO
M<W,I(&5A<FYI;F=S('!E<B!S:&%R93PO<#X\+W1D/B`\=&0@=VED=&@],T0Y
M,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI
M9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@-C@N,G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS
M1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB
M<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`H,"XP-BD\
M+W`^/"]T9#X@/'1D('=I9'1H/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q+CAP=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D
M/B`\=&0@=VED=&@],T0X-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD
M;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-C1P=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#L@,"XP-B`\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T
M:#TS1#,T,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`R-39P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/D1I;'5T960@*&QO
M<W,I(&5A<FYI;F=S('!E<B!S:&%R93PO<#X\+W1D/B`\=&0@=VED=&@],T0Y
M,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI
M9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@-C@N,G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS
M1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB
M<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`H,"XP-BD\
M+W`^/"]T9#X@/'1D('=I9'1H/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q+CAP=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D
M/B`\=&0@=VED=&@],T0X-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD
M;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-C1P=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#L@)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[,"XP-B`\+W`^/"]T9#X\+W1R/CPO=&%B;&4^(#QP('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN;W)M86P[
M($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z.R!T86(M<W1O
M<',Z-3`P+C%P="<@86QI9VX],T1C96YT97(^)FYB<W`[/"]P/B`\<"!S='EL
M93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L.R!-
M05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.CL@=&%B+7-T;W!S
M.C4P,"XQ<'0G(&%L:6=N/3-$8V5N=&5R/B9N8G-P.SPO<#X@/'`@<W1Y;&4]
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M=71I=F4Z)FYB<W`[/"]P/B`\=&%B;&4@=VED=&@],T0U,C`@<W1Y;&4],T0G
M34%21TE..F%U=&\@875T;R!A=71O("TP+C<U<'0[(%=)1%1(.C,Y,'!T.R!"
M3U)$15(M0T],3$%04T4Z8V]L;&%P<V4G(&-E;&QP861D:6YG/3-$,"!C96QL
M<W!A8VEN9STS1#`^(#QT<CX@/'1D('=I9'1H/3-$,S0Q('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#(U-G!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$W.2!C;VQS<&%N/3-$,R!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P
M9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@
M=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q,S1P
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([
M($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG
M;CTS1&-E;G1E<CX\8CY&;W(@=&AE(%1H<F5E($UO;G1H<SPO8CX\+W`^/"]T
M9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X\+W1D/B`\=&0@=VED=&@],T0Q-SD@8V]L<W!A;CTS1#,@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#$S-'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0G(&%L:6=N/3-$8V5N=&5R/CQB/D5N9&5D($UA<F-H(#,Q+#PO8CX\+W`^
M/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X\+W1D/B`\=&0@=VED=&@],T0X."!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-C8N,7!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@
M3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N
M/3-$8V5N=&5R/CQB/C(P,3,\+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M,2XX-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#@X('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`V-BXP-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4
M+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/C(P,3(\+V(^/"]P/CPO=&0^
M/"]T<CX@/'1R/B`\=&0@=VED=&@],T0S-#$@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,C4V<'0[('!A9&1I;F<M<FEG
M:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z
M("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^
M(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P
M:6X@,'!T)SY787)R86YT<R!W:71H(&5X97)C:7-E('!R:6-E<R!O9B`D,RXP
M,"!T;R`D,RXX,"!P97(@<VAA<F4\+W`^/"]T9#X@/'1D('=I9'1H/3-$.#@@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M-C8N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN
M;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[(#$U,"PP,#`@/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,2XX-7!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#@X('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8V+C`U<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,34P+#`P,"`\
M+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'
M24XZ,&EN(#!I;B`P<'0G/D]P=&EO;G,@=VET:"!A;B!E>&5R8VES92!P<FEC
M92!O9B`D,BXU-"!T;R`D,RXT-R!P97(@<VAA<F4\+W`^/"]T9#X@/'1D('=I
M9'1H/3-$.#@@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q
M<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#8V+C%P=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0G/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`R-2PP,#`@
M/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,2XX-7!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO
M=&0^(#QT9"!W:61T:#TS1#@X('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I
M;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V-BXP-7!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)
M3CHP:6X@,&EN(#!P="<^)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#,Q,"PP,#`@
M/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0S-#$@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,C4V<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@5$58
M5"U)3D1%3E0Z,3!P=#L@34%21TE..C!I;B`P:6X@,'!T)SY4;W1A;#PO<#X\
M+W1D/B`\=&0@=VED=&@],T0X."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W
M:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-C8N,7!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)
M3CHP:6X@,&EN(#!P="<^)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#$W-2PP,#`@
M/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,2XX-7!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO
M=&0^(#QT9"!W:61T:#TS1#@X('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I
M;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V-BXP-7!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)
M3CHP:6X@,&EN(#!P="<^)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#0V,"PP,#`@
M/"]P/CPO=&0^/"]T<CX\+W1A8FQE/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0[(%1%6%0M05543U-004-%.B<@86QI9VX],T1C96YT97(^)FYB<W`[/"]P
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE
M/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,#8P
M,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T,Z+S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y
M8V8W8V,V8C0R,"]7;W)K<VAE971S+U-H965T,#<N:'1M;`T*0V]N=&5N="U4
M<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4
M>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-
M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP
M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP
M="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@
M3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@
M(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-
M13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A
M;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY04D]$54-4(%)%0T%,3#QB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E!2
M3T150U0@4D5#04Q,/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!23T150U0@4D5#04Q,/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\(2TM96=X+2T^/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^
M/&(^3D]412`R("8C,34P.R!04D]$54-4(%)%0T%,3#PO8CX\+W`^(#QP('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.C$Q+C(U<'0[($U!4D=)3CHP:6X@,&EN(#!P
M="<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..FIU<W1I9GD[
M($Q)3D4M2$5)1TA4.C$Q+C(U<'0[($U!4D=)3CHP:6X@,&EN(#!P="<^26X@
M36%R8V@@,C`Q,RP@=&AE($-H:6YA($9O;V0@86YD($1R=6<@061M:6YI<W1R
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M(&%N9"!S86QE(&]F($)U9FQO;65D:6PM<F5L871E9"!P<F]D=6-T<RX\+W`^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z
M,3$N,C5P=#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#L\+W`^(#QP('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z,3$N,C5P
M=#L@34%21TE..C!I;B`P:6X@,'!T)SY0=7)S=6%N="!T;R!T:&4@0T9$02!.
M;W1I8V4L('1H92!#;VUP86YY(&-E87-E9"!T:&4@<')O9'5C=&EO;B!A;F0@
M<V%L92!O9B!"=69L;VUE9&EL+6)A<V5D('!R;V1U8W1S(&%N9"!C96%S960@
M86QL('!R;VUO=&EO;F%L(&%N9"!M87)K971I;F<@86-T:79I=&EE<R!F;W(@
M0G5F;&]M961I;"UB87-E9"!P<F]D=6-T<RX@/"]P/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.C$Q+C(U<'0[($U!4D=)
M3CHP:6X@,&EN(#!P="<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,
M24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P
M:6X@,'!T)SY&=7)T:&5R;6]R92P@=&AE($-O;7!A;GD@<F5C;V=N:7IE9"!A
M;B!I;G9E;G1O<GD@;V)S;VQE<V-E;F-E(&5X<&5N<V4@:6X@=&AE(&%M;W5N
M="!O9B`D,RPV.3(L.#DU('1O('=R:71E(&]F9B!"=69L;VUE9&EL+7)E;&%T
M960@<F%W(&UA=&5R:6%L<R!A;F0@9FEN:7-H960@9V]O9',@:6YV96YT;W)Y
M+B!4:&ES('=A<R!R96-O<F1E9"!A<R!I;G9E;G1O<GD@;V)S;VQE<V-E;F-E
M(&]N('1H92!A8V-O;7!A;GEI;F<@<W1A=&5M96YT(&]F(&]P97)A=&EO;G,@
M9F]R('1H92!T:')E92!M;VYT:',@96YD960@36%R8V@@,S$L(#(P,3,N(#PO
M<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[/"]P/B`\<"!S
M='EL93TS1"=415A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA
M;#L@34%21TE..C!I;B`P:6X@,'!T)SY);B!A9&1I=&EO;BP@=&AE($-O;7!A
M;GD@<F5C86QL960@0G5F;&]M961I;"UB87-E9"!P<F]D=6-T<R!F<F]M('1H
M92!M87)K970N($ET(&%U=&AO<FEZ960@=&AE(')E='5R;B!O9B!I=',@<')E
M=FEO=7-L>2!S;VQD($)U9FQO;65D:6PM<F5L871E9"!P<F]D=6-T<R!T:')O
M=6=H($%P<FEL(#,P+"`R,#$S+B!4:&4@;&]S<R!F<F]M('1H92!R969U;F1S
M('1O(&-U<W1O;65R<R!W87,@)#(Q+#4P-R!A;F0@<F5C;V=N:7IE9"!T:&%T
M(&5S=&EM871E9"!L;W-S(&%S(&$@<F5D=6-T:6]N(&]F(')E=F5N=65S(&9O
M<B!T:&4@=&AR964@;6]N=&AS(&5N9&5D($UA<F-H(#,Q+"`R,#$S+B!5;F1E
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M<W5C:"!F:6YI<VAE9"!G;V]D<R!I;6UE9&EA=&5L>2X\+W`^(#QP('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-
M05)'24XZ,&EN(#!I;B`P<'0@,3,N-7!T)SXF;F)S<#L\+W`^(#QP('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-
M05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^4'5R<W5A;G0@
M=&\@=&AE($-&1$$@3F]T:6-E+"!T:&4@0T9$02!R979O:V5D('1H92!P<F]D
M=6-T:6]N(&QI8V5N<V5S(&9O<B!"=69L;VUE9&EL(&)A<V5D('!R;V1U8W1S
M+B!4:&4@8V%R<GEI;F<@=F%L=64@;V8@=&AE($-O;7!A;GDF(S$T-CMS($)U
M9FQO;65D:6P@<F5L871E9"!I;G1A;F=I8FQE(&%S<V5T<R!I<R!Z97)O.R!T
M:&5R969O<F4L(&YO(&EM<&%I<FUE;G0@;V8@=&AE($-O;7!A;GDF(S$T-CMS
M(&EN=&%N9VEB;&4@87-S971S('=A<R!N96-E<W-A<GDN)FYB<W`[(#PO<#X@
M/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I
M;B`P<'0[(%1%6%0M05543U-004-%.B<^)FYB<W`[/"]P/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q-%\T
M.3@P7V$P,3-?-CEC9C=C8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,"]7
M;W)K<VAE971S+U-H965T,#@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#(^/'-T<F]N9SY)3E9%3E1/4EDN/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^24Y614Y43U)9+CPO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)3E9%3E1/4EDN
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM96=X+2T^/'`@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0[(%1%6%0M05543U-004-%.B<^/&(^3D]412`S("T@24Y614Y43U)9/"]B
M/CPO<#X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ
M,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^)FYB<W`[/"]P/B`\<"!S
M='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P
M=#L@5$585"U!551/4U!!0T4Z)SY);G9E;G1O<GD@8V]N<VES=&5D(&]F('1H
M92!F;VQL;W=I;F<Z)FYB<W`[/"]P/B`\<"!S='EL93TS1"=,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z
M)SX@/"]P/CQT86)L92!W:61T:#TS1#0X,R!S='EL93TS1"=-05)'24XZ875T
M;R!A=71O(&%U=&\@+3`N-S5P=#L@5TE$5$@Z,S8R+C1P=#L@0D]21$52+4-/
M3$Q!4%-%.F-O;&QA<'-E)R!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<]
M,T0P/B`\='(^(#QT9"!W:61T:#TS1#(U,2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q.#AP=#L@<&%D9&EN9RUR:6=H
M=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@
M(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\
M+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D
M('=I9'1H/3-$,3`X('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[
M(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B
M86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U
M+C1P=#L@=VED=&@Z(#@P+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXF;F)S<#M-87)C:"`S
M,2P@/"]B/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG
M:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T
M;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<U+C=P=#L@<&%D9&EN9RUR:6=H
M=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@
M(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXF
M;F)S<#M$96-E;6)E<B`S,2P@/"]B/CPO<#X\+W1D/CPO='(^(#QT<CX@/'1D
M('=I9'1H/3-$,C4Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[
M(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B
M86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U
M+C1P=#L@=VED=&@Z(#$X.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R
M9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D
M:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T
M:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#@@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[
M(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B
M86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U
M+C1P=#L@=VED=&@Z(#@P+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXR,#$S/"]B/CPO<#X\
M+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D
M('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E
M>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M<FEG
M:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z
M("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN
M;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C96YT97(^/&(^
M,C`Q,CPO8CX\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#(U,2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q
M.#AP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R
M;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/E)A=R!M871E<FEA;',\+W`^/"]T
M9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W
M:61T:#TS1#$P."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`X,"XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D
M97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I
M;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R0F;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,C@L,S@P+#DP
M,SPO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T
M9#X@/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F
M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#<U+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CIR:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-
M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^)FYB<W`[)"9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`S,"PQ.3@L
M.#$V(#PO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X.'!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[
M($U!4D=)3CHP:6X@,&EN(#!P="<^1FEN:7-H960@9V]O9',\+W`^/"]T9#X@
M/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F
M,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R
M9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D
M:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T
M:#TS1#$P."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P
M="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M
M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG
M+6QE9G0Z(#4N-'!T.R!W:61T:#H@.#`N-W!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
M='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%24=(5#IN;W)M86P[
M($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#XF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@-BPV-3DL,#4R(#PO<#X\+W1D/B`\
M=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P
M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@
M8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@
M-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D
M97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I
M;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H
M/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T
M('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R`W+#DS,"PV.#0@/"]P/CPO=&0^/"]T<CX@/'1R
M/B`\=&0@=VED=&@],T0R-3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@,3@X<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D
M('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS
M1#$P."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`X,"XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`S-2PP
M,SDL.34U/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X\+W1D/B`\=&0@=VED=&@],T0Q,#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S4N-W!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\
M<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#XF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#L@,S@L,3(Y+#4P,"`\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W
M:61T:#TS1#(U,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`Q.#AP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/D]B<V]L97-C
M96YC92!R97-E<G9E/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#@@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.#`N-W!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#XF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@*#$L-S<Y+#<R.2D\+W`^/"]T
M9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W
M:61T:#TS1#$P,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D
M97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I
M;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`H,2PW
M-CDL.3@T*3PO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X
M.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M
M86P[(%1%6%0M24Y$14Y4.C$P+C`U<'0[($U!4D=)3CHP:6X@,&EN(#!P="<^
M/&(^5&]T86P@26YV96YT;W)Y/"]B/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Q
M,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F
M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC
M;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H
M.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`X('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`X,"XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
M='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%24=(5#IN;W)M86P[
M($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#XF;F)S<#LD)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M(#,S+#(V,"PR,C8@/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#$@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<U
M+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z('=I;F1O
M=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I
M;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R0F;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,S8L,S4Y+#4Q-B`\+W`^
M/"]T9#X\+W1R/CPO=&%B;&4^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
M+2TM/5].97AT4&%R=%\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C
M-F(T,C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#8P,&8W,3-?
M,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P+U=O<FMS:&5E=',O4VAE970P
M.2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I
M;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M
M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E!2
M3U!%4E19($%.1"!%455)4$U%3E0\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY04D]015)462!!3D0@15%525!-14Y4
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!2
M3U!%4E19($%.1"!%455)4$U%3E0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CPA+2UE9W@M+3X\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SX\8CY.
M3U1%(#0@+2!04D]015)462!!3D0@15%525!-14Y4/"]B/CPO<#X@/'`@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[
M(%1%6%0M05543U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G/B9N8G-P.SPO
M<#X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^4')O<&5R='D@86YD(&5Q=6EP
M;65N="!C;VYS:7-T960@;V8@=&AE(&9O;&QO=VEN9SH\+W`^(#QT86)L92!W
M:61T:#TS1#0W-R!S='EL93TS1"=-05)'24XZ875T;R!A=71O(&%U=&\@+3`N
M-S5P=#L@5TE$5$@Z,S4W+C1P=#L@0D]21$52+4-/3$Q!4%-%.F-O;&QA<'-E
M)R!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P/B`\='(^(#QT9"!W
M:61T:#TS1#(U,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`Q.#AP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@]
M,T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`Q('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<U
M+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT
M97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A
M;&EG;CTS1&-E;G1E<CX\8CXF;F)S<#M-87)C:"`S,2P@/"]B/CPO<#X\+W1D
M/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F
M,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I
M;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F
M=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B
M;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A
M9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I
M9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#<U+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXF;F)S<#M$96-E;6)E<B`S
M,2P@/"]B/CPO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X
M.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#$@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<U
M+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT
M97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A
M;&EG;CTS1&-E;G1E<CX\8CXR,#$S/"]B/CPO<#X\+W1D/B`\=&0@=VED=&@]
M,T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`Q('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D
M97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I
M;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP
M:6X@,&EN(#!P="<@86QI9VX],T1C96YT97(^/&(^,C`Q,CPO8CX\+W`^/"]T
M9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#(U,2!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q.#AP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0G/E!E<FUI="!O9B!L86YD('5S93PO<#X\+W1D/B`\=&0@=VED
M=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`Q
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#<U+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIR
M:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G
M(&%L:6=N/3-$<FEG:'0^)FYB<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R`T-#DL-#<T(#PO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<U+C=P=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIR:6=H=#L@3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^
M)FYB<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`T-#<L,#$S(#PO
M<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X.'!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)
M3CHP:6X@,&EN(#!P="<^0G5I;&1I;F<\+W`^/"]T9#X@/'1D('=I9'1H/3-$
M,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P,2!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P
M9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@
M=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW
M<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P
M.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V
M86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ<FEG:'0[
M($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG
M;CTS1')I9VAT/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`R+#0S,BPT
M-#(@/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG
M+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@
M<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H
M=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@
M(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\
M+W1D/B`\=&0@=VED=&@],T0Q,#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M
M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG
M+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S4N-W!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
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M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#$X.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL
M93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^
M4&QA;G0L(&UA8VAI;F5R>2!A;F0@97%U:7!M96YT/"]P/CPO=&0^(#QT9"!W
M:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q
M,#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@-S4N-W!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.G)I9VAT.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P
M="<@86QI9VX],T1R:6=H=#XF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@
M-BPT,3@L-S8X(#PO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG
M+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@
M<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<U+C=P=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIR:6=H=#L@3$E.12U(14E'2%0Z
M;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#8L,S@Q+#(P.2`\+W`^/"]T9#X\
M+W1R/B`\='(^(#QT9"!W:61T:#TS1#(U,2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q.#AP=#L@<&%D9&EN9RUR:6=H
M=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@
M(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@
M/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I
M;B`P<'0G/DUO=&]R('9E:&EC;&4\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P,2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ<FEG:'0[($Q)
M3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS
M1')I9VAT/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R`Q-#<L.#DP(#PO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P
M9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@
M=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<U+C=P=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIR:6=H=#L@3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$<FEG
M:'0^)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[("9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.S$T-RPP.#`@/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0R
M-3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@,3@X<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SY/9F9I8V4@97%U:7!M96YT
M/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D
M/B`\=&0@=VED=&@],T0Q,#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@-S4N-W!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL
M93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%24=(5#IN;W)M86P[($U!
M4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#XF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,C(S+#DT-R`\+W`^
M/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M
M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG
M+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT
M9"!W:61T:#TS1#$P,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P
M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@
M8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@
M-2XT<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B
M;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A
M9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`R,C(L,C<S(#PO<#X\+W1D
M/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG
M+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@
M<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X.'!T.R!P861D:6YG+7)I
M9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT
M.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M
M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@
M,&EN(#!P="<^0V]N<W1R=6-T:6]N(&EN('!R;V=R97-S/"]P/CPO=&0^(#QT
M9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[
M(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B
M86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U
M+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@]
M,T0Q,#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@
M<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#<U+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CIR:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-
M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[(#0L,3(W+#,Y-B`\+W`^/"]T9#X@/'1D('=I9'1H
M/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P,2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@-S4N-W!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R
M9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D
M:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..G)I9VAT.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP
M:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#XF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#L@,RPV.#@L-38W(#PO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I
M9'1H/3-$,C4Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#$X.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%
M+4A%24=(5#IN;W)M86P[(%1%6%0M24Y$14Y4.C$P+C`U<'0[($U!4D=)3CHP
M:6X@,&EN(#!P="<^/&(^5&]T86P\+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS
M1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#$@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F
M,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z
M('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S4N
M-W!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT
M.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI
M9VX],T1R:6=H=#XF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,3,L-SDY+#DQ-R`\+W`^/"]T
M9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W
M:61T:#TS1#$P,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D
M97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I
M;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`Q,RPS
M,#4L,C8W(#PO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X
M.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^3&5S<SH@86-C=6UU;&%T960@9&5P
M<F5C:6%T:6]N/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#$@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S4N-W!T.R!P861D:6YG+7)I
M9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT
M.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M
M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%24=(5#IN
M;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#XF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[*#0L-3$Q+#8U."D\+W`^/"]T9#X@/'1D('=I9'1H/3-$
M,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P,2!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P
M9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@
M=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW
M<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P
M.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V
M86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ<FEG:'0[
M($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG
M;CTS1')I9VAT/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`H-"PR-S,L,S<S*3PO<#X\+W1D
M/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG
M+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@
M<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X.'!T.R!P861D:6YG+7)I
M9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT
M.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M
M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@
M,&EN(#!P="<^/&(^4')O<&5R='D@86YD($5Q=6EP;65N="P@;F5T/"]B/CPO
M<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@
M/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O
M=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B!W:6YD;W=T97AT(#%P="!S;VQI
M9#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT
M.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI
M9VX],T1R:6=H=#XF;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#DL,C@X+#(U.2`\+W`^/"]T
M9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W
M:61T:#TS1#$P,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT
M(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S4N-W!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIR:6=H=#L@3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$
M<FEG:'0^)FYB<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`Y+#`S,2PX.30@/"]P/CPO=&0^/"]T
M<CX\+W1A8FQE/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M0554
M3U-004-%.B<@86QI9VX],T1C96YT97(^)FYB<W`[/"]P/B`\<"!S='EL93TS
M1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$58
M5"U!551/4U!!0T4Z.R!T86(M<W1O<',Z-3`P+C%P="<^)FYB<W`[/"]P/B`\
M<"!S='EL93TS1"=415A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/B9N
M8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/
M4U!!0T4Z)SY#;VYS=')U8W1I;VX@:6X@<')O9W)E<W,@8V]N<VES=',@;V8@
M;6%C:&EN97)Y(&%N9"!C;VYS=')U8W1I;VX@<W5P<&QI97,@=&AA="!H879E
M(&)E96X@<&%I9"!F;W(L(&)U="!A<F4@;F]T('EE="!C;VUP;&5T960@86YD
M('!L86-E9"!I;G1O('!R;V1U8W1I;VXN)FYB<W`[)FYB<W`[3VYC92!T:&4@
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M;&QO=W,Z/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..FIU<W1I9GD[($Q)
M3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%5
M5$]34$%#13HG/B9N8G-P.SPO<#X@/'1A8FQE('=I9'1H/3-$,S4Y('-T>6QE
M/3-$)TU!4D=)3CIA=71O(&%U=&\@875T;R`M,"XW-7!T.R!724142#HR-CEP
M=#L@0D]21$52+4-/3$Q!4%-%.F-O;&QA<'-E)R!C96QL<&%D9&EN9STS1#`@
M8V5L;'-P86-I;F<],T0P/B`\='(^(#QT9"!W:61T:#TS1#(U,2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@,3@X<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN
M(#!P="<@86QI9VX],T1C96YT97(^07-S970\+W`^/"]T9#X@/'1D('=I9'1H
M/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#DV('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`Q:6X[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M
M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@
M,&EN(#!P="<@86QI9VX],T1C96YT97(^)FYB<W`[3&EF92`M('EE87)S(#PO
M<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X.'!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)
M3CHP:6X@,&EN(#!P="<^4&5R;6ET(&]F(&QA;F0@=7-E/"]P/CPO=&0^(#QT
M9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[
M(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B
M86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U
M+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@]
M,T0Y-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`Q:6X[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M8V5N=&5R.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P
M="<@86QI9VX],T1C96YT97(^-#`@+2`W,#PO<#X\+W1D/CPO='(^(#QT<CX@
M/'1D('=I9'1H/3-$,C4Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#$X.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS
M1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^0G5I
M;&1I;F<\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I
M9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT
M.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M
M/CPO=&0^(#QT9"!W:61T:#TS1#DV('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#%I;CL@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CXR,"`M(#,U/"]P
M/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0R-3$@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@X<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)SY0;&%N="P@;6%C:&EN97)Y(&%N9"!E<75I<&UE;G0\
M+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^
M(#QT9"!W:61T:#TS1#DV('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#%I;CL@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CXQ,#PO<#X\+W1D/CPO='(^
M(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X.'!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
M='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P
M="<^36]T;W(@=F5H:6-L93PO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P
M9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@
M=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.38@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,6EN.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R
M/C4@+2`Q,#PO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X
M.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^3V9F:6-E(&5Q=6EP;65N=#PO<#X\
M+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D
M('=I9'1H/3-$.38@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@,6EN.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4
M+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C,M-3PO<#X\+W1D/CPO='(^/"]T
M86)L93X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)
M1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#
M13HG(&%L:6=N/3-$8V5N=&5R/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG(&%L:6=N/3-$8V5N=&5R/B9N
M8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/
M4U!!0T4Z)SY&;W(@=&AE('1H<F5E(&UO;G1H<R!E;F1E9"!-87)C:"`S,2P@
M,C`Q,R!A;F0@,C`Q,BP@9&5P<F5C:6%T:6]N(&5X<&5N<V4@=V%S("0R,30L
M-#`V(&%N9"`D,C$R+#0R-"P@<F5S<&5C=&EV96QY+CPO<#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S`V,#!F-S$S7S!B,31?
M-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C-F(T,C`O
M5V]R:W-H965T<R]3:&5E=#$P+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^24Y404Y'24),12!!4U-%5%,\8G(^/"]S=')O;F<^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY)3E1!3D=)0DQ%
M($%34T544SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y)3E1!3D=)0DQ%($%34T544SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/"$M+65G>"TM/CQP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/CQB
M/DY/5$4@-2`M($E.5$%.1TE"3$4@05-31513/"]B/CPO<#X@/'`@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%
M6%0M05543U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G/B9N8G-P.SPO<#X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN
M;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SY)
M;G1A;F=I8FQE(&%S<V5T<R!R97!R97-E;G0@=&AE(&-O<W0@;V8@;65D:6-A
M;"!F;W)M=6QA<R!A<'!R;W9E9"!F;W(@<')O9'5C=&EO;B!B>2!T:&4@0T9$
M02!I;B!#:&EN82X@1'5R:6YG('1H92!T:')E92!M;VYT:',@96YD960@36%R
M8V@@,S$L(#(P,3,@;W(@,C`Q,BP@=&AE($-O;7!A;GD@9&ED(&YO="!O8G1A
M:6X@0T9$02!P<F]D=6-T:6]N(&%P<')O=F%L(&9O<B!A;GD@;65D:6-A;"!F
M;W)M=6QA(&%N9"!T:&5R969O<F4@=&AE<F4@=V5R92!N;R!C;W-T<R!R96-L
M87-S:69I960@9G)O;2!A9'9A;F-E<R!T;R!M961I8V%L(&9O<FUU;&%S+CPO
M<#X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0[(%1%6%0M05543U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G
M/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,
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M;&%T:6YG('1O(&EN=&%N9VEB;&4@87-S971S('=A<R`D,3,V+#`V,B!A;F0@
M)#$U,BPW.3D@9F]R('1H92!T:')E92!M;VYT:',@96YD960@36%R8V@@,S$L
M(#(P,3,@86YD(#(P,3(L(')E<W!E8W1I=F5L>2X@365D:6-A;"!F;W)M=6QA
M<R!T>7!I8V%L;'D@9&\@;F]T(&AA=F4@82!R97-I9'5A;"!V86QU92!A="!T
M:&4@96YD(&]F('1H96ER(&%M;W)T:7IA=&EO;B!P97)I;V0N/"]P/B`\<"!S
M='EL93TS1"=415A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA
M;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/B9N8G-P
M.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%
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M(&1U<FEN9R!T:&4@=&AR964@;6]N=&AS(&5N9&5D($UA<F-H(#,Q+"`R,#$S
M(&]R(#(P,3(N/"]P/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[
M($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z.R!T86(M<W1O
M<',Z-3`P+C%P="<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T.R!415A4+4%55$]34$%#13HG/D%T($UA<F-H(#,Q+"`R,#$S(&%N9"!$
M96-E;6)E<B`S,2P@,C`Q,BP@:6YT86YG:6)L92!A<W-E=',@8V]N<VES=&5D
M('-O;&5L>2!O9B!#1D1!(&%P<')O=F5D(&UE9&EC86P@9F]R;75L87,@87,@
M9F]L;&]W<SH\+W`^(#QT86)L92!W:61T:#TS1#,Y,R!S='EL93TS1"=-05)'
M24XZ875T;R!A=71O(&%U=&\@+3`N-S5P=#L@5TE$5$@Z,CDT+CEP=#L@0D]2
M1$52+4-/3$Q!4%-%.F-O;&QA<'-E)R!C96QL<&%D9&EN9STS1#`@8V5L;'-P
M86-I;F<],T0P/B`\='(^(#QT9"!W:61T:#TS1#$X-R!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q-#!P=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q-B!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q,G!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO
M=&0^(#QT9"!W:61T:#TS1#DQ('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F
M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#8X+C)P=#L@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CY-87)C:"`S
M,2P\+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X\+W1D/B`\=&0@=VED=&@],T0X."!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V-2XW<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C96YT97(^/&(^1&5C
M96UB97(@,S$L/"]B/CPO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$
M,3@W('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#$T,'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$V('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$R
M<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P
M.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V
M86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.3$@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#8X+C)P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXR,#$S/"]B/CPO<#X\+W1D/B`\=&0@
M=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M
M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$
M.#@@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L
M:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#8U+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%2
M1TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXR,#$R/"]B/CPO
M<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,3@W('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$T,'!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)
M3CHP:6X@,&EN(#!P="<^1W)O<W,@8V%R<GEI;F<@86UO=6YT/"]P/CPO=&0^
M(#QT9"!W:61T:#TS1#$V('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#$R<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B
M;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A
M9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I
M9'1H/3-$.3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@-C@N,G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)"9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`U+#,X-RPP-S4@/"]P/CPO
M=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F
M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@
M=VED=&@],T0X."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`V-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D
M97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I
M;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LD
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#4L,S4W+#4X,"`\+W`^
M/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#$X-R!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q-#!P=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ
M,&EN(#!I;B`P<'0G/D%C8W5M=6QA=&5D(&%M;W)T:7IA=&EO;CPO<#X\+W1D
M/B`\=&0@=VED=&@],T0Q-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F
M,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I
M;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F
M=#H@-2XT<'0[('=I9'1H.B`Q,G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W
M:61T:#TS1#DQ('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#8X+C)P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`H,RPP.3<L,C(T
M*3PO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T
M9#X@/'1D('=I9'1H/3-$.#@@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@-C4N-W!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL
M93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[("@R+#DT-"PW
M,C8I/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0Q.#<@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,30P<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)SY.970@8V%R<GEI;F<@86UO=6YT/"]P/CPO
M=&0^(#QT9"!W:61T:#TS1#$V('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F
M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#$R<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D
M('=I9'1H/3-$.3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X
M="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8X+C)P=#L@<&%D9&EN9RUR:6=H
M=#H@-2XT<'0[(&)O<F1E<BUT;W`Z('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[(#(L,C@Y+#@U,2`\+W`^/"]T9#X@/'1D('=I9'1H/3-$
M,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#@X('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`V-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
M='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P
M="<^)FYB<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`R+#0Q
M,BPX-30@/"]P/CPO=&0^/"]T<CX\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q-%\T.3@P7V$P
M,3-?-CEC9C=C8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,"]7;W)K<VAE
M971S+U-H965T,3$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY!1%9!3D-%4R!&3U(@4%520TA!4T53($]&($E.5$%.1TE"3$4@
M05-31513+CQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N
M(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/D%$5D%.0T53($9/4B!055)#2$%315,@3T8@24Y404Y'24),
M12!!4U-%5%,N/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D%$5D%.0T53($9/4B!055)#2$%315,@3T8@24Y404Y'24),12!!
M4U-%5%,N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM96=X
M+2T^/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^/&(^3D]412`V("8C,34P.R!!
M1%9!3D-%4R!&3U(@4%520TA!4T53($]&($E.5$%.1TE"3$4@05-31513/"]B
M/CPO<#X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ
M,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ
M<'0G/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y
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M92!R96QA=&5D('!A=&5N=',@:&%V92!N;W0@97AP:7)E9"X\+W`^(#QP('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T
M.R!415A4+4%55$]34$%#13H[('1A8BUS=&]P<SHU,#`N,7!T)SXF;F)S<#L\
M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%
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M8V5S<R!F<F]M('1H92!P;VEN="!O9B!T:&4@8V]N=')A8W0N/"]P/B`\<"!S
M='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P
M=#L@5$585"U!551/4U!!0T4Z.R!T86(M<W1O<',Z-3`P+C%P="<^)FYB<W`[
M/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)
M1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#
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M(&UE9&EC86P@9F]R;75L82!C;VYT<F%C=',N/"]P/B`\<"!S='EL93TS1"=,
M24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!
M551/4U!!0T4Z.R!T86(M<W1O<',Z-3`P+C%P="<^)FYB<W`[/"]P/B`\<"!S
M='EL93TS1"=415A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA
M;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/E5N9&5R
M('1H92!T97)M<R!O9B!T:&4@8V]N=')A8W1S+"!T:&4@;&%B;W)A=&]R:65S
M(&%R92!R97%U:7)E9"!T;R!O8G1A:6X@<')O9'5C=&EO;B!A<'!R;W9A;"`H
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M97,@;V8@:6YT86YG:6)L92!A<W-E=',N/"]P/B`\<"!S='EL93TS1"=415A4
M+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/B9N8G-P.SPO<#X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN;W)M86P[
M($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SY4;R!D871E
M+"!N;R!F;W)M=6QA(&AA<R!F86EL960@=&\@<F5C96EV92!#1D1!('!R;V1U
M8W1I;VX@87!P<F]V86P@;F]R(&AA<R!T:&4@0V]M<&%N>2!B965N(&EN9F]R
M;65D(&]R(&)E8V]M92!A=V%R92!O9B!A;GD@9F]R;75L82!T:&%T(&UA>2!F
M86EL('1O(')E8V5I=F4@<W5C:"!A<'!R;W9A;"X@2&]W979E<BP@=&AE<F4@
M:7,@;F\@87-S=7)A;F-E('1H870@=&AE(&UE9&EC86P@<')O9'5C=',@=VEL
M;"!R96-E:79E('!R;V1U8W1I;VX@87!P<F]V86P@86YD(&EF('1H92!#;VUP
M86YY(&1O97,@;F]T(')E8V5I=F4@<W5C:"!A<'!R;W9A;"P@:70@=VEL;"!E
M;F9O<F-E(&ET<R!C;VYT<F%C='5A;"!R:6=H=',@=&\@<F5C96EV92!T:&4@
M<F5F=6YD(&9R;VT@=&AE(&QA8F]R871O<GD@;W(@:&%V92!T:&4@<&%Y;65N
M=',@87!P;&EE9"!T;R!A;F]T:&5R(&UE9&EC86P@9F]R;75L82!W:71H('1H
M92!S86UE(&QA8F]R871O<GDN/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T.R!415A4+4%55$]34$%#13HG/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)
M3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SY!="!-87)C:"`S,2P@
M,C`Q,RP@=&AE($-O;7!A;GD@=V%S(&]B;&EG871E9"!T;R!P87D@;&%B;W)A
M=&]R:65S(&%N9"!O=&AE<G,@87!P<F]X:6UA=&5L>2`D-BPU,3DL,#`P('5P
M;VX@8V]M<&QE=&EO;B!O9B!T:&4@=F%R:6]U<R!P:&%S97,@;V8@8V]N=')A
M8W1S('1O('!R;W9I9&4@0T9$02!P<F]D=6-T:6]N(&%P<')O=F%L(&]F(&UE
M9&EC86P@9F]R;75L87,N/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C
M8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S`V,#!F-S$S
M7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,"]7;W)K<VAE971S+U-H965T
M,3(N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY2
M14Q!5$5$(%!!4E19(%1204Y304-424].4SQB<CX\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E)%3$%4140@4$%25%D@5%)!
M3E-!0U1)3TY3/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E)%3$%4140@4$%25%D@5%)!3E-!0U1)3TY3/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM96=X+2T^/'`@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M0554
M3U-004-%.B<^/&(^3D]412`W("8C,34P.R!214Q!5$5$(%!!4E19(%1204Y3
M04-424].4SPO8CX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF
M>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%
M6%0M05543U-004-%.B<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,
M24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P
M:6X@,'!T.R!415A4+4%55$]34$%#13HG/E1O=&%L(&%D=F%N8V5S(&]W:6YG
M('1O(&$@8F]A<F0@;65M8F5R('=E<F4@)#$L,S4T+#4V-R!A;F0@)#$L,S4T
M+#4V-R!A<R!O9B!-87)C:"`S,2P@,C`Q,R!A;F0@1&5C96UB97(@,S$L(#(P
M,3(L(')E<W!E8W1I=F5L>2P@86YD(&%R92!R96-O<F1E9"!A<R!O=&AE<B!P
M87EA8FQE<R`F(S$U,#L@<F5L871E9"!P87)T:65S(&]N('1H92!A8V-O;7!A
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M=&AS(&5N9&5D($UA<F-H(#,Q+"`R,#$S(&%N9"`R,#$R+CPO<#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S`V,#!F-S$S7S!B
M,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,`T*0V]N=&5N="U,;V-A=&EO;CH@
M9FEL93HO+R]#.B\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C-F(T
M,C`O5V]R:W-H965T<R]3:&5E=#$S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M
M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X
M="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D
M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%3$4^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^3D]415,@4$%904),13QB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DY/5$53(%!!64%"
M3$53/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DY/5$53(%!!64%"3$4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CPA+2UE9W@M+3X\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!
M4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SX\8CY.3U1%(#@@
M)B,Q-3`[($Y/5$53(%!!64%"3$4\+V(^/"]P/B`\<"!S='EL93TS1"=,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/
M4U!!0T4Z.R!T86(M<W1O<',Z-3`P+C%P="<^)FYB<W`[/"]P/B`\<"!S='EL
M93TS1"=415A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/D]N($]C=&]B
M97(@,S`L(#(P,3(L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A(&YE=R!R
M979O;'9I;F<@;&EN92!O9B!C<F5D:70@=VET:"!A;F]T:&5R(&)A;FL@:6X@
M=&AE(&%M;W5N="!O9B!234(@,S`L,#`P+#`P,"XF;F)S<#M4:&4@<F5L871E
M9"!N;W1E('!A>6%B;&4@8F5A<G,@:6YT97)E<W0@870@86X@86YN=6%L(')A
M=&4@;V8@-BXY,"4@*&)A<V5D('5P;VX@,3$U)2!O9B!T:&4@4%)#(&=O=F5R
M;FUE;G0F(S$T-CMS(&-U<G)E;G0@<VAO<G0@=&5R;2!R871E(&]F(#8N,#`E
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M9&ET('=A<R!234(@,S`L,#`P+#`P,"`H)#0L-S@W+#(X-2D@87,@;V8@36%R
M8V@@,S$L(#(P,3,N)FYB<W`[)FYB<W`[5&AE($-O;7!A;GD@:&%S(&YO(&%D
M9&ET:6]N86P@86UO=6YT<R!A=F%I;&%B;&4@=&\@:70@=6YD97(@=&AE(&QI
M;F4@;V8@8W)E9&ET+B9N8G-P.R9N8G-P.U1H:7,@86UO=6YT(&AA<R!B965N
M(&-L87-S:69I960@87,@<VAO<G0M=&5R;2!N;W1E<R!P87EA8FQE(&EN('1H
M92!A8V-O;7!A;GEI;F<@8V]N<V]L:61A=&5D(&)A;&%N8V4@<VAE970@870@
M1&5C96UB97(@,S$L(#(P,3(N/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T.R!415A4+4%55$]34$%#13HG/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G
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M(#,Q+"`R,#$S(&%N9"!$96-E;6)E<B`S,2P@,C`Q,B!A<'!R;WAI;6%T960@
M=&AE:7(@9F%I<B!V86QU92!B96-A=7-E(&]F(&5I=&AE<B!T:&4@:6UM961I
M871E(&]R('-H;W)T+71E<FT@;6%T=7)I='D@;V8@=&AE<V4@9FEN86YC:6%L
M(&EN<W1R=6UE;G1S(&]R(&)E8V%U<V4@=&AE('5N9&5R;'EI;F<@:6YS=')U
M;65N=',@8F5A<B!I;G1E<F5S="!R871E<R!T:&%T(&%P<')O>&EM871E9"!C
M=7)R96YT(&UA<FME="!R871E<RXF;F)S<#L\+W`^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-C`P9C<Q,U\P8C$T7S0Y.#!?
M83`Q,U\V.6-F-V-C-F(T,C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
M0SHO,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P+U=O<FMS
M:&5E=',O4VAE970Q-"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG
M.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@
M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/DE.0T]-12!405A%4SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DE.0T]-12!405A%4SPO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)3D-/344@5$%8
M15,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CPA+2UE9W@M+3X\
M<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN
M(#!P=#L@5$585"U!551/4U!!0T4Z)SX\8CY.3U1%(#D@+2!)3D-/344@5$%8
M15,\+V(^/"]P/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!
M4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z.R!T86(M<W1O<',Z
M-3`P+C%P="<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..FIU
M<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T
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M;F%C=&UE;G0@9&%T92X\+W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13H[('1A
M8BUS=&]P<SHU,#`N,7!T)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^56YD:7-T<FEB=71E9"!E87)N
M:6YG<R!O9B!(96QP<V]N+"!T:&4@0V]M<&%N>28C,30V.W,@9F]R96EG;B!S
M=6)S:61I87)Y+"!S:6YC92!I=',@86-Q=6ES:71I;VXL(&%M;W5N=&5D('1O
M(&%P<')O>&EM871E;'D@)#$Q,"XU(&UI;&QI;VX@870@36%R8V@@,S$L(#(P
M,3,N(%1H;W-E(&5A<FYI;F=S+"!A<R!W96QL(&%S('1H92!I;G9E<W1M96YT
M(&EN($AE;'!S;VX@;V8@87!P<F]X:6UA=&5L>2`D,C,N,R!M:6QL:6]N+"!A
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M8FEL:71Y+CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,
M24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!
M551/4U!!0T4Z)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0[(%1%6%0M05543U-004-%.B<^56YD97(@8W5R<F5N="!T87@@;&%W(&EN
M('1H92!04D,L('1H92!#;VUP86YY(&ES(&%N9"!W:6QL(&)E('-U8FIE8W0@
M=&\@=&AE(&9O;&QO=VEN9R!E;G1E<G!R:7-E(&EN8V]M92!T87@@<F%T97,Z
M/"]P/B`\=&%B;&4@=VED=&@],T0R-#`@<W1Y;&4],T0G34%21TE..F%U=&\@
M875T;R!A=71O("TP+C<U<'0[(%=)1%1(.C(N-6EN.R!"3U)$15(M0T],3$%0
M4T4Z8V]L;&%P<V4G(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`^
M(#QT<CX@/'1D('=I9'1H/3-$.38@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M
M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG
M+6QE9G0Z(#4N-'!T.R!W:61T:#H@,6EN.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT
M9"!W:61T:#TS1#(U('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[
M(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B
M86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U
M+C1P=#L@=VED=&@Z(#$Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D
M97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I
M;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H
M/3-$,3$Y('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#%P="!S;VQI
M9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@.#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG(')O=W-P86X],T0R('9A;&EG;CTS1&)O='1O;3X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CY%
M;G1E<G!R:7-E($EN8V]M92!487@@4F%T93PO8CX\+W`^/"]T9#X\+W1R/B`\
M='(^(#QT9"!W:61T:#TS1#DV('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I
M;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q:6X[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG
M:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T
M;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C96YT97(^
M/&(^665A<CPO8CX\+W`^/"]T9#X@/'1D('=I9'1H/3-$,C4@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$.38@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,6EN.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$
M8V5N=&5R/C(P,3,\+W`^/"]T9#X@/'1D('=I9'1H/3-$,C4@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,3D@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.#EP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4
M.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CXQ
M-24\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#DV('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#%I;CL@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M
M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E
M;G1E<CXR,#$T(&%N9"!A9G1E<CPO<#X\+W1D/B`\=&0@=VED=&@],T0R-2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q
M.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$Q.2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`X.7!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$
M8V5N=&5R/C(U)3PO<#X\+W1D/CPO='(^/"]T86)L93X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13H[('1A8BUS=&]P<SHU,#`N
M,7!T)R!A;&EG;CTS1&-E;G1E<CXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ
M,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^5&AE('!R;W9I<VEO;B!F
M;W(@:6YC;VUE('1A>&5S(&-O;G-I<W1E9"!O9B!T:&4@9F]L;&]W:6YG.CPO
M<#X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0[(%1%6%0M05543U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G
M/B9N8G-P.SPO<#X@/'1A8FQE('=I9'1H/3-$-3$U('-T>6QE/3-$)TU!4D=)
M3CIA=71O(&%U=&\@875T;R`M,"XW-7!T.R!724142#HS.#9P=#L@0D]21$52
M+4-/3$Q!4%-%.F-O;&QA<'-E)R!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I
M;F<],T0P/B`\='(^(#QT9"!W:61T:#TS1#,P-"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R,CAP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@
M/'1D('=I9'1H/3-$,3DY(&-O;'-P86X],T0S('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P
M9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@
M=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q-#EP
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([
M($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG
M;CTS1&-E;G1E<CX\8CY4:')E92!M;VYT:',@96YD960@36%R8V@@,S$L/"]B
M/CPO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,S`T('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#(R.'!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X\+W1D/B`\=&0@=VED=&@],T0Y."!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S,N-G!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$
M8V5N=&5R/CQB/C(P,3,\+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F
M,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z
M('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,2XX
M<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P
M.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V
M86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.3@@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#<S+C9P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXR,#$R/"]B/CPO<#X\+W1D/CPO='(^
M(#QT<CX@/'1D('=I9'1H/3-$,S`T('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#(R.'!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
M='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P
M="<^0W5R<F5N=#PO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.3@@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S,N-G!T.R!P861D:6YG+7)I
M9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT
M.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M
M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@
M,&EN(#!P="<^)FYB<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R`M)FYB<W`[)FYB<W`[(#PO<#X\+W1D/B`\=&0@=VED=&@],T0R
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#$N.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#DX('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<S+C9P
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L
M.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#L@-38T+#@Y,R`\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS
M1#,P-"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`R,CAP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/D1E9F5R<F5D/"]P/CPO
M=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F
M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@
M=VED=&@],T0Y."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT
M(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S,N-G!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\
M<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN
M(#!P="<^)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[("@R-CDL,#$Q*3PO
M<#X\+W1D/B`\=&0@=VED=&@],T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#$N.'!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^
M(#QT9"!W:61T:#TS1#DX('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O
M=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W,RXV<'0[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG
M:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T
M;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#L@*#,T+#,Q,BD\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS
M1#,P-"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`R,CAP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/CQB/E1O=&%L(&EN8V]M
M92!T87@@*&)E;F5F:70I(&5X<&5N<V4\+V(^/"]P/CPO=&0^(#QT9"!W:61T
M:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Y."!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@-S,N-G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R
M9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D
M:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,
M24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[
M)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R`H,C8Y+#`Q,2D\+W`^/"]T9#X@/'1D('=I9'1H/3-$,B!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q
M+CAP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Y."!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@-S,N-G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)"9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R`U,S`L-3@Q(#PO<#X\+W1D/CPO='(^/"]T86)L
M93X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4
M.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13H[
M('1A8BUS=&]P<SHU,#`N,7!T)R!A;&EG;CTS1&-E;G1E<CXF;F)S<#L\+W`^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN
M;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z.R!T
M86(M<W1O<',Z-3`P+C%P="<@86QI9VX],T1C96YT97(^)FYB<W`[/"]P/B`\
M<"!S='EL93TS1"=415A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/E1H
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M92!C=7)R96YT('!E<FEO9"X@/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T.R!415A4+4%55$]34$%#13HG/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G
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M<R!P87EA8FQE+CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R
M,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P-C`P9C<Q,U\P8C$T
M7S0Y.#!?83`Q,U\V.6-F-V-C-F(T,C`O5V]R:W-H965T<R]3:&5E=#$U+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^1D%)4B!6
M04Q512!-14%355)%345.5%,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY&04E2(%9!3%5%($U%05-54D5-14Y44SPO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&04E2
M(%9!3%5%($U%05-54D5-14Y44SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/"$M+65G>"TM/CQP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA
M;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/CQB/DY/
M5$4@,3`@)B,Q-3`[($9!25(@5D%,544@345!4U5214U%3E13/"]B/CPO<#X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN
M;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SXF
M;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M0554
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M86)I;&ET:65S(&%S(&9O;&QO=W,Z($QE=F5L(#$@)B,Q-3`[(%%U;W1E9"!P
M<FEC97,@:6X@86-T:79E(&UA<FME=',@9F]R(&ED96YT:6-A;"!A<W-E=',@
M;W(@;&EA8FEL:71I97,N($QE=F5L(#(@)B,Q-3`[($]B<V5R=F%B;&4@:6YP
M=71S(&]T:&5R('1H86X@3&5V96P@,2!I;F-L=61I;F<@<75O=&5D('!R:6-E
M<R!F;W(@<VEM:6QA<B!A<W-E=',@;W(@;&EA8FEL:71I97,L('%U;W1E9"!P
M<FEC97,@:6X@;&5S<R!A8W1I=F4@;6%R:V5T<RP@;W(@;W1H97(@;V)S97)V
M86)L92!I;G!U=',@=&AA="!C86X@8F4@8V]R<F]B;W)A=&5D(&)Y(&]B<V5R
M=F%B;&4@;6%R:V5T(&1A=&$N($QE=F5L(#,@)B,Q-3`[(%5N;V)S97)V86)L
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M;6%N86=E;65N="!J=61G;65N="!O<B!E<W1I;6%T:6]N+CPO<#X@/'`@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[
M(%1%6%0M05543U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G/B9N8G-P.SPO
M<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(
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M<R!O9B!-87)C:"`S,2P@,C`Q,R!A;F0@1&5C96UB97(@,S$L(#(P,3(Z)FYB
M<W`[/"]P/B`\9&EV(&%L:6=N/3-$8V5N=&5R/B`\=&%B;&4@=VED=&@],T0U
M-#D@<W1Y;&4],T0G34%21TE..F%U=&\@875T;R!A=71O("TP+C<U<'0[(%=)
M1%1(.C0Q,2XU-7!T.R!"3U)$15(M0T],3$%04T4Z8V]L;&%P<V4G(&-E;&QP
M861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`^(#QT<CX@/'1D('=I9'1H/3-$
M,38P('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#$R,'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,C(@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.3$N-7!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X\+W1D/B`\=&0@=VED=&@],T0R-#,@8V]L<W!A;CTS1#4@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@R+C`U<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,
M24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX]
M,T1C96YT97(^/&(^1F%I<B!686QU92!-96%S=7)E;65N=',@870\+V(^/"]P
M/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0Q-C`@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3(P<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO
M=&0^(#QT9"!W:61T:#TS1#$R,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`Y,2XU<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@
M/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F
M,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R
M9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D
M:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T
M:#TS1#(T,R!C;VQS<&%N/3-$-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W
M:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@R+C`U<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C
M96YT97(^/&(^4F5P;W)T:6YG($1A=&4@57-I;F<\+V(^/"]P/CPO=&0^/"]T
M<CX@/'1R/B`\=&0@=VED=&@],T0Q-C`@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$R,'!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!
M4D=)3CHP:6X@,&EN(#!P="<^/&(^1&5S8W)I<'1I;VX\+V(^/"]P/CPO=&0^
M(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED
M=&@],T0Q,C(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q
M<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#DQ+C5P=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CIR:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L
M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^/&(^36%R8V@@
M,S$L(#(P,3,\+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0V-2!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F
M,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z
M('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-#EP
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([
M($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG
M;CTS1&-E;G1E<CX\8CY,979E;"`Q/"]B/CPO<#X\+W1D/B`\=&0@=VED=&@]
M,T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P-B!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@-SDN.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CY,979E;"`R/"]B/CPO
M<#X\+W1D/B`\=&0@=VED=&@],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^
M(#QT9"!W:61T:#TS1#8U('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O
M=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`T.7!T.R!P861D:6YG+7)I
M9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT
M.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M
M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z
M;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB
M/DQE=F5L(#,\+V(^/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0Q
M-C`@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@,3(P<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SY"86YK97(G<R!A8V-E<'1A
M;F-E(&YO=&5S/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,C(@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#DQ+C5P
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L
M.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,2PQ.#`L.#8T
M/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D
M/B`\=&0@=VED=&@],T0V-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD
M;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-#EP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P
M.R9N8G-P.R`\+W`^/"]T9#X@/'1D('=I9'1H/3-$,R!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R+C%P=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#8@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<Y+C@U
M<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P
M.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V
M86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA
M;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#$L,3@P+#@V-#PO<#X\+W1D
M/B`\=&0@=VED=&@],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W
M:61T:#TS1#8U('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@
M,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`T.7!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
M='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P
M="<^)FYB<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`M)FYB<W`[)FYB<W`[
M(#PO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,38P('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$R,'!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!
M4D=)3CHP:6X@,&EN(#!P="<^5&]T86P\+W`^/"]T9#X@/'1D('=I9'1H/3-$
M,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R,B!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@.3$N-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)"9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R`Q+#$X,"PX-C0\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#8U('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`T
M.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)"9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R`M)FYB<W`[)FYB<W`[(#PO<#X\+W1D/B`\=&0@=VED=&@],T0S
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P-B!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@-SDN.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,2PQ
M.#`L.#8T/"]P/CPO=&0^(#QT9"!W:61T:#TS1#,@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,BXQ<'0[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG
M:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T
M;VT^/"]T9#X@/'1D('=I9'1H/3-$-C4@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#0Y<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%2
M1TE..C!I;B`P:6X@,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M("TF;F)S<#LF;F)S<#L@/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@]
M,T0Q-C`@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@,3(P<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3(@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R,B!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y,2XU<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/CPO=&0^(#QT9"!W:61T:#TS1#8U('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#0Y<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T
M9#X@/'1D('=I9'1H/3-$,R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F
M,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I
M;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F
M=#H@-2XT<'0[('=I9'1H.B`R+C%P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@
M=VED=&@],T0Q,#8@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@-SDN.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED
M=&@],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#8U
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#0Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS
M1#$V,"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`Q,C!P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,B!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y
M<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P
M.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V
M86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3(R('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#DQ+C5P=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG
M:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T
M;VT^/"]T9#X@/'1D('=I9'1H/3-$-C4@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-#EP=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D
M/B`\=&0@=VED=&@],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W
M:61T:#TS1#$P-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`W.2XX-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R
M9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D
M:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T
M:#TS1#,@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@,BXQ<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$-C4@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M-#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$
M,38P('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#$R,'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,C(@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.3$N-7!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X\+W1D/B`\=&0@=VED=&@],T0R-#,@8V]L<W!A;CTS1#4@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@R+C`U<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,
M24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX]
M,T1C96YT97(^/&(^1F%I<B!686QU92!-96%S=7)E;65N=',@870\+V(^/"]P
M/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0Q-C`@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3(P<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO
M=&0^(#QT9"!W:61T:#TS1#$R,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`Y,2XU<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@
M/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F
M,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R
M9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D
M:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T
M:#TS1#(T,R!C;VQS<&%N/3-$-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W
M:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@R+C`U<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C
M96YT97(^/&(^4F5P;W)T:6YG($1A=&4@57-I;F<\+V(^/"]P/CPO=&0^/"]T
M<CX@/'1R/B`\=&0@=VED=&@],T0Q-C`@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$R,'!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!
M4D=)3CHP:6X@,&EN(#!P="<^/&(^1&5S8W)I<'1I;VX\+V(^/"]P/CPO=&0^
M(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED
M=&@],T0Q,C(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q
M<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#DQ+C5P=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CIR:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L
M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^/&(^1&5C96UB
M97(@,S$L(#(P,3(\+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0V-2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M-#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT
M97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A
M;&EG;CTS1&-E;G1E<CX\8CY,979E;"`Q/"]B/CPO<#X\+W1D/B`\=&0@=VED
M=&@],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P
M-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI
M9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@-SDN.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%2
M1TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CY,979E;"`R/"]B
M/CPO<#X\+W1D/B`\=&0@=VED=&@],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO
M=&0^(#QT9"!W:61T:#TS1#8U('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I
M;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`T.7!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R
M/CQB/DQE=F5L(#,\+V(^/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@]
M,T0Q-C`@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@,3(P<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SY"86YK97(G<R!A8V-E
M<'1A;F-E(&YO=&5S/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,C(@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#DQ
M+C5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R
M;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#L@,3`Q+#4W,"`\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#8U('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`T.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)"9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R`M)FYB<W`[)FYB<W`[(#PO<#X\+W1D/B`\=&0@=VED
M=&@],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P
M-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI
M9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@-SDN.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N
M8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#L@,3`Q+#4W,"`\+W`^/"]T9#X@/'1D('=I
M9'1H/3-$,R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`R+C%P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0V
M-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI
M9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@-#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P
M.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N8G-P.R`\+W`^/"]T
M9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#$V,"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q,C!P=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0G/E1O=&%L/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,C(@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#DQ+C5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#L@,3`Q+#4W,"`\+W`^/"]T9#X@/'1D('=I9'1H/3-$
M,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#8U('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`T.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)"9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R`M)FYB<W`[)FYB<W`[(#PO<#X\+W1D/B`\=&0@
M=VED=&@],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS
M1#$P-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S
M;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@-SDN.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G
M/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,3`Q+#4W,"`\+W`^/"]T9#X@/'1D
M('=I9'1H/3-$,R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`R+C%P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@]
M,T0V-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S
M;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@-#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N
M8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N8G-P.R`\+W`^
M/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^(#QP('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#
M13HG/CQB/B9N8G-P.SPO8CX\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F
M-V-C-F(T,C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#8P,&8W
M,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P+U=O<FMS:&5E=',O4VAE
M970Q-BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M
M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB
M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/E-43T-+2$],1$524R<@15%52519/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4U1/0TM(3TQ$15)3)R!%455)5%D\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4U1/
M0TM(3TQ$15)3)R!%455)5%D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CPA+2UE9W@M+3X\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[
M($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SX\8CY.3U1%
M(#$Q("T@4U1/0TM(3TQ$15)3)R!%455)5%D\+V(^/"]P/B`\<"!S='EL93TS
M1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$58
M5"U!551/4U!!0T4Z.R!T86(M<W1O<',Z-3`P+C%P="<^)FYB<W`[/"]P/B`\
M<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN
M(#!P=#L@5$585"U!551/4U!!0T4Z)SX\8CX\=2!S='EL93TS1'1E>'0M=6YD
M97)L:6YE.F)L86-K/E!R969E<G)E9"!A;F0@0V]M;6]N(%-T;V-K/"]U/CPO
M8CX\+W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13H[('1A8BUS=&]P<SHU,#`N
M,7!T)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF
M>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%
M6%0M05543U-004-%.B<^5&AE('1O=&%L(&YU;6)E<B!O9B!A=71H;W)I>F5D
M('-H87)E<R!I<R`Y-2PP,#`L,#`P('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@
M86YD(#4L,#`P+#`P,"!S:&%R97,@;V8@<')E9F5R<F5D('-T;V-K+B!4:&4@
M<')E9F5R<F5D('-T;V-K(&UA>2!B92!I<W-U960@:6X@<V5R:65S('=I=&@@
M<W5C:"!D97-I9VYA=&EO;G,L('!R969E<F5N8V5S+"!S=&%T960@=F%L=65S
M+"!R:6=H=',L('%U86QI9FEC871I;VYS(&]R(&QI;6ET871I;VYS(&%S(&1E
M=&5R;6EN960@<V]L96QY(&)Y('1H92!#;VUP86YY)B,Q-#8[<R!B;V%R9"!O
M9B!D:7)E8W1O<G,N/"]P/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z.R!T86(M
M<W1O<',Z-3`P+C%P="<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,
M24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P
M:6X@,'!T.R!415A4+4%55$]34$%#13HG/CQB/CQU('-T>6QE/3-$=&5X="UU
M;F1E<FQI;F4Z8FQA8VL^5V%R<F%N=',\+W4^/"]B/CPO<#X@/'`@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%
M6%0M05543U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G/B9N8G-P.SPO<#X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN
M;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SY!
M<R!O9B!-87)C:"`S,2P@,C`Q,RP@=&AE($-O;7!A;GD@:&%D('=A<G)A;G1S
M(&]U='-T86YD:6YG(&%N9"!E>&5R8VES86)L92!T;R!P=7)C:&%S92!A;B!A
M9V=R96=A=&4@;V8@,34P+#`P,"!S:&%R97,@;V8@=&AE($-O;7!A;GDG<R!C
M;VUM;VX@<W1O8VL@870@97AE<F-I<V4@<')I8V5S(')A;F=I;F<@9G)O;2`D
M,RXP,"!T;R`D,RXX,"!P97(@<VAA<F4L('=H:6-H(&5X<&ER92!-87D@,38L
M(#(P,3,N($%T($UA<F-H(#,Q+"`R,#$S+"!T:&4@=V%R<F%N=',@:&%D(&$@
M=V5I9VAT960M879E<F%G92!E>&5R8VES92!P<FEC92!O9B`D,RXT,"!P97(@
M<VAA<F4L(&$@=V5I9VAT960M879E<F%G92!R96UA:6YI;F<@8V]N=')A8W1U
M86P@;&EF92!O9B`P+C(@>65A<G,@86YD(&$@=&]T86P@:6YT<FEN<VEC('9A
M;'5E(&]F("0P+CPO<#X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L
M.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.CL@=&%B+7-T
M;W!S.C4P,"XQ<'0G/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN
M(#!P=#L@5$585"U!551/4U!!0T4Z)SX\8CX\=2!S='EL93TS1'1E>'0M=6YD
M97)L:6YE.F)L86-K/E-T;V-K(&%N9"!3=&]C:R!/<'1I;VYS/"]U/CPO8CX\
M+W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T.R!415A4+4%55$]34$%#13H[('1A8BUS=&]P<SHU,#`N,7!T
M)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@
M3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M
M05543U-004-%.B<^/&D^,C`Q,"!);F-E;G1I=F4@4&QA;CPO:3X\+W`^(#QP
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T.R!415A4+4%55$]34$%#13H[('1A8BUS=&]P<SHU,#`N,7!T)SXF;F)S
M<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-0
M04-%.B<^3VX@3F]V96UB97(@,3(L(#(P,3`L('1H92!#;VUP86YY)B,Q-#8[
M<R!";V%R9"!O9B!$:7)E8W1O<G,@861O<'1E9"P@86YD(&]N($1E8V5M8F5R
M(#(R+"`R,#$P(&ET<R!S=&]C:VAO;&1E<G,@87!P<F]V960L('1H92`R,#$P
M($QO;F<M5&5R;2!);F-E;G1I=F4@4&QA;B9N8G-P.R9N8G-P.RAT:&4@)B,Q
M-#<[,C`Q,"!);F-E;G1I=F4@4&QA;B8C,30X.RDL('=H:6-H(&=A=F4@=&AE
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M0V]M<&%N>2!A;F0O;W(@:71S('-U8G-I9&EA<FEE<RX@5&AE(#(P,3`@26YC
M96YT:79E(%!L86X@8W5R<F5N=&QY(&%L;&]W<R!F;W(@97%U:71Y(&%W87)D
M<R!O9B!U<"!T;R`T+#`P,"PP,#`@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:RX@
M5&AR;W5G:"!-87)C:"`S,2P@,C`Q,RP@-S4L,#`P('-H87)E<R!O9B!C;VUM
M;VX@<W1O8VL@86YD(&]P=&EO;G,@=&\@<'5R8VAA<V4@86X@86=G<F5G871E
M(&]F(#(U+#`P,"!S:&%R97,@;V8@<W1O8VL@;W!T:6]N<R!H860@8F5E;B!G
M<F%N=&5D('5N9&5R('1H92`R,#$P($EN8V5N=&EV92!0;&%N+CPO<#X@/'`@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0[(%1%6%0M05543U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G/B9N8G-P
M.SPO<#X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ
M,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ
M<'0G/E1H97)E('=E<F4@;F\@<V5C=7)I=&EE<R!I<W-U960@9G)O;2!T:&4@
M,C`Q,"!);F-E;G1I=F4@4&QA;B!D=7)I;F<@=&AE('1H<F5E(&UO;G1H<R!E
M;F1E9"!-87)C:"`S,2P@,C`Q,RX\+W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#
M13H[('1A8BUS=&]P<SHU,#`N,7!T)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'
M24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^070@36%R8V@@,S$L
M(#(P,3,L('1H97)E('=A<R!N;R!R96UA:6YI;F<@=6YR96-O9VYI>F5D(&-O
M;7!E;G-A=&EO;B!E>'!E;G-E(')E;&%T960@=&\@<W1O8VL@;W!T:6]N<R!O
M<B!R97-T<FEC=&EV92!S=&]C:R!G<F%N=',N/"]P/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/B9N8G-P.SPO<#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S`V,#!F-S$S
M7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,`T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C
M-F(T,C`O5V]R:W-H965T<R]3:&5E=#$W+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%3$4^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^0T].5$E.1T5.0TE%4SQB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-/34U)5$U%
M3E13($%.1"!#3TY424Y'14Y#2453/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D-/3E1)3D=%3D-)15,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CPA+2UE9W@M+3X\<"!S='EL93TS1"=415A4
M+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/CQB/DY/5$4@,3(@)B,Q-3`[
M($-/3E1)3D=%3D-)15,\+V(^/"]P/B`\<"!S='EL93TS1"=,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z
M.R!T86(M<W1O<',Z-3`P+C%P="<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/CQB/CQI/D5C;VYO;6EC
M(&5N=FER;VYM96YT(#PO:3X\+V(^/&(^+2`\+V(^4W5B<W1A;G1I86QL>2!A
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M/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN
M;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SXF
M;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M0554
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M;W9E<FYM96YT+CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R
M,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P-C`P9C<Q,U\P8C$T
M7S0Y.#!?83`Q,U\V.6-F-V-C-F(T,C`O5V]R:W-H965T<R]3:&5E=#$X+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0T].0T5.
M5%)!5$E/3E,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R
M+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY#3TY#14Y44D%424].4SPO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#3TY#14Y44D%424].4SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/"$M+65G>"TM/CQP('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4
M+4%55$]34$%#13HG/CQB/DY/5$4@,3,@)B,Q-3`[($-/3D-%3E12051)3TY3
M/"]B/CPO<#X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'
M24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.CL@=&%B+7-T;W!S.C4P
M,"XQ<'0G/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T
M:69Y.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@
M5$585"U!551/4U!!0T4Z)SY!="!-87)C:"`S,2P@,C`Q,RP@;VYE(&-U<W1O
M;65R(&%C8V]U;G1E9"!F;W(@,3`N-24@;V8@86-C;W5N=',@<F5C96EV86)L
M92XF;F)S<#LF;F)S<#M!="!$96-E;6)E<B`S,2P@,C`Q,BP@;F\@8W5S=&]M
M97(@86-C;W5N=&5D(&9O<B!M;W)E('1H86X@,3`N,"4@;V8@86-C;W5N=',@
M<F5C96EV86)L92X\+W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA
M;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13H[('1A8BUS
M=&]P<SHU,#`N,7!T)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I
M;B`P<'0[(%1%6%0M05543U-004-%.B<^1F]R('1H92!T:')E92!M;VYT:',@
M96YD960@36%R8V@@,S$L(#(P,3,L(&YO(&-U<W1O;65R(&%C8V]U;G1E9"!F
M;W(@;6]R92!T:&%N(#$P)2!O9B!S86QE<RX@1F]R('1H92!T:')E92!M;VYT
M:',@96YD960@36%R8V@@,S$L(#(P,3(L(&]N92!C=7-T;VUE<B!A8V-O=6YT
M960@9F]R(#$P+C,E(&]F('-A;&5S+CPO<#X@/'`@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-0
M04-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G/B9N8G-P.SPO<#X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN;W)M86P[($U!
M4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SY&;W(@=&AE('1H
M<F5E(&UO;G1H<R!E;F1E9"!-87)C:"`S,2P@,C`Q,RP@<'5R8VAA<V5S(&9R
M;VT@;VYE('-U<'!L:65R(&%C8V]U;G1E9"!F;W(@,S0N,"4@;V8@<F%W(&UA
M=&5R:6%L('!U<F-H87-E<RX@1F]R('1H92!T:')E92!M;VYT:',@96YD960@
M36%R8V@@,S$L(#(P,3(L('!U<F-H87-E<R!F<F]M(&]N92!S=7!P;&EE<B!A
M8V-O=6YT960@9F]R(#$T+C$E(&]F(')A=R!M871E<FEA;"!P=7)C:&%S97,N
M)FYB<W`[/"]P/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!
M4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z.R!T86(M<W1O<',Z
M-3`P+C%P="<^)FYB<W`[/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C
M8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S`V,#!F-S$S
M7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,"]7;W)K<VAE971S+U-H965T
M,3DN:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5%0T%#/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/D%C8V]U;G1I;F<@4&]L:6-I97,@*%!O;&EC:65S*3QB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D%C8V]U;G1I;F<@
M4&]L:6-I97,@*%!O;&EC:65S*3PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y/<F=A;FEZ871I;VX@86YD($YA='5R92!O9B!/
M<&5R871I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM
M96=X+2T^/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!
M0T4Z)SX\8CX\:3Y/<F=A;FEZ871I;VX@86YD($YA='5R92!O9B!/<&5R871I
M;VYS("8C,34P.R`\+VD^/"]B/D-H:6YA(%!H87)M82!(;VQD:6YG<RP@26YC
M+BP@82!.979A9&$@8V]R<&]R871I;VXL(&]W;G,@,3`P)2!O9B!/;FYY($EN
M=F5S=&UE;G0@3&EM:71E9"`H)B,Q-#<[3VYN>28C,30X.RDL(&$@0G)I=&ES
M:"!6:7)G:6X@27-L86YD<R!C;W)P;W)A=&EO;BP@=&AA="!I;B!T=7)N(&]W
M;G,@,3`P)2!O9B!(86EN86X@2&5L<'-O;B!-961I8V%L("9A;7`[($)I;W1E
M8VAN;VQO9WD@0V\N+"!,=&0@*"8C,30W.TAE;'!S;VXF(S$T.#LI+"!A(&-O
M<G!O<F%T:6]N(&]R9V%N:7IE9"!U;F1E<B!T:&4@;&%W<R!O9B!T:&4@4&5O
M<&QE)W,@4F5P=6)L:6,@;V8@0VAI;F$@*'1H92`F(S$T-SM04D,F(S$T.#LI
M+B!#:&EN82!0:&%R;6$@2&]L9&EN9W,L($EN8RX@86YD(&ET<R!S=6)S:61I
M87)I97,@87)E(')E9F5R<F5D('1O(&AE<F5I;B!A<R!T:&4@0V]M<&%N>2X\
M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%
M.B<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..FIU<W1I9GD[
M($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4
M+4%55$]34$%#13H[('1A8BUS=&]P<SHU,#`N,7!T)SY/;B!$96-E;6)E<B`S
M,2P@,C`Q,BP@0VAI;F$@4&AA<FUA($AO;&1I;F=S+"!);F,@8V]N<W5M;6%T
M960@82!R96EN8V]R<&]R871I;VX@;65R9V5R(&9O<B!T:&4@<'5R<&]S92!O
M9B!C:&%N9VEN9R!T:&4@<W1A=&4@;V8@:6YC;W)P;W)A=&EO;B!F<F]M($1E
M;&%W87)E('1O($YE=F%D82!P=7)S=6%N="!T;R!T:&4@=&5R;7,@86YD(&-O
M;F1I=&EO;G,@;V8@86X@06=R965M96YT(&%N9"!0;&%N(&]F($UE<F=E<B!D
M871E9"!$96-E;6)E<B`R-RP@,C`Q,BXF;F)S<#LF;F)S<#M4:&4@<F5I;F-O
M<G!O<F%T:6]N(&UE<F=E<B!W87,@87!P<F]V960@8GD@<W1O8VMH;VQD97)S
M(&AO;&1I;F<@=&AE(&UA:F]R:71Y(&]F('1H92!O=71S=&%N9&EN9R!C;VUM
M;VX@<VAA<F5S(&]N($1E8V5M8F5R(#(Q+"`R,#$R+CPO<#X@/'`@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%
M6%0M05543U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G/B9N8G-P.SPO<#X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN
M;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SY4
M:&4@1F]R96EG;B!);G9E<W1M96YT($EN9'5S=')I86P@0V%T86QO9W5E/&D^
M)FYB<W`[/"]I/BAT:&4@)B,Q-#<[0V%T86QO9W5E)B,Q-#@[*2!J;VEN=&QY
M(&ES<W5E9"!B>2!T:&4@0VAI;F$F(S$T-CMS($UI;FES=')Y(&]F($-O;6UE
M<F-E(&%N9"!T:&4@3F%T:6]N86P@1&5V96QO<&UE;G0@86YD(%)E9F]R;2!#
M;VUM:7-S:6]N("AA<R!T:&4@;&%T97-T('9E<G-I;VX@:7,@=&AE('EE87(@
M,C`Q,B!V97)S:6]N+"!E9F9E8W1I=F4@2F%N=6%R>2`S,"P@,C`Q,BD@8VQA
M<W-I9FEE9"!V87)I;W5S(&EN9'5S=')I97,O8G5S:6YE<W-E<R!I;G1O('1H
M<F5E(&1I9F9E<F5N="!C871E9V]R:65S.B`H:2D@96YC;W5R86=E9"!F;W(@
M9F]R96EG;B!I;G9E<W1M96YT.R`H:6DI(')E<W1R:6-T960@=&\@9F]R96EG
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M96YT(&5N=&5R<')I<V4@*'1H92`F(S$T-SM&244F(S$T.#LI('-H86QL(&YO
M="!H879E('1H92!W:&]L92!O<B!M86IO<FET>2!O9B!I=',@97%U:71Y(&EN
M=&5R97-T<R!O=VYE9"!B>2!A(&9O<F5I9VX@;W=N97(@:68@=&AE($9)12!E
M<W1A8FQI<VAE<R!M;W)E('1H86X@,S`@8G)A;F-H('-T;W)E<R!A;F0@9&ES
M=')I8G5T97,@82!V87)I971Y(&]F(&)R86YD<R!I;B!T:&]S92!F<F%N8VAI
M<V4@<W1O<F5S+"!W:&EC:"!I<R!N;W0@=&AE(&-A<V4@;V8@=&AE($-O;7!A
M;GDF(S$T-CMS(&)U<VEN97-S+CPO<#X@/'`@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%
M.CL@=&%B+7-T;W!S.C4P,"XQ<'0G/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G
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M96-T('1O(&%N>2!O=VYE<G-H:7`@<F5S=')I8W1I;VYS('!R97-C<FEB960@
M=6YD97(@=&AE($-A=&%L;V=U92X@3VYN>2!A8W%U:7)E9"`Q,#`E(&]F('1H
M92!O=VYE<G-H:7`@:6X@2&5L<'-O;B!F<F]M($AE;'!S;VXF(S$T-CMS('1H
M<F5E(&9O<FUE<B!S:&%R96AO;&1E<G,@;VX@36%Y(#(U+"`R,#`U(&)Y(&5N
M=')Y(&EN=&\@86X@17%U:71Y(%1R86YS9F5R($%G<F5E;65N="!W:71H('-U
M8V@@=&AR964@<&%R=&EE<R!O;B!-87D@,C4L(#(P,#4N(%1H92!T<F%N<V%C
M=&EO;B!W87,@87!P<F]V960@8GD@=&AE($-O;6UE<F-I86P@0G5R96%U(&]F
M($AA:6YA;B!0<F]V:6YC92!O;B!*=6YE(#$R+"`R,#`U(&%N9"!(96QP<V]N
M(')E8V5I=F5D('1H92!#97)T:69I8V%T92!O9B!!<'!R;W9A;"!F;W(@17-T
M86)L:7-H:6YG(&]F($5N=&5R<')I<V5S('=I=&@@1F]R96EG;B!);G9E<W1M
M96YT(&EN('1H92!04D,@;VX@=&AE('-A;64@9&%Y(&%N9"!I=',@8G5S:6YE
M<W,@;&EC96YS92!E=FED96YC:6YG(&ET<R!71D]%("A7:&]L;'D@1F]R96EG
M;B!/=VYE9"!%;G1E<G!R:7-E*2!S=&%T=7,@;VX@2G5N92`R,2P@,C`P-2X\
M+W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T.R!415A4+4%55$]34$%#13H[('1A8BUS=&]P<SHU,#`N,7!T
M)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@
M3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M
M05543U-004-%.B<^5&AE($-O;7!A;GD@:&%S(&%N9"!C;VYT:6YU97,@=&\@
M86-Q=6ER92!W96QL+6%C8V5P=&5D(&UE9&EC86P@9F]R;75L87,@=&\@82!D
M:79E<G-E('!O<G1F;VQI;R!O9B!797-T97)N(&%N9"!#:&EN97-E(&UE9&EC
M:6YE<RX\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#;VYS;VQI9&%T:6]N(&%N9"!"87-I<R!O9B!0<F5S96YT
M871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CPA+2UE9W@M
M+3X\<"!S='EL93TS1"=415A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4
M.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG
M/CQB/CQI/D-O;G-O;&ED871I;VX@86YD($)A<VES(&]F(%!R97-E;G1A=&EO
M;B`\+VD^/"]B/B8C,34P.R!4:&4@86-C;VUP86YY:6YG(&9I;F%N8VEA;"!S
M=&%T96UE;G1S(&AA=F4@8F5E;B!P<F5P87)E9"!I;B!A8V-O<F1A;F-E('=I
M=&@@86-C;W5N=&EN9R!P<FEN8VEP;&5S(&=E;F5R86QL>2!A8V-E<'1E9"!I
M;B!T:&4@56YI=&5D(%-T871E<R!O9B!!;65R:6-A("@F(S$T-SM5+E,N($=!
M05`F(S$T.#LI(&%N9"!A<F4@97AP<F5S<V5D(&EN(%5N:71E9"!3=&%T97,@
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M8V]N<V]L:61A=&EO;BX\+W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13H[('1A
M8BUS=&]P<SHU,#`N,7!T)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^2&5L<'-O;B8C,30V.W,@9G5N
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M;VYS+CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-O;F1E;G-E9"!&:6YA;F-I86P@4W1A=&5M96YT<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/"$M+65G>"TM/CQP('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-
M05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^/&(^/&D^0V]N
M9&5N<V5D($9I;F%N8VEA;"!3=&%T96UE;G1S(#PO:3X\+V(^)B,Q-3`[(%1H
M92!A8V-O;7!A;GEI;F<@=6YA=61I=&5D(&-O;F1E;G-E9"!C;VYS;VQI9&%T
M960@9FEN86YC:6%L('-T871E;65N=',@=V5R92!P<F5P87)E9"!P=7)S=6%N
M="!T;R!T:&4@<G5L97,@86YD(')E9W5L871I;VYS(&]F('1H92!5;FET960@
M4W1A=&5S(%-E8W5R:71I97,@86YD($5X8VAA;F=E($-O;6UI<W-I;VX@*'1H
M92`F(S$T-SM#;VUM:7-S:6]N)B,Q-#@[*2X@0V5R=&%I;B!I;F9O<FUA=&EO
M;B!A;F0@;F]T92!D:7-C;&]S=7)E<R!N;W)M86QL>2!I;F-L=61E9"!I;B!F
M:6YA;F-I86P@<W1A=&5M96YT<R!P<F5P87)E9"!I;B!A8V-O<F1A;F-E('=I
M=&@@52Y3+B!'04%0(&AA=F4@8F5E;B!C;VYD96YS960@;W(@;VUI='1E9"!P
M=7)S=6%N="!T;R!S=6-H(')U;&5S(&%N9"!R96=U;&%T:6]N<RX@36%N86=E
M;65N="!O9B!T:&4@0V]M<&%N>2`H)B,Q-#<[36%N86=E;65N="8C,30X.RD@
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M;FYU86P@4F5P;W)T(&]N($9O<FT@,3`M2R!F;W(@=&AE('EE87(@96YD960@
M1&5C96UB97(@,S$L(#(P,3(@9FEL960@=VET:"!T:&4@0V]M;6ES<VEO;B!O
M;B!-87)C:"`Q-"P@,C`Q,RX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0[(%1%6%0M05543U-004-%.B<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/E1H97-E('5N875D:71E
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M:&4@=&AR964@;6]N=&AS(&5N9&5D($UA<F-H(#,Q+"`R,#$S(&%R92!N;W0@
M;F5C97-S87)I;'D@:6YD:6-A=&EV92!O9B!T:&4@<F5S=6QT<R!T:&%T(&UA
M>2!B92!E>'!E8W1E9"!F;W(@=&AE('EE87(@96YD:6YG($1E8V5M8F5R(#,Q
M+"`R,#$S+CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D%C8V]U;G1I;F<@17-T:6UA=&5S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM96=X+2T^/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CIJ=7-T:69Y.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP
M:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SX\8CX\:3Y!8V-O=6YT:6YG
M($5S=&EM871E<R`\+VD^/"]B/CQB/BT@/"]B/E1H92!P<F5P87)A=&EO;B!O
M9B!F:6YA;F-I86P@<W1A=&5M96YT<R!I;B!C;VYF;W)M:71Y('=I=&@F;F)S
M<#M5+E,N($=!05`@<F5Q=6ER97,@36%N86=E;65N="!T;R!M86ME(&5S=&EM
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M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A
M<VEC(&%N9"!$:6QU=&5D($5A<FYI;F=S('!E<B!#;VUM;VX@4VAA<F4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CPA+2UE9W@M+3X\<"!S='EL
M93TS1"=415A4+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/CQB/CQI/D)A
M<VEC(&%N9"!$:6QU=&5D($5A<FYI;F=S('!E<B!#;VUM;VX@4VAA<F4@/"]I
M/CPO8CX\8CXM(#PO8CY"87-I8R!E87)N:6YG<R!P97(@8V]M;6]N('-H87)E
M(&ES(&-O;7!U=&5D(&)Y(&1I=FED:6YG(&YE="!I;F-O;64@8GD@=&AE('=E
M:6=H=&5D+6%V97)A9V4@;G5M8F5R(&]F(&-O;6UO;B!S:&%R97,@;W5T<W1A
M;F1I;F<@9'5R:6YG('1H92!P97)I;V0N($1I;'5T960@96%R;FEN9W,@<&5R
M('-H87)E(&ES(&-A;&-U;&%T960@=&\@9VEV92!E9F9E8W0@=&\@<&]T96YT
M:6%L;'D@:7-S=6%B;&4@9&EL=71I=F4@8V]M;6]N('-H87)E<RX\+W`^(#QP
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T.R!415A4+4%55$]34$%#13H[('1A8BUS=&]P<SHU,#`N,7!T)SXF;F)S
M<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-0
M04-%.B<^5&AE(&9O;&QO=VEN9R!T86)L92!I<R!A('!R97-E;G1A=&EO;B!O
M9B!T:&4@;G5M97)A=&]R<R!A;F0@9&5N;VUI;F%T;W)S('5S960@:6X@=&AE
M(&-A;&-U;&%T:6]N(&]F(&)A<VEC(&%N9"!D:6QU=&5D(&5A<FYI;F=S('!E
M<B!S:&%R93H\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@
M3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M
M05543U-004-%.B<^)FYB<W`[/"]P/B`\=&%B;&4@=VED=&@],T0U,C`@<W1Y
M;&4],T0G34%21TE..F%U=&\@875T;R!A=71O("TP+C<U<'0[(%=)1%1(.C,Y
M,'!T.R!"3U)$15(M0T],3$%04T4Z8V]L;&%P<V4G(&-E;&QP861D:6YG/3-$
M,"!C96QL<W!A8VEN9STS1#`^(#QT<CX@/'1D('=I9'1H/3-$,S0Q('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#(U-G!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$W.2!C;VQS<&%N/3-$
M,R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F
M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC
M;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H
M.B`Q,S1P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC
M96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T
M)R!A;&EG;CTS1&-E;G1E<CX\8CY&;W(@=&AE(%1H<F5E($UO;G1H<SPO8CX\
M+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1'1O<#X\+W1D/B`\=&0@=VED=&@],T0Q-SD@8V]L<W!A;CTS1#,@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#$S-'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,
M24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I
M;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/D5N9&5D($UA<F-H(#,Q+#PO8CX\
M+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1'1O<#X\+W1D/B`\=&0@=VED=&@],T0Y,2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-C@N,G!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@
M3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N
M/3-$8V5N=&5R/CQB/C(P,3,\+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M,2XX<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.#4@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#8T<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN
M(#!P="<@86QI9VX],T1C96YT97(^/&(^,C`Q,CPO8CX\+W`^/"]T9#X\+W1R
M/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0G/DYE="`H;&]S<RD@:6YC;VUE/"]P/CPO=&0^(#QT9"!W:61T:#TS1#DQ
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED
M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@
M8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@
M-2XT<'0[('=I9'1H.B`V."XR<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B
M;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A
M9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S
M<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[("@R+#@Q,BPS,#<I/"]P/CPO
M=&0^(#QT9"!W:61T:#TS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@,2XX<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D
M('=I9'1H/3-$.#4@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X
M="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8T<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#(L
M.#`V+#,U.2`\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R
M-39P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R
M;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/D)A<VEC('=E:6=H=&5D+6%V97)A
M9V4@8V]M;6]N('-H87)E<R!O=71S=&%N9&EN9SPO<#X\+W1D/B`\=&0@=VED
M=&@],T0Y,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`V."XR<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M
M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P
M:6X@,'!T)R!A;&EG;CTS1')I9VAT/C0S+#4W.2PU-3<@/"]P/CPO=&0^(#QT
M9"!W:61T:#TS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@,2XX<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D
M97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I
M;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H
M/3-$.#4@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@-C1P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CIR:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0G(&%L:6=N/3-$<FEG:'0^-#,L-3(Y+#4U-R`\+W`^/"]T9#X\+W1R/B`\
M='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1'1O<#X@/'`@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/D5F
M9F5C="!O9B!D:6QU=&EV92!S96-U<FET:65S.CPO<#X\+W1D/B`\=&0@=VED
M=&@],T0Y,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`V."XR<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M
M=&]P.B`P:6X[)R!V86QI9VX],T1T;W`^/"]T9#X@/'1D('=I9'1H/3-$,B!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q
M+CAP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1'1O<#X\+W1D/B`\=&0@=VED=&@],T0X-2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V-'!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M=&]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0S-#$@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,C4V<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1T;W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@5$585"U)
M3D1%3E0Z,3!P=#L@34%21TE..C!I;B`P:6X@,'!T)SY787)R86YT<SPO<#X\
M+W1D/B`\=&0@=VED=&@],T0Y,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`V."XR<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1T;W`^(#QP('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N
M8G-P.R`\+W`^/"]T9#X@/'1D('=I9'1H/3-$,B!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q+CAP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1'1O<#X\
M+W1D/B`\=&0@=VED=&@],T0X-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`V-'!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$=&]P/B`\<"!S='EL93TS
M1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[("TF;F)S<#LF;F)S
M<#L@/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0S-#$@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,C4V<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1T;W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@5$58
M5"U)3D1%3E0Z,3!P=#L@34%21TE..C!I;B`P:6X@,'!T)SY/<'1I;VYS/"]P
M/CPO=&0^(#QT9"!W:61T:#TS1#DQ('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V."XR<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1T;W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#L@+29N8G-P.R9N8G-P.R`\+W`^/"]T9#X@/'1D('=I9'1H/3-$,B!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q
M+CAP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1'1O<#X\+W1D/B`\=&0@=VED=&@],T0X-2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@-C1P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1'1O<#X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R
M;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R`M)FYB<W`[)FYB<W`[(#PO<#X\+W1D/CPO='(^
M(#QT<CX@/'1D('=I9'1H/3-$,S0Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#(U-G!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
M='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P
M="<^1&EL=71E9"!W96EG:'1E9"UA=F5R86=E(&-O;6UO;B!S:&%R97,@;W5T
M<W1A;F1I;F<\+W`^/"]T9#X@/'1D('=I9'1H/3-$.3$@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#8X+C)P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIR
M:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G
M(&%L:6=N/3-$<FEG:'0^-#,L-3<Y+#4U-R`\+W`^/"]T9#X@/'1D('=I9'1H
M/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`Q+CAP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0X-2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@-C1P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CIR:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^-#,L-3(Y+#4U-R`\+W`^/"]T9#X\
M+W1R/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D9&EN9RUR:6=H
M=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@
M(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@
M/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I
M;B`P<'0G/D)A<VEC("AL;W-S*2!E87)N:6YG<R!P97(@<VAA<F4\+W`^/"]T
M9#X@/'1D('=I9'1H/3-$.3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN
M9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8X+C)P=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ
M,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#L@*#`N,#8I/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,2XX<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.#4@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#8T<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#`N,#8@/"]P/CPO=&0^/"]T
M<CX@/'1R/B`\=&0@=VED=&@],T0S-#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,C4V<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T)SY$:6QU=&5D("AL;W-S*2!E87)N:6YG<R!P97(@<VAA<F4\+W`^/"]T
M9#X@/'1D('=I9'1H/3-$.3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN
M9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8X+C)P=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ
M,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#L@*#`N,#8I/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,2XX<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.#4@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#8T<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[("9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.S`N,#8@/"]P/CPO=&0^/"]T
M<CX\+W1A8FQE/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M0554
M3U-004-%.CL@=&%B+7-T;W!S.C4P,"XQ<'0G(&%L:6=N/3-$8V5N=&5R/B9N
M8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M
M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]3
M4$%#13H[('1A8BUS=&]P<SHU,#`N,7!T)R!A;&EG;CTS1&-E;G1E<CXF;F)S
M<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-0
M04-%.B<^5&AE(&9O;&QO=VEN9R!P;W1E;G1I86P@8V]M;6]N('-H87)E<R!W
M97)E(&YO="!I;F-L=61E9"!I;B!T:&4@8V]M<'5T871I;VX@;V8@9&EL=71E
M9"!E87)N:6YG<R!P97(@<VAA<F4@87,@=&AE:7(@969F96-T('=O=6QD(&AA
M=F4@8F5E;B!A;G1I+61I;'5T:79E.B9N8G-P.SPO<#X@/'1A8FQE('=I9'1H
M/3-$-3(P('-T>6QE/3-$)TU!4D=)3CIA=71O(&%U=&\@875T;R`M,"XW-7!T
M.R!724142#HS.3!P=#L@0D]21$52+4-/3$Q!4%-%.F-O;&QA<'-E)R!C96QL
M<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P/B`\='(^(#QT9"!W:61T:#TS
M1#,T,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`R-39P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q-SD@
M8V]L<W!A;CTS1#,@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@,3,T<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D
M97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I
M;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP
M:6X@,&EN(#!P="<@86QI9VX],T1C96YT97(^/&(^1F]R('1H92!4:')E92!-
M;VYT:',\+V(^/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0S-#$@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M,C4V<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3<Y(&-O;'-P
M86X],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T
M('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`Q,S1P=#L@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CY%;F1E9"!-
M87)C:"`S,2P\+V(^/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0S
M-#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@,C4V<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.#@@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#8V+C%P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXR,#$S/"]B/CPO<#X\+W1D
M/B`\=&0@=VED=&@],T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#$N.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@
M=VED=&@],T0X."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT
M(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-C8N,#5P=#L@<&%D9&EN9RUR:6=H
M=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@
M(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXR
M,#$R/"]B/CPO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,S0Q('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#(U
M-G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^5V%R<F%N=',@=VET:"!E>&5R8VES
M92!P<FEC97,@;V8@)#,N,#`@=&\@)#,N.#`@<&5R('-H87)E/"]P/CPO=&0^
M(#QT9"!W:61T:#TS1#@X('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#8V+C%P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R`Q-3`L,#`P(#PO<#X\+W1D/B`\=&0@=VED
M=&@],T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#$N.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0X
M."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F
M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC
M;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H
M.B`V-BXP-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[(#$U,"PP,#`@/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@]
M,T0S-#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@,C4V<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SY/<'1I;VYS('=I=&@@
M86X@97AE<F-I<V4@<')I8V4@;V8@)#(N-30@=&\@)#,N-#<@<&5R('-H87)E
M/"]P/CPO=&0^(#QT9"!W:61T:#TS1#@X('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V-BXQ<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#L@,C4L,#`P(#PO<#X\+W1D/B`\=&0@=VED=&@],T0R('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$N.#5P
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0X."!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@-C8N,#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R`S,3`L,#`P(#PO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H
M/3-$,S0Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#(U-G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%
M24=(5#IN;W)M86P[(%1%6%0M24Y$14Y4.C$P<'0[($U!4D=)3CHP:6X@,&EN
M(#!P="<^5&]T86P\+W`^/"]T9#X@/'1D('=I9'1H/3-$.#@@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#8V+C%P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R`Q-S4L,#`P(#PO<#X\+W1D/B`\=&0@=VED=&@],T0R('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$N.#5P
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0X."!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@-C8N,#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R`T-C`L,#`P(#PO<#X\+W1D/CPO='(^/"]T86)L93X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S`V,#!F-S$S7S!B
M,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,`T*0V]N=&5N="U,;V-A=&EO;CH@
M9FEL93HO+R]#.B\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C-F(T
M,C`O5V]R:W-H965T<R]3:&5E=#(P+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M
M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X
M="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D
M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%6D8^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^0D%325,@3T8@4%)%4T5.5$%424].("A486)L
M97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L
M(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^0D%325,@3T8@4%)%4T5.5$%424].("A486)L97,I/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R97-E;G1A=&EO
M;B!O9B!T:&4@;G5M97)A=&]R<R!A;F0@9&5N;VUI;F%T;W)S('5S960@:6X@
M=&AE(&-A;&-U;&%T:6]N(&]F(&)A<VEC(&%N9"!D:6QU=&5D(&5A<FYI;F=S
M('!E<B!S:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/"$M
M+65G>"TM/CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-0
M04-%.B<^5&AE(&9O;&QO=VEN9R!T86)L92!I<R!A('!R97-E;G1A=&EO;B!O
M9B!T:&4@;G5M97)A=&]R<R!A;F0@9&5N;VUI;F%T;W)S('5S960@:6X@=&AE
M(&-A;&-U;&%T:6]N(&]F(&)A<VEC(&%N9"!D:6QU=&5D(&5A<FYI;F=S('!E
M<B!S:&%R93H\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@
M3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M
M05543U-004-%.B<^)FYB<W`[/"]P/B`\=&%B;&4@=VED=&@],T0U,C`@<W1Y
M;&4],T0G34%21TE..F%U=&\@875T;R!A=71O("TP+C<U<'0[(%=)1%1(.C,Y
M,'!T.R!"3U)$15(M0T],3$%04T4Z8V]L;&%P<V4G(&-E;&QP861D:6YG/3-$
M,"!C96QL<W!A8VEN9STS1#`^(#QT<CX@/'1D('=I9'1H/3-$,S0Q('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#(U-G!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$W.2!C;VQS<&%N/3-$
M,R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F
M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC
M;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H
M.B`Q,S1P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC
M96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T
M)R!A;&EG;CTS1&-E;G1E<CX\8CY&;W(@=&AE(%1H<F5E($UO;G1H<SPO8CX\
M+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1'1O<#X\+W1D/B`\=&0@=VED=&@],T0Q-SD@8V]L<W!A;CTS1#,@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#$S-'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,
M24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I
M;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/D5N9&5D($UA<F-H(#,Q+#PO8CX\
M+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1'1O<#X\+W1D/B`\=&0@=VED=&@],T0Y,2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-C@N,G!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@
M3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N
M/3-$8V5N=&5R/CQB/C(P,3,\+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M,2XX<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.#4@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#8T<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN
M(#!P="<@86QI9VX],T1C96YT97(^/&(^,C`Q,CPO8CX\+W`^/"]T9#X\+W1R
M/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0G/DYE="`H;&]S<RD@:6YC;VUE/"]P/CPO=&0^(#QT9"!W:61T:#TS1#DQ
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED
M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@
M8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@
M-2XT<'0[('=I9'1H.B`V."XR<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B
M;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A
M9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S
M<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[("@R+#@Q,BPS,#<I/"]P/CPO
M=&0^(#QT9"!W:61T:#TS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@,2XX<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D
M('=I9'1H/3-$.#4@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X
M="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8T<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#(L
M.#`V+#,U.2`\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R
M-39P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R
M;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/D)A<VEC('=E:6=H=&5D+6%V97)A
M9V4@8V]M;6]N('-H87)E<R!O=71S=&%N9&EN9SPO<#X\+W1D/B`\=&0@=VED
M=&@],T0Y,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`V."XR<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M
M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P
M:6X@,'!T)R!A;&EG;CTS1')I9VAT/C0S+#4W.2PU-3<@/"]P/CPO=&0^(#QT
M9"!W:61T:#TS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@,2XX<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D
M97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I
M;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H
M/3-$.#4@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@-C1P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CIR:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0G(&%L:6=N/3-$<FEG:'0^-#,L-3(Y+#4U-R`\+W`^/"]T9#X\+W1R/B`\
M='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1'1O<#X@/'`@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/D5F
M9F5C="!O9B!D:6QU=&EV92!S96-U<FET:65S.CPO<#X\+W1D/B`\=&0@=VED
M=&@],T0Y,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`V."XR<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M
M=&]P.B`P:6X[)R!V86QI9VX],T1T;W`^/"]T9#X@/'1D('=I9'1H/3-$,B!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q
M+CAP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1'1O<#X\+W1D/B`\=&0@=VED=&@],T0X-2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V-'!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M=&]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0S-#$@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,C4V<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1T;W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@5$585"U)
M3D1%3E0Z,3!P=#L@34%21TE..C!I;B`P:6X@,'!T)SY787)R86YT<SPO<#X\
M+W1D/B`\=&0@=VED=&@],T0Y,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`V."XR<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1T;W`^(#QP('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N
M8G-P.R`\+W`^/"]T9#X@/'1D('=I9'1H/3-$,B!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q+CAP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1'1O<#X\
M+W1D/B`\=&0@=VED=&@],T0X-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`V-'!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$=&]P/B`\<"!S='EL93TS
M1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[("TF;F)S<#LF;F)S
M<#L@/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0S-#$@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,C4V<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1T;W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@5$58
M5"U)3D1%3E0Z,3!P=#L@34%21TE..C!I;B`P:6X@,'!T)SY/<'1I;VYS/"]P
M/CPO=&0^(#QT9"!W:61T:#TS1#DQ('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V."XR<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1T;W`^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#L@+29N8G-P.R9N8G-P.R`\+W`^/"]T9#X@/'1D('=I9'1H/3-$,B!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q
M+CAP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1'1O<#X\+W1D/B`\=&0@=VED=&@],T0X-2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@-C1P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1'1O<#X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R
M;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R`M)FYB<W`[)FYB<W`[(#PO<#X\+W1D/CPO='(^
M(#QT<CX@/'1D('=I9'1H/3-$,S0Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#(U-G!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
M='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P
M="<^1&EL=71E9"!W96EG:'1E9"UA=F5R86=E(&-O;6UO;B!S:&%R97,@;W5T
M<W1A;F1I;F<\+W`^/"]T9#X@/'1D('=I9'1H/3-$.3$@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#8X+C)P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIR
M:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G
M(&%L:6=N/3-$<FEG:'0^-#,L-3<Y+#4U-R`\+W`^/"]T9#X@/'1D('=I9'1H
M/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`Q+CAP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0X-2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@-C1P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CIR:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN
M(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^-#,L-3(Y+#4U-R`\+W`^/"]T9#X\
M+W1R/B`\='(^(#QT9"!W:61T:#TS1#,T,2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R-39P=#L@<&%D9&EN9RUR:6=H
M=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@
M(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@
M/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I
M;B`P<'0G/D)A<VEC("AL;W-S*2!E87)N:6YG<R!P97(@<VAA<F4\+W`^/"]T
M9#X@/'1D('=I9'1H/3-$.3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN
M9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8X+C)P=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ
M,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#L@*#`N,#8I/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,2XX<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.#4@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#8T<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#`N,#8@/"]P/CPO=&0^/"]T
M<CX@/'1R/B`\=&0@=VED=&@],T0S-#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,C4V<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T)SY$:6QU=&5D("AL;W-S*2!E87)N:6YG<R!P97(@<VAA<F4\+W`^/"]T
M9#X@/'1D('=I9'1H/3-$.3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN
M9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8X+C)P=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ
M,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#L@*#`N,#8I/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,2XX<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.#4@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#8T<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[("9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.S`N,#8@/"]P/CPO=&0^/"]T
M<CX\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4&]T96YT:6%L(&-O;6UO;B!S:&%R97,@=V5R92!N;W0@
M:6YC;'5D960@:6X@=&AE(&-O;7!U=&%T:6]N(&]F(&1I;'5T960@96%R;FEN
M9W,@<&5R('-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M(2TM96=X+2T^/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/
M4U!!0T4Z)SY4:&4@9F]L;&]W:6YG('!O=&5N=&EA;"!C;VUM;VX@<VAA<F5S
M('=E<F4@;F]T(&EN8VQU9&5D(&EN('1H92!C;VUP=71A=&EO;B!O9B!D:6QU
M=&5D(&5A<FYI;F=S('!E<B!S:&%R92!A<R!T:&5I<B!E9F9E8W0@=V]U;&0@
M:&%V92!B965N(&%N=&DM9&EL=71I=F4Z)FYB<W`[/"]P/B`\=&%B;&4@=VED
M=&@],T0U,C`@<W1Y;&4],T0G34%21TE..F%U=&\@875T;R!A=71O("TP+C<U
M<'0[(%=)1%1(.C,Y,'!T.R!"3U)$15(M0T],3$%04T4Z8V]L;&%P<V4G(&-E
M;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`^(#QT<CX@/'1D('=I9'1H
M/3-$,S0Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#(U-G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$W
M.2!C;VQS<&%N/3-$,R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P
M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@
M8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@
M-2XT<'0[('=I9'1H.B`Q,S1P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CY&;W(@=&AE(%1H<F5E
M($UO;G1H<SPO8CX\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#,T
M,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F
M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC
M;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H
M.B`R-39P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q-SD@8V]L
M<W!A;CTS1#,@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q
M<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#$S-'!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
M='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L
M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/D5N9&5D
M($UA<F-H(#,Q+#PO8CX\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS
M1#,T,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`R-39P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0X."!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@-C8N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R
M9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D
M:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ
M,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/C(P,3,\+V(^/"]P/CPO
M=&0^(#QT9"!W:61T:#TS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@,2XX-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT
M9"!W:61T:#TS1#@X('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E
M>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V-BXP-7!T.R!P861D:6YG+7)I
M9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT
M.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M
M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z
M;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB
M/C(P,3(\+V(^/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0S-#$@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M,C4V<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SY787)R86YT<R!W:71H(&5X97)C
M:7-E('!R:6-E<R!O9B`D,RXP,"!T;R`D,RXX,"!P97(@<VAA<F4\+W`^/"]T
M9#X@/'1D('=I9'1H/3-$.#@@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@-C8N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL
M93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#$U,"PP,#`@/"]P/CPO=&0^(#QT9"!W
M:61T:#TS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@,2XX-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS
M1#@X('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#8V+C`U<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#L@,34P+#`P,"`\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T
M:#TS1#,T,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`R-39P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/D]P=&EO;G,@=VET
M:"!A;B!E>&5R8VES92!P<FEC92!O9B`D,BXU-"!T;R`D,RXT-R!P97(@<VAA
M<F4\+W`^/"]T9#X@/'1D('=I9'1H/3-$.#@@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8V+C%P
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L
M.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R`R-2PP,#`@/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F
M,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z
M('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,2XX
M-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#@X('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`V-BXP-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[(#,Q,"PP,#`@/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED
M=&@],T0S-#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@,C4V<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M
M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.FYO<FUA;#L@5$585"U)3D1%3E0Z,3!P=#L@34%21TE..C!I;B`P
M:6X@,'!T)SY4;W1A;#PO<#X\+W1D/B`\=&0@=VED=&@],T0X."!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@-C8N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[(#$W-2PP,#`@/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F
M,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z
M('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,2XX
M-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#@X('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`V-BXP-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[(#0V,"PP,#`@/"]P/CPO=&0^/"]T<CX\+W1A8FQE/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?
M,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V
M8C0R,"]7;W)K<VAE971S+U-H965T,C$N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5,13X-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@
M<F]W<W!A;CTS1#(^/'-T<F]N9SY)3E9%3E1/4EDH5&%B;&5S*3QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DE.5D5.
M5$]262`H5&%B;&5S*3PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y);G9E;G1O<GD@8V]N<VES=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CPA+2UE9W@M+3X\<"!S='EL93TS1"=,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!
M0T4Z)SY);G9E;G1O<GD@8V]N<VES=&5D(&]F('1H92!F;VQL;W=I;F<Z)FYB
M<W`[/"]P/B`\<#X@/"]P/CQT86)L92!W:61T:#TS1#0X,R!S='EL93TS1"=-
M05)'24XZ875T;R!A=71O(&%U=&\@+3`N-S5P=#L@5TE$5$@Z,S8R+C1P=#L@
M0D]21$52+4-/3$Q!4%-%.F-O;&QA<'-E)R!C96QL<&%D9&EN9STS1#`@8V5L
M;'-P86-I;F<],T0P/B`\='(^(#QT9"!W:61T:#TS1#(U,2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q.#AP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG
M:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z
M("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^
M/"]T9#X@/'1D('=I9'1H/3-$,3`X('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#@P+C=P=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA
M;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXF;F)S
M<#M-87)C:"`S,2P@/"]B/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P
M9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@
M=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<U+C=P=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M
M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E
M;G1E<CX\8CXF;F)S<#M$96-E;6)E<B`S,2P@/"]B/CPO<#X\+W1D/CPO='(^
M(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X.'!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^
M(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED
M=&@],T0Q,#@@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q
M<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#@P+C=P=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA
M;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXR,#$S
M/"]B/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG
M:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z
M("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^
M/"]T9#X@/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C
M96YT97(^/&(^,C`Q,CPO8CX\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T
M:#TS1#(U,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`Q.#AP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/E)A=R!M871E<FEA
M;',\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO
M=&0^(#QT9"!W:61T:#TS1#$P."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`X,"XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R0F;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@
M,C@L,S@P+#DP,SPO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG
M+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@
M<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<U+C=P=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIR:6=H=#L@3$E.12U(14E'2%0Z
M;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^)FYB
M<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R`S,"PQ.3@L.#$V(#PO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$
M,C4Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#$X.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^1FEN:7-H960@9V]O9',\
M+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^
M(#QT9"!W:61T:#TS1#$P."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD
M;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.#`N-W!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#XF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@-BPV-3DL,#4R(#PO
M<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@
M/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O
M=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG
M:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T
M;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4
M.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`W+#DS,"PV.#0@/"]P/CPO=&0^
M/"]T<CX@/'1R/B`\=&0@=VED=&@],T0R-3$@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@X<'0[('!A9&1I;F<M<FEG
M:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z
M("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^
M/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M
M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG
M+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT
M9"!W:61T:#TS1#$P."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P
M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@
M8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@
M-2XT<'0[('=I9'1H.B`X,"XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B
M;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A
M9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R`S-2PP,SDL.34U/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#$@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S4N-W!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H
M=#XF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#L@,S@L,3(Y+#4P,"`\+W`^/"]T9#X\+W1R/B`\
M='(^(#QT9"!W:61T:#TS1#(U,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`Q.#AP=#L@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G
M/D]B<V]L97-C96YC92!R97-E<G9E/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#@@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.#`N-W!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,
M24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX]
M,T1R:6=H=#XF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@*#$L-S<Y+#<R
M.2D\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO
M=&0^(#QT9"!W:61T:#TS1#$P,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C
M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ
M(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M
M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R`H,2PW-CDL.3@T*3PO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H
M/3-$,C4Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#$X.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%
M24=(5#IN;W)M86P[(%1%6%0M24Y$14Y4.C$P+C`U<'0[($U!4D=)3CHP:6X@
M,&EN(#!P="<^/&(^5&]T86P@26YV96YT;W)Y/"]B/CPO<#X\+W1D/B`\=&0@
M=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M
M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$
M,3`X('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O
M;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I
M;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F
M=#H@-2XT<'0[('=I9'1H.B`X,"XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#XF
M;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[(#,S+#(V,"PR,C8@/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#$@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E
M<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O
M=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@
M=VED=&@Z(#<U+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R0F;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,S8L,S4Y
M+#4Q-B`\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M
M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q
M,U\V.6-F-V-C-F(T,C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO
M,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P+U=O<FMS:&5E
M=',O4VAE970R,BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q
M=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA
M<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\3454
M02!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H
M=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S
M8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M
M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE
M(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15I&/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/E!23U!%4E19($%.1"!%455)4$U%3E0@*%1A8FQE<RD\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY04D]0
M15)462!!3D0@15%525!-14Y4("A486)L97,I/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y(&%N9"!E<75I<&UE
M;G0@8V]N<VES=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CPA
M+2UE9W@M+3X\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)
M3CHP:6X@,&EN(#!P=#L@5$585"U!551/4U!!0T4Z)SY0<F]P97)T>2!A;F0@
M97%U:7!M96YT(&-O;G-I<W1E9"!O9B!T:&4@9F]L;&]W:6YG.CPO<#X@/'1A
M8FQE('=I9'1H/3-$-#<W('-T>6QE/3-$)TU!4D=)3CIA=71O(&%U=&\@875T
M;R`M,"XW-7!T.R!724142#HS-3<N-'!T.R!"3U)$15(M0T],3$%04T4Z8V]L
M;&%P<V4G(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`^(#QT<CX@
M/'1D('=I9'1H/3-$,C4Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#$X.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W
M:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q
M,#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@-S4N-W!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0G(&%L:6=N/3-$8V5N=&5R/CQB/B9N8G-P.TUA<F-H(#,Q+"`\+V(^/"]P
M/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\
M=&0@=VED=&@],T0Q,#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F
M,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@-S4N-W!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS
M1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'
M24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/B9N8G-P.T1E8V5M
M8F5R(#,Q+"`\+V(^/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0R
M-3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@,3@X<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F
M,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z
M('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P,2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@-S4N-W!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0G(&%L:6=N/3-$8V5N=&5R/CQB/C(P,3,\+V(^/"]P/CPO=&0^(#QT9"!W
M:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q
M,#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L
M:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#<U+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%2
M1TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXR,#$R/"]B/CPO
M<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X.'!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)
M3CHP:6X@,&EN(#!P="<^4&5R;6ET(&]F(&QA;F0@=7-E/"]P/CPO=&0^(#QT
M9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[
M(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B
M86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U
M+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@]
M,T0Q,#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@-S4N-W!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,
M24=..G)I9VAT.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN
M(#!P="<@86QI9VX],T1R:6=H=#XF;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[(#0T.2PT-S0@/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#$@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S4N-W!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R
M:6=H=#XF;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#0T-RPP
M,3,@/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0R-3$@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@X<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)SY"=6EL9&EN9SPO<#X\+W1D/B`\=&0@=VED
M=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`Q
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#<U+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIR
M:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G
M(&%L:6=N/3-$<FEG:'0^)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#(L
M-#,R+#0T,B`\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P,2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M<FEG
M:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z
M("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`R+#0Q.2PQ,C4@/"]P/CPO=&0^/"]T
M<CX@/'1R/B`\=&0@=VED=&@],T0R-3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@X<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@
M,'!T)SY0;&%N="P@;6%C:&EN97)Y(&%N9"!E<75I<&UE;G0\+W`^/"]T9#X@
M/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F
M,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R
M9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D
M:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T
M:#TS1#$P,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M
M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P
M:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R`V+#0Q."PW-C@@/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#$@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S4N-W!T.R!P861D
M:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R
M+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$
M8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H
M=#XF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@-BPS.#$L,C`Y(#PO<#X\
M+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$X.'!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP
M:6X@,&EN(#!P="<^36]T;W(@=F5H:6-L93PO<#X\+W1D/B`\=&0@=VED=&@]
M,T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`Q('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<U
M+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIR:6=H
M=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L
M:6=N/3-$<FEG:'0^)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[(#$T-RPX.3`@/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,#$@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S4N-W!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,
M24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX]
M,T1R:6=H=#XF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#L@)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[,30W+#`X,"`\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T
M:#TS1#(U,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`Q.#AP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/D]F9FEC92!E<75I
M<&UE;G0\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I
M9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT
M.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M
M/CPO=&0^(#QT9"!W:61T:#TS1#$P,2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA
M;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`R,C,L.30W
M(#PO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T
M9#X@/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F
M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#<U+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT
M<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F
M,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CIR:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-
M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#(R,BPR-S,@/"]P
M/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0R-3$@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@X<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)SY#;VYS=')U8W1I;VX@:6X@<')O9W)E<W,\+W`^/"]T
M9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W
M:61T:#TS1#$P,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT
M(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S4N-W!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\
M<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT.R!,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#XF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#L@-"PQ,C<L,SDV(#PO<#X\+W1D/B`\=&0@
M=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M
M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$
M,3`Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O
M;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I
M;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F
M=#H@-2XT<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%2
M1TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/B9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R`S+#8X."PU-C<@/"]P/CPO=&0^/"]T<CX@/'1R/B`\
M=&0@=VED=&@],T0R-3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F
M,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@,3@X<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B
M;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A
M9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.FYO<FUA;#L@5$585"U)3D1%3E0Z,3`N,#5P=#L@34%2
M1TE..C!I;B`P:6X@,'!T)SX\8CY4;W1A;#PO8CX\+W`^/"]T9#X@/'1D('=I
M9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P
M,2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F
M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC
M;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H
M.B`W-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T
M)R!A;&EG;CTS1')I9VAT/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`Q,RPW.3DL.3$W(#PO
M<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@
M/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#<U+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CIR:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'
M24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M(#$S+#,P-2PR-C<@/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0R
M-3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@,3@X<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SY,97-S.B!A8V-U;75L871E
M9"!D97!R96-I871I;VX\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P,2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ<FEG:'0[($Q)3D4M2$5)
M1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT
M/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`F;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LH-"PU,3$L-C4X*3PO<#X\+W1D/B`\=&0@=VED
M=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3`Q
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#<U+C=P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIR
M:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G
M(&%L:6=N/3-$<FEG:'0^)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[("@T+#(W,RPS-S,I/"]P
M/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0R-3$@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@X<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)SX\8CY0<F]P97)T>2!A;F0@17%U:7!M96YT+"!N970\
M+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG
M+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@
M<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H
M=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@
M(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\
M+W1D/B`\=&0@=VED=&@],T0Q,#$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<U+C=P=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z('=I;F1O=W1E>'0@,7!T
M('-O;&ED.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M<FEG:'0[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T
M)R!A;&EG;CTS1')I9VAT/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@.2PR.#@L,C4Y(#PO
M<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@
M/'1D('=I9'1H/3-$,3`Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O
M=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W-2XW<'0[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B!W:6YD;W=T97AT(#%P="!S;VQI
M9#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..G)I9VAT
M.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI
M9VX],T1R:6=H=#XF;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#DL,#,Q+#@Y-"`\+W`^/"]T
M9#X\+W1R/CPO=&%B;&4^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y5<V5F=6P@;&EV97,@;V8@=&AE(&%S<V5T<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/"$M+65G>"TM/CQP('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L
M.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%6%0M05543U-004-%.B<^1&5P<F5C
M:6%T:6]N(&ES(&-O;7!U=&5D(&]N(&$@<W1R86EG:'0M;&EN92!B87-I<R!O
M=F5R('1H92!E<W1I;6%T960@=7-E9G5L(&QI=F5S(&]F('1H92!A<W-E=',@
M87,@9F]L;&]W<SH\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF
M>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0[(%1%
M6%0M05543U-004-%.B<^)FYB<W`[/"]P/B`\=&%B;&4@=VED=&@],T0S-3D@
M<W1Y;&4],T0G34%21TE..F%U=&\@875T;R!A=71O("TP+C<U<'0[(%=)1%1(
M.C(V.7!T.R!"3U)$15(M0T],3$%04T4Z8V]L;&%P<V4G(&-E;&QP861D:6YG
M/3-$,"!C96QL<W!A8VEN9STS1#`^(#QT<CX@/'1D('=I9'1H/3-$,C4Q('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`Q.#AP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CY!<W-E=#PO<#X\+W1D/B`\=&0@
M=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M
M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$
M.38@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L
M:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#%I;CL@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CXF;F)S<#M,:69E("T@>65A
M<G,@/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0R-3$@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@X<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)SY097)M:70@;V8@;&%N9"!U<V4\+W`^/"]T
M9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W
M:61T:#TS1#DV('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#%I;CL@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!
M3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P
M:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CXT,"`M(#<P/"]P/CPO=&0^/"]T<CX@
M/'1R/B`\=&0@=VED=&@],T0R-3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M
M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG
M+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@X<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T
M)SY"=6EL9&EN9SPO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@
M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P
M87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.38@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,6EN.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\
M<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R
M;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C(P("T@
M,S4\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#(U,2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q.#AP=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-
M05)'24XZ,&EN(#!I;B`P<'0G/E!L86YT+"!M86-H:6YE<GD@86YD(&5Q=6EP
M;65N=#PO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG
M:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z
M("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^
M/"]T9#X@/'1D('=I9'1H/3-$.38@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M
M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG
M+6QE9G0Z(#4N-'!T.R!W:61T:#H@,6EN.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL
M93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L.R!-
M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C$P/"]P/CPO=&0^
M/"]T<CX@/'1R/B`\=&0@=VED=&@],T0R-3$@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@X<'0[('!A9&1I;F<M<FEG
M:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z
M("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^
M(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P
M:6X@,'!T)SY-;W1O<B!V96AI8VQE/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Y-B!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q:6X[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C
M96YT97(^-2`M(#$P/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0R
M-3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@,3@X<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SY/9F9I8V4@97%U:7!M96YT
M/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D
M/B`\=&0@=VED=&@],T0Y-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F
M,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I
M;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F
M=#H@-2XT<'0[('=I9'1H.B`Q:6X[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B
M;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A
M9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)
M3CHP:6X@,&EN(#!P="<@86QI9VX],T1C96YT97(^,RTU/"]P/CPO=&0^/"]T
M<CX\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S`V,#!F-S$S7S!B,31?-#DX
M,%]A,#$S7S8Y8V8W8V,V8C0R,"]7;W)K<VAE971S+U-H965T,C,N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5,13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY)3E1!3D=)0DQ%
M($%34T544R`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/DEN=&%N9VEB;&4@07-S971S("A486)L97,I
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN
M=&%N9VEB;&4@07-S971S($UE9&EC86P@1F]R;75L87,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CPA+2UE9W@M+3X\<"!S='EL93TS1"=415A4
M+4%,24=..FIU<W1I9GD[($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/D%T($UA<F-H(#,Q+"`R,#$S
M(&%N9"!$96-E;6)E<B`S,2P@,C`Q,BP@:6YT86YG:6)L92!A<W-E=',@8V]N
M<VES=&5D('-O;&5L>2!O9B!#1D1!(&%P<')O=F5D(&UE9&EC86P@9F]R;75L
M87,@87,@9F]L;&]W<SH\+W`^(#QT86)L92!W:61T:#TS1#,Y,R!S='EL93TS
M1"=-05)'24XZ875T;R!A=71O(&%U=&\@+3`N-S5P=#L@5TE$5$@Z,CDT+CEP
M=#L@0D]21$52+4-/3$Q!4%-%.F-O;&QA<'-E)R!C96QL<&%D9&EN9STS1#`@
M8V5L;'-P86-I;F<],T0P/B`\='(^(#QT9"!W:61T:#TS1#$X-R!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q-#!P=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q-B!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q,G!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/CPO=&0^(#QT9"!W:61T:#TS1#DQ('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8X+C)P=#L@<&%D9&EN9RUR:6=H
M=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@
M(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CY-
M87)C:"`S,2P\+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0X."!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN
M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[
M('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`V-2XW<'0[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG
M:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T
M;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C96YT97(^
M/&(^1&5C96UB97(@,S$L/"]B/CPO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I
M9'1H/3-$,3@W('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#$T,'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS
M1#$V('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#$R<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.3$@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#8X+C)P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXR,#$S/"]B/CPO<#X\+W1D
M/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F
M,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I
M;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F
M=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B
M;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A
M9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I
M9'1H/3-$.#@@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q
M<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#8U+C=P=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA
M;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CXR,#$R
M/"]B/CPO<#X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,3@W('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$T,'!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[
M($U!4D=)3CHP:6X@,&EN(#!P="<^1W)O<W,@8V%R<GEI;F<@86UO=6YT/"]P
M/CPO=&0^(#QT9"!W:61T:#TS1#$V('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#$R<'0[('!A9&1I;F<M<FEG:'0Z(#4N
M-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P
M9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@
M/'1D('=I9'1H/3-$.3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F
M,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@-C@N,G!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS
M1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB
M<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`U+#,X-RPP-S4@
M/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D
M/B`\=&0@=VED=&@],T0X."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F
M,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I
M;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F
M=#H@-2XT<'0[('=I9'1H.B`V-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF
M;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#4L,S4W+#4X
M,"`\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#$X-R!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q-#!P=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-
M05)'24XZ,&EN(#!I;B`P<'0G/D%C8W5M=6QA=&5D(&%M;W)T:7IA=&EO;CPO
M<#X\+W1D/B`\=&0@=VED=&@],T0Q-B!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q,G!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^
M(#QT9"!W:61T:#TS1#DQ('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#8X+C)P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`H,RPP
M.3<L,C(T*3PO<#X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG
M:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T
M;VT^/"]T9#X@/'1D('=I9'1H/3-$.#@@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-C4N-W!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\
M<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN
M(#!P="<^)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[("@R
M+#DT-"PW,C8I/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0Q.#<@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M,30P<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SY.970@8V%R<GEI;F<@86UO=6YT
M/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$V('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$R<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T
M9#X@/'1D('=I9'1H/3-$.3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN
M9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#8X+C)P=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z('=I;F1O=W1E>'0@,7!T('-O
M;&ED.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[(#(L,C@Y+#@U,2`\+W`^/"]T9#X@/'1D('=I
M9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#@X
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED
M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@
M8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@
M-2XT<'0[('=I9'1H.B`V-2XW<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B
M;W)D97(M=&]P.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+7)I9VAT
M.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M
M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@
M,&EN(#!P="<^)FYB<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R`R+#0Q,BPX-30@/"]P/CPO=&0^/"]T<CX\+W1A8FQE/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q-%\T
M.3@P7V$P,3-?-CEC9C=C8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,"]7
M;W)K<VAE971S+U-H965T,C0N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5:1CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#(^/'-T<F]N9SY)3D-/344@5$%815,@*%1A8FQE<RD\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY)3D-/344@
M5$%815,@*%1A8FQE<RD\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0W5R<F5N="!487AE<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/"$M+65G>"TM/CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M:G5S=&EF>3L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0[(%1%6%0M05543U-004-%.B<^56YD97(@8W5R<F5N="!T87@@;&%W(&EN
M('1H92!04D,L('1H92!#;VUP86YY(&ES(&%N9"!W:6QL(&)E('-U8FIE8W0@
M=&\@=&AE(&9O;&QO=VEN9R!E;G1E<G!R:7-E(&EN8V]M92!T87@@<F%T97,Z
M/"]P/B`\=&%B;&4@=VED=&@],T0R-#`@<W1Y;&4],T0G34%21TE..F%U=&\@
M875T;R!A=71O("TP+C<U<'0[(%=)1%1(.C(N-6EN.R!"3U)$15(M0T],3$%0
M4T4Z8V]L;&%P<V4G(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`^
M(#QT<CX@/'1D('=I9'1H/3-$.38@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M
M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG
M+6QE9G0Z(#4N-'!T.R!W:61T:#H@,6EN.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT
M9"!W:61T:#TS1#(U('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[
M(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B
M86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U
M+C1P=#L@=VED=&@Z(#$Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D
M97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I
M;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H
M/3-$,3$Y('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#%P="!S;VQI
M9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[
M(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z
M(#4N-'!T.R!W:61T:#H@.#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG(')O=W-P86X],T0R('9A;&EG;CTS1&)O='1O;3X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CY%
M;G1E<G!R:7-E($EN8V]M92!487@@4F%T93PO8CX\+W`^/"]T9#X\+W1R/B`\
M='(^(#QT9"!W:61T:#TS1#DV('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I
M;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q:6X[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG
M:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T
M;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C96YT97(^
M/&(^665A<CPO8CX\+W`^/"]T9#X@/'1D('=I9'1H/3-$,C4@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$.38@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,6EN.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$
M8V5N=&5R/C(P,3,\+W`^/"]T9#X@/'1D('=I9'1H/3-$,C4@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,3D@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.#EP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4
M.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CXQ
M-24\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#DV('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#%I;CL@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M
M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E
M;G1E<CXR,#$T(&%N9"!A9G1E<CPO<#X\+W1D/B`\=&0@=VED=&@],T0R-2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q
M.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$Q.2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`X.7!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$
M8V5N=&5R/C(U)3PO<#X\+W1D/CPO='(^/"]T86)L93X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W9I<VEO;B!&
M;W(@26YC;VUE(%1A>&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\(2TM96=X+2T^/'`@<W1Y;&4],T0G5$585"U!3$E'3CIJ=7-T:69Y.R!,
M24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!
M551/4U!!0T4Z)SY4:&4@<')O=FES:6]N(&9O<B!I;F-O;64@=&%X97,@8V]N
M<VES=&5D(&]F('1H92!F;VQL;W=I;F<Z/"]P/B`\<"!S='EL93TS1"=,24Y%
M+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P=#L@5$585"U!551/
M4U!!0T4Z.R!T86(M<W1O<',Z-3`P+C%P="<^)FYB<W`[/"]P/B`\=&%B;&4@
M=VED=&@],T0U,34@<W1Y;&4],T0G34%21TE..F%U=&\@875T;R!A=71O("TP
M+C<U<'0[(%=)1%1(.C,X-G!T.R!"3U)$15(M0T],3$%04T4Z8V]L;&%P<V4G
M(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`^(#QT<CX@/'1D('=I
M9'1H/3-$,S`T('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#(R.'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS
M1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q.3D@8V]L
M<W!A;CTS1#,@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q
M<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O
M;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN
M9RUL969T.B`U+C1P=#L@=VED=&@Z(#$T.7!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
M='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L
M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/E1H<F5E
M(&UO;G1H<R!E;F1E9"!-87)C:"`S,2P\+V(^/"]P/CPO=&0^/"]T<CX@/'1R
M/B`\=&0@=VED=&@],T0S,#0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@,C(X<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D
M('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS
M1#DX('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O
M;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I
M;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F
M=#H@-2XT<'0[('=I9'1H.B`W,RXV<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(5#IN;W)M86P[($U!
M4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C96YT97(^/&(^,C`Q,SPO8CX\
M+W`^/"]T9#X@/'1D('=I9'1H/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q+CAP=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D
M/B`\=&0@=VED=&@],T0Y."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD
M;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S,N-G!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R
M/CQB/C(P,3(\+V(^/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0S
M,#0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@,C(X<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SY#=7)R96YT/"]P/CPO=&0^
M(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED
M=&@],T0Y."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D
M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R
M;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[
M('=I9'1H.B`W,RXV<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M
M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M
M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LD)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[("TF;F)S<#LF;F)S
M<#L@/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,2XX<'0[('!A9&1I;F<M<FEG
M:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z
M("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^
M/"]T9#X@/'1D('=I9'1H/3-$.3@@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M
M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG
M+6QE9G0Z(#4N-'!T.R!W:61T:#H@-S,N-G!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
M='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P
M="<^)FYB<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`U-C0L.#DS(#PO<#X\
M+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,S`T('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#(R.'!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP
M:6X@,&EN(#!P="<^1&5F97)R960\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#DX('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`W,RXV<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P
M.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P
M.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#L@*#(V.2PP,3$I/"]P/CPO=&0^(#QT9"!W:61T:#TS
M1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@,2XX<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C
M9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P
M:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$.3@@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#<S+C9P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`H,S0L,S$R*3PO<#X\
M+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,S`T('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#(R.'!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP
M:6X@,&EN(#!P="<^/&(^5&]T86P@:6YC;VUE('1A>"`H8F5N969I="D@97AP
M96YS93PO8CX\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/CPO=&0^(#QT9"!W:61T:#TS1#DX('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W,RXV<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@
M34%21TE..C!I;B`P:6X@,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[("@R-CDL,#$Q
M*3PO<#X\+W1D/B`\=&0@=VED=&@],T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$N.'!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO
M=&0^(#QT9"!W:61T:#TS1#DX('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I
M;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`W,RXV<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE.
M.C!I;B`P:6X@,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#4S
M,"PU.#$@/"]P/CPO=&0^/"]T<CX\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q-%\T.3@P7V$P
M,3-?-CEC9C=C8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,"]7;W)K<VAE
M971S+U-H965T,C4N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5,13X-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY&04E2(%9!3%5%($U%05-54D5-14Y44R`H5&%B;&5S*3QB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9!
M25(@5D%,544@345!4U5214U%3E13("A486)L97,I/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%S<V5T<R!&86ER(%9A;'5E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM96=X+2T^/'`@
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M87)C:"`S,2P@,C`Q,R!A;F0@1&5C96UB97(@,S$L(#(P,3(Z)FYB<W`[/"]P
M/B`\9&EV(&%L:6=N/3-$8V5N=&5R/B`\=&%B;&4@=VED=&@],T0U-#D@<W1Y
M;&4],T0G34%21TE..F%U=&\@875T;R!A=71O("TP+C<U<'0[(%=)1%1(.C0Q
M,2XU-7!T.R!"3U)$15(M0T],3$%04T4Z8V]L;&%P<V4G(&-E;&QP861D:6YG
M/3-$,"!C96QL<W!A8VEN9STS1#`^(#QT<CX@/'1D('=I9'1H/3-$,38P('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$R
M,'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,C(@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.3$N-7!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D
M/B`\=&0@=VED=&@],T0R-#,@8V]L<W!A;CTS1#4@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@R+C`U<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C96YT
M97(^/&(^1F%I<B!686QU92!-96%S=7)E;65N=',@870\+V(^/"]P/CPO=&0^
M/"]T<CX@/'1R/B`\=&0@=VED=&@],T0Q-C`@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3(P<'0[('!A9&1I;F<M<FEG
M:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z
M("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^
M/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M
M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG
M+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT
M9"!W:61T:#TS1#$R,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P
M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@
M8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@
M-2XT<'0[('=I9'1H.B`Y,2XU<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B
M;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A
M9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I
M9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#(T
M,R!C;VQS<&%N/3-$-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T
M97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@R+C`U<'0[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG
M:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T
M;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C96YT97(^
M/&(^4F5P;W)T:6YG($1A=&4@57-I;F<\+V(^/"]P/CPO=&0^/"]T<CX@/'1R
M/B`\=&0@=VED=&@],T0Q-C`@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN
M9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$R,'!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP
M:6X@,&EN(#!P="<^/&(^1&5S8W)I<'1I;VX\+V(^/"]P/CPO=&0^(#QT9"!W
M:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q
M,C(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L
M:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#DQ+C5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CIR:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'
M24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^/&(^36%R8V@@,S$L(#(P
M,3,\+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X\+W1D/B`\=&0@=VED=&@],T0V-2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[
M('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS
M<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-#EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)3D4M
M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS1&-E
M;G1E<CX\8CY,979E;"`Q/"]B/CPO<#X\+W1D/B`\=&0@=VED=&@],T0S('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#(N
M,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P-B!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@-SDN.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!
M3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P
M:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CY,979E;"`R/"]B/CPO<#X\+W1D
M/B`\=&0@=VED=&@],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P
M9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W
M:61T:#TS1#8U('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@
M,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`T.7!T.R!P861D:6YG+7)I9VAT.B`U
M+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F
M,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S
M='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R;6%L
M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/DQE=F5L
M(#,\+V(^/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0Q-C`@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F
M,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z
M('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3(P
M<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P
M.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V
M86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA
M;#L@34%21TE..C!I;B`P:6X@,'!T)SY"86YK97(G<R!A8V-E<'1A;F-E(&YO
M=&5S/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG
M+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@
M<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H
M=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@
M(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\
M+W1D/B`\=&0@=VED=&@],T0Q,C(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#DQ+C5P=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'
M24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,2PQ.#`L.#8T/"]P/CPO
M=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F
M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@
M=VED=&@],T0V-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT
M(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-#EP=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N8G-P
M.R`\+W`^/"]T9#X@/'1D('=I9'1H/3-$,R!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`R+C%P=#L@<&%D9&EN9RUR:6=H
M=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@
M(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\
M+W1D/B`\=&0@=VED=&@],T0Q,#8@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#<Y+C@U<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%2
M1TE..C!I;B`P:6X@,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[(#$L,3@P+#@V-#PO<#X\+W1D/B`\=&0@
M=VED=&@],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS
M1#8U('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O
M;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I
M;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F
M=#H@-2XT<'0[('=I9'1H.B`T.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@
M8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P
M861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS
M1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB
M<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`M)FYB<W`[)FYB<W`[(#PO<#X\
M+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,38P('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$R,'!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP
M:6X@,&EN(#!P="<^5&]T86P\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F
M,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z
M('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R,B!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@.3$N-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)"9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`Q
M+#$X,"PX-C0\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A
M9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R
M96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/CPO=&0^(#QT9"!W:61T:#TS1#8U('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`T.7!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!
M4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)"9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R`M)FYB<W`[)FYB<W`[(#PO<#X\+W1D/B`\=&0@=VED=&@],T0S('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#(N,7!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P-B!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE
M9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M
M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T
M:#H@-SDN.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,2PQ.#`L.#8T
M/"]P/CPO=&0^(#QT9"!W:61T:#TS1#,@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T
M=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D
M:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,BXQ<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T
M9#X@/'1D('=I9'1H/3-$-C4@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN
M9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#0Y<'0[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG
M:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T
M;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T)SXF;F)S<#LD)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[("TF;F)S
M<#LF;F)S<#L@/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0Q-C`@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M,3(P<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R,B!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D
M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E
M;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y,2XU<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO
M=&0^(#QT9"!W:61T:#TS1#8U('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F
M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#0Y<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T
M.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[
M('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D
M('=I9'1H/3-$,R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B
M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT
M<'0[('=I9'1H.B`R+C%P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@]
M,T0Q,#8@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R
M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U
M;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W
M:61T:#H@-SDN.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0S
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#8U('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#0Y<'0[
M('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B
M;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI
M9VX],T1B;W1T;VT^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#$V,"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q
M,C!P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P
M9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG
M('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F
M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A
M;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A
M9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D
M97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX]
M,T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$,3(R('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#DQ+C5P=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,B!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Y<'0[('!A9&1I;F<M<FEG:'0Z
M(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F
M,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T
M9#X@/'1D('=I9'1H/3-$-C4@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P
M9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P
M:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE
M9G0Z(#4N-'!T.R!W:61T:#H@-#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@
M=VED=&@],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R
M+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG
M+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS
M1#$P-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`W.2XX-7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#,@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M,BXQ<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I9'1H/3-$-C4@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-#EP=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X\+W1D/CPO='(^(#QT<CX@/'1D('=I9'1H/3-$,38P('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C
M9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R
M.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$R
M,'!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D
M9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E
M<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS
M1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,C(@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.3$N-7!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O
M='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D
M9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D
M/B`\=&0@=VED=&@],T0R-#,@8V]L<W!A;CTS1#4@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I
M;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT
M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@R+C`U<'0[('!A9&1I
M;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M
M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B
M;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%
M24=(5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C96YT
M97(^/&(^1F%I<B!686QU92!-96%S=7)E;65N=',@870\+V(^/"]P/CPO=&0^
M/"]T<CX@/'1R/B`\=&0@=VED=&@],T0Q-C`@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3(P<'0[('!A9&1I;F<M<FEG
M:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z
M("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^
M/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M
M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG
M+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT
M9"!W:61T:#TS1#$R,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P
M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@
M8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@
M-2XT<'0[('=I9'1H.B`Y,2XU<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B
M;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A
M9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T;VT^/"]T9#X@/'1D('=I
M9'1H/3-$,3(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O
M<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O
M<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#(T
M,R!C;VQS<&%N/3-$-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T
M97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M
M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P
M861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@,3@R+C`U<'0[('!A9&1I;F<M
M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F,&8P.R!B;W)D97(M<FEG
M:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[)R!V86QI9VX],T1B;W1T
M;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!,24Y%+4A%24=(
M5#IN;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<@86QI9VX],T1C96YT97(^
M/&(^4F5P;W)T:6YG($1A=&4@57-I;F<\+V(^/"]P/CPO=&0^/"]T<CX@/'1R
M/B`\=&0@=VED=&@],T0Q-C`@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN
M9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#$R,'!T.R!P861D:6YG
M+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I
M9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T
M=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M86P[($U!4D=)3CHP
M:6X@,&EN(#!P="<^/&(^1&5S8W)I<'1I;VX\+V(^/"]P/CPO=&0^(#QT9"!W
M:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O
M<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K
M9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P
M=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q
M,C(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L
M:60[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN
M.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T
M.B`U+C1P=#L@=VED=&@Z(#DQ+C5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[
M(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@
M<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CIR:6=H=#L@3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'
M24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$<FEG:'0^/&(^1&5C96UB97(@,S$L
M(#(P,3(\+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X\+W1D/B`\=&0@=VED=&@],T0V-2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@-#EP=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CIC96YT97([($Q)
M3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)R!A;&EG;CTS
M1&-E;G1E<CX\8CY,979E;"`Q/"]B/CPO<#X\+W1D/B`\=&0@=VED=&@],T0S
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P-B!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@-SDN.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CIC96YT97([($Q)3D4M2$5)1TA4.FYO<FUA;#L@34%21TE..C!I
M;B`P:6X@,'!T)R!A;&EG;CTS1&-E;G1E<CX\8CY,979E;"`R/"]B/CPO<#X\
M+W1D/B`\=&0@=VED=&@],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F
M,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@
M,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL
M969T.B`U+C1P=#L@=VED=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P
M=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P
M.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT
M9"!W:61T:#TS1#8U('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ('=I;F1O=W1E
M>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB
M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A
M9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`T.7!T.R!P861D:6YG+7)I9VAT
M.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C
M9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M/B`\
M<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E<CL@3$E.12U(14E'2%0Z;F]R
M;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/DQE
M=F5L(#,\+V(^/"]P/CPO=&0^/"]T<CX@/'1R/B`\=&0@=VED=&@],T0Q-C`@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z
M("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L
M;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@
M,3(P<'0[('!A9&1I;F<M<FEG:'0Z(#4N-'!T.R!B;W)D97(M=&]P.B`C9C!F
M,&8P.R!B;W)D97(M<FEG:'0Z("-F,&8P9C`[('!A9&1I;F<M=&]P.B`P:6X[
M)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T)SY"86YK97(G<R!A8V-E<'1A;F-E
M(&YO=&5S/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P861D
M:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A<F5N
M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN9RUR
M:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H
M=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O
M;3X\+W1D/B`\=&0@=VED=&@],T0Q,C(@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F,&8P
M.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N
M<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#DQ+C5P=#L@
M<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O
M<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG
M;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-
M05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#L@,3`Q+#4W,"`\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F,&8P
M9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z('1R
M86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T.R!P
M861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@8F]R
M9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L:6=N
M/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#8U('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@
M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO
M<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`T
M.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F
M,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@
M=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN;W)M
M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)"9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P
M.R9N8G-P.R`M)FYB<W`[)FYB<W`[(#PO<#X\+W1D/B`\=&0@=VED=&@],T0S
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T
M.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O
M;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z
M(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P-B!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@-SDN.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#L@,3`Q+#4W,"`\+W`^/"]T9#X@/'1D('=I9'1H/3-$
M,R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F
M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC
M;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H
M.B`R+C%P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F
M,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I
M;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0V-2!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R
M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG
M<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T
M.R!W:61T:#H@-#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT
M;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT
M;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N8G-P.R`\+W`^/"]T9#X\+W1R
M/B`\='(^(#QT9"!W:61T:#TS1#$V,"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T
M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I
M;F<M;&5F=#H@-2XT<'0[('=I9'1H.B`Q,C!P=#L@<&%D9&EN9RUR:6=H=#H@
M-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P
M9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P
M<'0G/E1O=&%L/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL969T.B`C9C!F,&8P.R!P
M861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T<F%N<W!A
M<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#EP=#L@<&%D9&EN
M9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR
M:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O
M='1O;3X\+W1D/B`\=&0@=VED=&@],T0Q,C(@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@=VEN9&]W=&5X="`Q<'0@<V]L:60[(&)O<F1E<BUL969T.B`C9C!F
M,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD+6-O;&]R.B!T
M<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED=&@Z(#DQ+C5P
M=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z("-F,&8P9C`[
M(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z(#!I;CLG('9A
M;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.12U(14E'2%0Z;F]R;6%L
M.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#L@,3`Q+#4W,"`\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@(V8P9C!F,#L@8F]R9&5R+6QE9G0Z("-F
M,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A8VMG<F]U;F0M8V]L;W(Z
M('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!W:61T:#H@.7!T
M.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P9C!F,#L@
M8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN.R<@=F%L
M:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#8U('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!B;W)D97(M;&5F
M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC
M;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I9'1H
M.B`T.7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@(V8P
M9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@,&EN
M.R<@=F%L:6=N/3-$8F]T=&]M/B`\<"!S='EL93TS1"=,24Y%+4A%24=(5#IN
M;W)M86P[($U!4D=)3CHP:6X@,&EN(#!P="<^)FYB<W`[)"9N8G-P.R9N8G-P
M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N
M8G-P.R9N8G-P.R`M)FYB<W`[)FYB<W`[(#PO<#X\+W1D/B`\=&0@=VED=&@]
M,T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ("-F,&8P9C`[(&)O<F1E<BUL
M969T.B`C9C!F,&8P.R!P861D:6YG+6)O='1O;3H@,&EN.R!B86-K9W)O=6YD
M+6-O;&]R.B!T<F%N<W!A<F5N=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=VED
M=&@Z(#(N,7!T.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@8F]R9&5R+71O<#H@
M(V8P9C!F,#L@8F]R9&5R+7)I9VAT.B`C9C!F,&8P.R!P861D:6YG+71O<#H@
M,&EN.R<@=F%L:6=N/3-$8F]T=&]M/CPO=&0^(#QT9"!W:61T:#TS1#$P-B!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@-SDN.#5P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O
M<F1E<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D
M9&EN9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P
M.R0F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF
M;F)S<#LF;F)S<#LF;F)S<#L@,3`Q+#4W,"`\+W`^/"]T9#X@/'1D('=I9'1H
M/3-$,R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M
M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N
M9"UC;VQO<CH@=')A;G-P87)E;G0[('!A9&1I;F<M;&5F=#H@-2XT<'0[('=I
M9'1H.B`R+C%P=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E<BUT;W`Z
M("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN9RUT;W`Z
M(#!I;CLG('9A;&EG;CTS1&)O='1O;3X\+W1D/B`\=&0@=VED=&@],T0V-2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@
M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F<M8F]T=&]M.B`P:6X[(&)A
M8VMG<F]U;F0M8V]L;W(Z('1R86YS<&%R96YT.R!P861D:6YG+6QE9G0Z(#4N
M-'!T.R!W:61T:#H@-#EP=#L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[(&)O<F1E
M<BUT;W`Z("-F,&8P9C`[(&)O<F1E<BUR:6=H=#H@(V8P9C!F,#L@<&%D9&EN
M9RUT;W`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;3X@/'`@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z;F]R;6%L.R!-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.R0F
M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S
M<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N8G-P.R`\+W`^/"]T9#X\
M+W1R/CPO=&%B;&4^/"]D:78^(#QP('-T>6QE/3-$)TQ)3D4M2$5)1TA4.FYO
M<FUA;#L@34%21TE..C!I;B`P:6X@,'!T.R!415A4+4%55$]34$%#13HG/CQB
M/B9N8G-P.SPO8CX\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
M/5].97AT4&%R=%\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C-F(T
M,C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#8P,&8W,3-?,&(Q
M-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P+U=O<FMS:&5E=',O4VAE970R-BYH
M=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A
M8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C
M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P14)'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D)!4TE3
M($]&(%!215-%3E1!5$E/3B`H1&5T86EL<RD\8G(^/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5R8V5N=&%G92!O9B!S
M:&%R92!O=VYE9"!B>2!#:&EN82!0:&%R;6$@2&]L9&EN9W,@26YC(&]F($]N
M;GD@26YV97-T;65N="!,:6UI=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,#`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y097)C96YT86=E(&]F('-H87)E(&]W;F5D(&)Y
M($-H:6YA(%!H87)M82!(;VQD:6YG<R!);F,@;V8@2&5L<'-O;B!-961I8V%L
M("9A;7`[($)I;W1E8VAN;VQO9WD@0V\N+"!,=&0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$P,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<F-E=&%G92!O9B!A8W%U:7)E
M9"!B>2!/;FYY(&EN($AE;'!S;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$P,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R
M,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P-C`P9C<Q,U\P8C$T
M7S0Y.#!?83`Q,U\V.6-F-V-C-F(T,C`O5V]R:W-H965T<R]3:&5E=#(W+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%6$M!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY"05-)
M4R!/1B!04D5314Y4051)3TX@0F%S:6,@86YD($1I;'5T960@16%R;FEN9W,@
M<&5R($-O;6UO;B!3:&%R92`H1&5T86EL<RD@*%531"`D*3QB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!I;F-O;64\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BPX,3(L,S`W*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPX
M,#8L,S4Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y"87-I8R!W96EG:'1E9"UA=F5R86=E(&-O;6UO;B!S:&%R97,@
M;W5T<W1A;F1I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0S
M+#4W.2PU-3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT,RPU,CDL-34W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1&EL=71E9"!W96EG:'1E9"UA=F5R86=E
M(&-O;6UO;B!S:&%R97,@;W5T<W1A;F1I;F<\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0S+#4W.2PU-3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,RPU,CDL-34W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"87-I8R!E87)N
M:6YG<R!P97(@<VAA<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M)"`H,"XP-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#`N,#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D1I;'5T960@96%R;FEN9W,@<&5R('-H87)E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N,#8I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C`V/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-C`P9C<Q
M,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C-F(T,C`-"D-O;G1E;G0M3&]C871I
M;VXZ(&9I;&4Z+R\O0SHO,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C
M8S9B-#(P+U=O<FMS:&5E=',O4VAE970R."YH=&UL#0I#;VYT96YT+51R86YS
M9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z
M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14A"04,^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0R/CQS=')O;F<^0D%325,@3T8@4%)%4T5.5$%424].
M(%!/3$E#2453("A$971A:6QS*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S('=I=&@@97AE<F-I<V4@<')I8V5S
M(&]F("0S+C`P('1O("0S+C@P('!E<B!S:&%R93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,34P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$U,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@=VET:"!A
M;B!E>&5R8VES92!P<FEC92!O9B`D,BXU-"!T;R`D,RXT-R!P97(@<VAA<F4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(U+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Q,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E1O=&%L(%=A<G)A;G1S($%N9"!/<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-S4L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-#8P+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q-%\T.3@P7V$P
M,3-?-CEC9C=C8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,"]7;W)K<VAE
M971S+U-H965T,CDN:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4T14%#/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,3X\<W1R;VYG/DE.5D5.5$]262X@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@
M,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2
M87<@;6%T97)I86QS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#(X+#,X,"PY,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#,P+#$Y."PX,38\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9I;FES:&5D(&=O;V1S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#8U.2PP-3(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#DS,"PV.#0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DEN=F5N=&]R>2!'<F]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,S4L,#,Y+#DU-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,X+#$R.2PU,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%L;&]W86YC92!F;W(@;V)S;VQE
M<V-E;F-E("T@<F%W(&UA=&5R:6%L<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,2PW-SDL-S(Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#$L-S8Y+#DX-"D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L($EN=F5N=&]R
M>2!N970\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,S,L,C8P
M+#(R-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,S8L,S4Y+#4Q-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B
M-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S`V,#!F-S$S7S!B
M,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,"]7;W)K<VAE971S+U-H965T,S`N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$5:34%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/E!2
M3U!%4E19($%.1"!%455)4$U%3E0@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@
M,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M97)M:70@;V8@;&%N9"!U<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@-#0Y+#0W-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@-#0W+#`Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0G5I;&1I;F<\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(L-#,R+#0T,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-#$Y+#$R-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&QA;G0L
M(&UA8VAI;F5R>2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XV+#0Q."PW-C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XV+#,X,2PR,#D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUO=&]R('9E:&EC;&4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T-RPX.3`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-#<L,#@P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y/9F9I8V4@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR,C,L.30W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,C(R+#(W,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V]N<W1R=6-T:6]N(&EN('!R;V=R97-S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#$R-RPS.38\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#8X
M."PU-C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E1O=&%L(%!R;W!E<G1Y(&%N9"!%<75I<&UE;G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$S+#<Y.2PY,3<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,RPS,#4L,C8W/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,
M97-S.B!A8V-U;75L871E9"!D97!R96-I871I;VX@9&5T86EL<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-"PU,3$L-C4X*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0L,C<S+#,W,RD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E!R;W!E<G1Y(&%N9"!%<75I<&UE;G0L(&YE=#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Y+#(X."PR-3D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#DL,#,Q+#@Y-#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q
M-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R
M,"]7;W)K<VAE971S+U-H965T,S$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$571T%#/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R
M;W=S<&%N/3-$,3X\<W1R;VYG/E!23U!%4E19($%.1"!%455)4$U%3E0@07-S
M971S($QI9F4@*$1E=&%I;',I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<FUI="!O9B!L86YD('5S92!M:6YI
M;75M(&QI9F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M97)M:70@;V8@;&%N9"!U<V4@;6%X:6UU;2!L:69E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XW,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0G5I;&1I;F<@;6EN:6UU;2!L:69E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0G5I;&1I;F<@;6%X
M:6UU;2!L:69E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4&QA;G0L(&UA8VAI;F5R>2!A;F0@97%U:7!M96YT(&QI9F4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-;W1O<B!V96AI8VQE(&UI;FEM
M=6T@;&EF93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36]T
M;W(@=F5H:6-L92!M87AI;75M(&QI9F4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y/9F9I8V4@97%U:7!M96YT(&UI;FEM=6T@;&EF93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3V9F:6-E(&5Q=6EP
M;65N="!M87AI;75M(&QI9F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,`T*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q
M,U\V.6-F-V-C-F(T,C`O5V]R:W-H965T<R]3:&5E=#,R+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%2$@^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^05-31513($1E<')E8VEA
M=&EO;B`H1&5T86EL<RD@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D1E<')E8VEA=&EO;B!%>'!E;G-E('!R;W!E
M<G1Y(&%N9"!E<75I<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,C$T+#0P-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,C$R+#0R-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I>F%T:6]N($5X<&5N<V4@
M26YT86YG:6)L92!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,3,V+#`V,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,34R+#<Y.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC
M9C=C8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S`V,#!F
M-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,"]7;W)K<VAE971S+U-H
M965T,S,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$4V04%#/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R
M;VYG/DE.5$%.1TE"3$4@05-31513(%-&1$$@07!P<F]V960@365D:6-A;"!&
M;W)M=6QA<R`H1&5T86EL<RD@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R;W-S(&-A<G)Y:6YG
M(&%M;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U+#,X
M-RPP-S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#4L,S4W+#4X,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^06-C=6UU;&%T960@86UO<G1I>F%T:6]N($EN
M=&%N9VEB;&4@87-S971S(%-&1$$@07!P<F]V960@365D:6-A;"!&;W)M=6QA
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPP.3<L,C(T*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L
M.30T+#<R-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DYE="!C87)R>6EN9R!A;6]U;G0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,BPR.#DL.#4Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#0Q,BPX-30\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S`V,#!F-S$S7S!B
M,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,`T*0V]N=&5N="U,;V-A=&EO;CH@
M9FEL93HO+R]#.B\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C-F(T
M,C`O5V]R:W-H965T<R]3:&5E=#,T+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M
M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X
M="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D
M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%,D@^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^4D5,051%1"!005)462!44D%.4T%#5$E/3E,@
M365M8F5R($]F($)/1"`H1&5T86EL<RD@*%531"`D*3QB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3(\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&EN=&5R97-T(&5X
M<&5N<V4@<F5C;V=N:7IE9"!F;W(@=&AE('!E<FEO9#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`S+#,X-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PY-S`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&5R97-T(')A
M=&4@;VX@861V86YC97,@9G)O;2!-96UB97(@;V8@0D]$/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$N,#`E/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-C`P9C<Q,U\P8C$T7S0Y.#!?
M83`Q,U\V.6-F-V-C-F(T,C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
M0SHO,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P+U=O<FMS
M:&5E=',O4VAE970S-2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG
M.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@
M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%&/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,3X\<W1R;VYG/E)%3$%4140@4$%25%D@5%)!3E-!0U1)3TY3($]W:6YG<R`H
M1&5T86EL<RD@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%D879A;F-E<R!O=VEN9R!T;R!B;V%R
M9"!M96UB97(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PS
M-30L-38W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`Q+#,U-"PU-C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V
M8C0R,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P-C`P9C<Q,U\P
M8C$T7S0Y.#!?83`Q,U\V.6-F-V-C-F(T,C`O5V]R:W-H965T<R]3:&5E=#,V
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%2D)!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY.
M3U1%4R!005E!0DQ%4RX@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y/8W0N(#,P+"`R,#$R
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2979O;'9I
M;F<@;&EN92!O9B!C<F5D:70@=VET:"!A(&)A;FL\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,S`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06YN=6%L(&EN=&5R97-T
M(')A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8N.3`E/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M=71S=&%N9&EN9R!B86QA;F-E(&1U92!U;F1E<B!R979O;'9I;F<@;&EN92!O
M9B!C<F5D:70@*%)-0B`S,"PP,#`L,#`P*3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`T+#<X-RPR.#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
M#0HM+2TM+2T]7TYE>'1087)T7S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y
M8V8W8V,V8C0R,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P-C`P
M9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C-F(T,C`O5V]R:W-H965T<R]3
M:&5E=#,W+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E
M9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T
M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%4$@^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O
M;F<^24Y#3TU%(%1!6$53(%5N9&ES=')I8G5T960@16%R;FEN9W,@06YD($EN
M8V]M92!487@@4F%T97,@*$1E=&%I;',I/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5N9&ES=')I8G5T960@96%R
M;FEN9W,@;V8@2&5L<'-O;B!I;B!M:6QL:6]N<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3$P+C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=F5S=&UE;G0@:6X@2&5L<'-O;BP@
M82!F;W)E:6=N('-U8G-I9&EA<GD@9F]R('1H92!C;VUP86YY(&EN(&UI;&QI
M;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,RXS/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1E
M<G!R:7-E($EN8V]M92!487@@4F%T97,@9F]R('1H92!Y96%R(#(P,3,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+C`P)3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT97)P<FES
M92!);F-O;64@5&%X(%)A=&5S(&9O<B!T:&4@>65A<B`R,#$T(&%N9"!A9G1E
M<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4N,#`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-C`P9C<Q,U\P
M8C$T7S0Y.#!?83`Q,U\V.6-F-V-C-F(T,C`-"D-O;G1E;G0M3&]C871I;VXZ
M(&9I;&4Z+R\O0SHO,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B
M-#(P+U=O<FMS:&5E=',O4VAE970S."YH=&UL#0I#;VYT96YT+51R86YS9F5R
M+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E
M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14A"04,^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^24Y#3TU%(%1!6$53(%!R;W9I<VEO;B`H
M1&5T86EL<RD@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/DUA<BX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-U<G)E;G0@=&%X('!R;W9I<VEO;BX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-38T+#@Y,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5F97)R960@
M=&%X('!R;W9I<VEO;BX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#(V.2PP,3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,S0L,S$R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^5&]T86P@:6YC;VUE('1A>"!E>'!E;G-E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#(V.2PP,3$I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U,S`L
M-3@Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P
M-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C-F(T,C`-"D-O;G1E;G0M
M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?
M-CEC9C=C8S9B-#(P+U=O<FMS:&5E=',O4VAE970S.2YH=&UL#0I#;VYT96YT
M+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT
M+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL
M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M13%+04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^1D%)4B!604Q512!-14%3
M55)%345.5%,@070@4F5P;W)T:6YG($1A=&4@57-I;F<@*$1E=&%I;',I("A5
M4T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y"86YK97)S(&%C8V5P=&%N8V4@;F]T97,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PQ.#`L.#8T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,#$L-3<P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4
M;W1A;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PQ.#`L.#8T
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3`Q+#4W,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0F%N:V5R<R!A8V-E<'1A;F-E(&YO=&5S($QE=F5L(#$\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!,979E;"`Q
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%N:V5R<R!A
M8V-E<'1A;F-E(&YO=&5S($QE=F5L(#(\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$L,3@P+#@V-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$P,2PU-S`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L($QE=F5L(#(\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,3@P+#@V-#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P,2PU-S`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D)A;FME<G,@86-C97!T86YC92!N;W1E<R!,979E;"`S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@3&5V96P@,SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-C`P9C<Q,U\P8C$T7S0Y.#!?
M83`Q,U\V.6-F-V-C-F(T,C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
M0SHO,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P+U=O<FMS
M:&5E=',O4VAE970T,"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG
M.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@
M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14Y'04,^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0Q/CQS=')O;F<^4')E9F5R<F5D($-O;6UO;B!3=&]C:R!!;F0@5V%R<F%N
M=',@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-H87)E<R!A=71H;W)I
M>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY-2PP,#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y0<F5F97)R960@<VAA<F5S(&%U=&AO<FEZ960\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3G5M8F5R(&]F(&-O;6UO;B!S
M=&]C:R!S:&%R97,@=&\@<'5R8VAA<V4@8GD@=V%R<F%N=',@;W5T<W1A;FEN
M9R!A;F0@97AE<F-I<V%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E=A<G)A;G1S('-T87)T(')A;F=E(&5X97)C:7-E('!R
M:6-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A
M;G1S(&5N9"!R86YG92!E>&5R8VES92!P<FEC93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`S+C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S('=E:6=H=&5D(&%V97)A
M9V4@97AE<F-I<V4@<')I8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,RXT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y787)R86YT<R!W96EG:'1E9"!A=F5R86=E(&-O;G1R86-T
M=6%L(&QI9F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M5&]T86P@:6YT<FEN<VEC('9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,`T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P-C`P9C<Q,U\P8C$T7S0Y
M.#!?83`Q,U\V.6-F-V-C-F(T,C`O5V]R:W-H965T<R]3:&5E=#0Q+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%-D%!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SXR,#$P(%-T
M;V-K($]P=&EO;B!0;&%N("A$971A:6QS*3QB<CX\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DYO=BX@,3(L(#(P,3`\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!C;VUM
M;VX@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PP
M,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y.=6UB97(@;V8@8V]M;6]N('-H87)E<R!P=7)C:&%S960@8GD@
M;W!T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S4L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4W1O8VL@;W!T:6]N<R!G<F%N=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
M+2TM/5].97AT4&%R=%\P-C`P9C<Q,U\P8C$T7S0Y.#!?83`Q,U\V.6-F-V-C
M-F(T,C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#8P,&8W,3-?
M,&(Q-%\T.3@P7V$P,3-?-CEC9C=C8S9B-#(P+U=O<FMS:&5E=',O4VAE970T
M,BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I
M;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M
M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P14A"04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M0T].0T5.5%)!5$E/3E,@4V%L97,@06YD(%!U<F-H87-E<R`H1&5T86EL<RD\
M8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q
M,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R
M,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y097)C
M96YT86=E(&]F(&YO(&-U<W1O;65R(&%C8V]U;G1E9"!F;W(@;6]R92!T:&%N
M('-A;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"XP,"4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E!E<F-E;G1A9V4@;V8@;VYE(&-U<W1O;65R(&%C8V]U;G1E9"!F;W(@;6]R
M92!T:&%N('-A;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,"XS,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!E<F-E;G1A9V4@;V8@<'5R8VAA<V5S(&9R;VT@;VYE('-U<'!L
M:65R(&]F(')A=R!M871E<FEA;',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,T+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$T+C$P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?,#8P,&8W,3-?,&(Q-%\T.3@P7V$P,3-?-CEC9C=C
M8S9B-#(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S`V,#!F-S$S
M7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R,"]7;W)K<VAE971S+U-H965T
M-#,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$4V1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#
M3TY#14Y44D%424].4R!!8V-O=6YT<R!296-E:79A8FQE("A$971A:6QS*3QB
M<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N
M(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E!E<F-E;G1A9V4@;V8@86-C;W5N=',@<F5C96EV86)L92!B>2!O;F4@
M8W5S=&]M97(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+C4P
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F\@;V8@8W5S=&]M97)S(&%C8V]U;G1E9"!F;W(@;6]R92!T:&%N(#$P
M+C`E(&]F(&%C8V]U;G1S(')E8V5I=F%B;&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y8V8W8V,V8C0R
M,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P-C`P9C<Q,U\P8C$T
M7S0Y.#!?83`Q,U\V.6-F-V-C-F(T,C`O5V]R:W-H965T<R]F:6QE;&ES="YX
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M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`R+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970P,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,#0N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`U+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P-BYH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,#<N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS
M1")3:&5E=#`X+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P.2YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3`N:'1M;"(O/@T*(#QO
M.D9I;&4@2%)E9CTS1")3:&5E=#$Q+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970Q,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3,N
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$T+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970Q-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,38N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$W
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q."YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,3DN:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#(P+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R
M,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C(N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(S+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970R-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,C4N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(V+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970R-RYH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,C@N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#(Y+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S,"YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S$N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#,R+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970S,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S0N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,U+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970S-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,S<N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,X+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S.2YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T-#`N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#0Q+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T,BYH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#,N:'1M;"(O/@T*/"]X;6P^
M#0HM+2TM+2T]7TYE>'1087)T7S`V,#!F-S$S7S!B,31?-#DX,%]A,#$S7S8Y
..8V8W8V,V8C0R,"TM#0H`
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E6G">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONCENTRATIONS Accounts Receivable (Details)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfAccountsReceivableByOneCustomer', window );">Percentage of accounts receivable by one customer</a></td>
        <td class="nump">10.50%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable', window );">No of customers accounted for more than 10.0% of accounts receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>No of customers accounted for more than 10.0% of accounts receivable</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NoOfCustomersAccountedForMoreThan100OfAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfAccountsReceivableByOneCustomer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of accounts receivable by one customer</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfAccountsReceivableByOneCustomer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E4EAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>INVENTORY. (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
        <td class="nump">$ 28,380,903<span></span></td>
        <td class="nump">$ 30,198,816<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
        <td class="nump">6,659,052<span></span></td>
        <td class="nump">7,930,684<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory Gross</a></td>
        <td class="nump">35,039,955<span></span></td>
        <td class="nump">38,129,500<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AllowanceForObsolescenceRawMaterials', window );">Allowance for obsolescence - raw materials</a></td>
        <td class="num">(1,779,729)<span></span></td>
        <td class="num">(1,769,984)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalInventoryNet', window );">Total Inventory net</a></td>
        <td class="nump">$ 33,260,226<span></span></td>
        <td class="nump">$ 36,359,516<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AllowanceForObsolescenceRawMaterials">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Allowance for obsolescence - raw materials</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AllowanceForObsolescenceRawMaterials</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalInventoryNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_TotalInventoryNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 6<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.6(a)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryFinishedGoods</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.6(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.  Also includes purchased parts that will be used as components of a finished product.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 6<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.6(a)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryRawMaterials</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EHBAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>BASIS OF PRESENTATION POLICIES (Details)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsWithExercisePrice', window );">Warrants with exercise prices of $3.00 to $3.80 per share</a></td>
        <td class="nump">150,000<span></span></td>
        <td class="nump">150,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OptionsWithAnExercisePrice', window );">Options with an exercise price of $2.54 to $3.47 per share</a></td>
        <td class="nump">25,000<span></span></td>
        <td class="nump">310,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalWarrantsAndOptions', window );">Total Warrants And Options</a></td>
        <td class="nump">175,000<span></span></td>
        <td class="nump">460,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OptionsWithAnExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Options with an exercise price of $2.54 to $3.47 per share</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_OptionsWithAnExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalWarrantsAndOptions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total Warrants And Options</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_TotalWarrantsAndOptions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsWithExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants with exercise prices of $3.00 to $3.80 per share</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsWithExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EZMAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PermitOfLandUse', window );">Permit of land use</a></td>
        <td class="nump">$ 449,474<span></span></td>
        <td class="nump">$ 447,013<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Building</a></td>
        <td class="nump">2,432,442<span></span></td>
        <td class="nump">2,419,125<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PlantMachineryAndEquipmentGross', window );">Plant, machinery and equipment</a></td>
        <td class="nump">6,418,768<span></span></td>
        <td class="nump">6,381,209<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MotorVehicleGross', window );">Motor vehicle</a></td>
        <td class="nump">147,890<span></span></td>
        <td class="nump">147,080<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Office equipment</a></td>
        <td class="nump">223,947<span></span></td>
        <td class="nump">222,273<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
        <td class="nump">4,127,396<span></span></td>
        <td class="nump">3,688,567<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalPropertyAndEquipment', window );">Total Property and Equipment</a></td>
        <td class="nump">13,799,917<span></span></td>
        <td class="nump">13,305,267<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LessAccumulatedDepreciationDetails', window );">Less: accumulated depreciation details</a></td>
        <td class="num">(4,511,658)<span></span></td>
        <td class="num">(4,273,373)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PropertyAndEquipmentNet', window );">Property and Equipment, net</a></td>
        <td class="nump">$ 9,288,259<span></span></td>
        <td class="nump">$ 9,031,894<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LessAccumulatedDepreciationDetails">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_LessAccumulatedDepreciationDetails</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MotorVehicleGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of motor vehicle gross as on the date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MotorVehicleGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PermitOfLandUse">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of permit of land use as on the date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PermitOfLandUse</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PlantMachineryAndEquipmentGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of plant machinery and equipment gross as on the date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PlantMachineryAndEquipmentGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PropertyAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PropertyAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalPropertyAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total Property and Equipment</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_TotalPropertyAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross amount, as of the balance sheet date, of long-lived, depreciable assets that include building structures held for productive use including any addition, improvement, or renovation to the structure, such as interior masonry, interior flooring, electrical, and plumbing.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -Subparagraph (f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6812-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BuildingsAndImprovementsGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross amount, at the balance sheet date, of long-lived assets under construction that include construction costs to date on capital projects that have not been completed and assets being constructed that are not ready to be placed into service.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConstructionInProgressGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross amount, at the balance sheet date, of long-lived, depreciable assets commonly used in offices and stores. Examples include desks, chairs, and store fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FurnitureAndFixturesGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EWGAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT Assets Life (Details)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PermitOfLandUseMinimumLife', window );">Permit of land use minimum life</a></td>
        <td class="nump">40<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PermitOfLandUseMaximumLife', window );">Permit of land use maximum life</a></td>
        <td class="nump">70<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_BuildingMinimumLife', window );">Building minimum life</a></td>
        <td class="nump">20<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_BuildingMaximumLife', window );">Building maximum life</a></td>
        <td class="nump">35<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PlantMachineryAndEquipmentLife', window );">Plant, machinery and equipment life</a></td>
        <td class="nump">10<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MotorVehicleMinimumLife', window );">Motor vehicle minimum life</a></td>
        <td class="nump">5<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MotorVehicleMaximumLife', window );">Motor vehicle maximum life</a></td>
        <td class="nump">10<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OfficeEquipmentMinimumLife', window );">Office equipment minimum life</a></td>
        <td class="nump">3<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OfficeEquipmentMaximumLife', window );">Office equipment maximum life</a></td>
        <td class="nump">5<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_BuildingMaximumLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum useful life of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_BuildingMaximumLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_BuildingMinimumLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The minimum useful life of long lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_BuildingMinimumLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MotorVehicleMaximumLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum useful life of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MotorVehicleMaximumLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MotorVehicleMinimumLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The minimum useful life of long lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MotorVehicleMinimumLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OfficeEquipmentMaximumLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum useful life of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_OfficeEquipmentMaximumLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OfficeEquipmentMinimumLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The minimum useful life of long lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_OfficeEquipmentMinimumLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PermitOfLandUseMaximumLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum useful life of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PermitOfLandUseMaximumLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PermitOfLandUseMinimumLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The minimum useful life of long lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PermitOfLandUseMinimumLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PlantMachineryAndEquipmentLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Plant, machinery and equipment life</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PlantMachineryAndEquipmentLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INVENTORY.<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>INVENTORY.</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORY.</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 3 - INVENTORY</b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Inventory consisted of the following:&nbsp;</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"> </p><table width="483" style="MARGIN:auto auto auto -0.75pt; WIDTH:362.4pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>&nbsp;March 31, </b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>&nbsp;December 31, </b></p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Raw materials</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 28,380,903</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30,198,816 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Finished goods</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,659,052 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7,930,684 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 35,039,955</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38,129,500 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Obsolescence reserve</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1,779,729)</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1,769,984)</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10.05pt; MARGIN:0in 0in 0pt"><b>Total Inventory</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33,260,226 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 36,359,516 </p></td></tr></table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.6)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Chapter 3<br><br> -Section A<br><br> -Paragraph 9<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 6<br><br> -Subparagraph a, b, c<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EHH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>ASSETS Depreciation (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DepreciationExpensePropertyAndEquipment', window );">Depreciation Expense property and equipment</a></td>
        <td class="nump">$ 214,406<span></span></td>
        <td class="nump">$ 212,424<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmortizationExpenseIntangibleAssets', window );">Amortization Expense Intangible assets</a></td>
        <td class="nump">$ 136,062<span></span></td>
        <td class="nump">$ 152,799<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmortizationExpenseIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amortization Expense Intangible assets</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmortizationExpenseIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DepreciationExpensePropertyAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Depreciation Expense property and equipment</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DepreciationExpensePropertyAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ENGAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Preferred Common Stock And Warrants (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonSharesAuthorized', window );">Common shares authorized</a></td>
        <td class="nump">95,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PreferredSharesAuthorized', window );">Preferred shares authorized</a></td>
        <td class="nump">5,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable', window );">Number of common stock shares to purchase by warrants outstaning and exercisable</a></td>
        <td class="nump">150,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsStartRangeExercisePrice', window );">Warrants start range exercise price</a></td>
        <td class="nump">$ 3.00<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsEndRangeExercisePrice', window );">Warrants end range exercise price</a></td>
        <td class="nump">$ 3.80<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsWeightedAverageExercisePrice', window );">Warrants weighted average exercise price</a></td>
        <td class="nump">$ 3.40<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsWeightedAverageContractualLife', window );">Warrants weighted average contractual life</a></td>
        <td class="nump">0.2<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalIntrinsicValue', window );">Total intrinsic value</a></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_CommonSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of common stock shares to purchase by warrants outstaning and exercisable</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NumberOfCommonStockSharesToPurchaseByWarrantsOutstaningAndExercisable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PreferredSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PreferredSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total intrinsic value</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_TotalIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsEndRangeExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants start range exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsEndRangeExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsStartRangeExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants start range exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsStartRangeExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsWeightedAverageContractualLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants weighted average contractual life</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsWeightedAverageContractualLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants weighted average exercise price</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E5JAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 4,750,468<span></span></td>
        <td class="nump">$ 4,029,708<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Banker's acceptances</a></td>
        <td class="nump">1,180,864<span></span></td>
        <td class="nump">101,570<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade accounts receivable, less allowance for doubtful accounts of $4,333,411 and $4,429,945, respectively</a></td>
        <td class="nump">62,697,675<span></span></td>
        <td class="nump">66,175,570<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables, less allowance for doubtful accounts of $50,592 and $49,881, respectively</a></td>
        <td class="nump">255,292<span></span></td>
        <td class="nump">80,799<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdvancesToSuppliers', window );">Advances to suppliers</a></td>
        <td class="nump">5,119,729<span></span></td>
        <td class="nump">4,816,354<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, less allowance for obsolescence of $1,779,729 and $1,769,984, respectively</a></td>
        <td class="nump">33,260,226<span></span></td>
        <td class="nump">36,359,516<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetCurrent', window );">Deferred tax assets</a></td>
        <td class="nump">954,980<span></span></td>
        <td class="nump">967,671<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
        <td class="nump">108,219,234<span></span></td>
        <td class="nump">112,531,188<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdvancesForPurchasesOfIntangibleAssets', window );">Advances for purchases of intangible assets</a></td>
        <td class="nump">39,462,268<span></span></td>
        <td class="nump">39,263,977<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation of $4,511,658 and $4,273,373, respectively</a></td>
        <td class="nump">9,288,259<span></span></td>
        <td class="nump">9,031,894<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net of accumulated amortization of $3,097,224 and $2,944,726, respectively</a></td>
        <td class="nump">2,289,851<span></span></td>
        <td class="nump">2,412,854<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
        <td class="nump">159,259,612<span></span></td>
        <td class="nump">163,239,913<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade accounts payable</a></td>
        <td class="nump">2,978,636<span></span></td>
        <td class="nump">2,841,862<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
        <td class="nump">240,003<span></span></td>
        <td class="nump">202,185<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Accrued taxes payable</a></td>
        <td class="nump">514,245<span></span></td>
        <td class="nump">2,426,826<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other payables</a></td>
        <td class="nump">1,014,647<span></span></td>
        <td class="nump">1,094,886<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerAdvancesCurrent', window );">Advances from customers</a></td>
        <td class="nump">1,735,917<span></span></td>
        <td class="nump">1,945,984<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Other payables - related parties</a></td>
        <td class="nump">1,354,567<span></span></td>
        <td class="nump">1,354,567<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Short-term notes payable</a></td>
        <td class="nump">4,787,285<span></span></td>
        <td class="nump">4,761,073<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
        <td class="nump">12,625,300<span></span></td>
        <td class="nump">14,627,383<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Long-term deferred tax liability</a></td>
        <td class="nump">110,286<span></span></td>
        <td class="nump">95,963<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
        <td class="nump">12,735,586<span></span></td>
        <td class="nump">14,723,346<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued or outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 95,000,000 shares authorized; 43,579,557 shares and 43,579,557 shares outstanding, respectively</a></td>
        <td class="nump">43,580<span></span></td>
        <td class="nump">43,580<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
        <td class="nump">23,590,204<span></span></td>
        <td class="nump">23,590,204<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
        <td class="nump">106,092,017<span></span></td>
        <td class="nump">108,904,325<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
        <td class="nump">16,798,225<span></span></td>
        <td class="nump">15,978,458<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
        <td class="nump">146,524,026<span></span></td>
        <td class="nump">148,516,567<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
        <td class="nump">$ 159,259,612<span></span></td>
        <td class="nump">$ 163,239,913<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdvancesForPurchasesOfIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Advances for purchases of intangible assets</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AdvancesForPurchasesOfIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdvancesToSuppliers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of advances to suppliers.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AdvancesToSuppliers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, which are not elsewhere specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6935-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Chapter 3<br><br> -Section A<br><br> -Paragraph 7<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableOtherCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6935-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Chapter 3<br><br> -Section A<br><br> -Paragraph 7<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableTradeCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e653-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 14, 17, 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FAS115-1/124-1<br><br> -Paragraph 15D<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e681-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 7<br><br> -Section 03<br><br> -Paragraph 12<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br> -Section S99<br><br> -Name Accounting Standards Codification<br><br> -Publisher FASB<br><br> -Paragraph 1<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Concepts (CON)<br><br> -Number 6<br><br> -Paragraph 25<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 18<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6801-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Section 45<br><br> -SubTopic 10<br><br> -Topic 210<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Paragraph 1<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 9<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.9)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrestricted cash available for day-to-day operating needs, for an entity that has cash equivalents, but does not aggregate cash equivalents with cash on the balance sheet.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7<br><br> -Footnote 1<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Cash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash equivalents may be reported as cash equivalents, while legally restricted equivalents held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular equivalents are not generally reported as part of unrestricted cash equivalents.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 8, 9<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerAdvancesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current portion of prepayments received from customers for goods or services to be provided in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CustomerAdvancesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current portion of the aggregate tax effects as of the balance sheet date of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after deducting the allocated valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, are classified according to the expected reversal date of the temporary difference. An unrecognized tax benefit that is directly related to a position taken in a tax year that results in a net operating loss carryforward is presented as a reduction of the related deferred tax asset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31928-109318<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 41, 42, 43<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31958-109318<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31917-109318<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31931-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise separates deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, are classified according to the expected reversal date of the temporary difference.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31958-109318<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 41, 42<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31917-109318<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31931-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 4<br><br> -Section 08<br><br> -Paragraph k<br><br> -Subparagraph 1<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 57<br><br> -Paragraph 2<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DueToRelatedPartiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 142<br><br> -Paragraph 42, 45<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph ((a)(1),(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsNetExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.6(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 330<br><br> -SubTopic 10<br><br> -Section 35<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6386567&amp;loc=d3e3927-108312<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19-26)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Liabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 32<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.32)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 7<br><br> -Section 03<br><br> -Paragraph 25<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 21<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19,20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NotesPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The carrying amount of other receivables, net, due within one year of the balance sheet date (or one operating cycle, if longer) from third parties or arising from transactions not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherReceivablesNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 02<br><br> -Paragraph 29<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 7<br><br> -Section 03<br><br> -Paragraph 8<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -Subparagraph b, c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 4<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 3<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.3,4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ReceivablesNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A3<br><br> -Appendix A<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19,20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TaxesPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>BASIS OF PRESENTATION</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 1 - BASIS OF PRESENTATION</b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><i>Organization and Nature of Operations &#150; </i></b>China Pharma Holdings, Inc., a Nevada corporation, owns 100% of Onny Investment Limited (&#147;Onny&#148;), a British Virgin Islands corporation, that in turn owns 100% of Hainan Helpson Medical &amp; Biotechnology Co., Ltd (&#147;Helpson&#148;), a corporation organized under the laws of the People's Republic of China (the &#147;PRC&#148;). China Pharma Holdings, Inc. and its subsidiaries are referred to herein as the Company.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">On December 31, 2012, China Pharma Holdings, Inc consummated a reincorporation merger for the purpose of changing the state of incorporation from Delaware to Nevada pursuant to the terms and conditions of an Agreement and Plan of Merger dated December 27, 2012.&nbsp;&nbsp;The reincorporation merger was approved by stockholders holding the majority of the outstanding common shares on December 21, 2012.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The Foreign Investment Industrial Catalogue<i>&nbsp;</i>(the &#147;Catalogue&#148;) jointly issued by the China&#146;s Ministry of Commerce and the National Development and Reform Commission (as the latest version is the year 2012 version, effective January 30, 2012) classified various industries/businesses into three different categories: (i) encouraged for foreign investment; (ii) restricted to foreign investment; and (iii) prohibited from foreign investment. For any industry/business not covered by any of these three categories, they will be deemed industries/businesses permitted for foreign investment. A typical foreign investment ownership restriction in the pharmaceutical industry is that a foreign investment enterprise (the &#147;FIE&#148;) shall not have the whole or majority of its equity interests owned by a foreign owner if the FIE establishes more than 30 branch stores and distributes a variety of brands in those franchise stores, which is not the case of the Company&#146;s business.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Helpson manufactures and markets generic and branded pharmaceutical products as well as biochemical products primarily to hospitals and private retailers located throughout the PRC. The Company believes Helpson&#146;s business is not subject to any ownership restrictions prescribed under the Catalogue. Onny acquired 100% of the ownership in Helpson from Helpson&#146;s three former shareholders on May 25, 2005 by entry into an Equity Transfer Agreement with such three parties on May 25, 2005. The transaction was approved by the Commercial Bureau of Hainan Province on June 12, 2005 and Helpson received the Certificate of Approval for Establishing of Enterprises with Foreign Investment in the PRC on the same day and its business license evidencing its WFOE (Wholly Foreign Owned Enterprise) status on June 21, 2005.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The Company has and continues to acquire well-accepted medical formulas to a diverse portfolio of Western and Chinese medicines.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><i>Consolidation and Basis of Presentation </i></b>&#150; The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;U.S. GAAP&#148;) and are expressed in United States dollars. The accompanying consolidated financial statements include the accounts and operations of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Helpson&#146;s functional currency is the Chinese Renminbi. Helpson&#146;s revenue and expenses are translated into United States dollars at the average exchange rate for the period. Assets and liabilities are translated at the exchange rate as of the end of the reporting period. Gains or losses from translating Helpson&#146;s financial statements are included in accumulated other comprehensive income, which is a component of stockholders&#146; equity. Gains and losses arising from transactions denominated in a currency other than the functional currency of the entity that is a party to the transaction are included in the results of operations.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><i>Condensed Financial Statements </i></b>&#150; The accompanying unaudited condensed consolidated financial statements were prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission (the &#147;Commission&#148;). Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Management of the Company (&#147;Management&#148;) believes the following disclosures are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2012 filed with the Commission on March 14, 2013.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">These unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) that, in the opinion of Management, are necessary to present fairly the consolidated financial position and results of operations of the Company for the periods presented. Operating results for the three months ended March 31, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><i>Accounting Estimates </i></b><b>- </b>The preparation of financial statements in conformity with&nbsp;U.S. GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><i>Basic and Diluted Earnings per Common Share </i></b><b>- </b>Basic earnings per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is calculated to give effect to potentially issuable dilutive common shares.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The following table is a presentation of the numerators and denominators used in the calculation of basic and diluted earnings per share:</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <table width="520" style="MARGIN:auto auto auto -0.75pt; WIDTH:390pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="179" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>For the Three Months</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="179" colspan="3" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Ended March 31,</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Net (loss) income</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; (2,812,307)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,806,359 </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Basic weighted-average common shares outstanding</p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">43,579,557 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">43,529,557 </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Effect of dilutive securities:</p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="85" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt">Warrants</p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="85" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt">Options</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr> <tr style="HEIGHT:19.5pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Diluted weighted-average common shares outstanding</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">43,579,557 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">43,529,557 </p></td></tr> <tr style="HEIGHT:0.25in"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Basic (loss) earnings per share</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.06)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.06 </p></td></tr> <tr style="HEIGHT:0.25in"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Diluted (loss) earnings per share</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.06)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.06 </p></td></tr></table> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt" align="center">&nbsp;</p> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt" align="center">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The following potential common shares were not included in the computation of diluted earnings per share as their effect would have been anti-dilutive:&nbsp;</p> <table width="520" style="MARGIN:auto auto auto -0.75pt; WIDTH:390pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="179" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>For the Three Months</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="179" colspan="3" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Ended March 31,</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Warrants with exercise prices of $3.00 to $3.80 per share</p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150,000 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150,000 </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Options with an exercise price of $2.54 to $3.47 per share</p></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25,000 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 310,000 </p></td></tr> <tr style="HEIGHT:13.5pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt">Total</p></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 175,000 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 460,000 </p></td></tr></table> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:" align="center">&nbsp;</p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 720<br><br> -SubTopic 15<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122524<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6921930&amp;loc=d3e5614-111684<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6970148&amp;loc=SL6228881-111685<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Name Statement of Position (SOP)<br><br> -Publisher AICPA<br><br> -Number 94-6<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 272<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FAS140-4/FIN46(R)-8<br><br> -Paragraph 8, C1, C7<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Name FASB Interpretation (FIN)<br><br> -Publisher FASB<br><br> -Number 46R<br><br> -Paragraph 4, 14, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 852<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2209116<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2134480<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 2-6<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 915<br><br> -SubTopic 235<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472506&amp;loc=d3e38932-110933<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122150<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6359553&amp;loc=d3e288-107754<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2197480<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAF">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS Owings (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdavanceOwingToBoardmember', window );">Adavances owing to board member</a></td>
        <td class="nump">$ 1,354,567<span></span></td>
        <td class="nump">$ 1,354,567<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdavanceOwingToBoardmember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Adavance owing to boardmember</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AdavanceOwingToBoardmember</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EZF">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PropertyAndEquipmentTablesAbstract', window );"><strong>PROPERTY AND EQUIPMENT (Tables)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and equipment consists</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Property and equipment consisted of the following:</p> <table width="477" style="MARGIN:auto auto auto -0.75pt; WIDTH:357.4pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>&nbsp;March 31, </b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>&nbsp;December 31, </b></p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Permit of land use</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 449,474 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 447,013 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Building</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,432,442 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,419,125 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Plant, machinery and equipment</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,418,768 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,381,209 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Motor vehicle</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 147,890 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;147,080 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Office equipment</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 223,947 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 222,273 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Construction in progress</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,127,396 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3,688,567 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10.05pt; MARGIN:0in 0in 0pt"><b>Total</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13,799,917 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13,305,267 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Less: accumulated depreciation</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;(4,511,658)</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4,273,373)</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt"><b>Property and Equipment, net</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9,288,259 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9,031,894 </p></td></tr></table><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_UsefulLivesOfTheAssetsTableTextBlock', window );">Useful lives of the assets</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Depreciation is computed on a straight-line basis over the estimated useful lives of the assets as follows:</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <table width="359" style="MARGIN:auto auto auto -0.75pt; WIDTH:269pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">Asset</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">&nbsp;Life - years </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Permit of land use</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">40 - 70</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Building</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">20 - 35</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Plant, machinery and equipment</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">10</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Motor vehicle</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">5 - 10</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Office equipment</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">3-5</p></td></tr></table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PropertyAndEquipmentTablesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PropertyAndEquipmentTablesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_UsefulLivesOfTheAssetsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of useful lives of the assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_UsefulLivesOfTheAssetsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the useful life and salvage value of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph b<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EJBAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>NOTES PAYABLES. (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Oct. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RevolvingLineOfCreditWithABank', window );">Revolving line of credit with a bank</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 30,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AnnualInterestRate', window );">Annual interest rate</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6.90%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000', window );">Outstanding balance due under revolving line of credit (RMB 30,000,000)</a></td>
        <td class="nump">$ 4,787,285<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AnnualInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Annual interest rate</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AnnualInterestRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Outstanding balance due under revolving line of credit (RMB 30,000,000)</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_OutstandingBalanceDueUnderRevolvingLineOfCreditRMB30000000</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RevolvingLineOfCreditWithABank">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revolving line of credit with a bank</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_RevolvingLineOfCreditWithABank</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EZF">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IncomeTaxesTablesAbstract', window );"><strong>INCOME TAXES (Tables)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IncomeTaxesTableTextBlock', window );">Current Taxes</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Under current tax law in the PRC, the Company is and will be subject to the following enterprise income tax rates:</p> <table width="240" style="MARGIN:auto auto auto -0.75pt; WIDTH:2.5in; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:12.75pt"> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="25" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="119" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:89pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" rowspan="2" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Enterprise Income Tax Rate</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Year</b></p></td> <td width="25" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="HEIGHT:12.75pt"> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">2013</p></td> <td width="25" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="119" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:89pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">15%</p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">2014 and after</p></td> <td width="25" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="119" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:89pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">25%</p></td></tr></table><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProvisionForIncomeTaxesTableTextBlock', window );">Provision For Income Taxes</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The provision for income taxes consisted of the following:</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <table width="515" style="MARGIN:auto auto auto -0.75pt; WIDTH:386pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:13.9pt"> <td width="304" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="199" colspan="3" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:149pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Three months ended March 31,</b></p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="304" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="304" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Current</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 564,893 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="304" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Deferred</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (269,011)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (34,312)</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="304" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt"><b>Total income tax (benefit) expense</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (269,011)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 530,581 </p></td></tr></table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IncomeTaxesTablesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_IncomeTaxesTablesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IncomeTaxesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabluar disclosure of Provision For Income Taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_IncomeTaxesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ProvisionForIncomeTaxesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabluar disclosure of Provision For Income Taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ProvisionForIncomeTaxesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.1.0.1
 *
 */

var moreDialog = null;
var Show = {
    Default:'raw',

    more:function( obj ){
        var bClosed = false;
        if( moreDialog != null )
        {
			try
			{
				bClosed = moreDialog.closed;
			}
			catch(e)
			{
				//Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control
				// that somtimes causes it to throw when checking the closed property on a child window that has been
				//closed.  So if the exception occurs we assume the window is closed and move on from there.
				bClosed = true;
			}

			if( !bClosed ){
				moreDialog.close();
			}
        }

        obj = obj.parentNode.getElementsByTagName( 'pre' )[0];
		var hasHtmlTag = false;
		var objHtml = '';
		var raw = '';

		//Check for raw HTML
		var nodes = obj.getElementsByTagName( '*' );
		if( nodes.length ){
			objHtml = obj.innerHTML;
		}else{
			if( obj.innerText ){
				raw = obj.innerText;
			}else{
				raw = obj.textContent;
			}

			var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g );
			if( matches && matches.length ){
				objHtml = raw;

				//If there is an html node it will be 1st or 2nd,
				//   but we can check a little further.
				var n = Math.min( 5, matches.length );
				for( var i = 0; i < n; i++ ){
					var el = matches[ i ].toString().toLowerCase();
					if( el.indexOf( '<html' ) >= 0 ){
						hasHtmlTag = true;
						break;
					}
				}
			}
		}

        if( objHtml.length ){
			var html = '';

			if( hasHtmlTag ){
				html = objHtml;
			}else{
				html = '<html>'+
					"\n"+'<head>'+
					"\n"+'    <title>Report Preview Details</title>'+
					"\n"+'    <style type="text/css">'+
					"\n"+'    body {'+
					"\n"+'    }'+
					"\n"+'    table {'+
					"\n"+'    }'+
					"\n"+'    </style>'+
					"\n"+'</head>'+
					"\n"+'<body>'+
						objHtml +
					"\n"+'</body>'+
					"\n"+'</html>';
			}

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write( html );
			moreDialog.document.close();

			if( !hasHtmlTag ){
				moreDialog.document.body.style.margin = '0.5em';
			}
        }
        else
        {
			//default view logic
			var lines = raw.split( "\n" );
			var longest = 0;

			if( lines.length > 0 ){
				for( var p = 0; p < lines.length; p++ ){
					longest = Math.max( longest, lines[p].length );
				}
			}

			//Decide on the default view
			this.Default = longest < 120 ? 'raw' : 'formatted';

			//Build formatted view
			var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ;
			var formatted = '';

			if( text.length > 0 ){
				if( text.length == 1 ){
					text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ;
					formatted = "<p>"+ text.join( "<br /><br />\n" ) +"</p>";
				}else{
					for( var p = 0; p < text.length; p++ ){
						formatted += "<p>" + text[p] + "</p>\n";
					}
				}
			}else{
				formatted = '<p>' + raw + '</p>';
			}

			html = '<html>'+
				"\n"+'<head>'+
				"\n"+'    <title>Report Preview Details</title>'+
				"\n"+'    <style type="text/css">'+
				"\n"+'    body {'+
				"\n"+'       background-color: #f0f9ee;'+
				"\n"+'       font-family: Arial, san-serif; font-size: 0.8em;'+
				"\n"+'    }'+
				"\n"+'    table {'+
				"\n"+'       font-size: 1em;'+
				"\n"+'    }'+
				"\n"+'    </style>'+
				"\n"+'</head>'+
				"\n"+'<body>'+
				"\n"+'    <table border="0" width="100%">'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            formatted: <a href="javascript:void(0);" onclick="opener.Show.toggle( window, this );">'+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +'</a>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <div id="formatted" style="display: none;">'+formatted+'</div>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <pre id="raw" style="display: none; font-size: 1.2em;">'+raw+'</pre>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    </table>'+
				"\n"+'</body>'+
				"\n"+'</html>';

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write(html);
			moreDialog.document.close();

			this.toggle( moreDialog );
        }

		moreDialog.document.title = 'Report Preview Details';
    },

    toggle:function( win, domLink ){
        var domId = this.Default;

        var doc = win.document;
        var domEl = doc.getElementById( domId );
        domEl.style.display = 'block';

        this.Default = domId == 'raw' ? 'formatted' : 'raw';

        if( domLink ){
            domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed';
        }

        var domElOpposite = doc.getElementById( this.Default );
        domElOpposite.style.display = 'none';
    },

	LastAR : null,
	showAR : function ( link, id, win ){
		if( Show.LastAR ){
			Show.hideAR();
		}

		var ref = link;
		do {
			ref = ref.nextSibling;
		} while (ref && ref.nodeName != 'TABLE');

		if (!ref || ref.nodeName != 'TABLE') {
			var tmp = win ?
				win.document.getElementById(id) :
				document.getElementById(id);

			if( tmp ){
				ref = tmp.cloneNode(true);
				ref.id = '';
				link.parentNode.appendChild(ref);
			}
		}

		if( ref ){
			ref.style.display = 'block';
			Show.LastAR = ref;
		}
	},

	toggleNext : function( link ){
		var ref = link;

		do{
			ref = ref.nextSibling;
		}while( ref.nodeName != 'DIV' );

		if( ref.style &&
			ref.style.display &&
			ref.style.display == 'none' ){
			ref.style.display = 'block';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '+', '-' );
			}else{
				link.innerText = link.innerText.replace( '+', '-' );
			}
		}else{
			ref.style.display = 'none';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '-', '+' );
			}else{
				link.innerText = link.innerText.replace( '-', '+' );
			}
		}
	},

	hideAR : function(){
		Show.LastAR.style.display = 'none';
	}
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>PRODUCT RECALL<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PRODUCTRECALLAbstract', window );"><strong>PRODUCT RECALL</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">PRODUCT RECALL</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 2 &#150; PRODUCT RECALL</b></p> <p style="LINE-HEIGHT:11.25pt; MARGIN:0in 0in 0pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:11.25pt; MARGIN:0in 0in 0pt">In March 2013, the China Food and Drug Administration (&#147;CFDA&#148;) issued a nationwide notice (the &#147;CFDA Notice&#148;) for the cessation of the production, sale and use of Buflomedil effective immediately. The CFDA Notice was a result of the reevaluation done by the CFDA based on the indications from the recent China and international research materials, which found the side effect risks of buflomedil to nerve system and cardiovascular system have surpassed its clinical treatment effect.&nbsp; The CFDA Notice was applicable to all the manufacturers and distributers in China who are in the business of the production and sale of Buflomedil-related products.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:11.25pt; MARGIN:0in 0in 0pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:11.25pt; MARGIN:0in 0in 0pt">Pursuant to the CFDA Notice, the Company ceased the production and sale of Buflomedil-based products and ceased all promotional and marketing activities for Buflomedil-based products. </p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:11.25pt; MARGIN:0in 0in 0pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Furthermore, the Company recognized an inventory obsolescence expense in the amount of $3,692,895 to write off Buflomedil-related raw materials and finished goods inventory. This was recorded as inventory obsolescence on the accompanying statement of operations for the three months ended March 31, 2013. </p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">In addition, the Company recalled Buflomedil-based products from the market. It authorized the return of its previously sold Buflomedil-related products through April 30, 2013. The loss from the refunds to customers was $21,507 and recognized that estimated loss as a reduction of revenues for the three months ended March 31, 2013. Under CFDA regulatory provisions, the CFDA notice does not impose legal liability to the manufacturers of Buflomedil as long as they act pursuant to the CFDA Notice to cease the production, sale and use of Buflomedil and destroy such finished goods immediately.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt 13.5pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Pursuant to the CFDA Notice, the CFDA revoked the production licenses for Buflomedil based products. The carrying value of the Company&#146;s Buflomedil related intangible assets is zero; therefore, no impairment of the Company&#146;s intangible assets was necessary.&nbsp; </p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PRODUCTRECALLAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PRODUCTRECALLAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Interpretation (FIN)<br><br> -Number 45<br><br> -Paragraph 14<br><br> -Subparagraph a, b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProductWarrantyDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ELEAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS PARENTHETICALS (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts on trade accounts receivables</a></td>
        <td class="nump">$ 4,333,411<span></span></td>
        <td class="nump">$ 4,429,945<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AllowanceForDoubtfulAccountsOnOtherReceivables', window );">Allowance for doubtful accounts on other receivables</a></td>
        <td class="nump">50,592<span></span></td>
        <td class="nump">49,881<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation on property and equipment</a></td>
        <td class="nump">4,511,658<span></span></td>
        <td class="nump">4,273,373<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization on intangible assets</a></td>
        <td class="nump">$ 3,097,224<span></span></td>
        <td class="nump">$ 2,944,726<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, par or stated value</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, shares authorized</a></td>
        <td class="nump">5,000,000<span></span></td>
        <td class="nump">5,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, shares issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, shares outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, par or stated value</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, shares authorized</a></td>
        <td class="nump">95,000,000<span></span></td>
        <td class="nump">95,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, shares issued</a></td>
        <td class="nump">43,579,557<span></span></td>
        <td class="nump">43,579,557<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
        <td class="nump">43,579,557<span></span></td>
        <td class="nump">43,579,557<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AllowanceForDoubtfulAccountsOnOtherReceivables">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A valuation allowance for other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AllowanceForDoubtfulAccountsOnOtherReceivables</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 14<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 4<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6965416&amp;loc=d3e5074-111524<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The accumulated amount of amortization of a major finite-lived intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 142<br><br> -Paragraph 45<br><br> -Subparagraph a(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 02<br><br> -Paragraph 29<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 02<br><br> -Paragraph 29<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 02<br><br> -Paragraph 29<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 02<br><br> -Paragraph 29<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONTINGENCIES<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommitmentAndContingenciesAbstract', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">CONTINGENCIES</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 12 &#150; CONTINGENCIES</b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><i>Economic environment </i></b><b>- </b>Substantially all of the Company's operations are conducted in the PRC, and therefore the Company is subject to special considerations and significant risks not typically associated with companies operating in the United States of America. These risks include, among others, the political, economic and legal environments and fluctuations in the foreign currency exchange rate. The Company's results from operations may be adversely affected by changes in the political and social conditions in the PRC, and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things. The unfavorable changes in global macroeconomic factors may also adversely affect the Company&#146;s operations.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">In addition, all of the Company's revenue is denominated in the PRC's currency of Renminbi (RMB), which must be converted into other currencies before remittance out of the PRC. Both the conversion of RMB into foreign currencies and the remittance of foreign currencies abroad require approval of the PRC government.</p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommitmentAndContingenciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_CommitmentAndContingenciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6952336&amp;loc=d3e14435-108349<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Interpretation (FIN)<br><br> -Number 14<br><br> -Paragraph 3<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 5<br><br> -Paragraph 9, 10, 11, 12<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ENGAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>May 10, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">CHINA PHARMA HOLDINGS, INC.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Mar. 31,
         2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0001106644<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">43,579,557<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Smaller Reporting Company<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document as an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type is limited to the same value as the supporting SEC submission type, minus any "/A" suffix. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, 497, NCSR, N-CSR, N-CSRS, N-Q, 10-KT, 10-QT, 20-FT, POS AM and Other.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityWellKnownSeasonedIssuer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONCENTRATIONS<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>CONCENTRATIONS</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">CONCENTRATIONS</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 13 &#150; CONCENTRATIONS</b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">At March 31, 2013, one customer accounted for 10.5% of accounts receivable.&nbsp;&nbsp;At December 31, 2012, no customer accounted for more than 10.0% of accounts receivable.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">For the three months ended March 31, 2013, no customer accounted for more than 10% of sales. For the three months ended March 31, 2012, one customer accounted for 10.3% of sales.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">For the three months ended March 31, 2013, purchases from one supplier accounted for 34.0% of raw material purchases. For the three months ended March 31, 2012, purchases from one supplier accounted for 14.1% of raw material purchases.&nbsp;</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6404-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Statement of Position (SOP)<br><br> -Number 94-6<br><br> -Paragraph 21, 22, 24<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13537-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 15A<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6442-108592<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13531-108611<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6327-108592<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 18<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6351-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConcentrationRiskDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RisksAndUncertaintiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EPXAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
        <td class="nump">$ 8,249,387<span></span></td>
        <td class="nump">$ 16,086,731<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
        <td class="nump">6,125,400<span></span></td>
        <td class="nump">10,782,384<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory obsolescence</a></td>
        <td class="nump">3,692,895<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
        <td class="num">(1,568,908)<span></span></td>
        <td class="nump">5,304,347<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">Selling expenses</a></td>
        <td class="nump">812,054<span></span></td>
        <td class="nump">894,060<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
        <td class="nump">739,427<span></span></td>
        <td class="nump">676,402<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense.</a></td>
        <td class="num">(119,930)<span></span></td>
        <td class="nump">320,098<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
        <td class="nump">1,431,551<span></span></td>
        <td class="nump">1,890,560<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(Loss) income from operations</a></td>
        <td class="num">(3,000,459)<span></span></td>
        <td class="nump">3,413,787<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income (expense):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
        <td class="nump">1,586<span></span></td>
        <td class="nump">690<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
        <td class="num">(82,445)<span></span></td>
        <td class="num">(77,537)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Net other expense</a></td>
        <td class="num">(80,859)<span></span></td>
        <td class="num">(76,847)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income before income taxes</a></td>
        <td class="num">(3,081,318)<span></span></td>
        <td class="nump">3,336,940<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
        <td class="nump">269,011<span></span></td>
        <td class="num">(530,581)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
        <td class="nump">2,812,307<span></span></td>
        <td class="nump">2,806,359<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease', window );">Other comprehensive income - foreign currency translation adjustment</a></td>
        <td class="nump">819,767<span></span></td>
        <td class="num">(407,517)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss) income</a></td>
        <td class="num">$ (1,992,540)<span></span></td>
        <td class="nump">$ 2,398,842<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>(Loss) earnings per share:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
        <td class="num">$ (0.06)<span></span></td>
        <td class="nump">$ 0.06<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
        <td class="num">$ (0.06)<span></span></td>
        <td class="nump">$ 0.06<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e540-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A5<br><br> -Appendix A<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph c(3)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 8, 9, 10, 11, 12, 13, 14<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508144<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e557-108580<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 2<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CostOfRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 52<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945512&amp;loc=d3e4984-109258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 07-4<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 20<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 7<br><br> -Paragraph 18<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-04.23)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 36, 37, 38<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 21<br><br> -Article 9<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1252-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDilutedAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 11, 12, 36<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 20<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1252-109256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 7<br><br> -Paragraph 18<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 21<br><br> -Article 9<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 07-4<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1,2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GrossProfit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 10<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Income Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 45<br><br> -Subparagraph a, b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cost of borrowed funds accounted for as interest that was charged against earnings during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-04.9)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 34<br><br> -Paragraph 21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 9<br><br> -Article 9<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher OTS<br><br> -Name Federal Regulation (FR)<br><br> -Number Title 12<br><br> -Chapter V<br><br> -Section 563c.102<br><br> -Paragraph 9<br><br> -Subsection II<br><br> -LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy.  It will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Charge to cost of goods sold that represents the reduction of the carrying amount of inventory, generally attributable to obsolescence or market conditions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 330<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6386783&amp;loc=d3e4542-108314<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Chapter 4<br><br> -Section 7<br><br> -Paragraph 14<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Concepts (CON)<br><br> -Number 6<br><br> -Paragraph 86<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryWriteDown</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 7<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 14<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentIncomeInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency of the reporting entity, net of tax.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 20<br><br> -Subparagraph (b),(c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32211-110900<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920433&amp;loc=d3e998-108581<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 24<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph c(3)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 14, 17, 19, 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 52<br><br> -Paragraph 13, 20, 31<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents a sum total of expenses not separately reflected on the income statement for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4,6)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherIncomeAndExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 4J<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4591551-111686<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A1, A4, A5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph c(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 29<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1A<br><br> -Subparagraph (a),(c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6921930&amp;loc=SL4573702-111684<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 4K<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4591552-111686<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 5<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 19<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6921628&amp;loc=SL4569616-111683<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProfitLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the current period expense charged against operations, the offset which is generally to the allowance for doubtful accounts for the purpose of reducing receivables, including notes receivable, to an amount that approximates their net realizable value (the amount expected to be collected).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.5)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProvisionForDoubtfulAccounts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 1<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Revenues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expenses recognized in the period that are directly related to the selling and distribution of products or services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SellingExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 7 &#150; RELATED PARTY TRANSACTIONS</b></p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Total advances owing to a board member were $1,354,567 and $1,354,567 as of March 31, 2013 and December 31, 2012, respectively, and are recorded as other payables &#150; related parties on the accompanying condensed consolidated balance sheets.<font style="BACKGROUND:white"> </font>The advances bear interest at a rate of 1.0% per year.&nbsp;&nbsp;Total interest expense of $3,386 and $1,970 was recognized for the three months ended March 31, 2013 and 2012.</p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RelatedPartyTransactionsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for related party transactions, including the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(k))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 3A<br><br> -Section 04<br><br> -Paragraph b<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 57<br><br> -Paragraph 1-4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 4<br><br> -Section 08<br><br> -Paragraph k<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RelatedPartyTransactionsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS.<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdvancesForPurchasesOfIntangibleAssetsAbstract', window );"><strong>ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS.</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock', window );">ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS.</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 6 &#150; ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS</b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">In order to expand the number of medicines manufactured and marketed by the Company, the Company has entered into contracts with independent laboratories for the purchase of medical formulas. Although CFDA approval has not been obtained for these medical formulas as of the dates of the contracts, the object of the contracts is for the purchase of CFDA-approved medical formulas once the CFDA approval process is completed. Some of the medical formulas currently in the CFDA approval process also come with patents. The Company has received the title for two patents. The related patents have not expired.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Prior to entering into the contracts, the laboratories typically have completed all required research and development to determine the medical formula for and the method of production of the generic medicine.&nbsp;&nbsp;Since the laboratories are not eligible to apply for CFDA production approval, they usually collaborate with a production facility (such as the Company) and apply for the production approval in the name of the manufacturer. The Company buys the final products with the production approval from the CFDA and the laboratories have to complete the CFDA approval process from the point of the contract.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">A typical CFDA approval process for the production of a generic medical product involves a number of steps that generally requires three to five years. If the medical formula is purchased at the point when the generic medical product receives the CFDA&#146;s approval for clinical study, which is very typical for the Company, the clinical study that follows will usually take from one and a half to three years to complete. After the clinical study is completed, the results are submitted to the CFDA and a production approval application is filed with the CFDA. In most cases, it will take between eight to eighteen months to prepare and submit the production approval application and obtain CFDA approval. Upon approving the generic medical product, the CFDA issues a production certificate and the Company can produce and sell the generic medical product. As a result of this process, CFDA approval is expected to be received in approximately two to five years from the dates of the medical formula contracts.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Under the terms of the contracts, the laboratories are required to obtain production approval (on behalf of the Company) for the medical formulas from the CFDA. Management monitors the status of each medical formula on a regular basis in order to assess whether the laboratories are performing adequately under the contracts. If a medical product is not approved by the CFDA, as evidenced by their issuance of a denial letter, or if the laboratory breaches the contract, the laboratory is required under the contract to provide a refund to the Company of the full amount of the payments made to the laboratory for that formula, or the Company can require the application of those payments to another medical formula with the same laboratory. As a result of the refund right, the Company is purchasing an approved medical product. Accordingly, payments made prior to the issuance of production approval by the CFDA are recorded as advances for purchases of intangible assets.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">To date, no formula has failed to receive CFDA production approval nor has the Company been informed or become aware of any formula that may fail to receive such approval. However, there is no assurance that the medical products will receive production approval and if the Company does not receive such approval, it will enforce its contractual rights to receive the refund from the laboratory or have the payments applied to another medical formula with the same laboratory.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">At March 31, 2013, the Company was obligated to pay laboratories and others approximately $6,519,000 upon completion of the various phases of contracts to provide CFDA production approval of medical formulas.</p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdvancesForPurchasesOfIntangibleAssetsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AdvancesForPurchasesOfIntangibleAssetsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure of advances for purchases of intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AdvancesForPurchasesOfIntangibleAssetsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INTANGIBLE ASSETS (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IntangibleAssetsTablesAbstract', window );"><strong>Intangible Assets (Tables)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IntangibleAssetsMedicalFormulasTablesTextBlock', window );">Intangible Assets Medical Formulas</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">At March 31, 2013 and December 31, 2012, intangible assets consisted solely of CFDA approved medical formulas as follows:</p> <table width="393" style="MARGIN:auto auto auto -0.75pt; WIDTH:294.9pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:12.75pt"> <td width="187" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>March 31,</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>December 31,</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="187" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="187" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Gross carrying amount</p></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,387,075 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,357,580 </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="187" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Accumulated amortization</p></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3,097,224)</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2,944,726)</p></td></tr> <tr style="HEIGHT:13.5pt"> <td width="187" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Net carrying amount</p></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,289,851 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,412,854 </p></td></tr></table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IntangibleAssetsMedicalFormulasTablesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabluar disclosure of Intangible Assets Medical Formulas</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_IntangibleAssetsMedicalFormulasTablesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IntangibleAssetsTablesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_IntangibleAssetsTablesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EECAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Accounting Policies (Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccountingPoliciesPoliciesAbstract', window );"><strong>Accounting Policies (Policies)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Organization and Nature of Operations</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><i>Organization and Nature of Operations &#150; </i></b>China Pharma Holdings, Inc., a Nevada corporation, owns 100% of Onny Investment Limited (&#147;Onny&#148;), a British Virgin Islands corporation, that in turn owns 100% of Hainan Helpson Medical &amp; Biotechnology Co., Ltd (&#147;Helpson&#148;), a corporation organized under the laws of the People's Republic of China (the &#147;PRC&#148;). China Pharma Holdings, Inc. and its subsidiaries are referred to herein as the Company.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">On December 31, 2012, China Pharma Holdings, Inc consummated a reincorporation merger for the purpose of changing the state of incorporation from Delaware to Nevada pursuant to the terms and conditions of an Agreement and Plan of Merger dated December 27, 2012.&nbsp;&nbsp;The reincorporation merger was approved by stockholders holding the majority of the outstanding common shares on December 21, 2012.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The Foreign Investment Industrial Catalogue<i>&nbsp;</i>(the &#147;Catalogue&#148;) jointly issued by the China&#146;s Ministry of Commerce and the National Development and Reform Commission (as the latest version is the year 2012 version, effective January 30, 2012) classified various industries/businesses into three different categories: (i) encouraged for foreign investment; (ii) restricted to foreign investment; and (iii) prohibited from foreign investment. For any industry/business not covered by any of these three categories, they will be deemed industries/businesses permitted for foreign investment. A typical foreign investment ownership restriction in the pharmaceutical industry is that a foreign investment enterprise (the &#147;FIE&#148;) shall not have the whole or majority of its equity interests owned by a foreign owner if the FIE establishes more than 30 branch stores and distributes a variety of brands in those franchise stores, which is not the case of the Company&#146;s business.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Helpson manufactures and markets generic and branded pharmaceutical products as well as biochemical products primarily to hospitals and private retailers located throughout the PRC. The Company believes Helpson&#146;s business is not subject to any ownership restrictions prescribed under the Catalogue. Onny acquired 100% of the ownership in Helpson from Helpson&#146;s three former shareholders on May 25, 2005 by entry into an Equity Transfer Agreement with such three parties on May 25, 2005. The transaction was approved by the Commercial Bureau of Hainan Province on June 12, 2005 and Helpson received the Certificate of Approval for Establishing of Enterprises with Foreign Investment in the PRC on the same day and its business license evidencing its WFOE (Wholly Foreign Owned Enterprise) status on June 21, 2005.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The Company has and continues to acquire well-accepted medical formulas to a diverse portfolio of Western and Chinese medicines.</p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation and Basis of Presentation</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><i>Consolidation and Basis of Presentation </i></b>&#150; The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;U.S. GAAP&#148;) and are expressed in United States dollars. The accompanying consolidated financial statements include the accounts and operations of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Helpson&#146;s functional currency is the Chinese Renminbi. Helpson&#146;s revenue and expenses are translated into United States dollars at the average exchange rate for the period. Assets and liabilities are translated at the exchange rate as of the end of the reporting period. Gains or losses from translating Helpson&#146;s financial statements are included in accumulated other comprehensive income, which is a component of stockholders&#146; equity. Gains and losses arising from transactions denominated in a currency other than the functional currency of the entity that is a party to the transaction are included in the results of operations.</p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Condensed Financial Statements</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><i>Condensed Financial Statements </i></b>&#150; The accompanying unaudited condensed consolidated financial statements were prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission (the &#147;Commission&#148;). Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Management of the Company (&#147;Management&#148;) believes the following disclosures are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2012 filed with the Commission on March 14, 2013.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">These unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) that, in the opinion of Management, are necessary to present fairly the consolidated financial position and results of operations of the Company for the periods presented. Operating results for the three months ended March 31, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013.</p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Accounting Estimates</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><i>Accounting Estimates </i></b><b>- </b>The preparation of financial statements in conformity with&nbsp;U.S. GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Earnings per Common Share</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><i>Basic and Diluted Earnings per Common Share </i></b><b>- </b>Basic earnings per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is calculated to give effect to potentially issuable dilutive common shares.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The following table is a presentation of the numerators and denominators used in the calculation of basic and diluted earnings per share:</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <table width="520" style="MARGIN:auto auto auto -0.75pt; WIDTH:390pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="179" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>For the Three Months</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="179" colspan="3" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Ended March 31,</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Net (loss) income</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; (2,812,307)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,806,359 </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Basic weighted-average common shares outstanding</p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">43,579,557 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">43,529,557 </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Effect of dilutive securities:</p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="85" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt">Warrants</p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="85" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt">Options</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr> <tr style="HEIGHT:19.5pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Diluted weighted-average common shares outstanding</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">43,579,557 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">43,529,557 </p></td></tr> <tr style="HEIGHT:0.25in"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Basic (loss) earnings per share</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.06)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.06 </p></td></tr> <tr style="HEIGHT:0.25in"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Diluted (loss) earnings per share</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.06)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.06 </p></td></tr></table> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt" align="center">&nbsp;</p> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt" align="center">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The following potential common shares were not included in the computation of diluted earnings per share as their effect would have been anti-dilutive:&nbsp;</p> <table width="520" style="MARGIN:auto auto auto -0.75pt; WIDTH:390pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="179" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>For the Three Months</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="179" colspan="3" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Ended March 31,</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Warrants with exercise prices of $3.00 to $3.80 per share</p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150,000 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150,000 </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Options with an exercise price of $2.54 to $3.47 per share</p></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25,000 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 310,000 </p></td></tr> <tr style="HEIGHT:13.5pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt">Total</p></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 175,000 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 460,000 </p></td></tr></table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccountingPoliciesPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AccountingPoliciesPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfAccounting</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 2-6<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 3A<br><br> -Section 02, 03<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2197480<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 18<br><br> -Paragraph 20<br><br> -Subparagraph a(2)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 97-2<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 96-16<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Interpretation (FIN)<br><br> -Number 46R<br><br> -Paragraph 4<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Interpretation (FIN)<br><br> -Number 46R<br><br> -Paragraph 4<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.3A-02)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959686&amp;loc=d3e355033-122828<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Interpretation (FIN)<br><br> -Number 46R<br><br> -Paragraph 14, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph k<br><br> -Article 1<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 325<br><br> -SubTopic 20<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2197087<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 860<br><br> -SubTopic 40<br><br> -Section 45<br><br> -URI http://asc.fasb.org/section&amp;trid=2197723<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 323<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2196966<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 18<br><br> -Paragraph 5, 6, 16-19<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 140<br><br> -Paragraph 46<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 323<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6382870&amp;loc=d3e33801-111570<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6921930&amp;loc=d3e5614-111684<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConsolidationPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144384<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 40<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 6, 8-16, 60<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerSharePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Name Statement of Position (SOP)<br><br> -Publisher AICPA<br><br> -Number 94-6<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6003-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NatureOfOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Statement of Position (SOP)<br><br> -Number 94-6<br><br> -Paragraph 11, 14<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-108592<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UseOfEstimates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 10 &#150; FAIR VALUE MEASUREMENTS</b></p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. To measure fair value, a hierarchy has been established which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs. This hierarchy uses three levels of inputs to measure the fair value of assets and liabilities as follows: Level 1 &#150; Quoted prices in active markets for identical assets or liabilities. Level 2 &#150; Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. Level 3 &#150; Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The Company uses fair value to measure the value of the banker&#146;s acceptance notes it holds.&nbsp;&nbsp;The banker&#146;s acceptance notes are recorded at cost which approximates fair value.&nbsp;&nbsp;The Company held the following assets recorded at fair value as of March 31, 2013 and December 31, 2012:&nbsp;</p> <div align="center"> <table width="549" style="MARGIN:auto auto auto -0.75pt; WIDTH:411.55pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="243" colspan="5" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Fair Value Measurements at</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="243" colspan="5" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Reporting Date Using</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt"><b>Description</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right"><b>March 31, 2013</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Level 1</b></p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Level 2</b></p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Level 3</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Banker's acceptance notes</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,180,864</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,180,864</p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr> <tr style="HEIGHT:13.5pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Total</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,180,864</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,180,864</p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="243" colspan="5" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Fair Value Measurements at</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="243" colspan="5" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:182.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Reporting Date Using</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt"><b>Description</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right"><b>December 31, 2012</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Level 1</b></p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Level 2</b></p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Level 3</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Banker's acceptance notes</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101,570 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101,570 </p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr> <tr style="HEIGHT:13.5pt"> <td width="160" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:120pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Total</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="122" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:91.5pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101,570 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101,570 </p></td> <td width="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:2.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="65" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr></table></div> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>&nbsp;</b></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the fair value measurement of assets and liabilities which includes [financial] instruments measured at fair value that are classified in stockholders' equity. Such assets and liabilities may be measured on a recurring or nonrecurring basis. The disclosures which may be required or desired include: (1) for assets and liabilities measured on a recurring basis, disclosure may include: (a) the fair value measurements at the reporting date; (b) the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3); (c) for fair value measurements using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (ii) purchases, sales, issuances, and settlements (net); (iii) transfers in and transfers out of Level 3 (for example,  transfers due to changes in the observability of significant inputs); (d) the amount of the total gains or losses for the period in subparagraph (c) (i) above included in earnings (or changes in net assets) that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date and a description of where those unrealized gains or losses are reported in the statement of income (or activities); (e) the valuation technique(s) used to measure fair value and a discussion of changes in valuation techniques, if any, during the period and (2) for assets and liabilities that are measured at fair value on a nonrecurring basis (for example,  impaired assets) disclosure may include, in addition to (a) above: (a) the reasons for the fair value measurements recorded; (b) the same as (b) above; (c) for fair value measurements using significant unobservable inputs (Level 3), a description of the inputs and the information used to develop the inputs; and (d) the valuation technique(s) used to measure fair value and a discussion of changes, if any, in the valuation technique(s) used to measure similar assets and/or liabilities in prior periods.  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6925170&amp;loc=d3e19279-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 157<br><br> -Paragraph 32<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 157<br><br> -Paragraph 33<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6925170&amp;loc=d3e19296-110258<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6925170&amp;loc=d3e19207-110258<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 157<br><br> -Paragraph 6<br><br> -Footnote 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6925170&amp;loc=d3e19190-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueMeasurementInputsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NOTES PAYABLE<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NotesPayable1Abstract', window );"><strong>NOTES PAYABLES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NotesPayableTextBlock', window );">NOTES PAYABLE</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 8 &#150; NOTES PAYABLE</b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">On October 30, 2012, the Company entered into a new revolving line of credit with another bank in the amount of RMB 30,000,000.&nbsp;The related note payable bears interest at an annual rate of 6.90% (based upon 115% of the PRC government&#146;s current short term rate of 6.00%). Advances on the line of credit are due one year from the date of the advance and are collateralized by certain land use rights, buildings and accounts receivable. The outstanding balance due under the revolving line of credit was RMB 30,000,000 ($4,787,285) as of March 31, 2013.&nbsp;&nbsp;The Company has no additional amounts available to it under the line of credit.&nbsp;&nbsp;This amount has been classified as short-term notes payable in the accompanying consolidated balance sheet at December 31, 2012.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><i>Fair Value of</i></b> <b><i>Notes Payable</i></b> &#150; Based on the borrowing rates currently available to the Company for bank loans with similar terms and maturities, the carrying amounts of notes payable outstanding as of March 31, 2013 and December 31, 2012 approximated their fair value because of either the immediate or short-term maturity of these financial instruments or because the underlying instruments bear interest rates that approximated current market rates.&nbsp;</p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NotesPayable1Abstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NotesPayable1Abstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NotesPayableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure of notes payable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NotesPayableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INCOME TAXES<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>INCOME TAXES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 9 - INCOME TAXES</b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax laws or rates is recognized in income in the period that includes the enactment date.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Undistributed earnings of Helpson, the Company&#146;s foreign subsidiary, since its acquisition, amounted to approximately $110.5 million at March 31, 2013. Those earnings, as well as the investment in Helpson of approximately $23.3 million, are considered to be indefinitely reinvested and, accordingly, no U.S. federal or state income taxes have been provided thereon. Upon distribution of those earnings in the form of dividends or otherwise, the Company would be subject to U.S. federal and state income taxes (net of an adjustment for foreign tax credits) and withholding taxes payable to the PRC. Determination of the amount of unrecognized deferred U.S. income tax liability is not practicable because of the complexities associated with its hypothetical calculation; however, unrecognized foreign tax credits may be available to reduce a portion of the U.S. tax liability.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Under current tax law in the PRC, the Company is and will be subject to the following enterprise income tax rates:</p> <table width="240" style="MARGIN:auto auto auto -0.75pt; WIDTH:2.5in; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:12.75pt"> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="25" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="119" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:89pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" rowspan="2" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Enterprise Income Tax Rate</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Year</b></p></td> <td width="25" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="HEIGHT:12.75pt"> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">2013</p></td> <td width="25" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="119" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:89pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">15%</p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">2014 and after</p></td> <td width="25" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:19pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="119" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:89pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center">25%</p></td></tr></table> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt" align="center">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The provision for income taxes consisted of the following:</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <table width="515" style="MARGIN:auto auto auto -0.75pt; WIDTH:386pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:13.9pt"> <td width="304" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="199" colspan="3" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:149pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Three months ended March 31,</b></p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="304" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="304" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Current</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 564,893 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="304" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Deferred</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (269,011)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (34,312)</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="304" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt"><b>Total income tax (benefit) expense</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (269,011)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 530,581 </p></td></tr></table> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt" align="center">&nbsp;</p> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt" align="center">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The Company has available to it net operating losses for PRC tax purposes of $482,668. The Company also provided a valuation allowance in this same amount against the operating losses during the current quarter related to the net operating loss carryforward since they did not meet the more likely than not criteria for recognition of the loss carryforward in the current period. </p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The Company has also incurred various other taxes, comprised primarily of business taxes, value-added taxes, urban construction taxes, education surcharges and others. Any unpaid amounts are reflected on the balance sheets as accrued taxes payable.</p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 136, 172<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 43, 44, 45, 46, 47, 48, 49<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 11 - STOCKHOLDERS' EQUITY</b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><u style="text-underline:black">Preferred and Common Stock</u></b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The total number of authorized shares is 95,000,000 shares of common stock and 5,000,000 shares of preferred stock. The preferred stock may be issued in series with such designations, preferences, stated values, rights, qualifications or limitations as determined solely by the Company&#146;s board of directors.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><u style="text-underline:black">Warrants</u></b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">As of March 31, 2013, the Company had warrants outstanding and exercisable to purchase an aggregate of 150,000 shares of the Company's common stock at exercise prices ranging from $3.00 to $3.80 per share, which expire May 16, 2013. At March 31, 2013, the warrants had a weighted-average exercise price of $3.40 per share, a weighted-average remaining contractual life of 0.2 years and a total intrinsic value of $0.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b><u style="text-underline:black">Stock and Stock Options</u></b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><i>2010 Incentive Plan</i></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">On November 12, 2010, the Company&#146;s Board of Directors adopted, and on December 22, 2010 its stockholders approved, the 2010 Long-Term Incentive Plan&nbsp;&nbsp;(the &#147;2010 Incentive Plan&#148;), which gave the Company the ability to grant stock options, restricted stock, stock appreciation rights and performance units to its employees, directors and consultants, or those who will become employees, directors and consultants of the Company and/or its subsidiaries. The 2010 Incentive Plan currently allows for equity awards of up to 4,000,000 shares of common stock. Through March 31, 2013, 75,000 shares of common stock and options to purchase an aggregate of 25,000 shares of stock options had been granted under the 2010 Incentive Plan.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">There were no securities issued from the 2010 Incentive Plan during the three months ended March 31, 2013.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">At March 31, 2013, there was no remaining unrecognized compensation expense related to stock options or restrictive stock grants.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable).  Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187143-122770<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 5<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 4<br><br> -Section 08<br><br> -Paragraph d<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Chapter 1<br><br> -Section B<br><br> -Paragraph 7, 11A<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 20: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 21: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 22: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 23: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E2H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS Member Of BOD (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalInterestExpenseRecognizedForThePeriod', window );">Total interest expense recognized for the period</a></td>
        <td class="nump">$ 3,386<span></span></td>
        <td class="nump">$ 1,970<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InterestRateOnAdvancesFromMemberOfBOD', window );">Interest rate on advances from Member of BOD</a></td>
        <td class="nump">1.00%<span></span></td>
        <td class="nump">1.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InterestRateOnAdvancesFromMemberOfBOD">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Interest rate on advances from Member of BOD</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_InterestRateOnAdvancesFromMemberOfBOD</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalInterestExpenseRecognizedForThePeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total interest expense recognized for the period</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_TotalInterestExpenseRecognizedForThePeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INVENTORY(Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InventoryTablesAbstract', window );"><strong>INVENTORY (Tables)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory consists</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Inventory consisted of the following:&nbsp;</p> <p> </p><table width="483" style="MARGIN:auto auto auto -0.75pt; WIDTH:362.4pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>&nbsp;March 31, </b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>&nbsp;December 31, </b></p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Raw materials</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 28,380,903</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30,198,816 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Finished goods</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,659,052 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7,930,684 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 35,039,955</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38,129,500 </p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Obsolescence reserve</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1,779,729)</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1,769,984)</p></td></tr> <tr style="HEIGHT:13.9pt"> <td width="251" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:188pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10.05pt; MARGIN:0in 0in 0pt"><b>Total Inventory</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:80.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33,260,226 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="101" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.9pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 36,359,516 </p></td></tr></table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InventoryTablesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_InventoryTablesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Topic <br><br> -SubTopic <br><br> -Publisher SEC<br><br> -Number 210<br><br> -Article 5<br><br> -Subparagraph a,b,c<br><br> -Name Regulation S-X (SX)<br><br> -Paragraph 6<br><br> -Section 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfInventoryCurrentTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EBG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>BASIS OF PRESENTATION (Details)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited', window );">Percentage of share owned by China Pharma Holdings Inc of Onny Investment Limited</a></td>
        <td class="nump">100.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd', window );">Percentage of share owned by China Pharma Holdings Inc of Helpson Medical &amp; Biotechnology Co., Ltd</a></td>
        <td class="nump">100.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercetageOfAcquiredByOnnyInHelpson', window );">Percetage of acquired by Onny in Helpson</a></td>
        <td class="nump">100.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of share owned by China Pharma Holdings Inc of Helpson Medical &amp;amp; Biotechnology Co., Ltd</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfHelpsonMedicalAmpBiotechnologyCoLtd</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of share owned by China Pharma Holdings Inc of Onny Investment Limited</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfShareOwnedByChinaPharmaHoldingsIncOfOnnyInvestmentLimited</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercetageOfAcquiredByOnnyInHelpson">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percetage of acquired by Onny in Helpson</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercetageOfAcquiredByOnnyInHelpson</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>2010 Stock Option Plan (Details)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Nov. 12, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfCommonShares', window );">Number of common shares</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">4,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfCommonSharesPurchasedByOptions', window );">Number of common shares purchased by options</a></td>
        <td class="nump">75,000<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockOptionsGranted', window );">Stock options granted</a></td>
        <td class="nump">25,000<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfCommonShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NumberOfCommonShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfCommonSharesPurchasedByOptions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of common shares purchased by options</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NumberOfCommonSharesPurchasedByOptions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockOptionsGranted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock options granted</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StockOptionsGranted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EBQAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income for the period</a></td>
        <td class="num">$ (2,812,307)<span></span></td>
        <td class="nump">$ 2,806,359<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">350,468<span></span></td>
        <td class="nump">365,223<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockBasedCompensation', window );">Stock based compensation.</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">56,489<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense.</a></td>
        <td class="num">(119,930)<span></span></td>
        <td class="nump">320,098<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
        <td class="nump">31,761<span></span></td>
        <td class="num">(34,312)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InventoryObsolescenceReserve', window );">Inventory obsolescence reserve</a></td>
        <td class="nump">3,692,895<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade accounts receivables.</a></td>
        <td class="nump">589,186<span></span></td>
        <td class="num">(4,141,146)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables.</a></td>
        <td class="num">(173,763)<span></span></td>
        <td class="num">(20,247)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ChangesInAdvancesToSuppliers', window );">Changes in Advances to suppliers.</a></td>
        <td class="num">(276,405)<span></span></td>
        <td class="nump">944,949<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory.</a></td>
        <td class="nump">1,890,843<span></span></td>
        <td class="num">(3,351,458)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Trade accounts payables.</a></td>
        <td class="nump">122,430<span></span></td>
        <td class="nump">2,725,945<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses.</a></td>
        <td class="num">(32,516)<span></span></td>
        <td class="nump">11,517<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Accrued taxes payables.</a></td>
        <td class="num">(1,922,780)<span></span></td>
        <td class="nump">443,684<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable', window );">Other payables.</a></td>
        <td class="num">(11,715)<span></span></td>
        <td class="nump">54,337<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCustomerAdvances', window );">Advances from customers.</a></td>
        <td class="num">(220,418)<span></span></td>
        <td class="nump">219,942<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by Operating Activities</a></td>
        <td class="nump">1,107,749<span></span></td>
        <td class="nump">401,380<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NetInvestmentInBankerSAcceptances', window );">Net investment in banker's acceptances</a></td>
        <td class="nump">0<span></span></td>
        <td class="num">(281,674)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets', window );">Advances for purchases of property and equipment and intangible assets</a></td>
        <td class="num">(399,992)<span></span></td>
        <td class="num">(790,092)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
        <td class="num">(4,373)<span></span></td>
        <td class="num">(7,926)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used in Investing Activities</a></td>
        <td class="num">(404,365)<span></span></td>
        <td class="num">(1,079,692)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by Financing Activity</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of Exchange Rate Changes on Cash</a></td>
        <td class="nump">17,376<span></span></td>
        <td class="num">(52,736)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net Increase in Cash and Cash Equivalents</a></td>
        <td class="nump">720,760<span></span></td>
        <td class="num">(731,048)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents at Beginning of Period</a></td>
        <td class="nump">4,029,708<span></span></td>
        <td class="nump">4,050,854<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents at End of Period</a></td>
        <td class="nump">4,750,468<span></span></td>
        <td class="nump">3,319,806<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid for interest</a></td>
        <td class="nump">111,346<span></span></td>
        <td class="nump">75,567<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
        <td class="nump">1,593,510<span></span></td>
        <td class="nump">274,587<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental Noncash Investing and Financing Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccountsPayableForPurchasesOfPropertyAndEquipment', window );">Accounts payable for purchases of property and equipment</a></td>
        <td class="nump">151,064<span></span></td>
        <td class="nump">144,057<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccountsReceivableCollectedWithBankerSAcceptances', window );">Accounts receivable collected with banker's acceptances</a></td>
        <td class="nump">3,366,655<span></span></td>
        <td class="nump">406,604<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InventoryPurchasedWithBankerSAcceptances', window );">Inventory purchased with banker's acceptances</a></td>
        <td class="nump">$ 2,289,690<span></span></td>
        <td class="nump">$ 406,604<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccountsPayableForPurchasesOfPropertyAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accounts receivable collected with banker's acceptances</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AccountsPayableForPurchasesOfPropertyAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccountsReceivableCollectedWithBankerSAcceptances">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accounts receivable collected with banker's acceptances</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AccountsReceivableCollectedWithBankerSAcceptances</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Advances paid  for purchases of property and equipment and intangible assets</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AdvancesForPurchasesOfPropertyAndEquipmentAndIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ChangesInAdvancesToSuppliers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Changes in Advances to suppliers.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ChangesInAdvancesToSuppliers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InventoryObsolescenceReserve">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Inventory obsolescence reserve</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_InventoryObsolescenceReserve</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InventoryPurchasedWithBankerSAcceptances">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Inventory purchased with banker's acceptances</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_InventoryPurchasedWithBankerSAcceptances</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NetInvestmentInBankerSAcceptances">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for the net investment in bankers acceptances.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NetInvestmentInBankerSAcceptances</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StockBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7<br><br> -Footnote 1<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 8, 9<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7, 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in cash and cash equivalents. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510177<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 6<br><br> -Section I<br><br> -Subsection 7<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 45<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 289<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I.7)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6889476&amp;loc=d3e330036-122817<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredIncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The effect of exchange rate changes on cash balances held in foreign currencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 25<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 29<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 27<br><br> -Subparagraph f<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxesPaidNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableTrade</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccruedTaxesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCustomerAdvances">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amount of prepayments by customers for goods or services to be provided at a later date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInCustomerAdvances</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInInventories</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other obligations due by the reporting entity that are payable within one year (or one business cycle), not otherwise defined in the taxonomy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherAccountsPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other amounts due to the reporting entity, which are not otherwise defined in the taxonomy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherReceivables</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid for interest during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 29<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from financing activity for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from investing activity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e565-108580<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 19<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3213-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 17<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the current period expense charged against operations, the offset which is generally to the allowance for doubtful accounts for the purpose of reducing receivables, including notes receivable, to an amount that approximates their net realizable value (the amount expected to be collected).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.5)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProvisionForDoubtfulAccounts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SupplementalCashFlowInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INTANGIBLE ASSETS<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>INTANGIBLE ASSETS</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS</a></td>
        <td class="text"><!--egx--><p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><b>NOTE 5 - INTANGIBLE ASSETS</b></p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Intangible assets represent the cost of medical formulas approved for production by the CFDA in China. During the three months ended March 31, 2013 or 2012, the Company did not obtain CFDA production approval for any medical formula and therefore there were no costs reclassified from advances to medical formulas.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Approved medical formulas are amortized from the date CFDA approval is obtained over their individually identifiable estimated useful life, which are from ten to thirteen years.&nbsp;&nbsp;It is at least reasonably possible that a change in the estimated useful lives of the medical formulas could occur in the near term due to changes in the demand for the drugs and medicines produced from these medical formulas. Amortization expense relating to intangible assets was $136,062 and $152,799 for the three months ended March 31, 2013 and 2012, respectively. Medical formulas typically do not have a residual value at the end of their amortization period.</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The Company evaluates each approved medical formula for impairment at the date of CFDA approval, when indications of impairment are present and at the date of each financial statement. The Company&#146;s evaluation is based on an estimated undiscounted net cash flow model, considering currently available market data for the related drug and the Company&#146;s estimated market share. If the carrying value of the medical formula exceeds the estimated future net cash flows, an impairment loss is recognized for the excess of the carrying value over the discounted estimated future net cash flows. As a result of the evaluation, the Company has determined that each medical formula continues to provide benefits to the Company and no impairment was recognized during the three months ended March 31, 2013 or 2012.</p> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; tab-stops:500.1pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">At March 31, 2013 and December 31, 2012, intangible assets consisted solely of CFDA approved medical formulas as follows:</p> <table width="393" style="MARGIN:auto auto auto -0.75pt; WIDTH:294.9pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:12.75pt"> <td width="187" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>March 31,</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>December 31,</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="187" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="187" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Gross carrying amount</p></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,387,075 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,357,580 </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="187" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Accumulated amortization</p></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3,097,224)</p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2,944,726)</p></td></tr> <tr style="HEIGHT:13.5pt"> <td width="187" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:140pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Net carrying amount</p></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:12pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,289,851 </p></td> <td width="12" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:9pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:65.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,412,854 </p></td></tr></table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all or part of the information related to intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16373-109275<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 142<br><br> -Paragraph 44, 45, 46<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16265-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EXKAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>BASIS OF PRESENTATION Basic and Diluted Earnings per Common Share (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NetIncome', window );">Net income</a></td>
        <td class="num">$ (2,812,307)<span></span></td>
        <td class="nump">$ 2,806,359<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Basic weighted-average common shares outstanding</a></td>
        <td class="nump">43,579,557<span></span></td>
        <td class="nump">43,529,557<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_Warrants', window );">Warrants</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_Options', window );">Options</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average common shares outstanding</a></td>
        <td class="nump">43,579,557<span></span></td>
        <td class="nump">43,529,557<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_BasicEarningsPerShare', window );">Basic earnings per share</a></td>
        <td class="num">$ (0.06)<span></span></td>
        <td class="nump">$ 0.06<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DilutedEarningsPerShare', window );">Diluted earnings per share</a></td>
        <td class="num">$ (0.06)<span></span></td>
        <td class="nump">$ 0.06<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_BasicEarningsPerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_BasicEarningsPerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DilutedEarningsPerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DilutedEarningsPerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NetIncome">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NetIncome</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_Options">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_Options</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_Warrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_Warrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1505-109256<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 07-4<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 40<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e2646-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 40<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1448-109256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesIssuedBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.4.0.6</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>9</ContextCount>
  <ElementCount>206</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>000030 - Statement - CONSOLIDATED BALANCE SHEETS PARENTHETICALS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_CONSOLIDATEDBALANCESHEETSPARENTHETICALS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS PARENTHETICALS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>000040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>000060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>000070 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureBASISOFPRESENTATION</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>000080 - Disclosure - PRODUCT RECALL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePRODUCTRECALL</Role>
      <ShortName>PRODUCT RECALL</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>000090 - Disclosure - INVENTORY.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINVENTORY</Role>
      <ShortName>INVENTORY.</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>000100 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePROPERTYANDEQUIPMENT</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>000110 - Disclosure - INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINTANGIBLEASSETS</Role>
      <ShortName>INTANGIBLE ASSETS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>000120 - Disclosure - ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureADVANCESFORPURCHASESOFINTANGIBLEASSETS</Role>
      <ShortName>ADVANCES FOR PURCHASES OF INTANGIBLE ASSETS.</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>000130 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureRELATEDPARTYTRANSACTIONS</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>000140 - Disclosure - NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureNOTESPAYABLE</Role>
      <ShortName>NOTES PAYABLE</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>000150 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>000160 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureFAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>000170 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureSTOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>000180 - Disclosure - CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureCONTINGENCIES</Role>
      <ShortName>CONTINGENCIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>000190 - Disclosure - CONCENTRATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureCONCENTRATIONS</Role>
      <ShortName>CONCENTRATIONS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>000200 - Disclosure - Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureAccountingPoliciesPolicies</Role>
      <ShortName>Accounting Policies (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>000210 - Disclosure - BASIS OF PRESENTATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureBASISOFPRESENTATIONTables</Role>
      <ShortName>BASIS OF PRESENTATION (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>000220 - Disclosure - INVENTORY(Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINVENTORYTables</Role>
      <ShortName>INVENTORY(Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>000230 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosurePROPERTYANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>000240 - Disclosure - INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINTANGIBLEASSETSTables</Role>
      <ShortName>INTANGIBLE ASSETS (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>000250 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureINCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>000260 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_DisclosureFAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>000270 - Statement - BASIS OF PRESENTATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONDetails</Role>
      <ShortName>BASIS OF PRESENTATION (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>000280 - Statement - BASIS OF PRESENTATION Basic and Diluted Earnings per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONBasicAndDilutedEarningsPerCommonShareDetails</Role>
      <ShortName>BASIS OF PRESENTATION Basic and Diluted Earnings per Common Share (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>000290 - Statement - BASIS OF PRESENTATION POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_BASISOFPRESENTATIONPOLICIESDetails</Role>
      <ShortName>BASIS OF PRESENTATION POLICIES (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>000300 - Statement - INVENTORY. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_INVENTORYDetails</Role>
      <ShortName>INVENTORY. (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>000310 - Statement - PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_PROPERTYANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>000320 - Statement - PROPERTY AND EQUIPMENT Assets Life (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_PROPERTYANDEQUIPMENTAssetsLifeDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT Assets Life (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>000330 - Statement - ASSETS Depreciation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_ASSETSDepreciationDetails</Role>
      <ShortName>ASSETS Depreciation (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>000340 - Statement - INTANGIBLE ASSETS SFDA Approved Medical Formulas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_INTANGIBLEASSETSSFDAApprovedMedicalFormulasDetails</Role>
      <ShortName>INTANGIBLE ASSETS SFDA Approved Medical Formulas (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>000350 - Statement - RELATED PARTY TRANSACTIONS Member Of BOD (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_RELATEDPARTYTRANSACTIONSMemberOfBODDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS Member Of BOD (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>000360 - Statement - RELATED PARTY TRANSACTIONS Owings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_RELATEDPARTYTRANSACTIONSOwingsDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS Owings (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>000370 - Statement - NOTES PAYABLES. (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_NOTESPAYABLESDetails</Role>
      <ShortName>NOTES PAYABLES. (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>000380 - Statement - INCOME TAXES Undistributed Earnings And Income Tax Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_INCOMETAXESUndistributedEarningsAndIncomeTaxRatesDetails</Role>
      <ShortName>INCOME TAXES Undistributed Earnings And Income Tax Rates (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>000390 - Statement - INCOME TAXES Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_INCOMETAXESProvisionDetails</Role>
      <ShortName>INCOME TAXES Provision (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>000400 - Statement - FAIR VALUE MEASUREMENTS At Reporting Date Using (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_FAIRVALUEMEASUREMENTSAtReportingDateUsingDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS At Reporting Date Using (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>000410 - Statement - Preferred Common Stock And Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_PreferredCommonStockAndWarrantsDetails</Role>
      <ShortName>Preferred Common Stock And Warrants (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>000420 - Statement - 2010 Stock Option Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_StockOptionPlanDetails</Role>
      <ShortName>2010 Stock Option Plan (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>000490 - Statement - CONCENTRATIONS Sales And Purchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_CONCENTRATIONSSalesAndPurchasesDetails</Role>
      <ShortName>CONCENTRATIONS Sales And Purchases (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>000510 - Statement - CONCENTRATIONS Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chinapharmaholdings.com/20130331/role/idr_CONCENTRATIONSAccountsReceivableDetails</Role>
      <ShortName>CONCENTRATIONS Accounts Receivable (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Process Flow-Through: 000020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</Log>
    <Log type="Info">Process Flow-Through: 000030 - Statement - CONSOLIDATED BALANCE SHEETS PARENTHETICALS</Log>
    <Log type="Info">Process Flow-Through: 000040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)</Log>
    <Log type="Info">Process Flow-Through: 000060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</Log>
    <Log type="Info">Process Flow-Through: 000270 - Statement - BASIS OF PRESENTATION (Details)</Log>
    <Log type="Info">Process Flow-Through: 000280 - Statement - BASIS OF PRESENTATION Basic and Diluted Earnings per Common Share (Details)</Log>
    <Log type="Info">Process Flow-Through: 000290 - Statement - BASIS OF PRESENTATION POLICIES (Details)</Log>
    <Log type="Info">Process Flow-Through: 000300 - Statement - INVENTORY. (Details)</Log>
    <Log type="Info">Process Flow-Through: 000310 - Statement - PROPERTY AND EQUIPMENT (Details)</Log>
    <Log type="Info">Process Flow-Through: 000320 - Statement - PROPERTY AND EQUIPMENT Assets Life (Details)</Log>
    <Log type="Info">Process Flow-Through: 000330 - Statement - ASSETS Depreciation (Details)</Log>
    <Log type="Info">Process Flow-Through: 000340 - Statement - INTANGIBLE ASSETS SFDA Approved Medical Formulas (Details)</Log>
    <Log type="Info">Process Flow-Through: 000350 - Statement - RELATED PARTY TRANSACTIONS Member Of BOD (Details)</Log>
    <Log type="Info">Process Flow-Through: 000360 - Statement - RELATED PARTY TRANSACTIONS Owings (Details)</Log>
    <Log type="Info">Process Flow-Through: 000370 - Statement - NOTES PAYABLES. (Details)</Log>
    <Log type="Info">Process Flow-Through: 000380 - Statement - INCOME TAXES Undistributed Earnings And Income Tax Rates (Details)</Log>
    <Log type="Info">Process Flow-Through: 000390 - Statement - INCOME TAXES Provision (Details)</Log>
    <Log type="Info">Process Flow-Through: 000400 - Statement - FAIR VALUE MEASUREMENTS At Reporting Date Using (Details)</Log>
    <Log type="Info">Process Flow-Through: 000410 - Statement - Preferred Common Stock And Warrants (Details)</Log>
    <Log type="Info">Process Flow-Through: 000420 - Statement - 2010 Stock Option Plan (Details)</Log>
    <Log type="Info">Process Flow-Through: 000490 - Statement - CONCENTRATIONS Sales And Purchases (Details)</Log>
    <Log type="Info">Process Flow-Through: 000510 - Statement - CONCENTRATIONS Accounts Receivable (Details)</Log>
  </Logs>
  <InputFiles>
    <File>cphi-20130331.xml</File>
    <File>cphi-20130331.xsd</File>
    <File>cphi-20130331_cal.xml</File>
    <File>cphi-20130331_def.xml</File>
    <File>cphi-20130331_lab.xml</File>
    <File>cphi-20130331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EHBAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INCOME TAXES Provision (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax provision.</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 564,893<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred tax provision.</a></td>
        <td class="num">(269,011)<span></span></td>
        <td class="num">(34,312)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalIncomeTaxExpense', window );">Total income tax expense</a></td>
        <td class="num">$ (269,011)<span></span></td>
        <td class="nump">$ 530,581<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalIncomeTaxExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_TotalIncomeTaxExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The component of income tax expense for the period representing amounts of income taxes paid or payable (or refundable) for the period for all income tax obligations as determined by applying the provisions of relevant enacted tax laws to relevant amounts of taxable Income or Loss from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 289<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 45<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 6<br><br> -Section I<br><br> -Subsection 7<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I.7)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6889476&amp;loc=d3e330036-122817<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CurrentIncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The component of total income tax expense for the period comprised of the increase (decrease) during the period in the entity's domestic deferred tax assets and liabilities attributable to continuing operations as determined by applying the provisions of the federally enacted tax law.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 6<br><br> -Section I<br><br> -Subsection 7<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 45<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 8, 16, 17, 289<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510177<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I.7)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6889476&amp;loc=d3e330036-122817<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredFederalIncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EZF">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>BASIS OF PRESENTATION (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_BasisOfPresentationTablesAbstract', window );"><strong>BASIS OF PRESENTATION (Tables)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Presentation of the numerators and denominators used in the calculation of basic and diluted earnings per share</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The following table is a presentation of the numerators and denominators used in the calculation of basic and diluted earnings per share:</p> <p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&nbsp;</p> <table width="520" style="MARGIN:auto auto auto -0.75pt; WIDTH:390pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="179" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>For the Three Months</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="179" colspan="3" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Ended March 31,</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Net (loss) income</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; (2,812,307)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,806,359 </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Basic weighted-average common shares outstanding</p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">43,579,557 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">43,529,557 </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Effect of dilutive securities:</p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="85" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt">Warrants</p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="85" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt">Options</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td></tr> <tr style="HEIGHT:19.5pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Diluted weighted-average common shares outstanding</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">43,579,557 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:19.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="right">43,529,557 </p></td></tr> <tr style="HEIGHT:0.25in"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Basic (loss) earnings per share</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.06)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.06 </p></td></tr> <tr style="HEIGHT:0.25in"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Diluted (loss) earnings per share</p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.06)</p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.8pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="85" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:64pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.06 </p></td></tr></table><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock', window );">Potential common shares were not included in the computation of diluted earnings per share</a></td>
        <td class="text"><!--egx--><p style="TEXT-ALIGN:justify; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">The following potential common shares were not included in the computation of diluted earnings per share as their effect would have been anti-dilutive:&nbsp;</p> <table width="520" style="MARGIN:auto auto auto -0.75pt; WIDTH:390pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="179" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>For the Three Months</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="179" colspan="3" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:134pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>Ended March 31,</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2013</b></p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; LINE-HEIGHT:normal; MARGIN:0in 0in 0pt" align="center"><b>2012</b></p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Warrants with exercise prices of $3.00 to $3.80 per share</p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150,000 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150,000 </p></td></tr> <tr style="HEIGHT:12.75pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">Options with an exercise price of $2.54 to $3.47 per share</p></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25,000 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 310,000 </p></td></tr> <tr style="HEIGHT:13.5pt"> <td width="341" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:256pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; TEXT-INDENT:10pt; MARGIN:0in 0in 0pt">Total</p></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 175,000 </p></td> <td width="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.85pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.05pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="LINE-HEIGHT:normal; MARGIN:0in 0in 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 460,000 </p></td></tr></table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_BasisOfPresentationTablesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_BasisOfPresentationTablesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of common shares not included in earnings per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PotentialCommonSharesWereNotIncludedInTheComputationOfDilutedEarningsPerShareTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of an entity's basic and diluted earnings per share calculations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
